aidx;assay_category;assay_cell_type;assay_chembl_id;assay_classifications;assay_organism;assay_parameters;assay_strain;assay_subcellular_fraction;assay_tax_id;assay_test_type;assay_tissue;assay_type;assay_type_description;bao_format;bao_label;cell_chembl_id;confidence_description;confidence_score;description;document_chembl_id;relationship_description;relationship_type;src_assay_id;src_id;target_chembl_id;tissue_chembl_id;variant_sequence
CLD0;;;CHEMBL619913;[];Rattus norvegicus;[];;;10116.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of rat basophilic leukemia cell 5-lipoxygenase;CHEMBL1153684;Direct protein target assigned;D;;1;CHEMBL312;;
CLD0;;;CHEMBL619243;[];;[];;;;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Tested for its inhibitory activity against 5-lipoxygenase;CHEMBL1149986;Homologous protein target assigned;H;;1;CHEMBL312;;
CLD0;;;CHEMBL618310;[];Homo sapiens;[];;;9606.0;;Plasma;A;ADME;BAO_0000366;cell-free format;;Default value - Target unknown or has yet to be assigned;0;Unbound fraction (plasma);CHEMBL1148291;Default value - Target has yet to be curated;U;;1;CHEMBL612558;CHEMBL3559721;
CLD0;;;CHEMBL624569;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Observed volume of distribution;CHEMBL1148291;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL631962;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Aqueous solubility;CHEMBL1132890;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;;CHEMBL631372;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Partition coefficient (logD7.4);CHEMBL1131302;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;;CHEMBL631377;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Partition coefficient (logD7.4);CHEMBL1134540;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;;CHEMBL631379;[];;[];;;;;;A;ADME;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;HPLC capacity factor (k);CHEMBL1133461;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL630098;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Partition coefficient (logP);CHEMBL1136781;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;;CHEMBL628746;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Human absorption A (%);CHEMBL1131302;Non-molecular target assigned;N;;1;CHEMBL372;;
CLD0;;;CHEMBL633649;[];;[];;;;;;A;ADME;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Delta logD (logD6.5 - logD7.4);CHEMBL1133765;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL635199;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Partition coefficient (logP);CHEMBL1121439;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;;CHEMBL636364;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Partition coefficient (logP);CHEMBL1122933;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;;CHEMBL636369;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;"Partition coefficient is determined in octanol/buffer solution; NT=Not tested";CHEMBL1135145;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;;CHEMBL634283;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Partition coefficient (logD6.5);CHEMBL1133765;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;;CHEMBL635170;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Dissociation constant (pKa);CHEMBL1148291;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;;CHEMBL635931;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Partition coefficient (logP);CHEMBL1133461;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;;CHEMBL639853;[];;[];;;;;;A;ADME;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Fraction ionized (pH 7.4);CHEMBL1135488;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL639855;[];;[];;;;;Plasma;A;ADME;BAO_0000366;cell-free format;;Default value - Target unknown or has yet to be assigned;0;Unbound fraction (plasma);CHEMBL1135488;Default value - Target has yet to be curated;U;;1;CHEMBL612558;CHEMBL3559721;
CLD0;;;CHEMBL638828;[];;[];;;;;;A;ADME;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Unbound fraction (tissues);CHEMBL1135488;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL874960;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Ionization constant (pKa);CHEMBL1133765;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;;CHEMBL637833;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Partition coefficient (logP) (HPLC);CHEMBL1133461;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;;CHEMBL637835;[];;[];;;;;;A;ADME;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;HPLC capacity factor (k');CHEMBL1135488;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL633098;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Oral bioavailability in human;CHEMBL1133765;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL632931;[];;[];;;;In vivo;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Volume of distribution in man (IV dose);CHEMBL1135488;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;HeLa;CHEMBL656036;[];;[];;;;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308376;Homologous single protein target assigned;8;Relative transcriptional activation in HeLa cells expressing glucocorticoid receptor;CHEMBL1135667;Homologous protein target assigned;H;;1;CHEMBL2034;;
CLD0;;;CHEMBL648332;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;"Binding affinity for human Androgen receptor; ND = Not determined";CHEMBL1129561;Direct protein target assigned;D;;1;CHEMBL1871;;
CLD0;;;CHEMBL652299;[];;[];;;;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Relative binding affinity for androgen receptor of prostate of rat at 2 hr;CHEMBL1124129;Homologous protein target assigned;H;;1;CHEMBL3072;;
CLD0;;;CHEMBL666775;[];Mus musculus;[];;;10090.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of mouse constitutive androstane receptor (mCAR) activity at 10 uM was determined as percent remaining activity;CHEMBL1145136;Direct protein target assigned;D;;1;CHEMBL3069;;
CLD0;;;CHEMBL664809;[];;[];;;;;;A;ADME;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Inhibition of human cytochrome P450 3A4;CHEMBL1136781;Homologous protein target assigned;H;;1;CHEMBL340;;
CLD0;;;CHEMBL679680;[];;[];;;;;;B;Binding;BAO_0000224;protein format;;Multiple homologous protein targets may be assigned;4;"Binding affinity determined for human estrogen receptor; ND = Not determined";CHEMBL1129561;Homologous protein target assigned;H;;1;CHEMBL2093866;;
CLD0;;;CHEMBL681744;[];;[];;;;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Binding affinity was determined for human glucocorticoid receptor(hGR).;CHEMBL1129561;Homologous protein target assigned;H;;1;CHEMBL2034;;
CLD0;;;CHEMBL685134;[];Oryctolagus cuniculus;[];;;9986.0;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Displacement of [3H]dexamethasone from Glucocorticoid receptor of rabbit kidney;CHEMBL1126937;Homologous protein target assigned;H;;1;CHEMBL2034;;
CLD0;;;CHEMBL685136;[];Rattus norvegicus;[];;Cytosol;10116.0;;Liver;B;Binding;BAO_0000019;assay format;;Direct single protein target assigned;9;Relative binding affinity against glucocorticoid receptor in rat liver cytosol extract;CHEMBL1127640;Direct protein target assigned;D;;1;CHEMBL3368;CHEMBL3559723;
CLD0;;;CHEMBL686331;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Homologous single protein target assigned;8;Relative binding affinity to glucocorticoid receptor on cytosol from hepatoma tissue cells at 24 hr;CHEMBL1124129;Homologous protein target assigned;H;;1;CHEMBL3368;;
CLD0;;;CHEMBL686332;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Homologous single protein target assigned;8;Relative binding affinity to glucocorticoid receptor on cytosol from hepatoma tissue cells at 4 hr;CHEMBL1124129;Homologous protein target assigned;H;;1;CHEMBL3368;;
CLD0;;;CHEMBL686333;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Homologous single protein target assigned;8;Relative binding affinity to glucocorticoid receptor on cytosol from liver at 24 hr;CHEMBL1124129;Homologous protein target assigned;H;;1;CHEMBL3368;;
CLD0;;;CHEMBL686334;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Homologous single protein target assigned;8;Relative binding affinity to glucocorticoid receptor on cytosol from liver at 4 hr;CHEMBL1124129;Homologous protein target assigned;H;;1;CHEMBL3368;;
CLD0;;;CHEMBL878587;[];;[];;;;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Relative binding affinity to glucocorticoid receptor on cytosol from thymus at 24 hr;CHEMBL1124129;Homologous protein target assigned;H;;1;CHEMBL3368;;
CLD0;;;CHEMBL686335;[];;[];;;;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Relative binding affinity to glucocorticoid receptor on cytosol from thymus at 4 hr;CHEMBL1124129;Homologous protein target assigned;H;;1;CHEMBL3368;;
CLD0;;;CHEMBL685815;[];;[];;;;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Relative binding affinity against glucocorticoid receptor.;CHEMBL1126871;Homologous protein target assigned;H;;1;CHEMBL3368;;
CLD0;;;CHEMBL683300;[];Cavia porcellus;[];;;10141.0;;Cardiac atrium;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Binding to guinea pig atrial homogenate;CHEMBL1121439;Non-molecular target assigned;N;;1;CHEMBL369;CHEMBL3638237;
CLD0;;;CHEMBL694758;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Potency relative to fluocinolone 16,17-acetonide in the human vasoconstictor test;CHEMBL1122453;Non-molecular target assigned;N;;1;CHEMBL372;;
CLD0;;;CHEMBL700109;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity measured by using McKenzie-Stoughton human vasoconstrictor assay;CHEMBL1123496;Non-molecular target assigned;N;;1;CHEMBL372;;
CLD0;;;CHEMBL702884;[];;[];;;;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Ability to bind to human serum albumin (HSA);CHEMBL1121439;Homologous protein target assigned;H;;1;CHEMBL3253;;
CLD0;;J774;CHEMBL872273;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307540;Target assigned is non-molecular;1;Inhibitory activity against nitric oxide production in lipopolysaccharide (LPS)-activated macrophage -like J774.1 cell;CHEMBL1136417;Non-molecular target assigned;N;;1;CHEMBL614123;;
CLD0;;;CHEMBL709839;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.5', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.5'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Compound was administered orally to mice before increase in foot-pad thickness at a dose of 2.5 mg/kg;CHEMBL1123901;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL722047;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.5', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.5'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percent reduction in mice after oral administration 2.5 mg/kg;CHEMBL1123901;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL725632;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Compound was evaluated for IL 4 production inhibition from mice splenocytes stimulated by anti-CD3 mAb;CHEMBL1132585;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL879834;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Compound was evaluated for IL 5 production inhibitio from mice splenocytes stimulated by anti-CD3 mAb;CHEMBL1132585;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL729178;[];Oryctolagus cuniculus;[];;;9986.0;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Displacement of [3H]aldosterone from mineralocorticoid receptor of rabbit kidney;CHEMBL1126937;Homologous protein target assigned;H;;1;CHEMBL1994;;
CLD0;;;CHEMBL728550;[];;[];;;;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Relative binding affinity for mineralocorticoid receptor of rat kidney at 24 hr;CHEMBL1124129;Homologous protein target assigned;H;;1;CHEMBL3507;;
CLD0;;;CHEMBL735499;[{'assay_class_id': 295, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Croton Oil Ear Edema', 'source': 'Vogel_2008'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Tested for its antiinflammatory activity in the A-23187 (calcium ionophore) ear edema model.;CHEMBL1149986;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL735501;[{'assay_class_id': 295, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Croton Oil Ear Edema', 'source': 'Vogel_2008'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Tested for its antiinflammatory activity in the arachidonic acid(AA) induced ear edema model;CHEMBL1149986;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL736952;[{'assay_class_id': 295, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Croton Oil Ear Edema', 'source': 'Vogel_2008'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Tested for its antiinflammatory activity in the contact sensitive (CS) ear edema model;CHEMBL1149986;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL736955;[{'assay_class_id': 295, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Croton Oil Ear Edema', 'source': 'Vogel_2008'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Tested for its antiinflammatory activity in the tetradecanoyl phorbol acetate induced ear edema model (TPA Ear); ND: not determined";CHEMBL1149986;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL737716;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Ability to inhibit the accumulation of PGE-2 in stimulated murine peritoneal macrophages;CHEMBL1132472;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL737717;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Ability to inhibit the generation of NO by stimulated murine peritoneal macrophages;CHEMBL1132472;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL741596;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Inhibitory activity against production of nitric oxide induced by interferon-gamma in mouse macrophages;CHEMBL1131907;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL738538;[{'assay_class_id': 231, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'DERMATOLOGICALS', 'l2': 'Experimental Dermatitis', 'l3': 'General Dermatitis Models', 'source': 'phenotype'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vivo antiinflammatory activity of 0.04 uM concentration of compound was determined by inhibition of oxazolone-induced allergic contact dermatitis (ACD) in mouse up on tropical application;CHEMBL1146773;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL738541;[{'assay_class_id': 231, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'DERMATOLOGICALS', 'l2': 'Experimental Dermatitis', 'l3': 'General Dermatitis Models', 'source': 'phenotype'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vivo antiinflammatory activity of 0.4 uM concentration of compound was determined by inhibition of oxazolone-induced allergic contact dermatitis (ACD) in mouse up on tropical application;CHEMBL1146773;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL738544;[{'assay_class_id': 231, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'DERMATOLOGICALS', 'l2': 'Experimental Dermatitis', 'l3': 'General Dermatitis Models', 'source': 'phenotype'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vivo antiinflammatory activity of 40 uM concentration of compound was determined by inhibition of oxazolone-induced allergic contact dermatitis (ACD) in mouse up on tropical application;CHEMBL1146773;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL738546;[{'assay_class_id': 231, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'DERMATOLOGICALS', 'l2': 'Experimental Dermatitis', 'l3': 'General Dermatitis Models', 'source': 'phenotype'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vivo antiinflammatory activity of compound was determined by inhibition of oxazolone-induced allergic contact dermatitis (ACD) in mouse up on tropical application;CHEMBL1146773;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL745411;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Inhibitory activity against production of nitric oxide induced by interferon gamma in mouse macrophages;CHEMBL1135965;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;N9;CHEMBL752372;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307264;Target assigned is non-molecular;1;Inhibitory activity against TNF-alpha release in N9 cells in the supernatant;CHEMBL1135625;Non-molecular target assigned;N;;1;CHEMBL613516;;
CLD0;;;CHEMBL755826;[];;[];;;;;;F;Functional;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;Inhibition of P-glycoprotein using ATPase in MDR1 membranes;CHEMBL1136781;Homologous protein target assigned;H;;1;CHEMBL4302;;
CLD0;;LLC-PK1;CHEMBL755827;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307655;Homologous single protein target assigned;8;Inhibition of P-glycoprotein, human L-MDR1 expressed in LLC-PK1 epithelial cells using calcein-AM polarisation assay;CHEMBL1136781;Homologous protein target assigned;H;;1;CHEMBL4302;;
CLD0;;LLC-PK1;CHEMBL755828;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307655;Homologous single protein target assigned;8;Inhibition of P-glycoprotein, mouse L-mdr1a expressed in LLC-PK1 epithelial cells using calcein-AM polarisation assay;CHEMBL1136781;Homologous protein target assigned;H;;1;CHEMBL2573;;
CLD0;;LLC-PK1;CHEMBL754159;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307655;Homologous single protein target assigned;8;Inhibition of P-glycoprotein, mouse L-mdr1b expressed in LLC-PK1 epithelial cells using calcein-AM polarisation assay;CHEMBL1136781;Homologous protein target assigned;H;;1;CHEMBL3467;;
CLD0;;;CHEMBL754160;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;Inhibition of P-glycoprotein using calcein-AM assay transfected in porcine PBCEC;CHEMBL1136781;Homologous protein target assigned;H;;1;CHEMBL4302;;
CLD0;;Caco-2;CHEMBL754161;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307519;Homologous single protein target assigned;8;Inhibition of P-gp was determined using rhodamine-assay in human CaCo-2 cells;CHEMBL1136781;Homologous protein target assigned;H;;1;CHEMBL4302;;
CLD0;;Epithelial cell;CHEMBL754162;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307627;Homologous single protein target assigned;8;P-gp activity was measured by a direct transport assay, using polarized LLC-MDR1 epithelial cells;CHEMBL1136781;Homologous protein target assigned;H;;1;CHEMBL2573;;
CLD0;;LLC-PK1;CHEMBL754163;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307655;Homologous single protein target assigned;8;P-gp activity was measured by a direct transport assay, using polarized LLC-PK1 epithelial cells;CHEMBL1136781;Homologous protein target assigned;H;;1;CHEMBL2573;;
CLD0;;Epithelial cell;CHEMBL754164;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307627;Homologous single protein target assigned;8;P-gp activity was measured by a direct transport assay, using polarized LLC-mdr1a epithelial cells;CHEMBL1136781;Homologous protein target assigned;H;;1;CHEMBL2573;;
CLD0;;;CHEMBL756458;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibitory concentration against TNF-alpha production from human peripheral blood mononuclear cells stimulated by LPS;CHEMBL1134198;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL756459;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibitory concentration against growth of LPS stimulated human peripheral blood mononuclear cells;CHEMBL1134198;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL759981;[];Mus musculus;[];;;10090.0;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Tested for its inhibitory activity against Phospholipase A2 (PLA2);CHEMBL1149986;Homologous protein target assigned;H;;1;CHEMBL4715;;
CLD0;;;CHEMBL765138;[];Rattus norvegicus;[];;;10116.0;;;B;Binding;BAO_0000019;assay format;;Direct single protein target assigned;9;Inhibitory activity against polymorphonuclear cell phospholipase-A2 in rat;CHEMBL1153684;Direct protein target assigned;D;;1;CHEMBL5016;;
CLD0;;;CHEMBL758515;[{'assay_class_id': 231, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'DERMATOLOGICALS', 'l2': 'Experimental Dermatitis', 'l3': 'General Dermatitis Models', 'source': 'phenotype'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Sus scrofa;[];;;9823.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vivo antiinflammatory activity of 130 uM concentration of compound was determined by inhibition of oxazolone-induced allergic contact dermatitis (ACD) in pig up on tropical application;CHEMBL1146773;Non-molecular target assigned;N;;1;CHEMBL613488;;
CLD0;;;CHEMBL758517;[{'assay_class_id': 231, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'DERMATOLOGICALS', 'l2': 'Experimental Dermatitis', 'l3': 'General Dermatitis Models', 'source': 'phenotype'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Sus scrofa;[];;;9823.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vivo antiinflammatory activity of 40 uM concentration of compound was determined by inhibition of oxazolone-induced allergic contact dermatitis (ACD) in pig up on tropical application;CHEMBL1146773;Non-molecular target assigned;N;;1;CHEMBL613488;;
CLD0;;;CHEMBL758518;[{'assay_class_id': 231, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'DERMATOLOGICALS', 'l2': 'Experimental Dermatitis', 'l3': 'General Dermatitis Models', 'source': 'phenotype'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Sus scrofa;[];;;9823.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vivo antiinflammatory activity of 400 uM concentration of compound was determined by inhibition of oxazolone-induced allergic contact dermatitis (ACD) in pig up on tropical application;CHEMBL1146773;Non-molecular target assigned;N;;1;CHEMBL613488;;
CLD0;;;CHEMBL766947;[];Bos taurus;[];;;9913.0;;;B;Binding;BAO_0000224;protein format;;Multiple direct protein targets may be assigned;5;"Tested for its inhibitory activity against PGS (prostaglandin synthetase); Not determined";CHEMBL1149986;Direct protein target assigned;D;;1;CHEMBL2096674;;
CLD0;;;CHEMBL766130;[];Ovis aries;[];;;9940.0;;Seminal vesicle;B;Binding;BAO_0000221;tissue-based format;;Multiple direct protein targets may be assigned;5;Inhibition of ovine seminal vesicle prostaglandin synthetase;CHEMBL1153684;Direct protein target assigned;D;;1;CHEMBL2111358;CHEMBL3987572;
CLD0;;;CHEMBL765828;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;"Binding affinity for human Progesterone receptor A isoform; ND = Not determined";CHEMBL1129561;Direct protein target assigned;D;;1;CHEMBL208;;
CLD0;;;CHEMBL763130;[];Oryctolagus cuniculus;[];;;9986.0;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Relative binding affinity for progestin receptor of uterus of rabbit at 24 hr;CHEMBL1124129;Homologous protein target assigned;H;;1;CHEMBL208;;
CLD0;;RAW264.7;CHEMBL770014;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Inhibitory activity against TNF-alpha release in RAW 264.7 cells in the supernatant;CHEMBL1135625;Non-molecular target assigned;N;;1;CHEMBL612557;;
CLD0;;;CHEMBL779950;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 301, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Paw Edema Test', 'source': 'Hock_2016'}];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Compound was tested for its oral antiinflammatory activity in the rat carrageenan paw edema assay (CAR);CHEMBL1153684;Non-molecular target assigned;N;;1;CHEMBL376;;
CLD0;;;CHEMBL785429;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Compound was evaluated in vivo for the inhibition of LPS-stimulated serum TNF-alpha production in rat after oral administration of the compound;CHEMBL1135145;Non-molecular target assigned;N;;1;CHEMBL376;;
CLD0;;;CHEMBL784017;[];Rattus norvegicus;[];;;10116.0;;Blood;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vitro inhibition of lipopolysaccharide stimulated tumor necrosis factor-alpha production in rat whole blood;CHEMBL1135145;Non-molecular target assigned;N;;1;CHEMBL376;CHEMBL3638178;
CLD0;;;CHEMBL784331;[];Rattus norvegicus;[];;;10116.0;;Blood;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Evaluated for its ability to inhibit LPS stimulated production of TNF-alpha in rat whole blood;CHEMBL1135175;Non-molecular target assigned;N;;1;CHEMBL376;CHEMBL3638178;
CLD0;;;CHEMBL790173;[];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.1', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.1'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percent inhibition value on the Sephadex-induced lung eosinophilia model at an intraperitoneal (ip) dose of 0.1 mg/kg;CHEMBL1131605;Non-molecular target assigned;N;;1;CHEMBL376;;
CLD0;;;CHEMBL789493;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 301, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Paw Edema Test', 'source': 'Hock_2016'}];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.3', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.3'}];;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percentage inhibition of Carrageenan-induced rat paw edema at a concentration of 0.3 mg/kg;CHEMBL1122529;Non-molecular target assigned;N;;1;CHEMBL376;;
CLD0;;;CHEMBL790277;[{'assay_class_id': 105, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'General Rheumatoid Arthritis Models', 'source': 'phenotype'}];Rattus norvegicus;[];;;10116.0;;Talus;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Radiographic change was judged in the area of the talus joint, using an arbitrary scoring system upon termination of the test (0.5 mg/kg 1-5 days dosing,0.25 mg/kg 6-15 days dosing)in a model of type II collagen arthritis in the rat.;CHEMBL1125255;Non-molecular target assigned;N;;1;CHEMBL376;CHEMBL3987995;
CLD0;;;CHEMBL785912;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"TNF-alpha inhibiting activity was assessed by In vivo inhibition of serum TNF production in rat at 50 mg/kg, peroral administration; Not tested ( ED50= 0.12 mg/kg, po)";CHEMBL1135175;Non-molecular target assigned;N;;1;CHEMBL376;;
CLD0;;;CHEMBL789030;[];Rattus norvegicus;[];;;10116.0;;Caecum;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Recovery of steroid from cecum at 3h after administration of 7.5 mg of the compound;CHEMBL1122578;Non-molecular target assigned;N;;1;CHEMBL376;CHEMBL3833888;
CLD0;;;CHEMBL882013;[];Rattus norvegicus;[];;;10116.0;;Caecum;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Recovery of steroid from cecum at 4 hr after administration of 7.5 mg of the compound;CHEMBL1122578;Non-molecular target assigned;N;;1;CHEMBL376;CHEMBL3833888;
CLD0;;;CHEMBL789031;[];Rattus norvegicus;[];;;10116.0;;Caecum;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Recovery of steroid from cecum at 5 hr after administration of 7.5 mg of the compound;CHEMBL1122578;Non-molecular target assigned;N;;1;CHEMBL376;CHEMBL3833888;
CLD0;;;CHEMBL789032;[];Rattus norvegicus;[];;;10116.0;;Caecum;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Recovery of steroid from cecum at 6 hr after administration of 7.5 mg of the compound;CHEMBL1122578;Non-molecular target assigned;N;;1;CHEMBL376;CHEMBL3833888;
CLD0;;;CHEMBL789033;[];Rattus norvegicus;[];;;10116.0;;Small intestine;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Recovery of steroid from small intestine at 3h after administration of 7.5 mg of the compound;CHEMBL1122578;Non-molecular target assigned;N;;1;CHEMBL376;CHEMBL3638239;
CLD0;;;CHEMBL789034;[];Rattus norvegicus;[];;;10116.0;;Small intestine;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Recovery of steroid from small intestine at 4 hr after administration of 7.5 mg of the compound;CHEMBL1122578;Non-molecular target assigned;N;;1;CHEMBL376;CHEMBL3638239;
CLD0;;;CHEMBL789035;[];Rattus norvegicus;[];;;10116.0;;Small intestine;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Recovery of steroid from small intestine at 5 hr after administration of 7.5 mg of the compound;CHEMBL1122578;Non-molecular target assigned;N;;1;CHEMBL376;CHEMBL3638239;
CLD0;;;CHEMBL789036;[];Rattus norvegicus;[];;;10116.0;;Small intestine;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Recovery of steroid from small intestine at 6 hr after administration of 7.5 mg of the compound;CHEMBL1122578;Non-molecular target assigned;N;;1;CHEMBL376;CHEMBL3638239;
CLD0;;;CHEMBL790957;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 297, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Granuloma Models', 'source': 'phenotype'}];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Anti-inflammatory effect in rat granuloma assay, activity relative to hydrocortisone and hydrocortisone 21-acetate;CHEMBL1122453;Non-molecular target assigned;N;;1;CHEMBL376;;
CLD0;;;CHEMBL799288;[];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '30.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '30.0'}];;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Tested for sephadex-induced lung Eosinophilia inhibition at 30 mg/kg in rat;CHEMBL1129253;Non-molecular target assigned;N;;1;CHEMBL376;;
CLD0;;;CHEMBL807665;[];Rattus norvegicus;[];;;10116.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Binding affinity to Steroid Hormone Receptor was determined using [2-3H]dexamethasone as radioligand;CHEMBL1121469;Direct protein target assigned;D;;1;CHEMBL3368;;
CLD0;;T-cell;CHEMBL810776;[];Mus musculus;[];;;10090.0;;Spleen;F;Functional;BAO_0000219;cell-based format;CHEMBL3307588;Target assigned is non-molecular;1;Inhibitory concentration against T cell proliferation using concanavalin A stimulated mice spleen cells;CHEMBL1134198;Non-molecular target assigned;N;;1;CHEMBL614309;CHEMBL3559722;
CLD0;;;CHEMBL813557;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;Glucocorticoid induced Tyrosine Aminotransferase activity relative to Dexamethasone;CHEMBL1124129;Homologous protein target assigned;H;;1;CHEMBL3368;;
CLD0;;;CHEMBL811881;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Tested in vivo for inhibition of serum tumor necrosis factor alpha production in rats at 100 ug/kg subcutaneous dose;CHEMBL1146721;Non-molecular target assigned;N;;1;CHEMBL376;;
CLD0;;;CHEMBL822378;[];Rattus norvegicus;[];;;10116.0;;;B;Binding;BAO_0000019;assay format;;Direct single protein target assigned;9;Inhibition of [3H]dexamethasone binding to glucocorticoid receptor of rat liver cytosol;CHEMBL1135667;Direct protein target assigned;D;;1;CHEMBL3368;;
CLD0;;;CHEMBL843076;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Compound was evaluated for inhibitory activity against production of nitric oxide (NO) induced by interferon-gamma (IFN-gamma) in mouse macrophages;CHEMBL1130601;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL843088;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Inhibition of nitric oxide (NO) production induced by interferon-gamma (IFN-gamma) in mouse macrophages;CHEMBL1133509;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL844451;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 302, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Pleurisy Test for Anti-Inflammatory Activity', 'source': 'Hock_2016'}];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Inhibition of monocyte accumulation (DNA content) in a rat pleural exudate model of inflammation at 45 ug administered perorally;CHEMBL1123560;Non-molecular target assigned;N;;1;CHEMBL376;;
CLD0;;;CHEMBL844453;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 302, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Pleurisy Test for Anti-Inflammatory Activity', 'source': 'Hock_2016'}];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Inhibition of monocyte accumulation (exudate volume) in a rat pleural exudate model of inflammation at 45 ug administered perorally;CHEMBL1123560;Non-molecular target assigned;N;;1;CHEMBL376;;
CLD0;;;CHEMBL844273;[];;[];;;;;;A;ADME;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Binding energy by using the equation deltaG obsd = -RT ln KD;CHEMBL1122538;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL829153;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Binding affinity for glucocorticoid receptor;CHEMBL1140311;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL836230;[];Homo sapiens;[];;;9606.0;;Liver;A;ADME;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;log (1/Km) value for human liver microsome cytochrome P450 3A4;CHEMBL1142817;Direct protein target assigned;D;;1;CHEMBL340;CHEMBL3559723;
CLD0;;A549;CHEMBL835784;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Direct single protein target assigned;9;Glucocorticoid receptor mediated transrepression of NFkB reporter gene in human A549 lung epithelial cells;CHEMBL1140311;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;A549;CHEMBL835785;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Direct single protein target assigned;9;Antagonist activity for Glucocorticoid receptor in MMTV transactivation assay in human A549 lung epithelial cells at 10 uM;CHEMBL1140311;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;;CHEMBL826177;[];Mus musculus;[];;;10090.0;;Ear;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;inhibition of acute TPA-induced ear swelling in mice on oral administration of 0.1 nmol/kg;CHEMBL1137105;Non-molecular target assigned;N;;1;CHEMBL375;CHEMBL3987716;
CLD0;;;CHEMBL826534;[];Mus musculus;[];;;10090.0;;Ear;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percent inhibition of acute TPA-induced ear swelling in mice upon topical application at 2x 100 ug;CHEMBL1137105;Non-molecular target assigned;N;;1;CHEMBL375;CHEMBL3987716;
CLD0;;;CHEMBL872182;[];Rattus norvegicus;[];;;10116.0;;;B;Binding;BAO_0000019;assay format;;Direct single protein target assigned;9;Inhibitory concentration against recombinant rat androgen receptor expressed in Escherichia coli using [3H]methyltrienolone (R 1881);CHEMBL1141069;Direct protein target assigned;D;;1;CHEMBL3072;;
CLD0;;;CHEMBL883715;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;Effective agonist concentration for transcriptional repression of IL-6 production in IL-1 stimulated human foreskin fibroblasts;CHEMBL1143464;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;;CHEMBL883058;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;Percent efficacy for transcriptional repression of IL-6 production in IL-1 stimulated human foreskin fibroblasts at 2 uM;CHEMBL1143464;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;;CHEMBL865959;[];;[];;;;;;A;ADME;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;Membrane retention in 70% silicon-30% IPM membrane;CHEMBL1138041;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL865960;[];;[];;;;;;A;ADME;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;Membrane permeability, CA(t)/CD(0) in 70% silicon-30% IPM membrane;CHEMBL1138041;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL865961;[];;[];;;;;;A;ADME;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;Effective permeability coefficient in 70% silicon-30% IPM membrane;CHEMBL1138041;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL865441;[];Homo sapiens;[];;;9606.0;;Zone of skin;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Permeability in human skin;CHEMBL1138041;Non-molecular target assigned;N;;1;CHEMBL372;CHEMBL3638174;
CLD0;;;CHEMBL868676;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Binding affinity to GR relative to Dexamethasone;CHEMBL1138096;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;HeLa;CHEMBL868677;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Direct single protein target assigned;9;Stimulatory activity at HeLa cells by alkaline phosphatase bioassay relative to Dexamethasone;CHEMBL1138096;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;;CHEMBL869701;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of fluorescent-labeled Dexamethasone binding to GR;CHEMBL1138886;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;A549;CHEMBL869702;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Direct single protein target assigned;9;Agonist activity at GR assessed as NF-kappaB-mediated transrepression of secreted placental alkaline phosphatase gene in human A549 cells;CHEMBL1138886;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;A549;CHEMBL869707;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Direct single protein target assigned;9;Agonist activity at GR assessed as NF-kappaB-mediated transrepression of secreted placental alkaline phosphatase gene in human A549 cells relative to Dexamethasone;CHEMBL1138886;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;A549;CHEMBL869709;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Direct single protein target assigned;9;Activity at GR assessed as ability to antagonize dexamethasone-induced MMTV luciferase reporter gene transactivation in human A549 cells;CHEMBL1138886;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;A549;CHEMBL869706;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Direct single protein target assigned;9;Agonist activity at GR assessed as MMTV-mediated transactivation of renilla luciferase gene in human A549 cells relative to Dexamethasone;CHEMBL1138886;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;;CHEMBL869713;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 300, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Oxazolone Induced Ear Edema in Mice', 'source': 'Hock_2016'}];Mus musculus;[];Balb/c;;10090.0;;Ear;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Anti-inflammatory activity against oxazolone-induced ear skin delayed types hypersensitivity model in topically dosed BALB/c mouse;CHEMBL1138886;Non-molecular target assigned;N;;1;CHEMBL375;CHEMBL3987716;
CLD0;;;CHEMBL868526;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Reduction of edema in mouse ear inflammation model at 1 mg/kg, po;CHEMBL1138936;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL869760;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Reduction of swelling in mouse ear at 30 ug;CHEMBL1138936;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL909349;[];;[];;;;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Inhibition of tetramethylrhodamine labeled dexamethasone binding to GR by FP assay;CHEMBL1138857;Homologous protein target assigned;H;;1;CHEMBL2034;;
CLD0;;;CHEMBL909350;[];;[];;;;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Inhibition of tetramethylrhodamine labeled RU486 binding to PR by FP assay;CHEMBL1138857;Homologous protein target assigned;H;;1;CHEMBL208;;
CLD0;;;CHEMBL909351;[];;[];;;;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Inhibition of tetramethylrhodamine labeled dexamethasone binding to MR by FP assay;CHEMBL1138857;Homologous protein target assigned;H;;1;CHEMBL1994;;
CLD0;;HFF;CHEMBL909352;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307525;Target assigned is non-molecular;1;Inhibition of IL1-stimulated IL6 production in HFF cells;CHEMBL1138857;Non-molecular target assigned;N;;1;CHEMBL614071;;
CLD0;;HFF;CHEMBL909354;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307525;Target assigned is non-molecular;1;Induction of aromatase activity in HFF cells assessed as production of beta estradiol by aromatase assay;CHEMBL1138857;Non-molecular target assigned;N;;1;CHEMBL614071;;
CLD0;;HeLa;CHEMBL911055;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Activation of MMTV in HeLa cells measured by luciferase activity;CHEMBL1138857;Non-molecular target assigned;N;;1;CHEMBL399;;
CLD0;;;CHEMBL915866;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mesocricetus auratus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '10.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '10.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intramuscular', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intramuscular', 'type': 'ROUTE', 'units': None, 'value': None}];;;10036.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity against carrageenan-induced paw inflammation in golden Syrian hamster at 10 mg/kg, im;CHEMBL1142999;Non-molecular target assigned;N;;1;CHEMBL612563;;
CLD0;;RAW;CHEMBL915281;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307413;Target assigned is non-molecular;1;Inhibition of interferon gamma-stimulated NO production in RAW 264.7 cells after 24 hrs;CHEMBL1143003;Non-molecular target assigned;N;;1;CHEMBL614631;;
CLD0;;RAW264.7;CHEMBL919403;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Inhibition of PGE2 production in LPS-stimulated mouse RAW264.7 cells at 1 uM after 18 hrs;CHEMBL1147139;Non-molecular target assigned;N;;1;CHEMBL612557;;
CLD0;;RAW264.7;CHEMBL919405;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Inhibition of PGE2 production in LPS-stimulated mouse RAW264.7 cells at 1 uM after 2 hrs;CHEMBL1147139;Non-molecular target assigned;N;;1;CHEMBL612557;;
CLD0;;RAW264.7;CHEMBL919407;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Inhibition of mPGES1 expression in LPS-stimulated mouse RAW264.7 cells after 2 hrs by Western blot analysis;CHEMBL1147139;Non-molecular target assigned;N;;1;CHEMBL612557;;
CLD0;;;CHEMBL919409;[{'assay_class_id': 299, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Granuloma Pouch Technique', 'source': 'Hock_2016'}];Mus musculus;[];Swiss;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Decrease of mPGES1 expression in zymosan-stimulated Swiss mouse air pouch model after 24 hrs;CHEMBL1147139;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL919410;[{'assay_class_id': 299, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Granuloma Pouch Technique', 'source': 'Hock_2016'}];Mus musculus;[];Swiss;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Inhibition of COX2 expression in zymosan-stimulated Swiss mouse air pouch model after 24 hrs;CHEMBL1147139;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;RAW264.7;CHEMBL919413;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Inhibition of COX2 expression in LPS-stimulated mouse RAW264.7 cells after 2 hrs by Western blot analysis;CHEMBL1147139;Non-molecular target assigned;N;;1;CHEMBL612557;;
CLD0;;;CHEMBL905612;[];;[];;;;;;A;ADME;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Permeability coefficient through artificial membrane in presence of unstirred water layer by PAMPA;CHEMBL1143050;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL905613;[];;[];;;;;;A;ADME;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Permeability coefficient through artificial membrane in presence of stirred water layer;CHEMBL1143050;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL905620;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Partition coefficient, log P of the compound;CHEMBL1143050;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;;CHEMBL889673;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];Swiss;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Inhibition of peritoneal cell count in zymosan-induced Swiss mouse peritoneal fluid at 1 mg/kg, po;CHEMBL1146234;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL889674;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];Swiss;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Inhibition of peritoneal granulocyte count in zymosan-induced Swiss mouse peritoneal fluid at 1 mg/kg, po;CHEMBL1146234;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL889675;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];Swiss;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Inhibition of monocyte count in zymosan-induced Swiss mouse peritoneal fluid at 1 mg/kg, po;CHEMBL1146234;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL889676;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];Swiss;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Inhibition of lymphocyte count in zymosan-induced Swiss mouse peritoneal fluid at 1 mg/kg, po;CHEMBL1146234;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL889677;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];Swiss;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Inhibition of granulocyte count in zymosan-induced Swiss mouse peritoneal fluid at 1 mg/kg, po;CHEMBL1146234;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL890011;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '3.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '3.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Suppression of lipopolysaccharide-induced TNFalpha release in mouse at 3 mg/kg, po after 30 mins;CHEMBL1146285;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL890013;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '3.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '3.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Suppression of lipopolysaccharide-induced TNFalpha release in mouse at 3 mg/kg, po after 120 mins;CHEMBL1146285;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL890052;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '5.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '5.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];BALB/c;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Direct single protein target assigned;9;Inhibition of ovalbumin-induced eosinophil infiltration in BALB/c mouse allergic inflammation model at 5 mg/kg, po;CHEMBL1146290;Direct protein target assigned;D;;1;CHEMBL5410;;
CLD0;;;CHEMBL890119;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human GR;CHEMBL1146304;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;;CHEMBL890122;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human PR;CHEMBL1146304;Direct protein target assigned;D;;1;CHEMBL208;;
CLD0;;;CHEMBL890123;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human MR;CHEMBL1146304;Direct protein target assigned;D;;1;CHEMBL1994;;
CLD0;;CV-1;CHEMBL896154;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308033;Direct single protein target assigned;9;Agonist activity at human GR expressed in CV1 cells by GRE activation assay;CHEMBL1148778;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;CV-1;CHEMBL896155;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308033;Direct single protein target assigned;9;Agonist efficacy at human GR expressed in CV1 cells by GRE activation assay relative to Dexamethasone;CHEMBL1148778;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;NHDFneo;CHEMBL896156;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Activity at human GR expressed in NHDFneo cells assessed as inhibition of IL-6 production;CHEMBL1148778;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;NHDFneo;CHEMBL896157;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Absolute efficacy at human GR expressed in NHDFneo cells assessed as repression of IL-6 production relative to Dexamethasone;CHEMBL1148778;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;RPMI-8226;CHEMBL896158;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307732;Target assigned is non-molecular;1;Antiproliferative activity against human RPMI8226 cells after 4 days;CHEMBL1148778;Non-molecular target assigned;N;;1;CHEMBL614882;;
CLD0;;RPMI-8226;CHEMBL896159;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307732;Target assigned is non-molecular;1;Antiproliferative activity against human RPMI8226 cells after 4 days relative to Dexamethasone;CHEMBL1148778;Non-molecular target assigned;N;;1;CHEMBL614882;;
CLD0;;;CHEMBL896162;[];;[];;;;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Binding affinity to GR;CHEMBL1148778;Homologous protein target assigned;H;;1;CHEMBL2034;;
CLD0;;;CHEMBL896164;[];;[];;;;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Binding affinity to MR;CHEMBL1148778;Homologous protein target assigned;H;;1;CHEMBL1994;;
CLD0;;;CHEMBL897790;[];;[];;;;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Binding affinity to glucocorticoid receptor;CHEMBL1149655;Homologous protein target assigned;H;;1;CHEMBL2034;;
CLD0;;A549;CHEMBL897791;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Direct single protein target assigned;9;Agonist activity at glucocorticoid receptor in human A549 cells by NF-kappaB transrepression assay;CHEMBL1149655;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;A549;CHEMBL897792;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Direct single protein target assigned;9;Agonist activity at glucocorticoid receptor in human A549 cells by MMTV transactivation assay;CHEMBL1149655;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;A549;CHEMBL897788;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Direct single protein target assigned;9;Antagonist activity at glucocorticoid receptor in human A549 cells transfected with MMTV luciferase reporter gene assessed as inhibition of dexamethasone-induced activation;CHEMBL1149655;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;A549;CHEMBL897794;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Direct single protein target assigned;9;Agonist activity at glucocorticoid receptor in human A549 cells by NF-kappaB transrepression assay relative to dexamethasone;CHEMBL1149655;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;A549;CHEMBL897795;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Direct single protein target assigned;9;Agonist activity at glucocorticoid receptor in human A549 cells by MMTV transactivation assay relative to Dexamethasone;CHEMBL1149655;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;;CHEMBL899205;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Displacement of TAMRA labeled Dexamethasone at human glucocorticoid receptor in insect cell;CHEMBL1149697;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;;CHEMBL899206;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Displacement of TAMRA labeled Dexamethasone at human progesterone receptor in insect cell;CHEMBL1149697;Direct protein target assigned;D;;1;CHEMBL208;;
CLD0;;;CHEMBL899207;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Displacement of TAMRA labeled mifepristone at human mineralocorticoid receptor in insect cell;CHEMBL1149697;Direct protein target assigned;D;;1;CHEMBL1994;;
CLD0;;HFF;CHEMBL899208;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307525;Target assigned is non-molecular;1;Antiinflammatory activity assessed as inhibition of IL1 stimulated IL6 production in HFF cells by transrepression assay;CHEMBL1149697;Non-molecular target assigned;N;;1;CHEMBL614071;;
CLD0;;HFF;CHEMBL899210;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307525;Target assigned is non-molecular;1;Antiinflammatory activity assessed as upregulation of aromatase in HFF cells by transactivation assay;CHEMBL1149697;Non-molecular target assigned;N;;1;CHEMBL614071;;
CLD0;;J774.A1;CHEMBL900398;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307516;Target assigned is non-molecular;1;Inhibition of LPS-induced TNFalpha production in mouse J774A.1 cells;CHEMBL1137544;Non-molecular target assigned;N;;1;CHEMBL614040;;
CLD0;;;CHEMBL902641;[];;[];;;;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Displacement of fluorescent labeled Dexamethasone from glucocorticoid receptor;CHEMBL1138343;Homologous protein target assigned;H;;1;CHEMBL2034;;
CLD0;;A549;CHEMBL902642;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Direct single protein target assigned;9;Agonist activity at glucocorticoid receptor in human A549 cells by NF-kappaB transrepression assay;CHEMBL1138343;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;A549;CHEMBL902643;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Direct single protein target assigned;9;Agonist activity at glucocorticoid receptor in human A549 cells by MMTV transactivation assay;CHEMBL1138343;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;A549;CHEMBL902644;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Direct single protein target assigned;9;Agonist activity at glucocorticoid receptor in human A549 cells at 10 mM by NF-kappaB transrepression assay relative to Dexamethasone;CHEMBL1138343;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;A549;CHEMBL902645;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Direct single protein target assigned;9;Agonist activity at glucocorticoid receptor in human A549 cells at 10 mM by MMTV transactivation assay relative to Dexamethasone;CHEMBL1138343;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;A549;CHEMBL902646;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Direct single protein target assigned;9;Antagonist activity at glucocorticoid receptor in human A549 cells transfected with MMTV luciferase reporter gene assessed as inhibition of dexamethasone-induced activation;CHEMBL1138343;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;COS-7;CHEMBL902647;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307648;Direct single protein target assigned;9;Agonist activity at glucocorticoid receptor Q570A mutant in COS7 cells at 1 uM by NF-kappaB-luciferase reporter gene assay;CHEMBL1138343;Direct protein target assigned;D;;1;CHEMBL2034;;{'accession': 'P04150', 'isoform': None, 'mutation': 'Q570A', 'organism': 'Homo sapiens', 'sequence': 'MDSKESLTPGREENPSSVLAQERGDVMDFYKTLRGGATVKVSASSPSLAVASQSDSKQRRLLVDFPKGSVSNAQQPDLSKAVSLSMGLYMGETETKVMGNDLGFPQQGQISLSSGETDLKLLEESIANLNRSTSVPENPKSSASTAVSAAPTEKEFPKTHSDVSSEQQHLKGQTGTNGGNVKLYTTDQSTFDILQDLEFSSGSPGKETNESPWRSDLLIDENCLLSPLAGEDDSFLLEGNSNEDCKPLILPDTKPKIKDNGDLVLSSPSNVTLPQVKTEKEDFIELCTPGVIKQEKLGTVYCQASFPGANIIGNKMSAISVHGVSTSGGQMYHYDMNTASLSQQQDQKPIFNVIPPIPVGSENWNRCQGSGDDNLTSLGTLNFPGRTVFSNGYSSPSMRPDVSSPPSSSSTATTGPPPKLCLVCSDEASGCHYGVLTCGSCKVFFKRAVEGQHNYLCAGRNDCIIDKIRRKNCPACRYRKCLQAGMNLEARKTKKKIKGIQQATTGVSQETSENPGNKTIVPATLPQLTPTLVSLLEVIEPEVLYAGYDSSVPDSTWRIMTTLNMLGGRAVIAAVKWAKAIPGFRNLHLDDQMTLLQYSWMFLMAFALGWRSYRQSSANLLCFAPDLIINEQRMTLPCMYDQCKHMLYVSSELHRLQVSYEEYLCMKTLLLLSSVPKDGLKSQELFDEIRMTYIKELGKAIVKREGNSSQNWQRFYQLTKLLDSMHEVVENLLNYCFQTFLDKTMSIEFPEMLAEIITNQIPKYSNGNIKKLLFHQK', 'tax_id': 9606, 'version': 1}
CLD0;;COS-7;CHEMBL902648;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307648;Direct single protein target assigned;9;Agonist activity at glucocorticoid receptor R611A mutant in COS7 cells at 1 uM by NF-kappaB-luciferase reporter gene assay;CHEMBL1138343;Direct protein target assigned;D;;1;CHEMBL2034;;{'accession': 'P04150', 'isoform': None, 'mutation': 'R611A', 'organism': 'Homo sapiens', 'sequence': 'MDSKESLTPGREENPSSVLAQERGDVMDFYKTLRGGATVKVSASSPSLAVASQSDSKQRRLLVDFPKGSVSNAQQPDLSKAVSLSMGLYMGETETKVMGNDLGFPQQGQISLSSGETDLKLLEESIANLNRSTSVPENPKSSASTAVSAAPTEKEFPKTHSDVSSEQQHLKGQTGTNGGNVKLYTTDQSTFDILQDLEFSSGSPGKETNESPWRSDLLIDENCLLSPLAGEDDSFLLEGNSNEDCKPLILPDTKPKIKDNGDLVLSSPSNVTLPQVKTEKEDFIELCTPGVIKQEKLGTVYCQASFPGANIIGNKMSAISVHGVSTSGGQMYHYDMNTASLSQQQDQKPIFNVIPPIPVGSENWNRCQGSGDDNLTSLGTLNFPGRTVFSNGYSSPSMRPDVSSPPSSSSTATTGPPPKLCLVCSDEASGCHYGVLTCGSCKVFFKRAVEGQHNYLCAGRNDCIIDKIRRKNCPACRYRKCLQAGMNLEARKTKKKIKGIQQATTGVSQETSENPGNKTIVPATLPQLTPTLVSLLEVIEPEVLYAGYDSSVPDSTWRIMTTLNMLGGRQVIAAVKWAKAIPGFRNLHLDDQMTLLQYSWMFLMAFALGWASYRQSSANLLCFAPDLIINEQRMTLPCMYDQCKHMLYVSSELHRLQVSYEEYLCMKTLLLLSSVPKDGLKSQELFDEIRMTYIKELGKAIVKREGNSSQNWQRFYQLTKLLDSMHEVVENLLNYCFQTFLDKTMSIEFPEMLAEIITNQIPKYSNGNIKKLLFHQK', 'tax_id': 9606, 'version': 1}
CLD0;;;CHEMBL925051;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Partition coefficient, log P of the compound;CHEMBL1140614;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;;CHEMBL925052;[];Homo sapiens;[];;;9606.0;;Zone of skin;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Permeability across human Skin;CHEMBL1140614;Non-molecular target assigned;N;;1;CHEMBL613427;CHEMBL3638174;
CLD0;;;CHEMBL925053;[];;[];;;;;;A;ADME;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Permeability across PAMPA membrane after 7 hrs;CHEMBL1140614;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL926551;[];Homo sapiens;[];;;9606.0;;Zone of skin;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Permeability coefficient in human skin;CHEMBL1141284;Non-molecular target assigned;N;;1;CHEMBL613427;CHEMBL3638174;
CLD0;;;CHEMBL937391;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;Agonist activity at glucocorticoid receptor-mediated luciferase reporter gene assay assessed as ratio of firefly luciferase activity to renilla luciferase activity at 10 uM;CHEMBL1144708;Homologous protein target assigned;H;;1;CHEMBL2034;;
CLD0;;CV-1;CHEMBL932407;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308033;Direct single protein target assigned;9;Activity at human glucocorticoid receptor expressed in CV1 cells assessed as repression of TNF and IL-1-beta-induced E-selectin gene expression by luciferase reporter gene assay;CHEMBL1147082;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;CV-1;CHEMBL932406;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308033;Direct single protein target assigned;9;Activity at human glucocorticoid receptor expressed in CV1 cells assessed as repression of TNF and IL-1-beta-induced E-selectin gene expression by luciferase reporter gene assay relative to control;CHEMBL1147082;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;;CHEMBL1014678;[{'assay_class_id': 295, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Croton Oil Ear Edema', 'source': 'Vogel_2008'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];Swiss;;10090.0;;Ear;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in Swiss mouse assessed as inhibition of ethylphenylpropiolate-induced ear edema at 0.5 mg/ear administered tropically 16 hrs prior to ethylphenylpropiolate challenge;CHEMBL1159217;Non-molecular target assigned;N;;1;CHEMBL375;CHEMBL3987716;
CLD0;;;CHEMBL958541;[{'assay_class_id': 295, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Croton Oil Ear Edema', 'source': 'Vogel_2008'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];Swiss;;10090.0;;Ear;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity against TPA-induced ear edema in Swiss mouse assessed as reduction in ear thickness at 0.05 mg/ear after 10 days;CHEMBL1158861;Non-molecular target assigned;N;;1;CHEMBL375;CHEMBL3987716;
CLD0;;;CHEMBL958543;[{'assay_class_id': 100, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Delayed Type Hypersensitivity', 'source': 'Vogel_2008'}, {'assay_class_id': 300, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Oxazolone Induced Ear Edema in Mice', 'source': 'Hock_2016'}];Mus musculus;[];Swiss;;10090.0;;Ear;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Effect on oxazolone-induced delayed type hypersensitivity in Swiss mouse assessed as reduction in ear thickness at 0.05 mg/ear after 24 hrs;CHEMBL1158861;Non-molecular target assigned;N;;1;CHEMBL375;CHEMBL3987716;
CLD0;;;CHEMBL958544;[{'assay_class_id': 100, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Delayed Type Hypersensitivity', 'source': 'Vogel_2008'}, {'assay_class_id': 300, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Oxazolone Induced Ear Edema in Mice', 'source': 'Hock_2016'}];Mus musculus;[];Swiss;;10090.0;;Ear;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Effect on oxazolone-induced delayed type hypersensitivity in Swiss mouse assessed as reduction in ear thickness at 0.05 mg/ear after 48 hrs;CHEMBL1158861;Non-molecular target assigned;N;;1;CHEMBL375;CHEMBL3987716;
CLD0;;;CHEMBL958545;[{'assay_class_id': 100, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Delayed Type Hypersensitivity', 'source': 'Vogel_2008'}, {'assay_class_id': 300, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Oxazolone Induced Ear Edema in Mice', 'source': 'Hock_2016'}];Mus musculus;[];Swiss;;10090.0;;Ear;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Effect on oxazolone-induced delayed type hypersensitivity in Swiss mouse assessed as reduction in ear thickness at 0.05 mg/ear after 72 hrs;CHEMBL1158861;Non-molecular target assigned;N;;1;CHEMBL375;CHEMBL3987716;
CLD0;;;CHEMBL958546;[{'assay_class_id': 100, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Delayed Type Hypersensitivity', 'source': 'Vogel_2008'}, {'assay_class_id': 300, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Oxazolone Induced Ear Edema in Mice', 'source': 'Hock_2016'}];Mus musculus;[];Swiss;;10090.0;;Ear;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Effect on oxazolone-induced delayed type hypersensitivity in Swiss mouse assessed as reduction in ear thickness at 0.05 mg/ear after 96 hrs;CHEMBL1158861;Non-molecular target assigned;N;;1;CHEMBL375;CHEMBL3987716;
CLD0;;;CHEMBL958547;[{'assay_class_id': 100, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Delayed Type Hypersensitivity', 'source': 'Vogel_2008'}, {'assay_class_id': 300, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Oxazolone Induced Ear Edema in Mice', 'source': 'Hock_2016'}];Mus musculus;[];Swiss;;10090.0;;Ear;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Effect on oxazolone-induced delayed type hypersensitivity in Swiss mouse assessed as reduction in ear thickness at 0.05 mg/ear after 102 hrs;CHEMBL1158861;Non-molecular target assigned;N;;1;CHEMBL375;CHEMBL3987716;
CLD0;;RAW264.7;CHEMBL1009404;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-stimulated mouse RAW264.7 cells assessed as effect on TNFalpha formation pretreated 1 hr before LPS challenge measured after 24 hrs;CHEMBL1148106;Non-molecular target assigned;N;;1;CHEMBL612557;;
CLD0;;;CHEMBL938588;[];;[];;;;;;A;ADME;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Binding affinity to beta cyclodextrin;CHEMBL1140846;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL947390;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Displacement of radiolabeled Dexamethasone from human glucocorticoid receptor;CHEMBL1140203;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;;CHEMBL1002079;[{'assay_class_id': 295, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Croton Oil Ear Edema', 'source': 'Vogel_2008'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;Ear;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in mouse ear edema model assessed as inhibition of PMA-induced ear edema at 1 mg/ear administered 2 times 30 mins before and 15 mins after PMA challenge measured after 6 hrs of PMA application relative to control;CHEMBL1153998;Non-molecular target assigned;N;;1;CHEMBL375;CHEMBL3987716;
CLD0;;;CHEMBL975349;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '3.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '3.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];Swiss;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity against zymosan-induced peritonitis in Swiss mouse assessed as peritoneal protein concentration at 3 mg/kg, po administered 1 hr before zymosan challenge by spectrophotometry;CHEMBL1138627;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL975350;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '3.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '3.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];Swiss;;10090.0;;Peritoneal cavity;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity against zymosan-induced peritonitis in Swiss mouse assessed as granulocyte content in peritoneal cavity lavage at 3 mg/kg, po administered 1 hr before zymosan challenge measured after 4 hrs;CHEMBL1138627;Non-molecular target assigned;N;;1;CHEMBL375;CHEMBL3987903;
CLD0;;;CHEMBL975351;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '3.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '3.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];Swiss;;10090.0;;Peritoneal cavity;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity against zymosan-induced peritonitis in Swiss mouse assessed as monocyte and lymphocyte content in peritoneal cavity lavage at 3 mg/kg, po administered 1 hr before zymosan challenge measured after 4 hrs;CHEMBL1138627;Non-molecular target assigned;N;;1;CHEMBL375;CHEMBL3987903;
CLD0;;;CHEMBL975357;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '3.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '3.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];Swiss;;10090.0;;Peritoneal cavity;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity against zymosan-induced peritonitis in Swiss mouse assessed as inhibition of granulocyte infiltration into peritoneal cavity at 3 mg/kg, po administered 1 hr before zymosan challenge measured after 4 hrs;CHEMBL1138627;Non-molecular target assigned;N;;1;CHEMBL375;CHEMBL3987903;
CLD0;;;CHEMBL1025446;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '3.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '3.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];Swiss;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Inhibition of chemotaxis in zymosan-induced peritonitis Swiss mouse model assessed as peritoneal protein concentration at 3 mg/kg, po pretreated 1 hr before zymosan-challenge measured 4 hrs post inducer challenge (Rvb=1961+/-160 million);CHEMBL1136878;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL1025449;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '3.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '3.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];Swiss;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Inhibition of chemotaxis in zymosan-induced peritonitis Swiss mouse model assessed as number of peritoneal granulocytes per cavity at 3 mg/kg, po pretreated 1 hr before zymosan-challenge measured 4 hrs post inducer challenge (Rvb=27.1+/-3.5 million);CHEMBL1136878;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL1025450;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '3.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '3.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];Swiss;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Inhibition of chemotaxis in zymosan-induced peritonitis Swiss mouse model assessed as number of peritoneal cells per cavity at 3 mg/kg, po pretreated 1 hr before zymosan-challenge measured 4 hrs post inducer challenge (Rvb=31.5+/-1.2 million);CHEMBL1136878;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL1019340;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Displacement of FITC-dexamethasone from human recombinant glucocorticoid receptor alpha by fluorescence polarization assay;CHEMBL1138590;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;A549;CHEMBL1019341;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307651;Direct single protein target assigned;9;Transrepression activity at GR in PMA-stimulated human A549 cells assessed as inhibition of AP1 response element-induced luciferase reporter gene activity;CHEMBL1138590;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;A549;CHEMBL1019342;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307651;Direct single protein target assigned;9;Transrepression activity at GR in IL-1-beta-stimulated human A549 cells assessed as inhibition of NF-kappaB-dependent E-selectin transcription by luciferase reporter gene assay;CHEMBL1138590;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;NP1;CHEMBL1022034;[];;[];;;;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;Agonist activity at GR ligand binding domain expressed in human NP1 cells assessed as glucocorticoid response element transactivation by GAL4 luciferase reporter gene assay;CHEMBL1138590;Homologous protein target assigned;H;;1;CHEMBL2034;;
CLD0;;RAW264.7;CHEMBL1005690;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-stimulated mouse RAW264.7 cells assessed as inhibition of TNFalpha formation at 10 uM pretreated 1 hr before LPS challenge measured after 24 hrs by enzyme immunoassay;CHEMBL1150836;Non-molecular target assigned;N;;1;CHEMBL612557;;
CLD0;;N9;CHEMBL1005692;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307264;Target assigned is non-molecular;1;Antiinflammatory activity in LPS/IFN-gamma-stimulated mouse N9 cells assessed as inhibition of TNFalpha formation at 10 uM pretreated 1 hr before LPS/IFNgamma challenge measured after 24 hrs by enzyme immunoassay;CHEMBL1150836;Non-molecular target assigned;N;;1;CHEMBL613516;;
CLD0;;;CHEMBL1002119;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 458, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'NERVOUS SYSTEM', 'l2': 'Peripheral Analgesic Activity', 'l3': 'Pain in Inflamed Tissue (Randall-Selitto Test) for Analgesic Activity', 'source': 'Hock_2016'}];Mus musculus;[];C57BL/6J;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity against ip dosed zymosan-induced C57BL/6J mouse inflamed paw model assessed as effect on paw swelling administered 30 mins before zymosan challenge;CHEMBL1156424;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL1002120;[{'assay_class_id': 458, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'NERVOUS SYSTEM', 'l2': 'Peripheral Analgesic Activity', 'l3': 'Pain in Inflamed Tissue (Randall-Selitto Test) for Analgesic Activity', 'source': 'Hock_2016'}];Mus musculus;[];C57BL/6J;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Reduction of IL6 protein level in ip dosed zymosan-induced C57BL/6J mouse inflamed paw model measured 6 hrs after zymosan challenge;CHEMBL1156424;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;THP-1;CHEMBL967083;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Antiinflammatory activity in human THP1 cells assessed as inhibition of LPS-induced TNFalpha by ELISA;CHEMBL1155871;Non-molecular target assigned;N;;1;CHEMBL614245;;
CLD0;;THP-1;CHEMBL967084;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Antiinflammatory activity in human THP1 cells assessed as inhibition of LPS-induced IL6 by ELISA;CHEMBL1155871;Non-molecular target assigned;N;;1;CHEMBL614245;;
CLD0;;THP-1;CHEMBL967085;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Cytotoxicity against human THP1 cells;CHEMBL1155871;Non-molecular target assigned;N;;1;CHEMBL614245;;
CLD0;;THP-1;CHEMBL967092;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Antiinflammatory activity in human THP1 cells assessed as inhibition of LPS-induced TNFalpha at 1 uM by ELISA;CHEMBL1155871;Non-molecular target assigned;N;;1;CHEMBL614245;;
CLD0;;THP-1;CHEMBL967093;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Antiinflammatory activity in human THP1 cells assessed as inhibition of LPS-induced IL6 at 1 uM by ELISA;CHEMBL1155871;Non-molecular target assigned;N;;1;CHEMBL614245;;
CLD0;;THP-1;CHEMBL967094;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Cytotoxicity against human THP1 cells at 1 uM;CHEMBL1155871;Non-molecular target assigned;N;;1;CHEMBL614245;;
CLD0;;;CHEMBL1000576;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in sc dosed mouse assessed as inhibition of LPS-induced TNFalpha upregulation measured 2 hrs after LPS challenge;CHEMBL1136923;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL1000577;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in sc dosed mouse assessed as inhibition of LPS-induced TNFalpha upregulation measured 2 hrs after LPS challenge relative to control;CHEMBL1136923;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL1000594;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in po dosed mouse assessed as inhibition of LPS-induced TNFalpha upregulation measured 2 hrs after LPS challenge;CHEMBL1136923;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL1000595;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in po dosed mouse assessed as inhibition of LPS-induced TNFalpha upregulation measured 2 hrs after LPS challenge relative to control;CHEMBL1136923;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL1006668;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in mouse assessed as inhibition of LPS-induced TNFalpha upregulation at 300 pg, sc measured 2 hrs after LPS challenge;CHEMBL1136923;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL1006669;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in mouse assessed as inhibition of LPS-induced TNFalpha upregulation at 0.003 ug, sc measured 2 hrs after LPS challenge;CHEMBL1136923;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL1006670;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in mouse assessed as inhibition of LPS-induced TNFalpha upregulation at 0.03 ug, sc measured 2 hrs after LPS challenge;CHEMBL1136923;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL1006671;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in mouse assessed as inhibition of LPS-induced TNFalpha upregulation at 0.3 ug, sc measured 2 hrs after LPS challenge;CHEMBL1136923;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL1006672;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in mouse assessed as inhibition of LPS-induced TNFalpha upregulation at 0.003 mg, sc measured 2 hrs after LPS challenge;CHEMBL1136923;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL1006673;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in mouse assessed as inhibition of LPS-induced TNFalpha upregulation at 0.015 mg, sc measured 2 hrs after LPS challenge;CHEMBL1136923;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL1006674;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in mouse assessed as inhibition of LPS-induced TNFalpha upregulation at 0.03 mg, sc measured 2 hrs after LPS challenge;CHEMBL1136923;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL1006675;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in mouse assessed as inhibition of LPS-induced TNFalpha upregulation at 0.06 mg, sc measured 2 hrs after LPS challenge;CHEMBL1136923;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL1006676;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in mouse assessed as inhibition of LPS-induced TNFalpha upregulation at 0.12 mg, sc measured 2 hrs after LPS challenge;CHEMBL1136923;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;A549;CHEMBL976722;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307651;Direct single protein target assigned;9;Activity at glucocorticoid receptor in human A549 cells assessed as effect on GRE promoter response by luciferase reporter assay;CHEMBL1157339;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;RAW264.7;CHEMBL976683;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Homologous single protein target assigned;8;Agonist activity at glucocorticoid receptor transfected in mouse RAW264.7 cells assessed as firefly/renilla luciferase ratio at 10 uM by dual liciferase reporter assay;CHEMBL1158081;Homologous protein target assigned;H;;1;CHEMBL2034;;
CLD0;;;CHEMBL969095;[{'assay_class_id': 231, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'DERMATOLOGICALS', 'l2': 'Experimental Dermatitis', 'l3': 'General Dermatitis Models', 'source': 'phenotype'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];Swiss;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity against Swiss mouse chronic dermatitis model assessed as inhibition of TPA-induced edema at 0.5 mg/ear applied twice daily for 4 days measured after 6 hrs;CHEMBL1141827;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL969096;[{'assay_class_id': 231, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'DERMATOLOGICALS', 'l2': 'Experimental Dermatitis', 'l3': 'General Dermatitis Models', 'source': 'phenotype'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];Swiss;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity against Swiss mouse chronic dermatitis model assessed as inhibition of TPA-induced tissue myeloperoxidase activity at 0.5 mg/ear applied twice daily for 4 days measured after 6 hrs;CHEMBL1141827;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL975914;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 301, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Paw Edema Test', 'source': 'Hock_2016'}, {'assay_class_id': 367, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'NERVOUS SYSTEM', 'l2': 'Central Analgesic Activity', 'l3': 'Formalin Test for Chronic Pain', 'source': 'Hock_2016'}];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '5.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '5.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity against formalin-induced chronic paw edema rat inflammatory model assessed as reduction of paw volume at 5 mg/kg, po after 1 day relative to control;CHEMBL1157213;Non-molecular target assigned;N;;1;CHEMBL376;;
CLD0;;;CHEMBL975915;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 301, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Paw Edema Test', 'source': 'Hock_2016'}, {'assay_class_id': 367, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'NERVOUS SYSTEM', 'l2': 'Central Analgesic Activity', 'l3': 'Formalin Test for Chronic Pain', 'source': 'Hock_2016'}];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '5.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '5.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity against formalin-induced chronic paw edema rat inflammatory model assessed as reduction of paw volume at 5 mg/kg, po after 2 days relative to control;CHEMBL1157213;Non-molecular target assigned;N;;1;CHEMBL376;;
CLD0;;;CHEMBL975916;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 301, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Paw Edema Test', 'source': 'Hock_2016'}, {'assay_class_id': 367, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'NERVOUS SYSTEM', 'l2': 'Central Analgesic Activity', 'l3': 'Formalin Test for Chronic Pain', 'source': 'Hock_2016'}];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '5.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '5.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity against formalin-induced chronic paw edema rat inflammatory model assessed as reduction of paw volume at 5 mg/kg, po after 3 days relative to control;CHEMBL1157213;Non-molecular target assigned;N;;1;CHEMBL376;;
CLD0;;;CHEMBL975917;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 301, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Paw Edema Test', 'source': 'Hock_2016'}, {'assay_class_id': 367, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'NERVOUS SYSTEM', 'l2': 'Central Analgesic Activity', 'l3': 'Formalin Test for Chronic Pain', 'source': 'Hock_2016'}];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '5.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '5.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity against formalin-induced chronic paw edema rat inflammatory model assessed as reduction of paw volume at 5 mg/kg, po after 4 days relative to control;CHEMBL1157213;Non-molecular target assigned;N;;1;CHEMBL376;;
CLD0;;;CHEMBL975918;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 301, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Paw Edema Test', 'source': 'Hock_2016'}, {'assay_class_id': 367, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'NERVOUS SYSTEM', 'l2': 'Central Analgesic Activity', 'l3': 'Formalin Test for Chronic Pain', 'source': 'Hock_2016'}];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '5.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '5.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity against formalin-induced chronic paw edema rat inflammatory model assessed as reduction of paw volume at 5 mg/kg, po after 5 days relative to control;CHEMBL1157213;Non-molecular target assigned;N;;1;CHEMBL376;;
CLD0;;;CHEMBL975924;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 301, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Paw Edema Test', 'source': 'Hock_2016'}];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '5.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '5.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];Sprague-Dawley;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity against carrageenan-induced acute paw edema Sprague-Dawley rat inflammatory model assessed as reduction of paw volume at 5 mg/kg, po after 3 hrs relative to control;CHEMBL1157213;Non-molecular target assigned;N;;1;CHEMBL376;;
CLD0;;;CHEMBL989654;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Intrinsic aqueous solubility at pH 10 by shake-flask method;CHEMBL1150239;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;RAW264.7;CHEMBL994980;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Inhibition of LPS-stimulated COX2 expression in mouse RAW264.7 cells at 10 uM by Western blot;CHEMBL1144230;Non-molecular target assigned;N;;1;CHEMBL612557;;
CLD0;;RAW264.7;CHEMBL994981;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Inhibition of LPS-stimulated microsomal prostaglandin E synthase 1 expression at 10 uM in mouse RAW264.7 cells by Western blot;CHEMBL1144230;Non-molecular target assigned;N;;1;CHEMBL612557;;
CLD0;;;CHEMBL1010789;[{'assay_class_id': 44, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ALIMENTARY TRACT AND METABOLISM', 'l2': 'Intestinal Function', 'l3': 'Experimental Colitis Inflammatory Gut Disease', 'source': 'Vogel_2008'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in DNBS-induced Sprague-Dawley rat colitis model assessed as effect on body weight loss at 0.25 umol/kg, ip for 7 days administered 1 day before colitis induction;CHEMBL1152769;Non-molecular target assigned;N;;1;CHEMBL376;;
CLD0;;;CHEMBL1010793;[{'assay_class_id': 44, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ALIMENTARY TRACT AND METABOLISM', 'l2': 'Intestinal Function', 'l3': 'Experimental Colitis Inflammatory Gut Disease', 'source': 'Vogel_2008'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;Spleen;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in DNBS-induced Sprague-Dawley rat colitis model assessed as reduction in DNBS-induced increase in spleen weight at 0.25 umol/kg, ip for 7 days administered 1 day before colitis induction;CHEMBL1152769;Non-molecular target assigned;N;;1;CHEMBL376;CHEMBL3559722;
CLD0;;;CHEMBL1013519;[{'assay_class_id': 44, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ALIMENTARY TRACT AND METABOLISM', 'l2': 'Intestinal Function', 'l3': 'Experimental Colitis Inflammatory Gut Disease', 'source': 'Vogel_2008'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;Colon;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in DNBS-induced Sprague-Dawley rat colitis model assessed as reduction in DNBS-induced macroscopic damage in colon at 0.25 umol/kg, ip for 7 days administered 1 day before colitis induction;CHEMBL1152769;Non-molecular target assigned;N;;1;CHEMBL376;CHEMBL3638202;
CLD0;;;CHEMBL1013520;[{'assay_class_id': 44, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ALIMENTARY TRACT AND METABOLISM', 'l2': 'Intestinal Function', 'l3': 'Experimental Colitis Inflammatory Gut Disease', 'source': 'Vogel_2008'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in DNBS-induced Sprague-Dawley rat colitis model assessed as reduction in DNBS-induced increase in colonic tissue malondialdehyde level at 0.25 umol/kg, ip for 7 days administered 1 day before colitis induction;CHEMBL1152769;Non-molecular target assigned;N;;1;CHEMBL376;;
CLD0;;;CHEMBL1013521;[{'assay_class_id': 44, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ALIMENTARY TRACT AND METABOLISM', 'l2': 'Intestinal Function', 'l3': 'Experimental Colitis Inflammatory Gut Disease', 'source': 'Vogel_2008'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in DNBS-induced Sprague-Dawley rat colitis model assessed as reduction in DNBS-induced increase in colonic tissue malondialdehyde level at 5 to 45 umol/kg, ip for 7 days administered 1 day before colitis induction;CHEMBL1152769;Non-molecular target assigned;N;;1;CHEMBL376;;
CLD0;;;CHEMBL1013523;[{'assay_class_id': 44, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ALIMENTARY TRACT AND METABOLISM', 'l2': 'Intestinal Function', 'l3': 'Experimental Colitis Inflammatory Gut Disease', 'source': 'Vogel_2008'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in DNBS-induced Sprague-Dawley rat colitis model assessed as reduction in DNBS-induced increase in colonic tissue TNFalpha level at 0.25 umol/kg, ip for 7 days administered 1 day before colitis induction;CHEMBL1152769;Non-molecular target assigned;N;;1;CHEMBL376;;
CLD0;;J774.1;CHEMBL1026695;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295470;Target assigned is non-molecular;1;Inhibition of LPS-induced NO production in mouse J774.1 cells after 24 hrs;CHEMBL1159342;Non-molecular target assigned;N;;1;CHEMBL4296442;;
CLD0;;Hepatocyte;CHEMBL997296;[];Rattus norvegicus;[];Wistar;;10116.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308027;Target assigned is non-molecular;1;Effect on 1.5 hrs galactosamine pretreatment-induced cytotoxicity in Wistar rat hepatocytes assessed as glutamic-pyruvic transaminase activity at 1 uM;CHEMBL1145673;Non-molecular target assigned;N;;1;CHEMBL613362;;
CLD0;;Hepatocyte;CHEMBL997297;[];Rattus norvegicus;[];Wistar;;10116.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308027;Target assigned is non-molecular;1;Effect on 1.5 hrs galactosamine pretreatment-induced cytotoxicity in Wistar rat hepatocytes at 1 uM;CHEMBL1145673;Non-molecular target assigned;N;;1;CHEMBL613362;;
CLD0;;RAW264.7;CHEMBL1016738;[];Mus musculus;[];;;10090.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Cytotoxicity against mouse RAW264.7 cells after 2 days by MTT assay;CHEMBL1151198;Non-molecular target assigned;N;;1;CHEMBL612557;;
CLD0;;HL-60;CHEMBL1016754;[];;[];;;;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307654;Homologous protein complex subunits assigned;6;Inhibition of LFA1/ICAM1-mediated HL60 cell aggregation;CHEMBL1151198;Homologous protein target assigned;H;;1;CHEMBL2096661;;
CLD0;;HL-60;CHEMBL1016755;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Cytotoxicity against human HL60 cells by XTT assay;CHEMBL1151198;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;HL-60;CHEMBL1016757;[];;[];;;;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307654;Homologous protein complex subunits assigned;6;Inhibition of LFA1/ICAM1-mediated adhesion of HL60 cells to CHO-ICAM1 cells;CHEMBL1151198;Homologous protein target assigned;H;;1;CHEMBL2096661;;
CLD0;;CHO;CHEMBL1016758;[];Cricetulus griseus;[];;;10029.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308072;Target assigned is non-molecular;1;Cytotoxicity against CHO cells transfected with ICAM1 by MTT assay;CHEMBL1151198;Non-molecular target assigned;N;;1;CHEMBL613853;;
CLD0;;RAW264.7;CHEMBL1016760;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Inhibition of iNOS production in LPS-activated mouse RAW264.7 cells after 20 hrs;CHEMBL1151198;Non-molecular target assigned;N;;1;CHEMBL612557;;
CLD0;;;CHEMBL1019382;[];;[];;;;;;U;Unassigned;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Specific index, ratio of IC50 for mouse RAW264.7 to IC50 for iNOS production in mouse RAW264.7;CHEMBL1151198;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL964792;[];Rattus norvegicus;[];;;10116.0;;;B;Binding;BAO_0000019;assay format;;Direct single protein target assigned;9;Displacement of 1-anilinonaphthalene-8-sulphonic acid from rat recombinant L-FABP high binding affinity site expressed in Escherichia coli BL21 by competitive fluorescence displacement assay;CHEMBL1157469;Direct protein target assigned;D;;1;CHEMBL5738;;
CLD0;;;CHEMBL964795;[];Rattus norvegicus;[];;;10116.0;;;B;Binding;BAO_0000019;assay format;;Direct single protein target assigned;9;Displacement of 1-anilinonaphthalene-8-sulphonic acid from rat recombinant L-FABP low binding affinity site expressed in Escherichia coli BL21 by competitive fluorescence displacement assay;CHEMBL1157469;Direct protein target assigned;D;;1;CHEMBL5738;;
CLD0;;R1;CHEMBL963781;[];;[];;;;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307379;Homologous single protein target assigned;8;Inhibition of glucocorticoid receptor-glucocorticoid complex transfected in rat R1 cells assessed as down-regulation of TPA-responsive element proinflammatory gene expression at 10 uM after 24 hrs by beta-galactosidase assay;CHEMBL1157381;Homologous protein target assigned;H;;1;CHEMBL2034;;
CLD0;;;CHEMBL964722;[];;[];;;;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Inhibition of glucocorticoid receptor;CHEMBL1150407;Homologous protein target assigned;H;;1;CHEMBL2034;;
CLD0;;;CHEMBL965578;[];Mus musculus;[];;;10090.0;;;B;Binding;BAO_0000019;assay format;;Direct single protein target assigned;9;Inhibition of mouse brain MAOA;CHEMBL1152129;Direct protein target assigned;D;;1;CHEMBL3681;;
CLD0;;;CHEMBL965580;[];Mus musculus;[];;;10090.0;;;B;Binding;BAO_0000019;assay format;;Direct single protein target assigned;9;Inhibition of mouse brain MAOB;CHEMBL1152129;Direct protein target assigned;D;;1;CHEMBL3050;;
CLD0;;TH2;CHEMBL964262;[];Mus musculus;[];BALB/c;;10090.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of pro-inflammatory cytokine IL5 production in ovalbumin-stimulated BALB/c mouse TH2 cells after 48 hrs by sandwich-ELISA;CHEMBL1153431;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;TH2;CHEMBL964263;[];Mus musculus;[];BALB/c;;10090.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of pro-inflammatory cytokine IL13 production in ovalbumin-stimulated BALB/c mouse TH2 cells after 48 hrs by sandwich-ELISA;CHEMBL1153431;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;TH2;CHEMBL964264;[];Mus musculus;[];BALB/c;;10090.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of pro-inflammatory cytokine IL5 production in ovalbumin-stimulated BALB/c mouse TH2 cells at 5 nM after 48 hrs by sandwich-ELISA relative to control;CHEMBL1153431;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;TH2;CHEMBL964267;[];Mus musculus;[];BALB/c;;10090.0;;;A;ADME;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against BALB/c mouse TH2 cells after 48 hrs by Trypan blue assay;CHEMBL1153431;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL963263;[];Rattus norvegicus;[];;;10116.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Binding affinity to rat uterus estrogen receptor at 0.01 uM;CHEMBL1153852;Direct protein target assigned;D;;1;CHEMBL2724;;
CLD0;;;CHEMBL963267;[];Rattus norvegicus;[];;;10116.0;;Prostate gland;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;Binding affinity to rat ventral prostate androgen receptor at 0.01 uM;CHEMBL1153852;Direct protein target assigned;D;;1;CHEMBL3072;CHEMBL3638250;
CLD0;;;CHEMBL965787;[];Rattus norvegicus;[];;;10116.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Binding affinity to rat uterus progesterone receptor at 0.01 uM;CHEMBL1153852;Direct protein target assigned;D;;1;CHEMBL2596;;
CLD0;;;CHEMBL965791;[];Rattus norvegicus;[];;;10116.0;;;B;Binding;BAO_0000019;assay format;;Direct single protein target assigned;9;Binding affinity to rat liver glucocorticoid receptor at 0.01 uM;CHEMBL1153852;Direct protein target assigned;D;;1;CHEMBL3368;;
CLD0;;;CHEMBL1032150;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Displacement of fluormone from human recombinant glucocorticoid receptor ligand binding domain by fluorescence polarization assay;CHEMBL1158488;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;;CHEMBL1035433;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Total body clearance in human;CHEMBL1151930;Non-molecular target assigned;N;;1;CHEMBL372;;
CLD0;;;CHEMBL1035434;[];Homo sapiens;[];;;9606.0;In vivo;Kidney;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Renal clearance in human;CHEMBL1151930;Non-molecular target assigned;N;;1;CHEMBL372;CHEMBL3638241;
CLD0;;MDA-kb2;CHEMBL1052486;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at androgen receptor in human MDA-kb2 cells assessed as stimulation of luciferase activity by luciferase reporter gene assay;CHEMBL1153076;Direct protein target assigned;D;;1;CHEMBL1871;;
CLD0;;MDA-kb2;CHEMBL1052488;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at glucocorticoid receptor in human MDA-kb2 cells assessed as stimulation of luciferase activity by luciferase reporter gene assay;CHEMBL1153076;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;A549;CHEMBL1052501;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Direct single protein target assigned;9;Agonist activity at GR in human A549 cells by NF-kappaB transrepression assay;CHEMBL1153077;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;A549;CHEMBL1052502;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Direct single protein target assigned;9;Agonist activity at human GR in A549 cells by NFkappaB transrepression assay relative to Dexamethasone;CHEMBL1153077;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;;CHEMBL1039873;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Displacement of GS-red from human glucocorticoid receptor by fluorescent polarization assay;CHEMBL1156812;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;A549;CHEMBL1039874;[];;[];;;;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307651;Homologous single protein target assigned;8;Transrepression activity at glucocorticoid receptor expressed in human A549 cells assessed as inhibition of PMA-induced AP1 activity after 6 hrs by luciferase reporter gene assay;CHEMBL1156812;Homologous protein target assigned;H;;1;CHEMBL2034;;
CLD0;;A549;CHEMBL1039876;[];;[];;;;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307651;Homologous single protein target assigned;8;Transrepression activity at glucocorticoid receptor expressed in human A549 cells assessed as inhibition of IL-1-beta-induced NF-kappaB dependent E-selection promoter activation after 6 hrs by luciferase reporter gene based ELAM assay;CHEMBL1156812;Homologous protein target assigned;H;;1;CHEMBL2034;;
CLD0;;HeLa;CHEMBL1039878;[];;[];;;;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308376;Homologous single protein target assigned;8;Transactivation of GAL-4 tagged glucocorticoid receptor ligand binding domain expressed in human HeLa cells assessed as NP1 activation by luciferase reporter gene assay;CHEMBL1156812;Homologous protein target assigned;H;;1;CHEMBL2034;;
CLD0;;;CHEMBL1040731;[];;[];;;;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Binding affinity to androgen receptor;CHEMBL1156812;Homologous protein target assigned;H;;1;CHEMBL1871;;
CLD0;;;CHEMBL1040732;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;Antagonist activity at mineralocorticoid receptor at 10 uM by antagonist mode functional assay;CHEMBL1156812;Homologous protein target assigned;H;;1;CHEMBL1994;;
CLD0;;;CHEMBL1040733;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;Agonist activity at mineralocorticoid receptor at 10 uM by agonist mode functional assay;CHEMBL1156812;Homologous protein target assigned;H;;1;CHEMBL1994;;
CLD0;;;CHEMBL1043580;[];Homo sapiens;[];;;9606.0;;Plasma;A;ADME;BAO_0000366;cell-free format;;Target assigned is non-molecular;1;Fraction unbound in human plasma;CHEMBL1156824;Non-molecular target assigned;N;;1;CHEMBL613652;CHEMBL3559721;
CLD0;;;CHEMBL1043581;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Total clearance in human;CHEMBL1156824;Non-molecular target assigned;N;;1;CHEMBL372;;
CLD0;;;CHEMBL1043582;[];Homo sapiens;[];;;9606.0;In vivo;Liver;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Hepatic clearance in human;CHEMBL1156824;Non-molecular target assigned;N;;1;CHEMBL372;CHEMBL3559723;
CLD0;;;CHEMBL1043583;[];Homo sapiens;[];;;9606.0;In vivo;Kidney;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Renal clearance in human;CHEMBL1156824;Non-molecular target assigned;N;;1;CHEMBL372;CHEMBL3638241;
CLD0;;;CHEMBL1043584;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Oral bioavailability in human;CHEMBL1156824;Non-molecular target assigned;N;;1;CHEMBL372;;
CLD0;;;CHEMBL1043585;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Fraction absorbed in human;CHEMBL1156824;Non-molecular target assigned;N;;1;CHEMBL372;;
CLD0;;;CHEMBL1043586;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Fraction escaping gut-wall elimination in human;CHEMBL1156824;Non-molecular target assigned;N;;1;CHEMBL372;;
CLD0;;;CHEMBL1043587;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Fraction escaping hepatic elimination in human;CHEMBL1156824;Non-molecular target assigned;N;;1;CHEMBL372;;
CLD0;;;CHEMBL1043588;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Volume of distribution at steady state in human;CHEMBL1156824;Non-molecular target assigned;N;;1;CHEMBL372;;
CLD0;;RAW264.7;CHEMBL1040729;[];;[];;;;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307977;Default value - Target unknown or has yet to be assigned;0;Inhibition of LPS-induced NF-kappaB transcriptional activation expressed in mouse RAW264.7 cells assessed as NF-kappaB activity at 10 uM treated after LPS challenge measured after 24 hrs by luciferase reporter gene assay relative to control;CHEMBL1152520;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;RAW264.7;CHEMBL1074851;[];;[];;;;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307977;Homologous single protein target assigned;8;Inhibition of LPS-induced AP1 transcriptional activation expressed in mouse RAW264.7 cells assessed as AP1 activity at 10 uM treated after LPS challenge measured after 24 hrs by luciferase reporter gene assay relative to control;CHEMBL1152520;Homologous protein target assigned;H;;1;CHEMBL4977;;
CLD0;;;CHEMBL1066717;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Lipophilicity, log D of the compound;CHEMBL1153196;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;Franz;CHEMBL1066718;[];Homo sapiens;[];;;9606.0;;Zone of skin;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Permeability in human skin after 48 hrs by Franz cell permeability assay;CHEMBL1153196;Non-molecular target assigned;N;;1;CHEMBL613427;CHEMBL3638174;
CLD0;;THP-1;CHEMBL1067421;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Antiinflammatory activity in human THP1 cells assessed as inhibition of LPS-induced TNFalpha release at 1 uM/mL after 24 hrs by ELISA;CHEMBL1153097;Non-molecular target assigned;N;;1;CHEMBL614245;;
CLD0;;THP-1;CHEMBL1067422;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Antiinflammatory activity in human THP1 cells assessed as inhibition of LPS-induced IL6 release at 1 uM/mL after 24 hrs by ELISA;CHEMBL1153097;Non-molecular target assigned;N;;1;CHEMBL614245;;
CLD0;;THP-1;CHEMBL1067424;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Cytotoxicity against human THP1 cells assessed as CCK8 release at 1 uM/mL after 24 hrs by ELISA;CHEMBL1153097;Non-molecular target assigned;N;;1;CHEMBL614245;;
CLD0;;Caco-2;CHEMBL1074672;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Target assigned is non-molecular;1;Permeability across human Caco-2 cells;CHEMBL1152590;Non-molecular target assigned;N;;1;CHEMBL614058;;
CLD0;;THP-1;CHEMBL1065861;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Antiinflammatory activity in human THP1 cells assessed as inhibition of LPS-induced TNFalpha release at 1 uM by ELISA;CHEMBL1159122;Non-molecular target assigned;N;;1;CHEMBL614245;;
CLD0;;;CHEMBL1072097;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in human CKLF1-electroporated transfected mouse assessed as decrease in infiltration of inflammatory cells at 2 mg/kg, po;CHEMBL1156907;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL1072101;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 503, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'RESPIRATORY SYSTEM', 'l2': 'Effects on Air Ways', 'l3': 'General Airway Models', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;Lung;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in human CKLF1-electroporated transfected mouse assessed as WBC count in per microL of bronchoalveolar lavage fluid at 2 mg/kg, po;CHEMBL1156907;Non-molecular target assigned;N;;1;CHEMBL375;CHEMBL3638235;
CLD0;;;CHEMBL1072104;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 503, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'RESPIRATORY SYSTEM', 'l2': 'Effects on Air Ways', 'l3': 'General Airway Models', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;Lung;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in human CKLF1-electroporated transfected mouse assessed as eosinophils in bronchoalveolar lavage fluid at 2 mg/kg, po;CHEMBL1156907;Non-molecular target assigned;N;;1;CHEMBL375;CHEMBL3638235;
CLD0;;;CHEMBL1072743;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in human CKLF1-electroporated transfected mouse assessed as decrease in collagen deposition at 2 mg/kg, po;CHEMBL1156907;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;THP-1;CHEMBL1067787;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Antiinflammatory activity in human THP1 cells assessed as inhibition of LPS-induced TNFalpha release at 1 uM preincubated for 30 mins before LPS challenge by ELISA;CHEMBL1156852;Non-molecular target assigned;N;;1;CHEMBL614245;;
CLD0;;CCK8;CHEMBL1067789;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Toxicity against human CCK8 cells assessed as cell growth;CHEMBL1156852;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;THP-1;CHEMBL1067791;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Antiinflammatory activity in human THP1 cells assessed as inhibition of LPS-induced IL6 release at 1 uM preincubated for 30 mins before LPS challenge by ELISA;CHEMBL1156852;Non-molecular target assigned;N;;1;CHEMBL614245;;
CLD0;;THP-1;CHEMBL1071626;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Antiinflammatory activity in human THP1 cells assessed as inhibition of LPS-induced TNFalpha release at 1 uM after 24 hrs by ELISA;CHEMBL1157556;Non-molecular target assigned;N;;1;CHEMBL614245;;
CLD0;;THP-1;CHEMBL1071627;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Antiinflammatory activity in human THP1 cells assessed as inhibition of LPS-induced IL6 release at 1 uM after 24 hrs by ELISA;CHEMBL1157556;Non-molecular target assigned;N;;1;CHEMBL614245;;
CLD0;;THP-1;CHEMBL1071628;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Cytotoxicity against human THP1 cells assessed as CCK8 release at 1 uM after 24 hrs by ELISA;CHEMBL1157556;Non-molecular target assigned;N;;1;CHEMBL614245;;
CLD0;;PBMC;CHEMBL1100397;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Antiinflammatory activity in human PBMC assessed as inhibition of 10 ng/ml LPS-induced TNFalpha release at 1.3 uM pretreated 24 hrs before inducer-challenge measured 24 hrs after LPS addition by ELISA;CHEMBL1154355;Non-molecular target assigned;N;;1;CHEMBL613107;;
CLD0;;PBMC;CHEMBL1101152;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Antiinflammatory activity in human PBMC assessed as inhibition of 10 ng/ml LPS-induced TNFalpha release at 5.1 uM pretreated 24 hrs before inducer-challenge measured 24 hrs after LPS addition by ELISA;CHEMBL1154355;Non-molecular target assigned;N;;1;CHEMBL613107;;
CLD0;;;CHEMBL1100461;[];Homo sapiens;[];;;9606.0;;Plasma;A;ADME;BAO_0000366;cell-free format;;Target assigned is non-molecular;1;Fraction unbound in human plasma;CHEMBL1153781;Non-molecular target assigned;N;;1;CHEMBL613652;CHEMBL3559721;
CLD0;;;CHEMBL1100462;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Volume of distribution at steady state in human;CHEMBL1153781;Non-molecular target assigned;N;;1;CHEMBL372;;
CLD0;;COS-7;CHEMBL1111212;[];;[];;;;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307648;Homologous single protein target assigned;8;Agonist activity at glucocorticoid receptor ligand binding domain expressed in african green monkey COS7 cells co-transfected with Gal4-LBD by luciferase reporter gene assay;CHEMBL1154793;Homologous protein target assigned;H;;1;CHEMBL2034;;
CLD0;;;CHEMBL1106115;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Displacement of fluoromone from human glucocorticoid receptor LBD assessed as reduction of maximum polarization by fluorescence polarization assay relative to control;CHEMBL1156190;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;;CHEMBL1106116;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Displacement of [3H]DEX from human glucocorticoid receptor;CHEMBL1156190;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;;CHEMBL1106118;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Displacement of fluoromone from human glucocorticoid receptor LBD at 1 uM assessed as reduction of maximum polarization by fluorescence polarization assay relative to control;CHEMBL1156190;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;A549;CHEMBL1106122;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307651;Direct single protein target assigned;9;Transrepression activity at glucocorticoid receptor in human A549 cells assessed as inhibition of IL-1-alpha-induced IL6 expression after 24 hrs by ELISA;CHEMBL1156190;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;;CHEMBL1107884;[{'assay_class_id': 295, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Croton Oil Ear Edema', 'source': 'Vogel_2008'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;Ear;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in mouse assessed as inhibition of phorbol ester-induced ear edema at 1 mg/ear;CHEMBL1156280;Non-molecular target assigned;N;;1;CHEMBL375;CHEMBL3987716;
CLD0;;THP-1;CHEMBL1115113;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-stimulated human THP1 cells assessed as inhibition of TNFalpha formation at 1 uM pretreated 30 mins before LPS challenge measured after 24 hrs by ELISA;CHEMBL1156322;Non-molecular target assigned;N;;1;CHEMBL614245;;
CLD0;;;CHEMBL1116254;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Human intestinal absorption in po dosed human;CHEMBL1157012;Non-molecular target assigned;N;;1;CHEMBL372;;
CLD0;;;CHEMBL1116294;[];;[];;;;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Binding affinity to glucocorticoid receptor;CHEMBL1157104;Homologous protein target assigned;H;;1;CHEMBL2034;;
CLD0;;;CHEMBL1111991;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;Agonist activity at glucocorticoid receptor in human fibroblast assessed as inhibition of IL-1-beta-induced IL6 production at 100 nM treated 1 hr before IL1-beta challenge measured after 24 hrs by transrepression assay;CHEMBL1157802;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;;CHEMBL1111992;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;Agonist activity at glucocorticoid receptor in human fibroblast assessed as inhibition of IL-1-beta-induced IL6 production at 2 nM treated 1 hr before IL1-beta challenge measured after 24 hrs by transrepression assay;CHEMBL1157802;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;;CHEMBL1112930;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Absolute bioavailability in human;CHEMBL1158536;Non-molecular target assigned;N;;1;CHEMBL372;;
CLD0;;MDCK;CHEMBL1112933;[];;[];;;;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308370;Target assigned is non-molecular;1;Transcellular permeability at pH 6.5 calculated from in vitro P app values in Caco-2 and/or MDCK cells;CHEMBL1158536;Non-molecular target assigned;N;;1;CHEMBL614068;;
CLD0;;;CHEMBL1119516;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;Antiinflammatory activity in human primary synovial fibroblasts assessed as inhibition of IL1-induced IL6 release after 18 hrs by MSD technology;CHEMBL1155531;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL1119517;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;Antiinflammatory activity in human primary synovial fibroblasts assessed as inhibition of IL1-induced IL8 release after 18 hrs by MSD technology;CHEMBL1155531;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL1119518;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;Antiinflammatory activity in human primary synovial fibroblasts assessed as inhibition of IL1-induced MMP1 release after 18 hrs by MSD technology;CHEMBL1155531;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL1119519;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Toxicity in human skeletal muscle cells assessed as increase in glutamine synthase mRNA level after 18 hrs by PCR;CHEMBL1155531;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;Hepatocyte;CHEMBL1119520;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000219;cell-based format;CHEMBL3308043;Target assigned is non-molecular;1;Toxicity in human hepatocytes assessed as increase in PEPCK mRNA level after 18 hrs by PCR;CHEMBL1155531;Non-molecular target assigned;N;;1;CHEMBL613690;;
CLD0;;NIH3T3;CHEMBL1119926;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '10.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '10.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;Plasma;A;ADME;BAO_0000218;organism-based format;CHEMBL3307716;Target assigned is non-molecular;1;Plasma concentration in mouse bearing mouse NIH-3T3 cells integrated with MMTV reporter gene at 10 mg/kg, po after 1 hr;CHEMBL1155531;Non-molecular target assigned;N;;1;CHEMBL375;CHEMBL3559721;
CLD0;;A549;CHEMBL1119927;[];;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '10.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '10.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;;;Plasma;A;ADME;BAO_0000218;organism-based format;CHEMBL3307651;Default value - Target unknown or has yet to be assigned;0;Relative plasma concentration in mouse assessed as ratio of plasma concentration in mouse at 10 mg/kg, po to IC50 for NF-kappaB transrepression activity in A549 cells expressing MMTV reporter gene;CHEMBL1155531;Default value - Target has yet to be curated;U;;1;CHEMBL612558;CHEMBL3559721;
CLD0;;NIH3T3;CHEMBL1119928;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '10.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '10.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;Plasma;A;ADME;BAO_0000218;organism-based format;CHEMBL3307716;Target assigned is non-molecular;1;Fraction unbound in mouse plasma bearing mouse NIH-3T3 cells integrated with MMTV reporter gene at 10 mg/kg, po after 1 hr;CHEMBL1155531;Non-molecular target assigned;N;;1;CHEMBL375;CHEMBL3559721;
CLD0;;A549;CHEMBL1119929;[];;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '10.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '10.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;;;;A;ADME;BAO_0000218;organism-based format;CHEMBL3307651;Default value - Target unknown or has yet to be assigned;0;Relative fraction unbound in mouse assessed as ratio of fraction unbound in mouse at 10 mg/kg, po to IC50 for NF-kappaB transrepression activity in A549 cells expressing MMTV reporter gene;CHEMBL1155531;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;NIH3T3;CHEMBL1119930;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;Plasma;A;ADME;BAO_0000218;organism-based format;CHEMBL3307716;Target assigned is non-molecular;1;Plasma concentration in mouse bearing mouse NIH-3T3 cells integrated with MMTV reporter gene at 1 mg/kg, po after 1 hr;CHEMBL1155531;Non-molecular target assigned;N;;1;CHEMBL375;CHEMBL3559721;
CLD0;;A549;CHEMBL1119931;[];;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;;;Plasma;A;ADME;BAO_0000218;organism-based format;CHEMBL3307651;Default value - Target unknown or has yet to be assigned;0;Relative plasma concentration in mouse assessed as ratio of plasma concentration in mouse at 1 mg/kg, po to IC50 for NF-kappaB transrepression activity in A549 cells expressing MMTV reporter gene;CHEMBL1155531;Default value - Target has yet to be curated;U;;1;CHEMBL612558;CHEMBL3559721;
CLD0;;NIH3T3;CHEMBL1119932;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;Plasma;A;ADME;BAO_0000218;organism-based format;CHEMBL3307716;Target assigned is non-molecular;1;Fraction unbound in mouse plasma bearing mouse NIH-3T3 cells integrated with MMTV reporter gene at 1 mg/kg, po after 1 hr;CHEMBL1155531;Non-molecular target assigned;N;;1;CHEMBL375;CHEMBL3559721;
CLD0;;A549;CHEMBL1119933;[];;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;;;;A;ADME;BAO_0000218;organism-based format;CHEMBL3307651;Default value - Target unknown or has yet to be assigned;0;Relative fraction unbound in mouse assessed as ratio of fraction unbound in mouse at 1 mg/kg, po to IC50 for NF-kappaB transrepression activity in A549 cells expressing MMTV reporter gene;CHEMBL1155531;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;NIH3T3;CHEMBL1119934;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.1', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.1'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;Plasma;A;ADME;BAO_0000218;organism-based format;CHEMBL3307716;Target assigned is non-molecular;1;Plasma concentration in mouse bearing mouse NIH-3T3 cells integrated with MMTV reporter gene at 0.1 mg/kg, po after 1 hr;CHEMBL1155531;Non-molecular target assigned;N;;1;CHEMBL375;CHEMBL3559721;
CLD0;;A549;CHEMBL1119935;[];;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.1', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.1'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;;;Plasma;A;ADME;BAO_0000218;organism-based format;CHEMBL3307651;Default value - Target unknown or has yet to be assigned;0;Relative plasma concentration in mouse assessed as ratio of plasma concentration in mouse at 0.1 mg/kg, po to IC50 for NF-kappaB transrepression activity in A549 cells expressing MMTV reporter gene;CHEMBL1155531;Default value - Target has yet to be curated;U;;1;CHEMBL612558;CHEMBL3559721;
CLD0;;NIH3T3;CHEMBL1119936;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.1', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.1'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;Plasma;A;ADME;BAO_0000218;organism-based format;CHEMBL3307716;Target assigned is non-molecular;1;Fraction unbound in mouse plasma bearing mouse NIH-3T3 cells integrated with MMTV reporter gene at 0.1 mg/kg, po after 1 hr;CHEMBL1155531;Non-molecular target assigned;N;;1;CHEMBL375;CHEMBL3559721;
CLD0;;A549;CHEMBL1119937;[];;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.1', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.1'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;;;;A;ADME;BAO_0000218;organism-based format;CHEMBL3307651;Default value - Target unknown or has yet to be assigned;0;Relative fraction unbound in mouse assessed as ratio of fraction unbound in mouse at 0.1 mg/kg, po to IC50 for NF-kappaB transrepression activity in A549 cells expressing MMTV reporter gene;CHEMBL1155531;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;NIH3T3;CHEMBL1119938;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.01', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.01'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;Plasma;A;ADME;BAO_0000218;organism-based format;CHEMBL3307716;Target assigned is non-molecular;1;Plasma concentration in mouse bearing mouse NIH-3T3 cells integrated with MMTV reporter gene at 0.01 mg/kg, po after 1 hr;CHEMBL1155531;Non-molecular target assigned;N;;1;CHEMBL375;CHEMBL3559721;
CLD0;;A549;CHEMBL1119939;[];;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.01', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.01'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;;;Plasma;A;ADME;BAO_0000218;organism-based format;CHEMBL3307651;Default value - Target unknown or has yet to be assigned;0;Relative plasma concentration in mouse assessed as ratio of plasma concentration in mouse at 0.01 mg/kg, po to IC50 for NF-kappaB transrepression activity in A549 cells expressing MMTV reporter gene;CHEMBL1155531;Default value - Target has yet to be curated;U;;1;CHEMBL612558;CHEMBL3559721;
CLD0;;NIH3T3;CHEMBL1119940;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.01', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.01'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;Plasma;A;ADME;BAO_0000218;organism-based format;CHEMBL3307716;Target assigned is non-molecular;1;Fraction unbound in mouse plasma bearing mouse NIH-3T3 cells integrated with MMTV reporter gene at 0.01 mg/kg, po after 1 hr;CHEMBL1155531;Non-molecular target assigned;N;;1;CHEMBL375;CHEMBL3559721;
CLD0;;A549;CHEMBL1119941;[];;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.01', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.01'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;;;;A;ADME;BAO_0000218;organism-based format;CHEMBL3307651;Default value - Target unknown or has yet to be assigned;0;Relative fraction unbound in mouse assessed as ratio of fraction unbound in mouse at 0.01 mg/kg, po to IC50 for NF-kappaB transrepression activity in A549 cells expressing MMTV reporter gene;CHEMBL1155531;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1119946;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '10.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '10.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Inhibition of IL1-induced circulating IL6 release in mouse at 10 mg/kg, po;CHEMBL1155531;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL1119947;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Inhibition of IL1-induced circulating IL6 release in mouse at 1 mg/kg, po;CHEMBL1155531;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL1119948;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.1', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.1'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Inhibition of IL1-induced circulating IL6 release in mouse at 0.1 mg/kg, po;CHEMBL1155531;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL1119949;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.01', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.01'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Inhibition of IL1-induced circulating IL6 release in mouse at 0.01 mg/kg, po;CHEMBL1155531;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL1119951;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Inhibition of IL1-induced circulating IL6 release in po dosed mouse;CHEMBL1155531;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;THP-1;CHEMBL1168531;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Antiinflammatory activity in human THP1 cells assessed as inhibition of LPS-induced TNFalpha secretion at 10 uM treated 30 mins before LPS challenge measured after 24 hrs by ELISA relative to control;CHEMBL1165858;Non-molecular target assigned;N;;1;CHEMBL614245;;
CLD0;;THP-1;CHEMBL1168532;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Antiinflammatory activity in human THP1 cells assessed as inhibition of LPS-induced IL-6 secretion at 10 uM treated 30 mins before LPS challenge measured after 24 hrs by ELISA relative to control;CHEMBL1165858;Non-molecular target assigned;N;;1;CHEMBL614245;;
CLD0;;CCK8;CHEMBL1168533;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against human CCK8 cells at 10 uM;CHEMBL1165858;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;THP-1;CHEMBL1175034;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Antiinflammatory activity in human THP1 cells assessed as inhibition of LPS-induced TNFalpha production at 1 uM treated 30 mins before LPS challenge measured after 24 hrs by ELISA relative to control;CHEMBL1177886;Non-molecular target assigned;N;;1;CHEMBL614245;;
CLD0;;THP-1;CHEMBL1175035;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Antiinflammatory activity in human THP1 cells assessed as inhibition of LPS-induced IL-6 production at 1 uM treated 30 mins before LPS challenge measured after 24 hrs by ELISA relative to control;CHEMBL1177886;Non-molecular target assigned;N;;1;CHEMBL614245;;
CLD0;;CCK8;CHEMBL1175036;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against human CCK8 cells at 1 uM;CHEMBL1177886;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1216998;[];Trypanosoma cruzi;[];;;5693.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimicrobial activity against Trypanosoma cruzi;CHEMBL1212812;Non-molecular target assigned;N;;1;CHEMBL368;;
CLD0;;;CHEMBL1216999;[];Trypanosoma brucei brucei;[];;;5702.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimicrobial activity against Trypanosoma brucei brucei;CHEMBL1212812;Non-molecular target assigned;N;;1;CHEMBL612851;;
CLD0;;;CHEMBL1217000;[];Plasmodium falciparum;[];;;5833.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimicrobial activity against Plasmodium falciparum;CHEMBL1212812;Non-molecular target assigned;N;;1;CHEMBL364;;
CLD0;;;CHEMBL1217001;[];Trypanosoma brucei;[];;;5691.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimicrobial activity against Trypanosoma brucei;CHEMBL1212812;Non-molecular target assigned;N;;1;CHEMBL612849;;
CLD0;;;CHEMBL1217002;[];Leishmania;[];;;5658.0;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;Antimicrobial activity against Leishmania;CHEMBL1212812;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL1217004;[];Trichomonas vaginalis;[];;;5722.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimicrobial activity against Trichomonas vaginalis;CHEMBL1212812;Non-molecular target assigned;N;;1;CHEMBL612884;;
CLD0;;;CHEMBL1217005;[];Toxoplasma gondii;[];;;5811.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimicrobial activity against Toxoplasma gondii;CHEMBL1212812;Non-molecular target assigned;N;;1;CHEMBL612888;;
CLD0;;;CHEMBL1217006;[];Leishmania mexicana;[];;;5665.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimicrobial activity against Leishmania mexicana;CHEMBL1212812;Non-molecular target assigned;N;;1;CHEMBL612880;;
CLD0;;;CHEMBL1217007;[];Entamoeba histolytica;[];;;5759.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimicrobial activity against Entamoeba histolytica;CHEMBL1212812;Non-molecular target assigned;N;;1;CHEMBL612853;;
CLD0;;;CHEMBL1217008;[];Leishmania amazonensis;[];;;5659.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimicrobial activity against Leishmania amazonensis;CHEMBL1212812;Non-molecular target assigned;N;;1;CHEMBL612877;;
CLD0;;;CHEMBL1217009;[];Leishmania donovani;[];;;5661.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimicrobial activity against Leishmania donovani;CHEMBL1212812;Non-molecular target assigned;N;;1;CHEMBL367;;
CLD0;;;CHEMBL1217010;[];Leishmania infantum;[];;;5671.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimicrobial activity against Leishmania infantum;CHEMBL1212812;Non-molecular target assigned;N;;1;CHEMBL612848;;
CLD0;;;CHEMBL1217011;[];Leishmania major;[];;;5664.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimicrobial activity against Leishmania major;CHEMBL1212812;Non-molecular target assigned;N;;1;CHEMBL612879;;
CLD0;;;CHEMBL1217012;[];Cryptosporidium parvum;[];;;5807.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimicrobial activity against Cryptosporidium parvum;CHEMBL1212812;Non-molecular target assigned;N;;1;CHEMBL612855;;
CLD0;;;CHEMBL1217013;[];Trypanosoma brucei rhodesiense;[];;;31286.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimicrobial activity against Trypanosoma brucei rhodesiense;CHEMBL1212812;Non-molecular target assigned;N;;1;CHEMBL612348;;
CLD0;;;CHEMBL1217186;[];Pneumocystis carinii;[];;;4754.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimicrobial activity against Pneumocystis carinii;CHEMBL1212812;Non-molecular target assigned;N;;1;CHEMBL613064;;
CLD0;;THP-1;CHEMBL1217691;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Antiinflammatory activity against human THP1 cells assessed as inhibition of LPS-induced TNFalpha release at 1 uM after 24 hrs;CHEMBL1212864;Non-molecular target assigned;N;;1;CHEMBL614245;;
CLD0;;THP-1;CHEMBL1217692;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Antiinflammatory activity against human THP1 cells assessed as inhibition of LPS-induced IL6 release at 1 uM after 24 hrs;CHEMBL1212864;Non-molecular target assigned;N;;1;CHEMBL614245;;
CLD0;;CCK8;CHEMBL1217693;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against human CCK8 cells at 1 uM;CHEMBL1212864;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1219383;[{'assay_class_id': 503, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'RESPIRATORY SYSTEM', 'l2': 'Effects on Air Ways', 'l3': 'General Airway Models', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '10.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '10.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];C57BL6;;10090.0;;Lung;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiallergic activity in C57BL/6 mouse assessed as reduction of HDM/CRA-induced chitinase activity in bronchoalveolar lavage fluid at 10 mg/kg, ip administered once daily;CHEMBL1212885;Non-molecular target assigned;N;;1;CHEMBL375;CHEMBL3638235;
CLD0;;;CHEMBL1219814;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Immunomodulatory activity in ip dosed mouse lung assessed as reduction in inhibition of ovalbumin-induced intense cell filtration;CHEMBL1212907;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL1219815;[{'assay_class_id': 503, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'RESPIRATORY SYSTEM', 'l2': 'Effects on Air Ways', 'l3': 'General Airway Models', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;Lung;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Immunomodulatory activity in ip dosed mouse lung assessed as reduction of eosinophils in bronchoalveolar lavage fluid;CHEMBL1212907;Non-molecular target assigned;N;;1;CHEMBL375;CHEMBL3638235;
CLD0;;COS-7;CHEMBL1219818;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307648;Direct single protein target assigned;9;Induction of nuclear translocation of YFP-fused GRalpha in human COS7 cells;CHEMBL1212907;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;PC-3;CHEMBL1226548;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307570;Target assigned is non-molecular;1;Antiproliferative activity against human PC3 cells at 500 nM after 120 hrs by MTT assay relative to DMSO;CHEMBL1221184;Non-molecular target assigned;N;;1;CHEMBL390;;
CLD0;;HeLa;CHEMBL1244038;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Cytotoxicity against human HeLa cells assessed as inhibition of DNA replication by imaging analysis;CHEMBL1240335;Non-molecular target assigned;N;;1;CHEMBL399;;
CLD0;;HeLa;CHEMBL1244039;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Inhibition of mitosis in human HeLa cells by imaging analysis;CHEMBL1240335;Non-molecular target assigned;N;;1;CHEMBL399;;
CLD0;;;CHEMBL1248175;[];Mus musculus;[];C3H/HeJ;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Protection against SEB-induced toxicity in C3H/HeJ mouse assessed as lethality at 1.2 mg/kg, in administered at 5 hrs after SEB challenge followed by 5 mg/kg, ip infusion after 24 to 96 hrs of SEB exposure;CHEMBL1240404;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL1250864;[];;[];;;;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;Binding affinity to glucocorticoid receptor expressed in baculovirus-infected insect cells using tetramethylrhodamine labeled Dexamethasone by fluorescence polarization microplate assay;CHEMBL1250518;Homologous protein target assigned;H;;1;CHEMBL2034;;
CLD0;;;CHEMBL1250865;[];;[];;;;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;Binding affinity to progesterone receptor expressed in baculovirus-infected insect cells using tetramethylrhodamine labeled RU-486 by fluorescence polarization microplate assay;CHEMBL1250518;Homologous protein target assigned;H;;1;CHEMBL208;;
CLD0;;;CHEMBL1250866;[];;[];;;;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;Binding affinity to mineralocorticoid receptor expressed in baculovirus-infected insect cells using tetramethylrhodamine labeled Dexamethasone by fluorescence polarization microplate assay;CHEMBL1250518;Homologous protein target assigned;H;;1;CHEMBL1994;;
CLD0;;;CHEMBL1250867;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Transrepression activity at glucocorticoid receptor in HFF assessed as inhibition of IL-1-induced IL-6 production after 18 to 24 hrs by ELISA;CHEMBL1250518;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;Sf9;CHEMBL1261746;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308860;Direct single protein target assigned;9;Binding affinity to human recombinant glucocorticoid receptor expressed in baculovirus infected Sf9 cells;CHEMBL1255506;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;Sf9;CHEMBL1261747;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308860;Direct single protein target assigned;9;Binding affinity to human recombinant progesterone receptor expressed in baculovirus infected Sf9 cells;CHEMBL1255506;Direct protein target assigned;D;;1;CHEMBL208;;
CLD0;;Sf9;CHEMBL1261748;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308860;Direct single protein target assigned;9;Binding affinity to human recombinant mineralocorticoid receptor expressed in baculovirus infected Sf9 cells;CHEMBL1255506;Direct protein target assigned;D;;1;CHEMBL1994;;
CLD0;;Sf9;CHEMBL1261749;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308860;Direct single protein target assigned;9;Binding affinity to human recombinant androgen receptor expressed in baculovirus infected Sf9 cells;CHEMBL1255506;Direct protein target assigned;D;;1;CHEMBL1871;;
CLD0;;THP-1;CHEMBL1261750;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307574;Direct single protein target assigned;9;Transrepression activity at glucocorticoid receptor-mediated antiinflammatory activity in human THP1 cells assessed as inhibition of LPS-induced IL-8 production;CHEMBL1255506;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;HeLa;CHEMBL1261752;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308376;Direct single protein target assigned;9;Transrepression activity at glucocorticoid receptor-mediated antiinflammatory activity in human HeLa cells assessed as inhibition of TPA-induced collagenase promoter activity by luciferase reporter gene assay;CHEMBL1255506;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;HeLa;CHEMBL1261753;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308376;Direct single protein target assigned;9;Transactivation activity at glucocorticoid receptor in human HeLa cells assessed as induction of MMTV promoter activity by luciferase reporter gene assay;CHEMBL1255506;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;U2OS;CHEMBL1259726;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307757;Direct single protein target assigned;9;Agonist activity at glucocorticoid receptor-LBD in human U2OS cells transfected with Gal4-DBD assessed as increase of transactivation activity after 18 hrs by luciferase reporter gene assay;CHEMBL1255573;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;U2OS;CHEMBL1259733;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307757;Direct single protein target assigned;9;Antagonist activity at glucocorticoid receptor-LBD in human U2OS cells transfected with Gal4-DBD assessed as inhibition of transactivation activity after 18 hrs by luciferase reporter gene assay;CHEMBL1255573;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;;CHEMBL1280374;[];Pseudomonas aeruginosa PAO1;[];;;208964.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Bactericidal activity against kanamycin-resistant Pseudomonas aeruginosa PAO1 up to 50 uM after 3 hrs by time-kill assay;CHEMBL1275585;Non-molecular target assigned;N;;1;CHEMBL613264;;
CLD0;;Neutrophil;CHEMBL1281360;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308052;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against human neutrophil assessed as effect on cell viability up to 20 uM after 12 hrs by microscopy;CHEMBL1275585;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1281494;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Homologous single protein target assigned;8;Induction of CFP-tagged glucocorticoid receptor nuclear localization expressed in BAEC at 0.01 to 1 uM after 1 hr by luminescence assay;CHEMBL1275585;Homologous protein target assigned;H;;1;CHEMBL2034;;
CLD0;;;CHEMBL1285392;[];Candida albicans;[];;;5476.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Binding affinity to Candida albicans CaCdr1p expressed in yeast AD1-8u;CHEMBL1275276;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL1285393;[];Saccharomyces cerevisiae;[];AD1-8u;;4932.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antifungal activity against yeast AD1-8u expressing Candida albicans CaMdr1p by agar disk diffusion assay;CHEMBL1275276;Non-molecular target assigned;N;;1;CHEMBL361;;
CLD0;;;CHEMBL1285394;[];Candida albicans;[];;;5476.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Binding affinity to Candida albicans CaMdr1p expressed in yeast AD1-8u;CHEMBL1275276;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL1285395;[];Saccharomyces cerevisiae;[];AD1-8u;;4932.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antifungal activity against yeast AD1-8u expressing Candida albicans CaCdr1p by agar disk diffusion assay;CHEMBL1275276;Non-molecular target assigned;N;;1;CHEMBL361;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1614132;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Cell Viability - LYMP2-021. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;974;7;CHEMBL614696;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1613785;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Cell Viability - LYMP2-010. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;981;7;CHEMBL614696;;
CLD0;confirmatory;;CHEMBL1614281;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;938;7;CHEMBL1963;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1613813;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Cell Viability - LYMP2-022. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;987;7;CHEMBL614696;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1614008;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Cell Viability - LYMP1-002 - Assay at 40 hr. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;994;7;CHEMBL614696;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1614092;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Cell Viability - LYMP2-019. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;973;7;CHEMBL614696;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1614097;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Cell Viability - LYMP2-024. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;988;7;CHEMBL614696;;
CLD0;confirmatory;;CHEMBL1614108;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Activators of Cytochrome P450 3A4. (Class of assay: confirmatory) [Related pubchem assays: 410 ];CHEMBL1201862;Direct protein target assigned;D;885;7;CHEMBL340;;
CLD0;confirmatory;;CHEMBL1614211;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;2517;7;CHEMBL5619;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1614216;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Cell Viability - LYMP2-001. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;921;7;CHEMBL614696;;
CLD0;confirmatory;;CHEMBL1614361;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;926;7;CHEMBL1963;;
CLD0;confirmatory;Lymphoblastoid cell;CHEMBL1613876;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307685;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Cell Viability - LYMP2-005. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;967;7;CHEMBL614696;;
CLD0;confirmatory;;CHEMBL1613886;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4. (Class of assay: confirmatory) [Related pubchem assays: 410 ];CHEMBL1201862;Direct protein target assigned;D;884;7;CHEMBL340;;
CLD0;;;CHEMBL1614670;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Volume of distribution at steady state in human after iv administration;CHEMBL1614632;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1614671;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Clearance in human after iv administration;CHEMBL1614632;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1614672;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Fraction unbound in human after iv administration;CHEMBL1614632;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL1614673;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Mean residence time in human after iv administration;CHEMBL1614632;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1614674;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Half life in human after iv administration;CHEMBL1614632;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1663609;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human glucocorticoid receptor;CHEMBL1649335;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;;CHEMBL1670637;[];;[];;;;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Displacement of fluorescent-labelled Dexamethasone from glucocorticoid receptor;CHEMBL1667843;Homologous protein target assigned;H;;1;CHEMBL2034;;
CLD0;;A549;CHEMBL1670638;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Direct single protein target assigned;9;Agonist activity at glucocorticoid receptor in human A549 cells by NF-kappaB transrepression assay;CHEMBL1667843;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;A549;CHEMBL1670639;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Direct single protein target assigned;9;Agonist activity at glucocorticoid receptor in human A549 cells by NFkappaB transrepression assay relative to Dexamethasone;CHEMBL1667843;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;A549;CHEMBL1670640;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Direct single protein target assigned;9;Agonist activity at GR in human A549 cells transfected with luciferase gene linked to MMTV promoter assessed as luciferase transactivation activity;CHEMBL1667843;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;A549;CHEMBL1670641;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Direct single protein target assigned;9;Agonist activity at GR in human A549 cells transfected with luciferase gene linked to MMTV promoter assessed as luciferase transactivation activity relative to Dexamethasone;CHEMBL1667843;Direct protein target assigned;D;;1;CHEMBL2034;;
CLD0;;RAW264.7;CHEMBL1670934;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production treated 2 hrs before LPS challenge measured after 18 hrs by griess reaction;CHEMBL1667862;Non-molecular target assigned;N;;1;CHEMBL612557;;
CLD0;;;CHEMBL1686601;[];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Displacement of [3H]dexamethasone from Sprague-Dawley rat GR by liquid scintillation counting;CHEMBL1681767;Direct protein target assigned;D;;1;CHEMBL3368;;
CLD0;;RAW264.7;CHEMBL1687028;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs by Griess method;CHEMBL1681777;Non-molecular target assigned;N;;1;CHEMBL612557;;
CLD0;;RAW264.7;CHEMBL1687076;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNF-alpha secretion after 18 hrs;CHEMBL1681777;Non-molecular target assigned;N;;1;CHEMBL612557;;
CLD0;;RAW264.7;CHEMBL1687080;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-stimulated mouse RAW264.7 cells assessed as nitrite level at 10 uM after 24 hrs by Griess method;CHEMBL1681777;Non-molecular target assigned;N;;1;CHEMBL612557;;
CLD0;;RAW264.7;CHEMBL1687082;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-stimulated mouse RAW264.7 cells assessed as TNF-alpha level at 10 uM after 18 hrs;CHEMBL1681777;Non-molecular target assigned;N;;1;CHEMBL612557;;
CLD0;;HMC1;CHEMBL1694278;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295401;Target assigned is non-molecular;1;Immunomodulatory activity in human HMC1 cells assessed as inhibition of phorbol 12-myristate 13-acetate/A23187-stimulated IL1-beta secretion treated 1 hr prior to 30 mins phorbol 12-myristate 13-acetate/A23187 challenge by Western blotting analysis;CHEMBL1687905;Non-molecular target assigned;N;;1;CHEMBL4296432;;
CLD0;;;CHEMBL1697722;[];;[];;;;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset;CHEMBL1697692;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;;;CHEMBL1697730;[];Homo sapiens;[];;;9606.0;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Human drug-induced liver injury (DILI) modelling dataset from Ekins et al;CHEMBL1697723;Non-molecular target assigned;N;;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1697778;[];Homo sapiens;[];;;9606.0;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans;CHEMBL1697731;Non-molecular target assigned;N;;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1697779;[];Rodentia;[];;;9989.0;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents;CHEMBL1697731;Non-molecular target assigned;N;;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1697780;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents;CHEMBL1697731;Non-molecular target assigned;N;;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1697797;[];Homo sapiens;[];;;9606.0;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;FDA HLAED, liver enzyme composite activity;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1697798;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;FDA HLAED, alkaline phosphatase increase;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;;;CHEMBL1697799;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;;;CHEMBL1697800;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;;;CHEMBL1697801;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;FDA HLAED, lactate dehydrogenase (LDH) increase;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;;;CHEMBL1697802;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;FDA HLAED, gamma-glutamyl transferase (GGT) increase;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;confirmatory;;CHEMBL1738588;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125];CHEMBL1201862;Direct protein target assigned;D;504467;7;CHEMBL1741209;;
CLD0;confirmatory;;CHEMBL1737902;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID485345, AID485355];CHEMBL1201862;Default value - Target has yet to be curated;U;493014;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1738184;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648];CHEMBL1201862;Direct protein target assigned;D;504444;7;CHEMBL1075094;;
CLD0;;;CHEMBL1743273;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Direct single protein target assigned;9;Clinically relevant substrates of human liver microsomal P450 enzymes, isoform CYP3A4;CHEMBL1743201;Direct protein target assigned;D;9;1;CHEMBL340;;
CLD0;;;CHEMBL1743284;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Direct single protein target assigned;9;Clinically relevant inducers of human liver microsomal P450 enzymes, isoform CYP2A6;CHEMBL1743201;Direct protein target assigned;D;20;1;CHEMBL5282;;
CLD0;;;CHEMBL1743290;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Direct single protein target assigned;9;Clinically relevant inducers of human liver microsomal P450 enzymes, isoform CYP3A4;CHEMBL1743201;Direct protein target assigned;D;26;1;CHEMBL340;;
CLD0;;RAW264.7;CHEMBL1763374;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of IFN-gamma induced NO production after 24 hrs by Griess reaction;CHEMBL1759862;Non-molecular target assigned;N;364712;1;CHEMBL612557;;
CLD0;;Caco-2;CHEMBL1769835;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Target assigned is non-molecular;1;Apparent permeability across human Caco2 cell membrane after 2 hrs by LC-MS/MS analysis;CHEMBL1764994;Non-molecular target assigned;N;372409;1;CHEMBL614058;;
CLD0;;;CHEMBL1786887;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;Antiinflammatory activity in rat Polymorphonuclear leukocyte assessed as inhibition of LPS-induced nitric oxide production at 5 uM;CHEMBL1781996;Non-molecular target assigned;N;380954;1;CHEMBL3879801;;
CLD0;confirmatory;;CHEMBL1794321;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS assay for small molecule agonists of androgen receptor signaling. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;588515;7;CHEMBL1871;;
CLD0;confirmatory;;CHEMBL1794345;[];Plasmodium falciparum;[];;;5833.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850];CHEMBL1201862;Non-molecular target assigned;N;504834;7;CHEMBL364;;
CLD0;confirmatory;;CHEMBL1794401;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962];CHEMBL1201862;Homologous protein target assigned;H;540317;7;CHEMBL1741193;;
CLD0;confirmatory;;CHEMBL1794415;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS assay for small molecule agonists of farnesoid X receptor signaling. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;588527;7;CHEMBL2047;;
CLD0;confirmatory;;CHEMBL1794456;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS assay for small molecule agonists of glucocorticoid receptor signaling. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;588532;7;CHEMBL2034;;
CLD0;confirmatory;;CHEMBL1794499;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504856];CHEMBL1201862;Homologous protein target assigned;H;504845;7;CHEMBL1795091;;
CLD0;confirmatory;;CHEMBL1794524;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor delta signaling. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;588535;7;CHEMBL3979;;
CLD0;confirmatory;;CHEMBL1794534;[];;[];;;;;;B;Binding;BAO_0000217;biochemical format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: Luciferase Inhibition Counter Screen Measured in Biochemical System Using Plate Reader - 2038-06_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2118];CHEMBL1201862;Homologous protein target assigned;H;588847;7;CHEMBL5150;;
CLD0;confirmatory;;CHEMBL1794560;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS assay for small molecule antagonists of androgen receptor signaling. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;588516;7;CHEMBL1871;;
CLD0;;Peritoneal macrophage cell;CHEMBL1799879;[];Mus musculus;[];C57BL/6J;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308045;Default value - Target unknown or has yet to be assigned;0;Inhibition of LPS-induced nitric oxide production in C57BL/6J mouse peritoneal macrophages at 10 uM after 24 hrs by Griess reaction;CHEMBL1795288;Default value - Target has yet to be curated;U;382409;1;CHEMBL612545;;
CLD0;;;CHEMBL1805661;[];;[];;;;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Displacement of GS-red from GRapha by fluorescence polarization assay;CHEMBL1799968;Homologous protein target assigned;H;385706;1;CHEMBL2034;;
CLD0;;A549;CHEMBL1805663;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307651;Direct single protein target assigned;9;Transrepression activity of glucocorticoid receptor in human A549 cells expressing AP-1 assessed as inhibition of PMA-induced AP-1 activity by luciferase reporter gene assay;CHEMBL1799968;Direct protein target assigned;D;385769;1;CHEMBL2034;;
CLD0;;HeLa;CHEMBL1805665;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308376;Direct single protein target assigned;9;Transactivation activity of glucocorticoid receptor ligand binding domain expressed in human NP-1 Hela cells co-expressing GAL4 DNA binding domain by luciferase reporter gene assay;CHEMBL1799968;Direct protein target assigned;D;385781;1;CHEMBL2034;;
CLD0;;A549;CHEMBL1805666;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307651;Direct single protein target assigned;9;Transrepression activity of glucocorticoid receptor in human A549 cells assessed as inhibition of IL1beta-stimulated NFkappaB-dependent E-selectin transcription by luciferase reporter gene assay;CHEMBL1799968;Direct protein target assigned;D;385776;1;CHEMBL2034;;
CLD0;;Huh-7 ;CHEMBL1805849;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307515;Direct single protein target assigned;9;Transactivation activity at glucocorticoid receptor in human 13D3/Huh7 cells assessed as induction of tyrosine aminotransferase activity after 24 hrs;CHEMBL1799968;Direct protein target assigned;D;385783;1;CHEMBL2034;;
CLD0;;THP-1;CHEMBL1809861;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Antiinflammatory activity in human THP1 cells assessed as inhibition of LPS-induced TNFalpha production at 1 uM treated 30 mins before LPS challenge measured after 24 hrs by ELISA;CHEMBL1806424;Non-molecular target assigned;N;389240;1;CHEMBL614245;;
CLD0;;THP-1;CHEMBL1809933;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Antiinflammatory activity in human THP1 cells assessed as inhibition of LPS-induced IL6 production at 1 uM treated 30 mins before LPS challenge measured after 24 hrs by ELISA;CHEMBL1806424;Non-molecular target assigned;N;389241;1;CHEMBL614245;;
CLD0;;RAW264.7;CHEMBL1814877;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide mRNA expression at 10 uM after 24 hrs by RT-PCR relative to control;CHEMBL1811832;Non-molecular target assigned;N;390909;1;CHEMBL612557;;
CLD0;;RAW264.7;CHEMBL1816440;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Inhibition of LPS-induced TNFalpha production in mouse RAW264.7 cells pre-incubated for 30 mins before LPS challenge measured 6 hrs post LPS challenge by ELISA;CHEMBL1811919;Non-molecular target assigned;N;393843;1;CHEMBL612557;;
CLD0;;RAW264.7;CHEMBL1816441;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Inhibition of LPS-induced nitric oxide production in mouse RAW264.7 cells pre-incubated for 20 mins before LPS challenge measured 18 hrs post LPS challenge by Griess method;CHEMBL1811919;Non-molecular target assigned;N;393844;1;CHEMBL612557;;
CLD0;;Monocyte;CHEMBL1827844;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308582;Target assigned is non-molecular;1;Antiinflammatory activity in knockout-transgenic sickle cell mouse monocytes assessed as inhibition of LPS-induced TNFalpha production at 1 uM administered 30 mins before LPS challenge measured after 24 hrs by ELISA;CHEMBL1821727;Non-molecular target assigned;N;392918;1;CHEMBL3879801;;
CLD0;;Monocyte;CHEMBL1839387;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307530;Target assigned is non-molecular;1;Antiinflammatory activity in human monocytes assessed as inhibition of LPS-induced COX2 expression at 5 uM after 20 hrs using rabbit polyclonal antibody IgG by SDS-PAGE analysis;CHEMBL1833952;Non-molecular target assigned;N;405671;1;CHEMBL3879801;;
CLD0;;;CHEMBL1840051;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 308, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'NERVOUS SYSTEM', 'l2': 'Analgesic Activity', 'l3': 'General Analgesic Nociceptic and Allodynic Activity', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antinociceptive activity against Freund's complete adjuvant-induced paw inflammation in mouse assessed as reduction in mechanical hyperalgesia at 2 mg/kg, ip administered 40 mins before CFA challenge measured after 2 to 6 hrs;CHEMBL1833877;Non-molecular target assigned;N;407946;1;CHEMBL375;;
CLD0;;;CHEMBL1840058;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 301, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Paw Edema Test', 'source': 'Hock_2016'}, {'assay_class_id': 308, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'NERVOUS SYSTEM', 'l2': 'Analgesic Activity', 'l3': 'General Analgesic Nociceptic and Allodynic Activity', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antinociceptive activity against Freund's complete adjuvant-induced paw inflammation in mouse assessed as reduction in paw edema at 2 mg/kg, ip administered 40 mins before CFA challenge measured after 2 hrs;CHEMBL1833877;Non-molecular target assigned;N;407953;1;CHEMBL375;;
CLD0;;;CHEMBL1840059;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 301, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Paw Edema Test', 'source': 'Hock_2016'}, {'assay_class_id': 308, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'NERVOUS SYSTEM', 'l2': 'Analgesic Activity', 'l3': 'General Analgesic Nociceptic and Allodynic Activity', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antinociceptive activity against Freund's complete adjuvant-induced paw inflammation in mouse assessed as reduction in paw edema at 2 mg/kg, ip administered 40 mins before CFA challenge measured after 4 hrs;CHEMBL1833877;Non-molecular target assigned;N;407954;1;CHEMBL375;;
CLD0;;;CHEMBL1840060;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 301, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Paw Edema Test', 'source': 'Hock_2016'}, {'assay_class_id': 308, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'NERVOUS SYSTEM', 'l2': 'Analgesic Activity', 'l3': 'General Analgesic Nociceptic and Allodynic Activity', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antinociceptive activity against Freund's complete adjuvant-induced paw inflammation in mouse assessed as reduction in paw edema at 2 mg/kg, ip administered 40 mins before CFA challenge measured after 6 hrs;CHEMBL1833877;Non-molecular target assigned;N;407955;1;CHEMBL375;;
CLD0;;;CHEMBL1840064;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Inhibition of IL1-beta production in Freund's complete adjuvant-induced mouse at 2 mg/kg, ip administered 40 mins before CFA challenge measured after 2 hrs by ELISA;CHEMBL1833877;Non-molecular target assigned;N;407959;1;CHEMBL375;;
CLD0;;;CHEMBL1840067;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Inhibition of TNF-alpha production in Freund's complete adjuvant-induced mouse at 2 mg/kg, ip administered 40 mins before CFA challenge measured after 2 hrs by ELISA;CHEMBL1833877;Non-molecular target assigned;N;407962;1;CHEMBL375;;
CLD0;;MDR1-MDCKII;CHEMBL1908285;[];Canis lupus familiaris;[];(null);;9615.0;In vitro;;A;ADME;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;Apparent permeability (Papp) from apical to basolateral side determined in MDR1-MDCKII cells;CHEMBL1908284;Homologous protein target assigned;H;1;1;CHEMBL4302;;
CLD0;;MDR1-MDCKII;CHEMBL1908286;[];Canis lupus familiaris;[];(null);;9615.0;In vitro;;A;ADME;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;Apparent permeability (Papp) from basolateral to apical side determined in MDR1-MDCKII cells;CHEMBL1908284;Homologous protein target assigned;H;2;1;CHEMBL4302;;
CLD0;;MDR1-MDCKII;CHEMBL1908289;[];Canis lupus familiaris;[];(null);;9615.0;In vitro;;A;ADME;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;Ratio of apparent permeability from basolateral to apical side over apical to basolateral side determined in MDR1-MDCKII cells;CHEMBL1908284;Homologous protein target assigned;H;5;1;CHEMBL4302;;
CLD0;;Sf9;CHEMBL1908291;[];Spodoptera frugiperda;[];(null);Membrane;7108.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308860;Homologous single protein target assigned;8;Drug-stimulated Pgp ATPase activity ratio determined in MDR1-Sf9 cell membranes with test compound at a concentration of 20uM;CHEMBL1908284;Homologous protein target assigned;H;7;1;CHEMBL4302;;
CLD0;;MDR1-MDCKII;CHEMBL1908292;[];Canis lupus familiaris;[];(null);;9615.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;Inhibition of Pgp expressed in MDR1-MDCKII cells measured by calcein-AM assay;CHEMBL1908284;Homologous protein target assigned;H;8;1;CHEMBL4302;;
CLD0;;;CHEMBL1909163;[];Cavia porcellus;[];;;10141.0;In vitro;Lung;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4);CHEMBL1909046;Direct protein target assigned;D;67;15;CHEMBL1909043;CHEMBL3638235;
CLD0;;CHO-K1;CHEMBL1909164;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4);CHEMBL1909046;Homologous protein target assigned;H;68;15;CHEMBL1798;;
CLD0;;Reticulocytes;CHEMBL1909165;[];Oryctolagus cuniculus;[];;;9986.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid);CHEMBL1909046;Direct protein target assigned;D;69;15;CHEMBL4358;;
CLD0;;HEK293;CHEMBL1909166;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH);CHEMBL1909046;Homologous protein target assigned;H;70;15;CHEMBL4644;;
CLD0;;HEK293;CHEMBL1909167;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH);CHEMBL1909046;Homologous protein target assigned;H;71;15;CHEMBL259;;
CLD0;;HEK293;CHEMBL1909168;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH);CHEMBL1909046;Homologous protein target assigned;H;72;15;CHEMBL4608;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909169;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine);CHEMBL1909046;Homologous protein target assigned;H;73;15;CHEMBL1951;;
CLD0;;CHO-K1;CHEMBL1909170;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine);CHEMBL1909046;Homologous protein target assigned;H;74;15;CHEMBL216;;
CLD0;;CHO-K1;CHEMBL1909171;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine);CHEMBL1909046;Homologous protein target assigned;H;75;15;CHEMBL211;;
CLD0;;CHO-K1;CHEMBL1909172;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine);CHEMBL1909046;Homologous protein target assigned;H;76;15;CHEMBL245;;
CLD0;;CHO-K1;CHEMBL1909173;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine);CHEMBL1909046;Homologous protein target assigned;H;77;15;CHEMBL1821;;
CLD0;;CHO-K1;CHEMBL1909174;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine);CHEMBL1909046;Homologous protein target assigned;H;78;15;CHEMBL2035;;
CLD0;;SK-N-MC;CHEMBL1909175;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307551;Homologous single protein target assigned;8;DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY);CHEMBL1909046;Homologous protein target assigned;H;79;15;CHEMBL4777;;
CLD0;;KAN-TS;CHEMBL1909176;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY);CHEMBL1909046;Homologous protein target assigned;H;80;15;CHEMBL4018;;
CLD0;;IMR-32;CHEMBL1909177;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307656;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine);CHEMBL1909046;Default value - Target has yet to be curated;U;81;15;CHEMBL612545;;
CLD0;;;CHEMBL1909178;[];Rattus norvegicus;[];;;10116.0;In vitro;Cerebellum;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine);CHEMBL1909046;Direct protein target assigned;D;82;15;CHEMBL3048;CHEMBL3638233;
CLD0;;;CHEMBL1909179;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine);CHEMBL1909046;Homologous protein target assigned;H;83;15;CHEMBL3464;;
CLD0;;HEK293;CHEMBL1909180;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole);CHEMBL1909046;Homologous protein target assigned;H;84;15;CHEMBL236;;
CLD0;;HEK293;CHEMBL1909181;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine);CHEMBL1909046;Homologous protein target assigned;H;85;15;CHEMBL237;;
CLD0;;CHO-K1;CHEMBL1909182;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine);CHEMBL1909046;Homologous protein target assigned;H;86;15;CHEMBL233;;
CLD0;;;CHEMBL1909183;[];Mus musculus;[];ICR;Membrane;10090.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu);CHEMBL1909046;Default value - Target has yet to be curated;U;87;15;CHEMBL612545;CHEMBL3638188;
CLD0;;Platelet;CHEMBL1909184;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833781;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP);CHEMBL1909046;Default value - Target has yet to be curated;U;88;15;CHEMBL612545;;
CLD0;;U-937;CHEMBL1909185;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308006;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP);CHEMBL1909046;Default value - Target has yet to be curated;U;89;15;CHEMBL612545;;
CLD0;;Platelet;CHEMBL1909186;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833781;Direct single protein target assigned;9;DRUGMATRIX: Phosphodiesterase PDE5 enzyme inhibition (substrate: [3H]cGMP + cGMP);CHEMBL1909046;Direct protein target assigned;D;90;15;CHEMBL1827;;
CLD0;;Platelet;CHEMBL1909187;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833781;Direct single protein target assigned;9;DRUGMATRIX: Platelet Activating Factor (PAF) radioligand binding (ligand: [3H] PAF);CHEMBL1909046;Direct protein target assigned;D;91;15;CHEMBL250;;
CLD0;;NIH3T3;CHEMBL1909188;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307716;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF);CHEMBL1909046;Default value - Target has yet to be curated;U;92;15;CHEMBL612545;;
CLD0;;HIT-T15;CHEMBL1909189;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide);CHEMBL1909046;Default value - Target has yet to be curated;U;93;15;CHEMBL612545;;
CLD0;;HEK293;CHEMBL1909190;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole);CHEMBL1909046;Homologous protein target assigned;H;94;15;CHEMBL240;;
CLD0;;;CHEMBL1909191;[];Bos taurus;[];;;9913.0;In vitro;Uterus;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020);CHEMBL1909046;Direct protein target assigned;D;95;15;CHEMBL1909044;CHEMBL3638197;
CLD0;;;CHEMBL1909192;[];Oryctolagus cuniculus;[];;;9986.0;In vitro;Lung;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG);CHEMBL1909046;Direct protein target assigned;D;96;15;CHEMBL4074;CHEMBL3638235;
CLD0;;;CHEMBL1909193;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC);CHEMBL1909046;Homologous protein target assigned;H;97;15;CHEMBL4801;;
CLD0;;Neutrophil;CHEMBL1909194;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3308052;Direct single protein target assigned;9;DRUGMATRIX: Protease, Cathepsin G enzyme inhibition (substrate: Suc-Ala-Ala-Pro-Phe-AMC);CHEMBL1909046;Direct protein target assigned;D;98;15;CHEMBL4071;;
CLD0;;Neutrophil;CHEMBL1909195;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3308052;Direct single protein target assigned;9;DRUGMATRIX: Peptidase, ELA2 (Neutrophil Elastase 2) enzyme inhibition (substrate: N-MeOSuc-Ala-Ala-Pro-Val-pNA);CHEMBL1909046;Direct protein target assigned;D;99;15;CHEMBL248;;
CLD0;;;CHEMBL1909196;[];Homo sapiens;[];;;9606.0;In vitro;Rheumatoid synovial fibroblasts;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Peptidase, Matrix Metalloprotease-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2);CHEMBL1909046;Direct protein target assigned;D;100;15;CHEMBL332;;
CLD0;;;CHEMBL1909197;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2);CHEMBL1909046;Homologous protein target assigned;H;101;15;CHEMBL321;;
CLD0;;Sf9;CHEMBL1909198;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308860;Homologous single protein target assigned;8;DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone);CHEMBL1909046;Homologous protein target assigned;H;102;15;CHEMBL299;;
CLD0;;;CHEMBL1909199;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein);CHEMBL1909046;Homologous protein target assigned;H;103;15;CHEMBL3385;;
CLD0;;;CHEMBL1909200;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein);CHEMBL1909046;Homologous protein target assigned;H;104;15;CHEMBL4040;;
CLD0;;;CHEMBL1909201;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein);CHEMBL1909046;Homologous protein target assigned;H;105;15;CHEMBL260;;
CLD0;;;CHEMBL1909202;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Serine/Threonine Phosphatase, PPP3CA (Calcineurin, PP2B) enzyme inhibition (substrate: DiFMUP);CHEMBL1909046;Homologous protein target assigned;H;106;15;CHEMBL4445;;
CLD0;;Insect cells;CHEMBL1909203;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr));CHEMBL1909046;Homologous protein target assigned;H;107;15;CHEMBL203;;
CLD0;;Insect cells;CHEMBL1909204;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr));CHEMBL1909046;Homologous protein target assigned;H;108;15;CHEMBL1841;;
CLD0;;Insect cells;CHEMBL1909205;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr));CHEMBL1909046;Homologous protein target assigned;H;109;15;CHEMBL1824;;
CLD0;;Insect cells;CHEMBL1909206;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr));CHEMBL1909046;Homologous protein target assigned;H;110;15;CHEMBL258;;
CLD0;;;CHEMBL1909207;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Tyrosine Phosphatase, PTPRC (CD45) enzyme inhibition (substrate: DiFMUP);CHEMBL1909046;Homologous protein target assigned;H;111;15;CHEMBL3243;;
CLD0;;;CHEMBL1909208;[];Oryctolagus cuniculus;[];New Zealand albino;Membrane;9986.0;In vitro;Urinary bladder;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Purinergic P2X radioligand binding (ligand: [3H] alpha, beta-Methylene-ATP);CHEMBL1909046;Default value - Target has yet to be curated;U;112;15;CHEMBL612545;CHEMBL3638205;
CLD0;;CHO-K1;CHEMBL1909209;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT);CHEMBL1909046;Homologous protein target assigned;H;113;15;CHEMBL273;;
CLD0;;;CHEMBL1909210;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Direct single protein target assigned;9;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol);CHEMBL1909046;Direct protein target assigned;D;114;15;CHEMBL3459;CHEMBL3559724;
CLD0;;CHO-K1;CHEMBL1909211;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin);CHEMBL1909046;Homologous protein target assigned;H;115;15;CHEMBL224;;
CLD0;;HEK293;CHEMBL1909212;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine);CHEMBL1909046;Homologous protein target assigned;H;1;15;CHEMBL220;;
CLD0;;CHO;CHEMBL1909213;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX);CHEMBL1909046;Homologous protein target assigned;H;2;15;CHEMBL226;;
CLD0;;HEK293;CHEMBL1909214;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA);CHEMBL1909046;Homologous protein target assigned;H;3;15;CHEMBL251;;
CLD0;;CHO-K1;CHEMBL1909215;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA);CHEMBL1909046;Homologous protein target assigned;H;4;15;CHEMBL256;;
CLD0;;;CHEMBL1909084;[];Cavia porcellus;[];Dunkin-Hartley;Membrane;10141.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine);CHEMBL1909046;Default value - Target has yet to be curated;U;5;15;CHEMBL612545;CHEMBL3559724;
CLD0;;;CHEMBL1909085;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Submaxillary gland;B;Binding;BAO_0000249;cell membrane format;;Direct single protein target assigned;9;DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin);CHEMBL1909046;Direct protein target assigned;D;6;15;CHEMBL319;CHEMBL3987361;
CLD0;;;CHEMBL1909086;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Liver;B;Binding;BAO_0000249;cell membrane format;;Direct single protein target assigned;9;DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin);CHEMBL1909046;Direct protein target assigned;D;7;15;CHEMBL315;CHEMBL3559723;
CLD0;;HEK293;CHEMBL1909087;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin);CHEMBL1909046;Homologous protein target assigned;H;8;15;CHEMBL223;;
CLD0;;Sf9;CHEMBL1909088;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308860;Homologous single protein target assigned;8;DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912);CHEMBL1909046;Homologous protein target assigned;H;9;15;CHEMBL1867;;
CLD0;;CHO-K1;CHEMBL1909089;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine);CHEMBL1909046;Homologous protein target assigned;H;10;15;CHEMBL1942;;
CLD0;;Sf9;CHEMBL1909090;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308860;Homologous single protein target assigned;8;DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912);CHEMBL1909046;Homologous protein target assigned;H;11;15;CHEMBL1916;;
CLD0;;CHO-K1;CHEMBL1909091;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol);CHEMBL1909046;Homologous protein target assigned;H;12;15;CHEMBL213;;
CLD0;;CHO;CHEMBL1909092;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177);CHEMBL1909046;Homologous protein target assigned;H;13;15;CHEMBL210;;
CLD0;;HEK293;CHEMBL1909093;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol);CHEMBL1909046;Homologous protein target assigned;H;14;15;CHEMBL246;;
CLD0;;MDCK;CHEMBL1909094;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308370;Homologous single protein target assigned;8;DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55);CHEMBL1909046;Homologous protein target assigned;H;15;15;CHEMBL222;;
CLD0;;;CHEMBL1909095;[];Rattus norvegicus;[];;;10116.0;In vitro;Lens of camera-type eye;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde);CHEMBL1909046;Direct protein target assigned;D;16;15;CHEMBL2622;CHEMBL3638191;
CLD0;;CHO-K1;CHEMBL1909096;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A);CHEMBL1909046;Homologous protein target assigned;H;17;15;CHEMBL4607;;
CLD0;;;CHEMBL1909097;[];Sus scrofa;[];;;9823.0;In vitro;Heart;B;Binding;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP);CHEMBL1909046;Default value - Target has yet to be curated;U;18;15;CHEMBL612545;CHEMBL3638187;
CLD0;;;CHEMBL1909098;[];Cavia porcellus;[];Dunkin-Hartley;Membrane;10141.0;In vitro;Adrenal gland;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat));CHEMBL1909046;Default value - Target has yet to be curated;U;19;15;CHEMBL612545;CHEMBL3638251;
CLD0;;;CHEMBL1909099;[];Bacillus cereus;[];;;1396.0;In vitro;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin);CHEMBL1909046;Default value - Target has yet to be curated;U;20;15;CHEMBL612545;;
CLD0;;Chem-1;CHEMBL1909100;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin);CHEMBL1909046;Homologous protein target assigned;H;21;15;CHEMBL3157;;
CLD0;;T47D;CHEMBL1909101;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307606;Homologous single protein target assigned;8;DRUGMATRIX: Calcitonin radioligand binding (ligand: [125I] Calcitonin (salmon));CHEMBL1909046;Homologous protein target assigned;H;22;15;CHEMBL1832;;
CLD0;;;CHEMBL1909102;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem);CHEMBL1909046;Default value - Target has yet to be curated;U;23;15;CHEMBL612545;CHEMBL3638188;
CLD0;;;CHEMBL1909103;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine);CHEMBL1909046;Default value - Target has yet to be curated;U;24;15;CHEMBL612545;CHEMBL3559724;
CLD0;;CHO-K1;CHEMBL1909104;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide);CHEMBL1909046;Homologous protein target assigned;H;116;15;CHEMBL1833;;
CLD0;;CHO-K1;CHEMBL1909105;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine);CHEMBL1909046;Homologous protein target assigned;H;117;15;CHEMBL225;;
CLD0;;HEK293;CHEMBL1909106;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630);CHEMBL1909046;Default value - Target has yet to be curated;U;118;15;CHEMBL612545;;
CLD0;;;CHEMBL1909107;[];Cavia porcellus;[];Dunkin-Hartley;Membrane;10141.0;In vitro;Striatum;B;Binding;BAO_0000249;cell membrane format;;Direct single protein target assigned;9;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808);CHEMBL1909046;Direct protein target assigned;D;119;15;CHEMBL5017;CHEMBL3638255;
CLD0;;HeLa;CHEMBL1909108;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308376;Homologous single protein target assigned;8;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide);CHEMBL1909046;Homologous protein target assigned;H;120;15;CHEMBL3371;;
CLD0;;HEK293;CHEMBL1909109;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine);CHEMBL1909046;Homologous protein target assigned;H;121;15;CHEMBL228;;
CLD0;;Jurkat;CHEMBL1909110;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307526;Homologous single protein target assigned;8;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);CHEMBL1909046;Homologous protein target assigned;H;122;15;CHEMBL287;;
CLD0;;;CHEMBL1909111;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil);CHEMBL1909046;Default value - Target has yet to be curated;U;123;15;CHEMBL612545;CHEMBL3638188;
CLD0;;;CHEMBL1909112;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin);CHEMBL1909046;Default value - Target has yet to be curated;U;124;15;CHEMBL612545;CHEMBL3638188;
CLD0;;CHO;CHEMBL1909113;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P);CHEMBL1909046;Homologous protein target assigned;H;125;15;CHEMBL249;;
CLD0;;CHO;CHEMBL1909114;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968);CHEMBL1909046;Homologous protein target assigned;H;126;15;CHEMBL2327;;
CLD0;;;CHEMBL1909115;[];Escherichia coli;[];;Membrane;562.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone);CHEMBL1909046;Homologous protein target assigned;H;127;15;CHEMBL3072;;
CLD0;;Platelet;CHEMBL1909116;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833781;Direct single protein target assigned;9;DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2);CHEMBL1909046;Direct protein target assigned;D;128;15;CHEMBL1835;;
CLD0;;U-937;CHEMBL1909117;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308006;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Tumor Necrosis Factor (TNF), Non-Selective radioligand binding (ligand: [125I] TNF-alpha);CHEMBL1909046;Default value - Target has yet to be curated;U;129;15;CHEMBL612545;;
CLD0;;HUVEC;CHEMBL1909118;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307501;Homologous single protein target assigned;8;DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF);CHEMBL1909046;Homologous protein target assigned;H;130;15;CHEMBL1868;;
CLD0;;HT-29;CHEMBL1909119;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307768;Homologous single protein target assigned;8;DRUGMATRIX: Vasoactive Intestinal Peptide VIP1 radioligand binding (ligand: [125I] VIP);CHEMBL1909046;Homologous protein target assigned;H;131;15;CHEMBL5144;;
CLD0;;HEK293;CHEMBL1909120;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr);CHEMBL1909046;Homologous protein target assigned;H;132;15;CHEMBL1889;;
CLD0;;;CHEMBL1909121;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888));CHEMBL1909046;Default value - Target has yet to be curated;U;25;15;CHEMBL612545;CHEMBL3638188;
CLD0;;Chem-1;CHEMBL1909122;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A);CHEMBL1909046;Homologous protein target assigned;H;26;15;CHEMBL218;;
CLD0;;Erythrocyte;CHEMBL1909123;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833281;Direct single protein target assigned;9;DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA));CHEMBL1909046;Direct protein target assigned;D;27;15;CHEMBL205;;
CLD0;;CHO-K1;CHEMBL1909124;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1);CHEMBL1909046;Homologous protein target assigned;H;28;15;CHEMBL4015;;
CLD0;;Chem-1;CHEMBL1909125;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC);CHEMBL1909046;Homologous protein target assigned;H;29;15;CHEMBL2414;;
CLD0;;HEK293;CHEMBL1909126;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha);CHEMBL1909046;Homologous protein target assigned;H;30;15;CHEMBL274;;
CLD0;;;CHEMBL1909127;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Chemokine CXCR1 (IL-8A);CHEMBL1909046;Homologous protein target assigned;H;31;15;CHEMBL4029;;
CLD0;;CHO-K1;CHEMBL1909128;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8);CHEMBL1909046;Homologous protein target assigned;H;32;15;CHEMBL2434;;
CLD0;;1321-N1;CHEMBL1909129;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718);CHEMBL1909046;Homologous protein target assigned;H;33;15;CHEMBL1901;;
CLD0;;Platelet;CHEMBL1909130;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833781;Direct single protein target assigned;9;DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid);CHEMBL1909046;Direct protein target assigned;D;34;15;CHEMBL221;;
CLD0;;Sf21;CHEMBL1909131;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL4106362;Homologous single protein target assigned;8;DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid);CHEMBL1909046;Homologous protein target assigned;H;35;15;CHEMBL230;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909132;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;36;15;CHEMBL3356;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909133;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;37;15;CHEMBL5282;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909134;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;38;15;CHEMBL3622;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909135;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;39;15;CHEMBL3397;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909136;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;40;15;CHEMBL289;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909137;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;41;15;CHEMBL5281;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909138;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin);CHEMBL1909046;Homologous protein target assigned;H;42;15;CHEMBL340;;
CLD0;;CHO;CHEMBL1909139;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390);CHEMBL1909046;Homologous protein target assigned;H;43;15;CHEMBL2056;;
CLD0;;CHO;CHEMBL1909140;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone);CHEMBL1909046;Homologous protein target assigned;H;44;15;CHEMBL217;;
CLD0;;CHO;CHEMBL1909141;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone);CHEMBL1909046;Homologous protein target assigned;H;45;15;CHEMBL234;;
CLD0;;CHO-K1;CHEMBL1909142;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone);CHEMBL1909046;Homologous protein target assigned;H;46;15;CHEMBL219;;
CLD0;;CHO-K1;CHEMBL1909143;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55);CHEMBL1909046;Homologous protein target assigned;H;47;15;CHEMBL238;;
CLD0;;CHO-K1;CHEMBL1909144;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1);CHEMBL1909046;Homologous protein target assigned;H;48;15;CHEMBL252;;
CLD0;;Sf9;CHEMBL1909145;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308860;Homologous single protein target assigned;8;DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol);CHEMBL1909046;Homologous protein target assigned;H;49;15;CHEMBL206;;
CLD0;;Sf9;CHEMBL1909146;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308860;Homologous single protein target assigned;8;DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol);CHEMBL1909046;Homologous protein target assigned;H;50;15;CHEMBL242;;
CLD0;;;CHEMBL1909147;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol);CHEMBL1909046;Default value - Target has yet to be curated;U;51;15;CHEMBL612545;CHEMBL3638188;
CLD0;;;CHEMBL1909148;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam);CHEMBL1909046;Default value - Target has yet to be curated;U;52;15;CHEMBL612545;CHEMBL3638188;
CLD0;;;CHEMBL1909149;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB);CHEMBL1909046;Default value - Target has yet to be curated;U;53;15;CHEMBL612545;CHEMBL3559724;
CLD0;;HeLa S3;CHEMBL1909150;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3886002;Homologous single protein target assigned;8;DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone);CHEMBL1909046;Homologous protein target assigned;H;54;15;CHEMBL2034;;
CLD0;;;CHEMBL1909151;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA);CHEMBL1909046;Default value - Target has yet to be curated;U;55;15;CHEMBL612545;CHEMBL3559724;
CLD0;;;CHEMBL1909152;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid);CHEMBL1909046;Default value - Target has yet to be curated;U;56;15;CHEMBL612545;CHEMBL3638188;
CLD0;;;CHEMBL1909153;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653);CHEMBL1909046;Default value - Target has yet to be curated;U;57;15;CHEMBL612545;CHEMBL3559724;
CLD0;;;CHEMBL1909154;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP);CHEMBL1909046;Default value - Target has yet to be curated;U;58;15;CHEMBL612545;CHEMBL3559724;
CLD0;;;CHEMBL1909155;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Spinal cord;B;Binding;BAO_0000249;cell membrane format;;Multiple direct protein targets may be assigned;5;DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine);CHEMBL1909046;Direct protein target assigned;D;59;15;CHEMBL3392921;CHEMBL3638246;
CLD0;;CHO-K1;CHEMBL1909156;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine);CHEMBL1909046;Homologous protein target assigned;H;60;15;CHEMBL231;;
CLD0;;CHO-K1;CHEMBL1909157;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine);CHEMBL1909046;Homologous protein target assigned;H;61;15;CHEMBL1941;;
CLD0;;;CHEMBL1909158;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA);CHEMBL1909046;Homologous protein target assigned;H;62;15;CHEMBL402;;
CLD0;;;CHEMBL1909159;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan);CHEMBL1909046;Default value - Target has yet to be curated;U;63;15;CHEMBL612545;CHEMBL3559724;
CLD0;;;CHEMBL1909160;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Liver;B;Binding;BAO_0000249;cell membrane format;;Direct single protein target assigned;9;DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin);CHEMBL1909046;Direct protein target assigned;D;64;15;CHEMBL5486;CHEMBL3559723;
CLD0;;NIH3T3;CHEMBL1909161;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307716;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta);CHEMBL1909046;Default value - Target has yet to be curated;U;65;15;CHEMBL612545;;
CLD0;;U-937;CHEMBL1909162;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308006;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4);CHEMBL1909046;Default value - Target has yet to be curated;U;66;15;CHEMBL612545;;
CLD0;;;CHEMBL1909292;[];;[];;;;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;FDA Liver Toxicity Knowledge Base Benchmark Dataset (LTKB-BD) drugs of less concern for DILI;CHEMBL1909281;Non-molecular target assigned;N;2;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909307;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia";CHEMBL1909294;Non-molecular target assigned;N;1;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909308;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis";CHEMBL1909294;Non-molecular target assigned;N;2;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909309;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis";CHEMBL1909294;Non-molecular target assigned;N;3;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909310;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis";CHEMBL1909294;Non-molecular target assigned;N;4;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909311;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests";CHEMBL1909294;Non-molecular target assigned;N;5;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909312;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure";CHEMBL1909294;Non-molecular target assigned;N;6;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909313;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis";CHEMBL1909294;Non-molecular target assigned;N;7;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909314;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis";CHEMBL1909294;Non-molecular target assigned;N;8;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909315;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly";CHEMBL1909294;Non-molecular target assigned;N;9;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909316;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice";CHEMBL1909294;Non-molecular target assigned;N;10;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909317;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease";CHEMBL1909294;Non-molecular target assigned;N;11;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909318;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty";CHEMBL1909294;Non-molecular target assigned;N;12;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909319;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal";CHEMBL1909294;Non-molecular target assigned;N;13;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909320;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score";CHEMBL1909294;Non-molecular target assigned;N;14;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1913330;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Displacement of tetramethylrhodamine-labeled Dexamethasone from human recombinant glucocorticoid receptor expressed in baculovirus infected insect cells by fluorescence polarization assay;CHEMBL1909618;Direct protein target assigned;D;409872;1;CHEMBL2034;;
CLD0;;;CHEMBL1913331;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Displacement of tetramethylrhodamine-labeled RU-486 from human recombinant progesterone receptor expressed in baculovirus infected insect cells by fluorescence polarization assay;CHEMBL1909618;Direct protein target assigned;D;409873;1;CHEMBL208;;
CLD0;;;CHEMBL1913332;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Displacement of tetramethylrhodamine-labeled Dexamethasone from human recombinant mineralocorticoid receptor expressed in baculovirus infected insect cells by fluorescence polarization assay;CHEMBL1909618;Direct protein target assigned;D;409874;1;CHEMBL1994;;
CLD0;;;CHEMBL1913336;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;Agonist activity at glucocorticoid receptor in HFF assessed as inhibition of IL1-induced IL-6 production after 18 to 24 hrs;CHEMBL1909618;Direct protein target assigned;D;409878;1;CHEMBL2034;;
CLD0;;;CHEMBL1912091;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Transactivation activity of glucocorticoid receptor in HFF assessed as induction of aromatase activity by measuring beta-estradiol activity after 18 to 24 hrs by ELISA;CHEMBL1909618;Direct protein target assigned;D;409880;1;CHEMBL2034;;
CLD0;;HeLa;CHEMBL1912093;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Direct single protein target assigned;9;Agonist activity at glucocorticoid receptor in human HeLa cells transfected with luciferase gene linked to MMTV promoter assessed as luciferase transactivation activity;CHEMBL1909618;Direct protein target assigned;D;409882;1;CHEMBL2034;;
CLD0;;;CHEMBL1912980;[];Rattus norvegicus;[];Sprague Dawley;;10116.0;;;B;Binding;BAO_0000019;assay format;;Direct single protein target assigned;9;Displacement of [3H]Dex from glucocorticoid receptor in Sprague-Dawley rat liver after 2 hrs by liquid scintillation counting;CHEMBL1909583;Direct protein target assigned;D;409623;1;CHEMBL3368;;
CLD0;;;CHEMBL1914174;[];Homo sapiens;[];;;9606.0;;Blood;F;Functional;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in human whole blood assessed as inhibition of LPS-induced TNFalpha production after overnight incubation by ELISA;CHEMBL1909630;Non-molecular target assigned;N;407630;1;CHEMBL613416;CHEMBL3638178;
CLD0;;;CHEMBL1914178;[];Homo sapiens;[];;;9606.0;;Blood;F;Functional;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in human whole blood assessed as inhibition of IL-1beta-induced IL-8 production after overnight incubation by ELISA;CHEMBL1909630;Non-molecular target assigned;N;407634;1;CHEMBL613416;CHEMBL3638178;
CLD0;;;CHEMBL1921050;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 503, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'RESPIRATORY SYSTEM', 'l2': 'Effects on Air Ways', 'l3': 'General Airway Models', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];BALB/c;;10090.0;;Lung;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in BALB/c mouse model assessed as inhibition of ovalbumin-induced eosinophil accumulation in bronchoalveolar lavage fluid at 1 mg/kg, ip administered 1 hr prior to and 7 hrs after ovalbumin challenge for 3 days measured 8 hrs after final dose by cell counting;CHEMBL1914440;Non-molecular target assigned;N;408340;1;CHEMBL375;CHEMBL3638235;
CLD0;;;CHEMBL1921128;[{'assay_class_id': 230, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'DERMATOLOGICALS', 'l2': 'Experimental Dermatitis', 'l3': 'Contact Hypersensitivity', 'source': 'Vogel_2008'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '5.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '5.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intravenous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intravenous', 'type': 'ROUTE', 'units': None, 'value': None}];BALB/c;;10090.0;;Ear;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in BALB/c mouse contact hypersensitivity model assessed as inhibition of FITC-mediated ear swelling at 5 mg/kg, iv administered 1 hr prior to and 7 hrs after the FITC-challenge measured 24 hrs after final dose;CHEMBL1914440;Non-molecular target assigned;N;413727;1;CHEMBL375;CHEMBL3987716;
CLD0;;;CHEMBL1944052;[{'assay_class_id': 230, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'DERMATOLOGICALS', 'l2': 'Experimental Dermatitis', 'l3': 'Contact Hypersensitivity', 'source': 'Vogel_2008'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];BALB/c;;10090.0;;Ear;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antihypersensitivity against TNCB-induced contact hypersensitivity in BALB/c mouse ear assessed as inhibition of edema at 0.025 mg/ear applied tropically after 30 mins, 24 hrs and 48 hrs of TNCB challenge measured after 24 hrs relative to control;CHEMBL1938323;Non-molecular target assigned;N;386790;1;CHEMBL375;CHEMBL3987716;
CLD0;;;CHEMBL1944055;[{'assay_class_id': 230, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'DERMATOLOGICALS', 'l2': 'Experimental Dermatitis', 'l3': 'Contact Hypersensitivity', 'source': 'Vogel_2008'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];BALB/c;;10090.0;;Ear;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antihypersensitivity against TNCB-induced contact hypersensitivity in BALB/c mouse ear assessed as inhibition of edema at 0.025 mg/ear applied tropically after 30 mins, 24 hrs and 48 hrs of TNCB challenge measured after 72 hrs relative to control;CHEMBL1938323;Non-molecular target assigned;N;386791;1;CHEMBL375;CHEMBL3987716;
CLD0;;;CHEMBL1944218;[{'assay_class_id': 231, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'DERMATOLOGICALS', 'l2': 'Experimental Dermatitis', 'l3': 'General Dermatitis Models', 'source': 'phenotype'}, {'assay_class_id': 233, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'DERMATOLOGICALS', 'l2': 'Experimental Dermatitis', 'l3': 'NC/Nga Mouse as Model for Atopic Dermatitis', 'source': 'Vogel_2008'}];Mus musculus;[];BALB/c;;10090.0;;Ear;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antihypersensitivity activity against TNCB-induced atopic dermatitis in BALB/c mouse ear assessed as inhibition of ear thickness at 0.025 mg/ear applied topically three times per week 30 min TNCB post challenge measured up to 25 days;CHEMBL1938323;Non-molecular target assigned;N;386834;1;CHEMBL375;CHEMBL3987716;
CLD0;;;CHEMBL1944221;[{'assay_class_id': 230, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'DERMATOLOGICALS', 'l2': 'Experimental Dermatitis', 'l3': 'Contact Hypersensitivity', 'source': 'Vogel_2008'}];Mus musculus;[];BALB/c;;10090.0;;Ear;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antihypersensitivity activity against TNCB-induced acute contact hypersensitivity in BALB/c mouse ear assessed as inhibition of neutrophil infiltration by measuring MPO activity at 0.025 mg/ear measured after 24 to 72 hrs relative to control;CHEMBL1938323;Non-molecular target assigned;N;386837;1;CHEMBL375;CHEMBL3987716;
CLD0;;;CHEMBL1944222;[{'assay_class_id': 230, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'DERMATOLOGICALS', 'l2': 'Experimental Dermatitis', 'l3': 'Contact Hypersensitivity', 'source': 'Vogel_2008'}];Mus musculus;[];BALB/c;;10090.0;;Ear;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antihypersensitivity activity against TNCB-induced acute contact hypersensitivity in BALB/c mouse ear assessed as inhibition of neutrophil infiltration by measuring MPO activity at 0.025 mg/ear measured after 22 days of repeated application of TNCB relative to control;CHEMBL1938323;Non-molecular target assigned;N;386838;1;CHEMBL375;CHEMBL3987716;
CLD0;;;CHEMBL1944227;[{'assay_class_id': 230, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'DERMATOLOGICALS', 'l2': 'Experimental Dermatitis', 'l3': 'Contact Hypersensitivity', 'source': 'Vogel_2008'}];Mus musculus;[];BALB/c;;10090.0;;Ear;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antihypersensitivity activity against TNCB-induced contact hypersensitivity in BALB/c mouse ear assessed as decrease cytokines levels at 0.025 mg/ear measured at 24 hrs by ELISA relative to control;CHEMBL1938323;Non-molecular target assigned;N;386845;1;CHEMBL375;CHEMBL3987716;
CLD0;;;CHEMBL1944359;[{'assay_class_id': 230, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'DERMATOLOGICALS', 'l2': 'Experimental Dermatitis', 'l3': 'Contact Hypersensitivity', 'source': 'Vogel_2008'}];Mus musculus;[];BALB/c;;10090.0;;Ear;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antihypersensitivity activity against TNCB-induced contact hypersensitivity in BALB/c mouse ear assessed as decreased COX2 expression at 0.025 mg/ear after at 24 hrs by Western blotting relative to control;CHEMBL1938323;Non-molecular target assigned;N;386862;1;CHEMBL375;CHEMBL3987716;
CLD0;;;CHEMBL1944360;[{'assay_class_id': 230, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'DERMATOLOGICALS', 'l2': 'Experimental Dermatitis', 'l3': 'Contact Hypersensitivity', 'source': 'Vogel_2008'}];Mus musculus;[];BALB/c;;10090.0;;Ear;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antihypersensitivity activity against TNCB-induced contact hypersensitivity in BALB/c mouse ear assessed as decreased COX2 expression at 0.025 mg/ear after at 72 hrs by Western blotting relative to control;CHEMBL1938323;Non-molecular target assigned;N;386863;1;CHEMBL375;CHEMBL3987716;
CLD0;;;CHEMBL1944395;[{'assay_class_id': 230, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'DERMATOLOGICALS', 'l2': 'Experimental Dermatitis', 'l3': 'Contact Hypersensitivity', 'source': 'Vogel_2008'}];Mus musculus;[];BALB/c;;10090.0;;Ear;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antihypersensitivity activity against TNCB-induced contact hypersensitivity in BALB/c mouse ear assessed as inhibition of MMP9 production at 0.025 mg/ear measured at 24 hrs by Western blot analysis relative to control;CHEMBL1938323;Non-molecular target assigned;N;386864;1;CHEMBL375;CHEMBL3987716;
CLD0;;;CHEMBL1944396;[{'assay_class_id': 230, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'DERMATOLOGICALS', 'l2': 'Experimental Dermatitis', 'l3': 'Contact Hypersensitivity', 'source': 'Vogel_2008'}];Mus musculus;[];BALB/c;;10090.0;;Ear;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antihypersensitivity activity against TNCB-induced contact hypersensitivity in BALB/c mouse ear assessed as inhibition of MMP9 production at 0.025 mg/ear measured at 72 hrs by Western blot analysis relative to control;CHEMBL1938323;Non-molecular target assigned;N;386865;1;CHEMBL375;CHEMBL3987716;
CLD0;confirmatory;SN12C;CHEMBL1963981;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307518;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;145;7;CHEMBL614054;;
CLD0;confirmatory;NCI-H23;CHEMBL1963985;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307750;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;1;7;CHEMBL614997;;
CLD0;confirmatory;ACHN;CHEMBL1963989;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307633;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;139;7;CHEMBL614519;;
CLD0;confirmatory;UO-31;CHEMBL1963990;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307612;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;143;7;CHEMBL614388;;
CLD0;confirmatory;HOP-92;CHEMBL1963991;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308091;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;13;7;CHEMBL613889;;
CLD0;confirmatory;HL-60;CHEMBL1963994;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;125;7;CHEMBL383;;
CLD0;confirmatory;SF-539;CHEMBL1964018;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307721;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;49;7;CHEMBL614860;;
CLD0;confirmatory;SK-MEL-5;CHEMBL1964021;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307744;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;37;7;CHEMBL614922;;
CLD0;confirmatory;Malme-3M;CHEMBL1964025;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307507;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;29;7;CHEMBL614021;;
CLD0;confirmatory;K562;CHEMBL1964030;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the K-562 Leukemia cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;121;7;CHEMBL385;;
CLD0;confirmatory;OVCAR-3;CHEMBL1964037;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307564;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the OVCAR-3 Ovarian cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;99;7;CHEMBL614213;;
CLD0;confirmatory;MOLT-4;CHEMBL1964040;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307557;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MOLT-4 Leukemia cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;123;7;CHEMBL614177;;
CLD0;confirmatory;HOP-62;CHEMBL1964043;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307671;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-62 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;9;7;CHEMBL614643;;
CLD0;confirmatory;U-251;CHEMBL1964047;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307756;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the U251 Central Nervous System cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;59;7;CHEMBL615022;;
CLD0;confirmatory;OVCAR-8;CHEMBL1964048;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307975;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the OVCAR-8 Ovarian cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;109;7;CHEMBL612555;;
CLD0;confirmatory;OVCAR-5;CHEMBL1964049;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307565;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the OVCAR-5 Ovarian cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;107;7;CHEMBL614214;;
CLD0;confirmatory;SNB-19;CHEMBL1964059;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307552;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SNB-19 Central Nervous System cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;53;7;CHEMBL614164;;
CLD0;confirmatory;SR;CHEMBL1964065;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307586;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SR Leukemia cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;115;7;CHEMBL614300;;
CLD0;confirmatory;TK-10;CHEMBL1964066;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308453;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the TK-10 Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;141;7;CHEMBL614056;;
CLD0;confirmatory;SW-620;CHEMBL1964072;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307944;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SW-620 Colon cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;81;7;CHEMBL612262;;
CLD0;confirmatory;M19-MEL;CHEMBL1964074;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307506;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the M19-MEL Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;27;7;CHEMBL614019;;
CLD0;confirmatory;NCI-H522;CHEMBL1964075;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308392;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H522 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;15;7;CHEMBL614387;;
CLD0;confirmatory;KM12;CHEMBL1964077;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307689;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the KM12 Colon cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;73;7;CHEMBL614709;;
CLD0;confirmatory;M14;CHEMBL1964085;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307591;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the M14 Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;25;7;CHEMBL614317;;
CLD0;confirmatory;XF498;CHEMBL1964086;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308037;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the XF 498 Central Nervous System cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;51;7;CHEMBL613533;;
CLD0;confirmatory;NCI-H322M;CHEMBL1964087;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307710;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H322M Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;5;7;CHEMBL614803;;
CLD0;confirmatory;OVCAR-4;CHEMBL1964091;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307517;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the OVCAR-4 Ovarian cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;105;7;CHEMBL614051;;
CLD0;confirmatory;LOX IMVI ;CHEMBL1964092;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307535;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the LOX IMVI Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;23;7;CHEMBL614096;;
CLD0;confirmatory;SK-MEL-2;CHEMBL1963844;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307743;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-2 Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;35;7;CHEMBL614917;;
CLD0;confirmatory;KM-20L2;CHEMBL1963848;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307782;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the KM20L2 Colon cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;75;7;CHEMBL614791;;
CLD0;confirmatory;A549;CHEMBL1963854;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the A549/ATCC Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;19;7;CHEMBL392;;
CLD0;confirmatory;SNB-75;CHEMBL1963866;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307616;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SNB-75 Central Nervous System cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;55;7;CHEMBL614451;;
CLD0;confirmatory;HCT-15;CHEMBL1963868;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307945;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HCT-15 Colon cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;71;7;CHEMBL612263;;
CLD0;confirmatory;HCT-116;CHEMBL1963874;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308372;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HCT-116 Colon cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;79;7;CHEMBL394;;
CLD0;confirmatory;SF-268;CHEMBL1963876;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307499;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-268 Central Nervous System cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;45;7;CHEMBL613977;;
CLD0;confirmatory;EKVX ;CHEMBL1963880;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307626;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the EKVX Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;21;7;CHEMBL614487;;
CLD0;confirmatory;DMS-114;CHEMBL1963887;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307670;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DMS 114 Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;63;7;CHEMBL614642;;
CLD0;confirmatory;LXFL 529;CHEMBL1963889;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307537;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the LXFL 529 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;17;7;CHEMBL614110;;
CLD0;confirmatory;SK-OV-3;CHEMBL1963895;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307746;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-OV-3 Ovarian cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;103;7;CHEMBL614925;;
CLD0;confirmatory;UACC-62;CHEMBL1963903;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307660;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UACC-62 Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;31;7;CHEMBL614610;;
CLD0;confirmatory;CAKI-1;CHEMBL1963911;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307522;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the CAKI-1 Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;131;7;CHEMBL614067;;
CLD0;confirmatory;SF-295;CHEMBL1963922;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307738;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-295 Central Nervous System cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;47;7;CHEMBL614908;;
CLD0;confirmatory;IGROV-1;CHEMBL1963929;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307502;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the IGROV1 Ovarian cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;101;7;CHEMBL613984;;
CLD0;confirmatory;786-0;CHEMBL1963953;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308018;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the 786-0 Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;137;7;CHEMBL613102;;
CLD0;confirmatory;SNB-78;CHEMBL1963954;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307969;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SNB-78 Central Nervous System cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;57;7;CHEMBL612543;;
CLD0;confirmatory;UACC-257;CHEMBL1963960;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308008;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UACC-257 Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;33;7;CHEMBL612796;;
CLD0;confirmatory;CCRF-CEM;CHEMBL1963961;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the CCRF-CEM Leukemia cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;119;7;CHEMBL382;;
CLD0;confirmatory;DLD-1;CHEMBL1963963;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307580;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DLD-1 Colon cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;69;7;CHEMBL614285;;
CLD0;confirmatory;NCI-H226;CHEMBL1964004;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307697;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H226 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;3;7;CHEMBL614740;;
CLD0;confirmatory;HT-29;CHEMBL1964006;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HT29 Colon cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;65;7;CHEMBL384;;
CLD0;confirmatory;SK-MEL-28;CHEMBL1964007;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308494;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-28 Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;39;7;CHEMBL614919;;
CLD0;confirmatory;COLO 205;CHEMBL1964012;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308348;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the COLO 205 Colon cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;67;7;CHEMBL614561;;
CLD0;;THP-1;CHEMBL2025727;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Antiinflammatory activity in human PMA-stimulated THP1 cells assessed as inhibition of LPS-induced TNFalpha production at 1 uM treated 30 mins before LPS challenge measured after 24 hrs by ELISA;CHEMBL2021896;Non-molecular target assigned;N;446012;1;CHEMBL614245;;
CLD0;;THP-1;CHEMBL2025729;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Antiinflammatory activity in human PMA-stimulated THP1 cells assessed as inhibition of LPS-induced IL-6 production at 1 uM treated 30 mins before LPS challenge measured after 24 hrs by ELISA;CHEMBL2021896;Non-molecular target assigned;N;446014;1;CHEMBL614245;;
CLD0;;;CHEMBL2034562;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-induced mouse assessed as decrease in cellular infiltration into BAL fluid at 100 mg/kg, ip administered 3 hrs prior LPS challenge relative to control;CHEMBL2029323;Non-molecular target assigned;N;449886;1;CHEMBL375;;
CLD0;;;CHEMBL2034563;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-induced mouse assessed as decrease in TNFalpha secretion at 100 mg/kg, ip administered 3 hrs prior LPS challenge relative to control;CHEMBL2029323;Non-molecular target assigned;N;449887;1;CHEMBL375;;
CLD0;;RAW264.7;CHEMBL2039403;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production pretreated for 2 hrs before LPS challenge measured after 18 hrs by Griess method;CHEMBL2034944;Non-molecular target assigned;N;452272;1;CHEMBL612557;;
CLD0;;;CHEMBL2037823;[{'assay_class_id': 96, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Adjuvant Arthritis in Rats', 'source': 'Hock_2016'}, {'assay_class_id': 105, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'General Rheumatoid Arthritis Models', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.1', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.1'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];B10/R3;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiarthritic activity in B10/R3 mouse immunized with bovine type2 collagen in Freund's complete adjuvant assessed as inhibition of increase in clinical arthritic scores at 0.1 mg/kg, po administered bid for 10 days measured for 10 days;CHEMBL2034857;Non-molecular target assigned;N;448783;1;CHEMBL375;;
CLD0;;;CHEMBL2038698;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in rat polymorphonuclear leukocytes assessed as inhibition of LPS-stimulated nitric oxide production after 20 mins by Griess method;CHEMBL2034945;Non-molecular target assigned;N;451829;1;CHEMBL3879801;;
CLD0;;RAW264.7;CHEMBL2039285;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-stimulated nitric oxide production pretreated for 2 hrs before LPS challenge measured after 18 hrs by Griess method;CHEMBL2034896;Non-molecular target assigned;N;451835;1;CHEMBL612557;;
CLD0;;;CHEMBL2046022;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 503, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'RESPIRATORY SYSTEM', 'l2': 'Effects on Air Ways', 'l3': 'General Airway Models', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];Balb/c;;10090.0;;Lung;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in ovalbumin-sensitised Balb/c mouse assessed as reduction in ovalbumin-induced eosinophil count in bronchoalveolar lavage fluid at 1 mg/kg, ip administered 1 hr before and 7 hrs after ovalbumin challenge measured after 8 hrs by haemocytometeric analysis;CHEMBL2040789;Non-molecular target assigned;N;453365;1;CHEMBL375;CHEMBL3638235;
CLD0;;;CHEMBL2043507;[];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '80.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '80.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];Sprague-Dawley;Microsomes;10116.0;;Liver;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Ex vivo induction of CYP-isozymes in Sprague-Dawley rat liver microsomes at 80 mg/kg, po bid for 3 days relative to control;CHEMBL2040745;Non-molecular target assigned;N;447171;1;CHEMBL376;CHEMBL3559723;
CLD0;;;CHEMBL2043510;[];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '80.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '80.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];Sprague-Dawley;;10116.0;;Liver;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in Sprague-Dawley rat assessed as changes in liver weight at 80 mg/kg, po bid for 3 days relative to control;CHEMBL2040745;Non-molecular target assigned;N;447174;1;CHEMBL376;CHEMBL3559723;
CLD0;;;CHEMBL2043513;[];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '80.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '80.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];Sprague-Dawley;;10116.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in Sprague-Dawley rat assessed as changes in microsomal protein level at 80 mg/kg, po bid for 3 days relative to control;CHEMBL2040745;Non-molecular target assigned;N;447177;1;CHEMBL376;;
CLD0;;;CHEMBL2062062;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 503, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'RESPIRATORY SYSTEM', 'l2': 'Effects on Air Ways', 'l3': 'General Airway Models', 'source': 'phenotype'}];Mus musculus;[];BALB/c;;10090.0;;Lung;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in BALB/c mouse assessed as reduction in LPS-induced neutrophil accumulation in bronchoalveolar lung fluid at 0.5 mg, it administered 1 hr prior to LPS-challenge and measured after 8 hrs relative to vehicle treated control;CHEMBL2057090;Non-molecular target assigned;N;458488;1;CHEMBL375;CHEMBL3638235;
CLD0;;A549;CHEMBL2072653;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Antiinflammatory activity in human A549 cells assessed as inhibition of IL-1beta-induced mPGES1 expression at 1 uM treated 30 mins prior to IL-1beta challenge measured after 48 hrs by Western blot analysis relative to control;CHEMBL2069190;Non-molecular target assigned;N;462073;1;CHEMBL392;;
CLD0;;;CHEMBL2071962;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human CYP1A2 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using ethoxyresorufin as substrate after 30 mins;CHEMBL2069259;Direct protein target assigned;D;467794;1;CHEMBL3356;;
CLD0;;;CHEMBL2071963;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human CYP2C9 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 7-methoxy-4-trifluoromethylcoumarin-3-acetic acid as substrate after 30 mins;CHEMBL2069259;Direct protein target assigned;D;467795;1;CHEMBL3397;;
CLD0;;;CHEMBL2071964;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human CYP2C19 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 3-butyryl-7-methoxycoumarin as substrate after 30 mins;CHEMBL2069259;Direct protein target assigned;D;467796;1;CHEMBL3622;;
CLD0;;;CHEMBL2071965;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human CYP2D6 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 4-methylaminoethyl-7-methoxycoumarin as substrate after 30 mins;CHEMBL2069259;Direct protein target assigned;D;467797;1;CHEMBL289;;
CLD0;;;CHEMBL2071966;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human CYP3A4 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using diethoxyfluorescein as substrate after 30 mins;CHEMBL2069259;Direct protein target assigned;D;467798;1;CHEMBL340;;
CLD0;;;CHEMBL2071967;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human CYP3A4 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 7-benzyloxyquinoline as substrate after 30 mins;CHEMBL2069259;Direct protein target assigned;D;467799;1;CHEMBL340;;
CLD0;;;CHEMBL2071971;[];Homo sapiens;[];;Microsome;9606.0;;Liver;A;ADME;BAO_0000251;microsome format;;Target assigned is subcellular fraction;2;Metabolic stability in human liver microsomes assessed as GSH adduct formation at 100 uM after 90 mins by HPLC-MS analysis;CHEMBL2069259;Subcellular target assigned;S;467803;1;CHEMBL613373;CHEMBL3559723;
CLD0;;;CHEMBL2071972;[];Homo sapiens;[];;Microsome;9606.0;;Liver;A;ADME;BAO_0000251;microsome format;;Target assigned is subcellular fraction;2;Covalent binding affinity to human liver microsomes assessed per mg of protein at 10 uM after 60 mins presence of NADPH;CHEMBL2069259;Subcellular target assigned;S;467804;1;CHEMBL613373;CHEMBL3559723;
CLD0;;LLC-PK1;CHEMBL2077110;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307655;Homologous single protein target assigned;8;TP_TRANSPORTER: transepithelial transport (basal to apical) in mdr1a-expressing LLC-PK1 cell;CHEMBL2074129;Homologous protein target assigned;H;246;18;CHEMBL2573;;
CLD0;;Hepatocyte;CHEMBL2077565;[];Rattus norvegicus;[];;;10116.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308027;Direct single protein target assigned;9;TP_TRANSPORTER: Western blot, primary hepatocytes;CHEMBL2074328;Direct protein target assigned;D;294;18;CHEMBL2073676;;
CLD0;;Hepatocyte;CHEMBL2077566;[];Rattus norvegicus;[];;;10116.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308027;Direct single protein target assigned;9;TP_TRANSPORTER: Northern blot from primary hepatocytes;CHEMBL2074328;Direct protein target assigned;D;295;18;CHEMBL2073676;;
CLD0;;;CHEMBL2075094;[];Rattus norvegicus;[];Sprague-Dawley;;10116.0;In vivo;Kidney;F;Functional;BAO_0000218;organism-based format;;Direct single protein target assigned;9;TP_TRANSPORTER: Western in vivo, kidney of SD rat;CHEMBL2074267;Direct protein target assigned;D;1636;18;CHEMBL2073676;CHEMBL3638241;
CLD0;;LLC-PK1;CHEMBL2076853;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307655;Homologous single protein target assigned;8;TP_TRANSPORTER: transepithelial transport (apical to basal) of Dexamethasone at a concentration of 24.7 nM in MDR1-expressing LLC-PK1 cells;CHEMBL2074016;Homologous protein target assigned;H;2591;18;CHEMBL4302;;
CLD0;;;CHEMBL2077011;[];Mus musculus;[];mdr1a(-/-);;10090.0;In vivo;Brain;F;Functional;BAO_0000218;organism-based format;;Direct single protein target assigned;9;TP_TRANSPORTER: increase in brain concentration in mdr1a(-/-) mouse;CHEMBL2074129;Direct protein target assigned;D;437;18;CHEMBL2573;CHEMBL3638188;
CLD0;;Oocyte;CHEMBL2076571;[];Xenopus laevis;[];;;8355.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308859;Homologous single protein target assigned;8;TP_TRANSPORTER: inhibition of DHEAS uptake (DHEAS: 5 uM, Dexamethasone: 100 uM) in Xenopus laevis oocytes;CHEMBL2073949;Homologous protein target assigned;H;1959;18;CHEMBL1743123;;
CLD0;;LLC-PK1;CHEMBL2075240;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307655;Homologous single protein target assigned;8;TP_TRANSPORTER: transepithelial transport (basal to apical) in MDR1-expressing LLC-PK1 cells;CHEMBL2074129;Homologous protein target assigned;H;717;18;CHEMBL4302;;
CLD0;;Oocyte;CHEMBL2076384;[];Xenopus laevis;[];;;8355.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308859;Homologous single protein target assigned;8;TP_TRANSPORTER: inhibition of Ouabain uptake (Ouabain: 100 uM, Dexamethasone: 100 uM) in Xenopus laevis oocytes;CHEMBL2074160;Homologous protein target assigned;H;2049;18;CHEMBL1781859;;
CLD0;;Hepatocyte;CHEMBL2075271;[];Rattus norvegicus;[];;;10116.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308027;Direct single protein target assigned;9;TP_TRANSPORTER: Western blot, primary hepatocytes;CHEMBL2074099;Direct protein target assigned;D;2190;18;CHEMBL1075229;;
CLD0;;Hepatocyte;CHEMBL2075710;[];Rattus norvegicus;[];;;10116.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308027;Direct single protein target assigned;9;TP_TRANSPORTER: Northern blot from primary hepatocytes;CHEMBL2074099;Direct protein target assigned;D;2200;18;CHEMBL1075229;;
CLD0;;LLC-PK1;CHEMBL2076206;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307655;Homologous single protein target assigned;8;TP_TRANSPORTER: inhibition of Calcein-AM efflux in Mdr1a-expressing LLC-PK1 cells;CHEMBL1136781;Homologous protein target assigned;H;7;18;CHEMBL2573;;
CLD0;;Caco-2;CHEMBL2076207;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307519;Homologous single protein target assigned;8;TP_TRANSPORTER: inhibition of Rhodamine 123 efflux in Caco-2 cells;CHEMBL1136781;Homologous protein target assigned;H;8;18;CHEMBL4302;;
CLD0;;MDCK-II;CHEMBL2076208;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308862;Homologous single protein target assigned;8;TP_TRANSPORTER: inhibition of Calcein-AM efflux in MDR1-expressing MDCKII cells;CHEMBL1908284;Homologous protein target assigned;H;9;18;CHEMBL4302;;
CLD0;;LLC-PK1;CHEMBL2076209;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307655;Homologous single protein target assigned;8;TP_TRANSPORTER: inhibition of Calcein-AM efflux in MDR1-expressing LLC-PK1 cells;CHEMBL1136781;Homologous protein target assigned;H;10;18;CHEMBL4302;;
CLD0;;LLC-PK1;CHEMBL2076215;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307655;Homologous single protein target assigned;8;TP_TRANSPORTER: inhibition of Calcein-AM efflux in Mdr1b-expressing LLC-PK1 cells;CHEMBL1136781;Homologous protein target assigned;H;16;18;CHEMBL3467;;
CLD0;;MDCK;CHEMBL2076223;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308370;Homologous single protein target assigned;8;TP_TRANSPORTER: inhibition of Taurocholate uptake in OAT-K2-expressing MDCK cells;CHEMBL2073966;Homologous protein target assigned;H;24;18;CHEMBL2073707;;
CLD0;;BTI-TN-5B1-4;CHEMBL2076251;[];;[];;Membrane fraction;;In vitro;;F;Functional;BAO_0000249;cell membrane format;CHEMBL3833782;Homologous single protein target assigned;8;TP_TRANSPORTER: ATP hydrolysis in membrane fraction from High Five (BTI-TN5B1-4) cells;CHEMBL2074016;Homologous protein target assigned;H;53;18;CHEMBL4302;;
CLD0;;LS174T;CHEMBL2076254;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307536;Homologous single protein target assigned;8;TP_TRANSPORTER: Northern blot from LS174T cell;CHEMBL2074021;Homologous protein target assigned;H;56;18;CHEMBL4302;;
CLD0;;HK-2;CHEMBL2076047;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;TP_TRANSPORTER: Western blot, HK-2 cells;CHEMBL2074170;Homologous protein target assigned;H;73;18;CHEMBL4302;;
CLD0;;LLC-PK1;CHEMBL2076064;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307655;Homologous single protein target assigned;8;TP_TRANSPORTER: transepithelial transport in MDR1-expressing LLC-PK1 cells;CHEMBL2074008;Homologous protein target assigned;H;90;18;CHEMBL4302;;
CLD0;;HK-2;CHEMBL2078152;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;TP_TRANSPORTER: RT-PCR in HK-2 cell;CHEMBL2074170;Homologous protein target assigned;H;123;18;CHEMBL4302;;
CLD0;;Hepatocyte;CHEMBL2078347;[];Rattus norvegicus;[];;;10116.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308027;Direct single protein target assigned;9;TP_TRANSPORTER: Western blot, primary hepatocytes;CHEMBL2074058;Direct protein target assigned;D;1506;18;CHEMBL1075135;;
CLD0;;;CHEMBL2078354;[];Rattus norvegicus;[];Sprague-Dawley;;10116.0;In vivo;Kidney;F;Functional;BAO_0000218;organism-based format;;Direct single protein target assigned;9;TP_TRANSPORTER: Western in vivo, kidney of SD rat;CHEMBL2074267;Direct protein target assigned;D;1513;18;CHEMBL1075135;CHEMBL3638241;
CLD0;;Hepatocyte;CHEMBL2078362;[];Rattus norvegicus;[];;;10116.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308027;Direct single protein target assigned;9;TP_TRANSPORTER: Northern blot from primary hepatocytes;CHEMBL2074058;Direct protein target assigned;D;1521;18;CHEMBL1075135;;
CLD0;;Oocyte;CHEMBL2078571;[];Xenopus laevis;[];;;8355.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308859;Homologous single protein target assigned;8;TP_TRANSPORTER: uptake in Xenopus laevis oocytes;CHEMBL2074160;Homologous protein target assigned;H;177;18;CHEMBL1781859;;
CLD0;;Hepatocyte;CHEMBL2078279;[];Rattus norvegicus;[];Sprague-Dawley;;10116.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308027;Direct single protein target assigned;9;TP_TRANSPORTER: Northern blot from primary hepatocytes;CHEMBL2074248;Direct protein target assigned;D;3309;18;CHEMBL2073674;;
CLD0;;;CHEMBL2078280;[];Rattus norvegicus;[];;;10116.0;In vivo;Liver;F;Functional;BAO_0000218;organism-based format;;Direct single protein target assigned;9;TP_TRANSPORTER: Northern blot in vivo rat;CHEMBL2074248;Direct protein target assigned;D;3310;18;CHEMBL2073674;CHEMBL3559723;
CLD0;;;CHEMBL2077851;[];Rattus norvegicus;[];Sprague-Dawley;;10116.0;In vivo;Liver;F;Functional;BAO_0000218;organism-based format;;Direct single protein target assigned;9;TP_TRANSPORTER: Western in vivo, liver of SD rat;CHEMBL2074267;Direct protein target assigned;D;1634;18;CHEMBL2073676;CHEMBL3559723;
CLD0;;;CHEMBL2077946;[];Rattus norvegicus;[];Sprague-Dawley;;10116.0;In vivo;Liver;F;Functional;BAO_0000218;organism-based format;;Direct single protein target assigned;9;TP_TRANSPORTER: Western in vivo SD rat, liver;CHEMBL2074300;Direct protein target assigned;D;59;18;CHEMBL1781860;CHEMBL3559723;
CLD0;confirmatory;;CHEMBL2114890;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;651741;7;CHEMBL1075094;;
CLD0;confirmatory;;CHEMBL2114797;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. qHTS assay for small molecule activators of the rat pregnane X receptor (rPXR) signaling pathway. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;651751;7;CHEMBL2146315;;
CLD0;;;CHEMBL2148671;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 308, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'NERVOUS SYSTEM', 'l2': 'Analgesic Activity', 'l3': 'General Analgesic Nociceptic and Allodynic Activity', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Subcutaneous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Subcutaneous', 'type': 'ROUTE', 'units': None, 'value': None}];Swiss;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antinociceptive activity in Swiss mouse inflammatory pain model assessed as reduction in mechanical hyperalgesia at 2 mg/kg, sc dosed 45 mins before complete Freund's adjuvant dosing measured 4 to 24 hrs post complete Freund's adjuvant challenge by electronic pressure-meter test;CHEMBL2146469;Non-molecular target assigned;N;473055;1;CHEMBL375;;
CLD0;;;CHEMBL2148674;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 308, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'NERVOUS SYSTEM', 'l2': 'Analgesic Activity', 'l3': 'General Analgesic Nociceptic and Allodynic Activity', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Subcutaneous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Subcutaneous', 'type': 'ROUTE', 'units': None, 'value': None}];Swiss;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antinociceptive activity in Swiss mouse inflammatory pain model assessed as reduction in paw withdrawal response at 2 mg/kg, sc dosed once daily for 7 days dosed 45 mins before complete Freund's adjuvant dosing measured post complete Freund's adjuvant challenge;CHEMBL2146469;Non-molecular target assigned;N;473065;1;CHEMBL375;;
CLD0;;;CHEMBL2148786;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 301, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Paw Edema Test', 'source': 'Hock_2016'}, {'assay_class_id': 308, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'NERVOUS SYSTEM', 'l2': 'Analgesic Activity', 'l3': 'General Analgesic Nociceptic and Allodynic Activity', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Subcutaneous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Subcutaneous', 'type': 'ROUTE', 'units': None, 'value': None}];Swiss;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antinociceptive activity in Swiss mouse inflammatory pain model assessed as reduction in paw edema at 2 mg/kg, sc dosed once daily for 7 days dosed 45 mins before complete Freund's adjuvant dosing measured post complete Freund's adjuvant challenge;CHEMBL2146469;Non-molecular target assigned;N;473067;1;CHEMBL375;;
CLD0;;;CHEMBL2148788;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 308, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'NERVOUS SYSTEM', 'l2': 'Analgesic Activity', 'l3': 'General Analgesic Nociceptic and Allodynic Activity', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.5', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.5'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Subcutaneous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Subcutaneous', 'type': 'ROUTE', 'units': None, 'value': None}];Swiss;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antinociceptive activity in Swiss mouse inflammatory pain model assessed as reduction in hyperalgesia at 0.5 mg/kg, sc dosed once daily for 7 days dosed 45 mins before carrageenan dosing measured 3 hrs post carrageenan challenge;CHEMBL2146469;Non-molecular target assigned;N;473072;1;CHEMBL375;;
CLD0;;;CHEMBL2148794;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Subcutaneous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Subcutaneous', 'type': 'ROUTE', 'units': None, 'value': None}];Swiss;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Inhibition of complete Freund's adjuvant-induced IL-1beta production in Swiss mouse at 2 mg/kg, sc dosed 45 mins before complete Freund's adjuvant dosing measured up to 24 hrs post complete Freund's adjuvant challenge by ELISA;CHEMBL2146469;Non-molecular target assigned;N;473083;1;CHEMBL375;;
CLD0;;;CHEMBL2148795;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Subcutaneous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Subcutaneous', 'type': 'ROUTE', 'units': None, 'value': None}];Swiss;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Inhibition of complete Freund's adjuvant-induced TNFalpha production in Swiss mouse at 2 mg/kg, sc dosed 45 mins before complete Freund's adjuvant dosing measured up to 2 hrs post complete Freund's adjuvant challenge by ELISA;CHEMBL2146469;Non-molecular target assigned;N;473084;1;CHEMBL375;;
CLD0;;;CHEMBL2148800;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Subcutaneous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Subcutaneous', 'type': 'ROUTE', 'units': None, 'value': None}];Swiss;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Inhibition of complete Freund's adjuvant-induced neutrophil migration to paw tissue in Swiss mouse at 2 mg/kg, sc dosed 45 mins before complete Freund's adjuvant dosing measured 3 to 4 hrs post complete Freund's adjuvant challenge by myeloperoxidase kinetic colorimetric assay;CHEMBL2146469;Non-molecular target assigned;N;473092;1;CHEMBL375;;
CLD0;;;CHEMBL2148801;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Subcutaneous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Subcutaneous', 'type': 'ROUTE', 'units': None, 'value': None}];Swiss;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Inhibition of carrageenan-induced neutrophil migration to paw tissue in Swiss mouse at 2 mg/kg, sc dosed 45 mins before carrageenan dosing measured 3 to 4 hrs post complete Freund's adjuvant challenge by myeloperoxidase kinetic colorimetric assay;CHEMBL2146469;Non-molecular target assigned;N;473093;1;CHEMBL375;;
CLD0;;HEK293;CHEMBL2149030;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307715;Direct single protein target assigned;9;Activation of GR transfected in HEK293 cells assessed as fold signal induction at 2.5 uM after 18 hrs by firefly luciferase reporter gene-based luminescence assay;CHEMBL2146414;Direct protein target assigned;D;415814;1;CHEMBL2034;;
CLD0;;THP-1;CHEMBL2156821;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Antiinflammatory activity in human PMA-activated THP1 cells assessed as inhibition of LPS-induced TNFalpha production at 1 uM incubated for 30 mins prior to LPS-challenge measured after 24 hrs by ELISA relative to control;CHEMBL2150945;Non-molecular target assigned;N;474440;1;CHEMBL614245;;
CLD0;;THP-1;CHEMBL2156823;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Antiinflammatory activity in human PMA-activated THP1 cells assessed as inhibition of LPS-induced IL6 production at 1 uM incubated for 30 mins prior to LPS-challenge measured after 24 hrs by ELISA relative to control;CHEMBL2150945;Non-molecular target assigned;N;474442;1;CHEMBL614245;;
CLD0;;;CHEMBL2161537;[{'assay_class_id': 105, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'General Rheumatoid Arthritis Models', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '3.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '3.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];BALB/c;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiarthritic activity in BALB/c mouse type 2 collagen antibody-induced arthritis model assessed as inhibition of disease burden at 3 mg/kg, po qd for 14 days measured on day 20 relative to control;CHEMBL2157919;Non-molecular target assigned;N;478355;1;CHEMBL375;;
CLD0;;;CHEMBL2162033;[{'assay_class_id': 105, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'General Rheumatoid Arthritis Models', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '3.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '3.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];BALB/c;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiarthritic activity in BALB/c mouse type 2 collagen antibody-induced arthritis model assessed as physiological disease-modifying affect at 3 mg/kg, po qd for 14 days measured on day 20 relative to control;CHEMBL2157919;Non-molecular target assigned;N;478366;1;CHEMBL375;;
CLD0;;;CHEMBL2162036;[{'assay_class_id': 105, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'General Rheumatoid Arthritis Models', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '3.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '3.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];BALB/c;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in BALB/c mouse type 2 collagen antibody-induced arthritis model assessed as change in body weight at 3 mg/kg, po qd for 14 days measured on day 20;CHEMBL2157919;Non-molecular target assigned;N;478369;1;CHEMBL375;;
CLD0;;THP-1;CHEMBL2160560;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Antiinflammatory activity in human THP1 cells assessed as inhibition of LPS-stimulated TNFalpha production at 1 uM incubated for 30 mins prior to LPS-challenge measured 24 hrs post LPS-challenge by ELISA;CHEMBL2157914;Non-molecular target assigned;N;478128;1;CHEMBL614245;;
CLD0;;THP-1;CHEMBL2160562;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Antiinflammatory activity in human THP1 cells assessed as inhibition of LPS-stimulated IL-6 production at 1 uM incubated for 30 mins prior to LPS-challenge measured 24 hrs post LPS-challenge by ELISA;CHEMBL2157914;Non-molecular target assigned;N;478130;1;CHEMBL614245;;
CLD0;;HEK293;CHEMBL2169429;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307715;Direct single protein target assigned;9;Inhibition of human liver OATP1B1 expressed in HEK293 Flp-In cells assessed as reduction in E17-betaG uptake at 20 uM by scintillation counting;CHEMBL2163248;Direct protein target assigned;D;466159;1;CHEMBL1697668;;
CLD0;;HEK293;CHEMBL2169430;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307715;Direct single protein target assigned;9;Inhibition of human liver OATP1B3 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E17-betaG uptake at 20 uM incubated for 5 mins by scintillation counting;CHEMBL2163248;Direct protein target assigned;D;466160;1;CHEMBL1743121;;
CLD0;;HEK293;CHEMBL2169431;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307715;Direct single protein target assigned;9;Inhibition of human liver OATP2B1 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E3S uptake at 20 uM incubated for 5 mins by scintillation counting;CHEMBL2163248;Direct protein target assigned;D;466161;1;CHEMBL1743124;;
CLD0;;;CHEMBL2217283;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 505, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'RESPIRATORY SYSTEM', 'l2': 'Effects on Air Ways', 'l3': 'Models of Chronic Obstructive Pulmonary Disease COPD', 'source': 'Vogel_2008'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.3', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.3'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];BALB/c;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-induced COPD BALB/c mouse model assessed as reduction in pulmonary neutrophilia at 0.3 mg/kg, ip qd;CHEMBL2216751;Non-molecular target assigned;N;502687;1;CHEMBL375;;
CLD0;;CCK8;CHEMBL3063175;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against Homo sapiens (human) CCK8 cells at 1 uM after 24 hr;CHEMBL3045329;Default value - Target has yet to be curated;U;508895;1;CHEMBL612558;;
CLD0;;THP-1;CHEMBL3063176;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Anti-inflammatory activity in Homo sapiens (human) PMA-stimulated THP1 cells assessed as inhibition of LPS-induced IL6 production at 1 uM incubated for 30 min prior to LPS-challenge measured after 24 hr by ELISA;CHEMBL3045329;Non-molecular target assigned;N;508893;1;CHEMBL614245;;
CLD0;;THP-1;CHEMBL3063177;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Anti-inflammatory activity in Homo sapiens (human) PMA-stimulated THP1 cells assessed as inhibition of LPS-induced TNFalpha production at 1 uM incubated for 30 min prior to LPS-challenge measured after 24 hr by ELISA;CHEMBL3045329;Non-molecular target assigned;N;508892;1;CHEMBL614245;;
CLD0;;CCK8;CHEMBL3068646;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against Homo sapiens (human) CCK8 cells at 1 uM;CHEMBL3046347;Default value - Target has yet to be curated;U;507167;1;CHEMBL612558;;
CLD0;;THP-1;CHEMBL3068647;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Anti-inflammatory activity in Homo sapiens (human) THP1 cells assessed as inhibition of LPS-induced IL6 production at 1 uM incubated for 30 min prior to LPS-challenge measured after 24 hr by ELISA;CHEMBL3046347;Non-molecular target assigned;N;507166;1;CHEMBL614245;;
CLD0;;THP-1;CHEMBL3068648;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Anti-inflammatory activity in Homo sapiens (human) THP1 cells assessed as inhibition of LPS-induced TNFalpha production at 1 uM incubated for 30 min prior to LPS-challenge measured after 24 hr by ELISA;CHEMBL3046347;Non-molecular target assigned;N;507165;1;CHEMBL614245;;
CLD0;;;CHEMBL3066822;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Dissociation constant, pKa of the compound at pH 7.3;CHEMBL3046441;Default value - Target has yet to be curated;U;519678;1;CHEMBL2362975;;
CLD0;;;CHEMBL3066823;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Apparent hydrophobicity, log D of the compound in Octanol-buffer;CHEMBL3046441;Default value - Target has yet to be curated;U;519679;1;CHEMBL2362975;;
CLD0;;;CHEMBL3066824;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Apparent permeability of the compound by PAMPA;CHEMBL3046441;Default value - Target has yet to be curated;U;519677;1;CHEMBL2362975;;
CLD0;;;CHEMBL3066825;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Hydrophobicity, log P of the compound in octanol-water by shaking-flask method;CHEMBL3046441;Default value - Target has yet to be curated;U;519676;1;CHEMBL2362975;;
CLD0;;;CHEMBL3054249;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 301, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Paw Edema Test', 'source': 'Hock_2016'}];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];Wistar;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Anti-inflammatory activity in fasted Rattus norvegicus Wistar (rat) assessed as inhibition of carrageenan-induced paw edema at 1 mg/kg, ip administered 1 hr prior to carrageenan challenge measured at 5 hr relative to control;CHEMBL3046247;Non-molecular target assigned;N;512928;1;CHEMBL376;;
CLD0;;;CHEMBL3054252;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 301, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Paw Edema Test', 'source': 'Hock_2016'}];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];Wistar;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Anti-inflammatory activity in fasted Rattus norvegicus Wistar (rat) assessed as inhibition of carrageenan-induced paw edema at 1 mg/kg, ip administered 1 hr prior to carrageenan challenge measured at 3 hr relative to control;CHEMBL3046247;Non-molecular target assigned;N;512923;1;CHEMBL376;;
CLD0;;;CHEMBL3054255;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 301, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Paw Edema Test', 'source': 'Hock_2016'}];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];Wistar;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Anti-inflammatory activity in fasted Rattus norvegicus Wistar (rat) assessed as inhibition of carrageenan-induced paw edema at 1 mg/kg, ip administered 1 hr prior to carrageenan challenge measured at 1 hr relative to control;CHEMBL3046247;Non-molecular target assigned;N;512916;1;CHEMBL376;;
CLD0;;THP-1;CHEMBL3054057;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Anti-inflammatory activity in Homo sapiens (human) THP1 cells assessed as inhibition of LPS-induced IL-6 production preincubated at 1 uM for 30 min before LPS treatment measured after 24 hr by ELISA;CHEMBL3045793;Non-molecular target assigned;N;512503;1;CHEMBL614245;;
CLD0;;THP-1;CHEMBL3054058;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Anti-inflammatory activity in Homo sapiens (human) THP1 cells assessed as inhibition of LPS-induced TNF-alpha production preincubated at 1 uM for 30 min before LPS treatment measured after 24 hr by ELISA;CHEMBL3045793;Non-molecular target assigned;N;512502;1;CHEMBL614245;;
CLD0;;THP-1;CHEMBL3077037;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Anti-inflammatory activity in Homo sapiens (human) THP1 cells assessed as inhibition of LPS-induced IL6 production at 1 uM incubated for 30 min prior to LPS-challenge measured after 24 hr by ELISA;CHEMBL3044536;Non-molecular target assigned;N;536848;1;CHEMBL614245;;
CLD0;;THP-1;CHEMBL3077038;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Anti-inflammatory activity in Homo sapiens (human) THP1 cells assessed as inhibition of LPS-induced TNFalpha production at 1 uM incubated for 30 min prior to LPS-challenge measured after 24 hr by ELISA;CHEMBL3044536;Non-molecular target assigned;N;536847;1;CHEMBL614245;;
CLD0;;THP-1;CHEMBL3076792;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Anti-inflammatory activity in Homo sapiens (human) THP1 cells assessed as inhibition of LPS-induced IL6 production at 1 uM incubated for 30 min prior to LPS-challenge measured after 24 hr by ELISA relative to control;CHEMBL3046943;Non-molecular target assigned;N;536748;1;CHEMBL614245;;
CLD0;;THP-1;CHEMBL3076793;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Anti-inflammatory activity in Homo sapiens (human) THP1 cells assessed as inhibition of LPS-induced TNFalpha production at 1 uM incubated for 30 min prior to LPS-challenge measured after 24 hr by ELISA relative to control;CHEMBL3046943;Non-molecular target assigned;N;536747;1;CHEMBL614245;;
CLD0;;;CHEMBL3069605;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 301, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Paw Edema Test', 'source': 'Hock_2016'}];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];Wistar;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Anti-inflammatory activity in Wistar Rattus norvegicus (rat) assessed as inhibition of carrageenan-induced paw edema at 1 mg/kg, ip administered 30 min prior to carrageenan-challenge measured at 6 hr by plethysmometric analysis relative to control;CHEMBL3046683;Non-molecular target assigned;N;545358;1;CHEMBL376;;
CLD0;;;CHEMBL3069608;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 301, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Paw Edema Test', 'source': 'Hock_2016'}];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];Wistar;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Anti-inflammatory activity in Wistar Rattus norvegicus (rat) assessed as inhibition of carrageenan-induced paw edema at 1 mg/kg, ip administered 30 min prior to carrageenan-challenge measured at 5 hr by plethysmometric analysis relative to control;CHEMBL3046683;Non-molecular target assigned;N;545355;1;CHEMBL376;;
CLD0;;;CHEMBL3069611;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 301, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Paw Edema Test', 'source': 'Hock_2016'}];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];Wistar;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Anti-inflammatory activity in Wistar Rattus norvegicus (rat) assessed as inhibition of carrageenan-induced paw edema at 1 mg/kg, ip administered 30 min prior to carrageenan-challenge measured at 4 hr by plethysmometric analysis relative to control;CHEMBL3046683;Non-molecular target assigned;N;545352;1;CHEMBL376;;
CLD0;;;CHEMBL3069614;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 301, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Paw Edema Test', 'source': 'Hock_2016'}];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];Wistar;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Anti-inflammatory activity in Wistar Rattus norvegicus (rat) assessed as inhibition of carrageenan-induced paw edema at 1 mg/kg, ip administered 30 min prior to carrageenan-challenge measured at 3 hr by plethysmometric analysis relative to control;CHEMBL3046683;Non-molecular target assigned;N;545349;1;CHEMBL376;;
CLD0;;;CHEMBL3075803;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 301, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Paw Edema Test', 'source': 'Hock_2016'}];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];Wistar;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Anti-inflammatory activity in Wistar Rattus norvegicus (rat) assessed as inhibition of carrageenan-induced paw edema at 1 mg/kg, ip administered 30 min prior to carrageenan-challenge measured at 2 hr by plethysmometric analysis relative to control;CHEMBL3046683;Non-molecular target assigned;N;545346;1;CHEMBL376;;
CLD0;;;CHEMBL3075806;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 301, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Paw Edema Test', 'source': 'Hock_2016'}];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];Wistar;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Anti-inflammatory activity in Wistar Rattus norvegicus (rat) assessed as inhibition of carrageenan-induced paw edema at 1 mg/kg, ip administered 30 min prior to carrageenan-challenge measured at 1 hr by plethysmometric analysis relative to control;CHEMBL3046683;Non-molecular target assigned;N;545343;1;CHEMBL376;;
CLD0;;RAW264.7;CHEMBL3073616;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Anti-inflammatory activity in Mus musculus (mouse) RAW264.7 cells assessed as inhibition of PMA-induced macrophages respiratory burst measured up to 30 min by chemiluminescence method;CHEMBL3045908;Non-molecular target assigned;N;540931;1;CHEMBL612557;;
CLD0;;HEK293;CHEMBL2320305;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307715;Direct single protein target assigned;9;Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells at 20 uM after 1.5 mins by fluorescence assay;CHEMBL2311273;Direct protein target assigned;D;518496;1;CHEMBL1743126;;
CLD0;;HEK293;CHEMBL2320306;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307715;Direct single protein target assigned;9;Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay;CHEMBL2311273;Direct protein target assigned;D;518494;1;CHEMBL1743126;;
CLD0;;PBMC;CHEMBL2321311;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Antiinflammatory activity in human PBMC assessed as inhibition of PHA-induced IL-5 production after 48 hrs;CHEMBL2311478;Non-molecular target assigned;N;525681;1;CHEMBL613107;;
CLD0;;PBMC;CHEMBL2321312;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Antiinflammatory activity in human PBMC assessed as inhibition of PHA-induced IL-10 production after 48 hrs;CHEMBL2311478;Non-molecular target assigned;N;525682;1;CHEMBL613107;;
CLD0;;PBMC;CHEMBL2321313;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Antiinflammatory activity in human PBMC assessed as inhibition of PHA-induced IL-3 production after 48 hrs;CHEMBL2311478;Non-molecular target assigned;N;525680;1;CHEMBL613107;;
CLD0;;PBMC;CHEMBL2321314;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Antiinflammatory activity in human PBMC assessed as inhibition of PHA-induced IL-2 production after 48 hrs;CHEMBL2311478;Non-molecular target assigned;N;525679;1;CHEMBL613107;;
CLD0;;PBMC;CHEMBL2321315;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Antiinflammatory activity in human PBMC assessed as inhibition of PHA-induced MCP-1 production after 24 hrs;CHEMBL2311478;Non-molecular target assigned;N;525678;1;CHEMBL613107;;
CLD0;;PBMC;CHEMBL2321571;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Antiinflammatory activity in human PBMC assessed as inhibition of PHA-induced IL-13 production after 24 hrs;CHEMBL2311478;Non-molecular target assigned;N;525676;1;CHEMBL613107;;
CLD0;;PBMC;CHEMBL2321572;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Antiinflammatory activity in human PBMC assessed as inhibition of PHA-induced IP-10 production after 24 hrs;CHEMBL2311478;Non-molecular target assigned;N;525677;1;CHEMBL613107;;
CLD0;;PBMC;CHEMBL2321573;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Antiinflammatory activity in human PBMC assessed as inhibition of PHA-induced IL-4 production after 24 hrs;CHEMBL2311478;Non-molecular target assigned;N;525675;1;CHEMBL613107;;
CLD0;;PBMC;CHEMBL2321574;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Antiinflammatory activity in human PBMC assessed as inhibition of PHA-induced IFNgamma production after 24 hrs;CHEMBL2311478;Non-molecular target assigned;N;525674;1;CHEMBL613107;;
CLD0;;PBMC;CHEMBL2321575;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Antiinflammatory activity in human PBMC assessed as inhibition of PHA-induced MIP1alpha production after 6 hrs;CHEMBL2311478;Non-molecular target assigned;N;525673;1;CHEMBL613107;;
CLD0;;PBMC;CHEMBL2321576;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Antiinflammatory activity in human PBMC assessed as inhibition of PHA-induced IL-8 production after 6 hrs;CHEMBL2311478;Non-molecular target assigned;N;525672;1;CHEMBL613107;;
CLD0;;PBMC;CHEMBL2321577;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Antiinflammatory activity in human PBMC assessed as inhibition of PHA-induced IL-6 production after 6 hrs;CHEMBL2311478;Non-molecular target assigned;N;525671;1;CHEMBL613107;;
CLD0;;PBMC;CHEMBL2321578;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Antiinflammatory activity in human PBMC assessed as inhibition of PHA-induced TNFalpha production after 6 hrs;CHEMBL2311478;Non-molecular target assigned;N;525669;1;CHEMBL613107;;
CLD0;;PBMC;CHEMBL2321579;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Antiinflammatory activity in human PBMC assessed as inhibition of PHA-induced IL-1beta production after 6 hrs;CHEMBL2311478;Non-molecular target assigned;N;525670;1;CHEMBL613107;;
CLD0;;PBMC;CHEMBL2321580;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Antiinflammatory activity in human PBMC assessed as inhibition of anti-CD3-induced GM-CSF production after 48 hrs;CHEMBL2311478;Non-molecular target assigned;N;525668;1;CHEMBL613107;;
CLD0;;PBMC;CHEMBL2321581;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Antiinflammatory activity in human PBMC assessed as inhibition of anti-CD3-induced IL-12p70 production after 48 hrs;CHEMBL2311478;Non-molecular target assigned;N;525667;1;CHEMBL613107;;
CLD0;;PBMC;CHEMBL2321582;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Antiinflammatory activity in human PBMC assessed as inhibition of anti-CD3-induced IL-1beta production after 48 hrs;CHEMBL2311478;Non-molecular target assigned;N;525666;1;CHEMBL613107;;
CLD0;;PBMC;CHEMBL2321583;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Antiinflammatory activity in human PBMC assessed as inhibition of anti-CD3-induced TNFalpha production after 48 hrs;CHEMBL2311478;Non-molecular target assigned;N;525665;1;CHEMBL613107;;
CLD0;;PBMC;CHEMBL2321584;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Antiinflammatory activity in human PBMC assessed as inhibition of LPS-induced MIP1alpha production after 6 hrs;CHEMBL2311478;Non-molecular target assigned;N;525664;1;CHEMBL613107;;
CLD0;;PBMC;CHEMBL2321585;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Antiinflammatory activity in human PBMC assessed as inhibition of LPS-induced IL-8 production after 6 hrs;CHEMBL2311478;Non-molecular target assigned;N;525663;1;CHEMBL613107;;
CLD0;;PBMC;CHEMBL2321586;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Antiinflammatory activity in human PBMC assessed as inhibition of LPS-induced TNFalpha production after 6 hrs;CHEMBL2311478;Non-molecular target assigned;N;525660;1;CHEMBL613107;;
CLD0;;PBMC;CHEMBL2321587;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Antiinflammatory activity in human PBMC assessed as inhibition of LPS-induced IL-6 production after 6 hrs;CHEMBL2311478;Non-molecular target assigned;N;525662;1;CHEMBL613107;;
CLD0;;;CHEMBL2321588;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Inhibition of glucocorticoid receptor in human H13 cells assessed as inhibition of glucocorticoid-induced cell proliferation after 3 hrs by [3H]-thymidine incorporation assay;CHEMBL2311478;Direct protein target assigned;D;525654;1;CHEMBL2034;;
CLD0;;;CHEMBL2321589;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Displacement of [3H]-dexamethasone human glucocorticoid receptor alpha expressed in 293 MSR cells after 60 mins by scintillation counting;CHEMBL2311478;Direct protein target assigned;D;525643;1;CHEMBL2034;;
CLD0;;;CHEMBL2321590;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Binding affinity to glucocorticoid receptor (unknown origin) by fluorescence polarization competitive binding assay;CHEMBL2311478;Direct protein target assigned;D;525639;1;CHEMBL2034;;
CLD0;;PBMC;CHEMBL2321591;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Antiinflammatory activity in human PBMC assessed as inhibition of LPS-induced IL-1beta production after 6 hrs;CHEMBL2311478;Non-molecular target assigned;N;525661;1;CHEMBL613107;;
CLD0;;J774.A1;CHEMBL2321596;[];Mus musculus;[];;;10090.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307516;Default value - Target unknown or has yet to be assigned;0;Drug uptake in mouse J774A1 cells at 10 uM after 3 hrs by LC-MS/MS method;CHEMBL2311478;Default value - Target has yet to be curated;U;525690;1;CHEMBL612558;;
CLD0;;J774.A1;CHEMBL2321597;[];Mus musculus;[];;;10090.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307516;Default value - Target unknown or has yet to be assigned;0;Drug uptake in mouse J774A1 cells assessed as compound retention at 10 uM after 3 hrs by LC-MS/MS method;CHEMBL2311478;Default value - Target has yet to be curated;U;525691;1;CHEMBL612558;;
CLD0;;HCT-116;CHEMBL2329674;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308372;Direct single protein target assigned;9;Agonist activity at glucocorticoid receptor (unknown origin) expressed in human HCT116 cells co-expressing GRE at 20 to 40 uM after 24 hrs by luciferase reporter gene assay;CHEMBL2321735;Direct protein target assigned;D;551846;1;CHEMBL2034;;
CLD0;;IOBA-NHC;CHEMBL2327500;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Inhibition of NF-kappaB p65 activation in HSV1 KOS infected human IOBA-NHC cells assessed as reduction of NF-kappaB p65 translocation at 40 uM after 24 hrs by indirect immunofluorescence assay;CHEMBL2321679;Direct protein target assigned;D;551617;1;CHEMBL5533;;
CLD0;;HCLE;CHEMBL2327501;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Inhibition of NF-kappaB p65 activation in HSV1 KOS infected human HCLE cells assessed as reduction of NF-kappaB p65 translocation at 40 uM after 24 hrs by indirect immunofluorescence assay;CHEMBL2321679;Direct protein target assigned;D;551621;1;CHEMBL5533;;
CLD0;;;CHEMBL2327502;[];Mus musculus;[];;;10090.0;;;B;Binding;BAO_0000019;assay format;;Direct single protein target assigned;9;Effect on NF-kappaB p65 activation in LPS-stimulated mouse J774A.1 cells assessed as NF-kappaB p65 translocation at 40 uM after 24 hrs by indirect immunofluorescence assay;CHEMBL2321679;Direct protein target assigned;D;551632;1;CHEMBL5902;;
CLD0;;IOBA-NHC;CHEMBL2327640;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Inhibition of NF-kappaB p65-mediated TNFalpha release in HSV1 KOS infected human IOBA-NHC cells at 40 uM after 24 hrs by ELISA;CHEMBL2321679;Direct protein target assigned;D;551648;1;CHEMBL5533;;
CLD0;;IOBA-NHC;CHEMBL2327641;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Inhibition of NF-kappaB p65-mediated IL-6 release in HSV1 KOS infected human IOBA-NHC cells at 40 uM after 24 hrs by ELISA;CHEMBL2321679;Direct protein target assigned;D;551649;1;CHEMBL5533;;
CLD0;;IOBA-NHC;CHEMBL2327642;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Inhibition of NF-kappaB p65-mediated IL-8 release in HSV1 KOS infected human IOBA-NHC cells at 40 uM after 24 hrs by ELISA;CHEMBL2321679;Direct protein target assigned;D;551650;1;CHEMBL5533;;
CLD0;;HCLE;CHEMBL2327643;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Inhibition of NF-kappaB p65-mediated IL-8 release in HSV1 KOS infected human HCLE cells at 40 uM after 24 hrs by ELISA;CHEMBL2321679;Direct protein target assigned;D;551651;1;CHEMBL5533;;
CLD0;;RAW264.7;CHEMBL2341808;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Inhibition of LPS-induced nitric oxide production in mouse RAW264.7 cells at 5 uM;CHEMBL2331283;Non-molecular target assigned;N;557025;1;CHEMBL612557;;
CLD0;;PBMC;CHEMBL2345230;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Antiinflammatory activity in human PBMCs assessed as inhibition of LPS-induced IL6 release at 10 uM incubated for 15 mins prior to LPS challenge measured after 24 hrs by HTRF assay relative to control;CHEMBL2331157;Non-molecular target assigned;N;560646;1;CHEMBL613107;;
CLD0;;PBMC;CHEMBL2345232;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Antiinflammatory activity in human PBMCs assessed as inhibition of LPS-induced IL1-beta release at 100 uM incubated for 15 mins prior to LPS challenge measured after 24 hrs by HTRF assay relative to control;CHEMBL2331157;Non-molecular target assigned;N;560627;1;CHEMBL613107;;
CLD0;;PBMC;CHEMBL2345233;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Antiinflammatory activity in human PBMCs assessed as inhibition of LPS-induced TNFalpha release at 100 uM incubated for 15 mins prior to LPS challenge measured after 24 hrs by HTRF assay relative to control;CHEMBL2331157;Non-molecular target assigned;N;560626;1;CHEMBL613107;;
CLD0;;PBMC;CHEMBL2345235;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Antiinflammatory activity in human PBMCs assessed as inhibition of LPS-induced IL1-beta release incubated for 15 mins prior to LPS challenge measured after 24 hrs by HTRF assay;CHEMBL2331157;Non-molecular target assigned;N;560617;1;CHEMBL613107;;
CLD0;;PBMC;CHEMBL2345236;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Antiinflammatory activity in human PBMCs assessed as inhibition of LPS-induced TNFalpha release incubated for 15 mins prior to LPS challenge measured after 24 hrs by HTRF assay;CHEMBL2331157;Non-molecular target assigned;N;560616;1;CHEMBL613107;;
CLD0;;;CHEMBL2345905;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '20.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '20.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];ICR;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in ICR mouse assessed as reversal in LPS-induced weight loss at 20 mg/kg, ip administered for 5 days prior to LPS-challenge measured from day 9 to 11 relative to control;CHEMBL2331446;Non-molecular target assigned;N;555064;1;CHEMBL375;;
CLD0;;;CHEMBL2345914;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '20.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '20.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];ICR;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in ICR mouse assessed as reversal in LPS-induced weight loss at 20 mg/kg, ip administered for 5 days prior to LPS-challenge measured up to day 8 relative to control;CHEMBL2331446;Non-molecular target assigned;N;529389;1;CHEMBL375;;
CLD0;;;CHEMBL2345916;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '20.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '20.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];ICR;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in ICR mouse assessed as protection against LPS-induced sepsis at 20 mg/kg, ip administered for 5 days prior to LPS-challenge measured after 2 hrs;CHEMBL2331446;Non-molecular target assigned;N;529381;1;CHEMBL375;;
CLD0;;RAW264.7;CHEMBL2346380;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production incubated for 2 hrs prior to LPS-challenge measured after 24 hrs by Griess method;CHEMBL2331446;Non-molecular target assigned;N;529319;1;CHEMBL612557;;
CLD0;;RAW264.7;CHEMBL2346381;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production at 50 uM incubated for 2 hrs prior to LPS-challenge measured after 24 hrs by Griess method;CHEMBL2331446;Non-molecular target assigned;N;529318;1;CHEMBL612557;;
CLD0;confirmatory;;CHEMBL2354254;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;686979;7;CHEMBL1075138;;
CLD0;confirmatory;;CHEMBL2354287;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;652104;7;CHEMBL2362981;;
CLD0;confirmatory;;CHEMBL2354311;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;686970;7;CHEMBL2007625;;
CLD0;;IEC-18;CHEMBL2388276;[];Rattus norvegicus;[];;;10116.0;;;A;ADME;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Antiproliferative activity against rat IEC-18 cells at 10 uM after 24 hrs by MTT assay;CHEMBL2385003;Default value - Target has yet to be curated;U;573441;1;CHEMBL612558;;
CLD0;;IEC-18;CHEMBL2388278;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Wound healing activity in rat IEC-18 cells assessed as reduction of cell migration at 10 uM after 24 hrs relative to control;CHEMBL2385003;Non-molecular target assigned;N;573443;1;CHEMBL3879801;;
CLD0;;;CHEMBL2394817;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Binding affinity to human glucocorticoid receptor by radioligand displacement assay;CHEMBL2390917;Direct protein target assigned;D;571546;1;CHEMBL2034;;
CLD0;;HeLa S3;CHEMBL2395265;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3886002;Direct single protein target assigned;9;Displacement of [3H]Dexamethasone from glucocorticoid receptor in human HeLaS3 cells after 2 hrs;CHEMBL2390918;Direct protein target assigned;D;563709;1;CHEMBL2034;;
CLD0;;HeLa S3;CHEMBL2396073;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3886002;Direct single protein target assigned;9;Displacement of [3H]Dexamethasone from glucocorticoid receptor in human HeLaS3 cells at 10 uM after 2 hrs relative to control;CHEMBL2390918;Direct protein target assigned;D;563641;1;CHEMBL2034;;
CLD0;;;CHEMBL2394919;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Binding affinity to human glucocorticoid receptor by radioligand displacement assay;CHEMBL2390830;Direct protein target assigned;D;567006;1;CHEMBL2034;;
CLD0;;THP-1;CHEMBL2427377;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Cytotoxicity against human THP1 cells assessed as cell viability at 1 ug/ml after 24 hrs by CCK-8 assay;CHEMBL2424627;Non-molecular target assigned;N;596011;1;CHEMBL614245;;
CLD0;;THP-1;CHEMBL2427379;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-stimulated human THP1 cells assessed as inhibition of IL-6 release at 1 ug/ml after 24 hrs by ELISA relative to control;CHEMBL2424627;Non-molecular target assigned;N;596006;1;CHEMBL614245;;
CLD0;;THP-1;CHEMBL2427381;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-stimulated human THP1 cells assessed as inhibition of TNFalpha release at 1 ug/ml after 24 hrs by ELISA relative to control;CHEMBL2424627;Non-molecular target assigned;N;596003;1;CHEMBL614245;;
CLD0;;HeLa;CHEMBL2428207;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308376;Direct single protein target assigned;9;Transactivation of glucocorticoid receptor ligand binding domain (unknown origin) transfected in human HeLa cells assessed as activation of NP-1 by GAL4 luciferase reporter gene assay;CHEMBL2424628;Direct protein target assigned;D;594463;1;CHEMBL2034;;
CLD0;;A549;CHEMBL2428210;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307651;Direct single protein target assigned;9;Agonist activity at glucocorticoid receptor in human A549 cells assessed as inhibition of PMA-induced AP-1 activation by luciferase reporter gene assay;CHEMBL2424628;Direct protein target assigned;D;594459;1;CHEMBL2034;;
CLD0;;A549;CHEMBL2428211;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307651;Direct single protein target assigned;9;Agonist activity at glucocorticoid receptor in human A549 cells assessed as inhibition of IL-1beta-induced NF-kappaB dependent E-selectin activation by luciferase reporter gene assay;CHEMBL2424628;Direct protein target assigned;D;594461;1;CHEMBL2034;;
CLD0;;;CHEMBL2428212;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Binding affinity to glucocorticoid receptor (unknown origin) by fluorescence polarization assay;CHEMBL2424628;Direct protein target assigned;D;594458;1;CHEMBL2034;;
CLD0;;HeLa;CHEMBL2428097;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308376;Direct single protein target assigned;9;Transactivation of GR-LBD expressed in human HeLa cells co-expressing GAL4-DBD by luciferase reporter gene assay;CHEMBL2424642;Direct protein target assigned;D;596180;1;CHEMBL2034;;
CLD0;;A549;CHEMBL2428099;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307651;Direct single protein target assigned;9;Transrepression of glucocorticoid receptor in human A549 cells assessed as inhibition of PMA-induced AP-1 activity by luciferase reporter gene assay;CHEMBL2424642;Direct protein target assigned;D;596175;1;CHEMBL2034;;
CLD0;;;CHEMBL2428100;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Binding affinity to glucocorticoid receptor-LBD (unknown origin) by fluorescence polarization assay;CHEMBL2424642;Direct protein target assigned;D;596173;1;CHEMBL2034;;
CLD0;;HeLa;CHEMBL2427917;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308376;Direct single protein target assigned;9;Transactivation activity at glucocorticoid receptor ligand binding domain (unknown origin) expressed in human Hela cells co-expressing GAL4 DNA binding domain assessed as NP-1-stimulated GRE activation by luciferase reporter gene assay;CHEMBL2424625;Direct protein target assigned;D;594432;1;CHEMBL2034;;
CLD0;;A549;CHEMBL2427920;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307651;Direct single protein target assigned;9;Transrepression activity at glucocorticoid receptor in human A549 cells assessed as inhibition of IL1beta-stimulated NFkappaB-dependent E-selectin transcription by luciferase reporter gene assay;CHEMBL2424625;Direct protein target assigned;D;594425;1;CHEMBL2034;;
CLD0;;A549;CHEMBL2428108;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307651;Direct single protein target assigned;9;Transrepression activity at glucocorticoid receptor in human A549 cells assessed as inhibition of PMA-stimulated AP1 response element by luciferase reporter gene assay;CHEMBL2424625;Direct protein target assigned;D;594423;1;CHEMBL2034;;
CLD0;;;CHEMBL2428109;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Binding affinity to glucocorticoid receptor (unknown origin) by fluorescence assay;CHEMBL2424625;Direct protein target assigned;D;594422;1;CHEMBL2034;;
CLD0;;;CHEMBL2443828;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];Balb/c;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in ovalbumin-sensitized Balb/c mouse asthma model model assessed as reduction of goblet cell hyperplasia in lungs at 1 mg/kg, po by PAS staining;CHEMBL2440088;Non-molecular target assigned;N;602097;1;CHEMBL375;;
CLD0;;;CHEMBL2443831;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];Balb/c;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in ovalbumin-sensitized Balb/c mouse asthma model model assessed as reduction of eosinophils, neutrophils, lymphocytes, and macrophages level in BAL fluid at 1 mg/kg, po;CHEMBL2440088;Non-molecular target assigned;N;602094;1;CHEMBL375;;
CLD0;;;CHEMBL2443834;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 503, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'RESPIRATORY SYSTEM', 'l2': 'Effects on Air Ways', 'l3': 'General Airway Models', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];Balb/c;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in ovalbumin-sensitized Balb/c mouse asthma model model assessed as reduction in methacholine-induced airway hyperresponsiveness at 1 mg/kg, po;CHEMBL2440088;Non-molecular target assigned;N;602084;1;CHEMBL375;;
CLD0;;CHO;CHEMBL3039491;[];Cricetulus griseus;[];;;10029.0;In vitro;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308072;Homologous single protein target assigned;8;Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM;CHEMBL3039007;Homologous protein target assigned;H;4;1;CHEMBL1743121;;
CLD0;;;CHEMBL3096915;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Agonist activity at glucocorticoid receptor in HFF assessed as inhibition of IL-1-induced IL-6 production at 2000 nM after 24 hrs relative to control;CHEMBL3091451;Direct protein target assigned;D;610185;1;CHEMBL2034;;
CLD0;;;CHEMBL3096916;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Agonist activity at glucocorticoid receptor in HFF assessed as inhibition of IL-1-induced IL-6 production after 24 hrs;CHEMBL3091451;Direct protein target assigned;D;610184;1;CHEMBL2034;;
CLD0;;;CHEMBL3096917;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Binding affinity to mineralocorticoid receptor (unknown origin) by fluorescence polarization competitive binding assay;CHEMBL3091451;Direct protein target assigned;D;610175;1;CHEMBL1994;;
CLD0;;;CHEMBL3096918;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Displacement of TAMRA-labeled mifepristone from progesterone receptor (unknown origin) by fluorescence polarization competitive binding assay;CHEMBL3091451;Direct protein target assigned;D;610173;1;CHEMBL208;;
CLD0;;;CHEMBL3096919;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Displacement of TAMRA-labeled dexamethasone from glucocorticoid receptor (unknown origin) by fluorescence polarization competitive binding assay;CHEMBL3091451;Direct protein target assigned;D;610166;1;CHEMBL2034;;
CLD0;;HEK293;CHEMBL3122502;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307715;Direct single protein target assigned;9;Displacement of [3H]-methyltrienolone from human progesterone receptor expressed in HEK293 cells;CHEMBL3120138;Direct protein target assigned;D;627104;1;CHEMBL208;;
CLD0;;HEK293;CHEMBL3122503;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307715;Direct single protein target assigned;9;Displacement of [3H]-methyltrienolone from human androgen receptor expressed in HEK293 cells;CHEMBL3120138;Direct protein target assigned;D;627101;1;CHEMBL1871;;
CLD0;;HEK293;CHEMBL3122504;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307715;Direct single protein target assigned;9;Displacement of [3H]-dexamethasone from human glucocorticoid receptor expressed in HEK293 cells;CHEMBL3120138;Direct protein target assigned;D;627098;1;CHEMBL2034;;
CLD0;;HEK293;CHEMBL3122505;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307715;Direct single protein target assigned;9;Displacement of [3H]-aldosterone from human mineralocorticoid receptor expressed in HEK293 cells;CHEMBL3120138;Direct protein target assigned;D;627103;1;CHEMBL1994;;
CLD0;;;CHEMBL3137722;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Moderate liver toxicity, defined via clinical-chemistry results: ALT or AST serum activity 6 times the normal upper limit (N) or alkaline phosphatase serum activity of 1.7 N. Value is number of references indexed. [column 'BIOL' in source];CHEMBL3137667;Non-molecular target assigned;N;1;1;CHEMBL3879801;CHEMBL3559723;
CLD0;;;CHEMBL3137723;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Highest frequency of moderate liver toxicity observed during clinical trials, expressed as a percentage. [column '% BIOL' in source];CHEMBL3137667;Non-molecular target assigned;N;2;1;CHEMBL3879801;CHEMBL3559723;
CLD0;;;CHEMBL3137724;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Acute liver toxicity defined via clinical observations and clear clinical-chemistry results: serum ALT or AST activity > 6 N or serum alkaline phosphatases activity > 1.7 N. This category includes cytolytic, choleostatic and mixed liver toxicity. Value is number of references indexed. [column 'AIGUE' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;3;1;CHEMBL612545;CHEMBL3559723;
CLD0;;;CHEMBL3137725;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Highest frequency of acute liver toxicity observed during clinical trials, expressed as a percentage. [column '% AIGUE' in source];CHEMBL3137667;Non-molecular target assigned;N;4;1;CHEMBL3879801;CHEMBL3559723;
CLD0;;;CHEMBL3137726;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Cytolytic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is > 5 (see ACUTE). Value is number of references indexed. [column 'CYTOL' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;5;1;CHEMBL612545;CHEMBL3559723;
CLD0;;;CHEMBL3137727;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Choleostatic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is < 2 (see ACUTE). Value is number of references indexed. [column 'CHOLE' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;6;1;CHEMBL612545;CHEMBL3559723;
CLD0;;;CHEMBL3137728;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Severe hepatitis, defined as possibly life-threatening liver failure or through clinical observations. Value is number of references indexed. [column 'MASS' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;7;1;CHEMBL612545;CHEMBL3559723;
CLD0;;;CHEMBL3137729;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Chronic liver disease either proven histopathologically, or through a chonic elevation of serum amino-transferase activity after 6 months. Value is number of references indexed. [column 'CHRON' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;8;1;CHEMBL612545;CHEMBL3559723;
CLD0;;;CHEMBL3137730;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Cirrhosis, proven histopathologically. Value is number of references indexed. [column 'CIRRH' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;9;1;CHEMBL612545;;
CLD0;;;CHEMBL3137731;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Granulomatous liver disease, proven histopathologically. Value is number of references indexed. [column 'GRAN' in source];CHEMBL3137667;Non-molecular target assigned;N;10;1;CHEMBL3879801;CHEMBL3559723;
CLD0;;;CHEMBL3137732;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Liver damage due to vascular disease: peliosis hepatitis, hepatic veno-occlusive disease, Budd-Chiari syndrome. Value is number of references indexed. [column 'VASC' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;11;1;CHEMBL612545;;
CLD0;;;CHEMBL3137733;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Steatosis, proven histopathologically. Value is number of references indexed. [column 'STEAT' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;12;1;CHEMBL612545;;
CLD0;;;CHEMBL3137734;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Malignant tumor, proven histopathologically. Value is number of references indexed. [column 'T.MAL' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;13;1;CHEMBL612545;;
CLD0;;;CHEMBL3137735;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Target assigned is non-molecular;1;Benign tumor, proven histopathologically. Value is number of references indexed. [column 'T.BEN' in source];CHEMBL3137667;Non-molecular target assigned;N;14;1;CHEMBL3879801;;
CLD0;;;CHEMBL3137736;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Target assigned is non-molecular;1;Animal toxicity known. [column 'TOXIC' in source];CHEMBL3137667;Non-molecular target assigned;N;15;1;CHEMBL3879801;;
CLD0;;;CHEMBL3137737;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Presence of at least one case with successful reintroduction. [column 'REINT' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;16;1;CHEMBL612545;;
CLD0;;;CHEMBL3137738;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Comments (NB not yet translated). [column 'COMMENTAIRES' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;17;1;CHEMBL612545;;
CLD0;;;CHEMBL3137739;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Target assigned is non-molecular;1;Times to onset, minimal and maximal, observed in the indexed observations. [column 'DELAI' in source];CHEMBL3137667;Non-molecular target assigned;N;18;1;CHEMBL3879801;;
CLD0;;;CHEMBL3137740;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Proposed mechanism(s) of liver damage. [column 'MEC' in source];CHEMBL3137667;Non-molecular target assigned;N;19;1;CHEMBL3879801;CHEMBL3559723;
CLD0;confirmatory;;CHEMBL3215112;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Target assigned is molecular non-protein target;3;PubChem BioAssay. qHTS assay for small molecule activators of the human pregnane X receptor (PXR) signaling pathway.   (Class of assay: confirmatory) ;CHEMBL1201862;Molecular target other than protein assigned;M;720659;7;CHEMBL612546;;
CLD0;confirmatory;;CHEMBL3214862;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. Nrf2 qHTS screen for inhibitors: Nrf2 A549 ARE-Fluc Confirmation Assay for Hit Validation.   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;720524;7;CHEMBL1075094;;
CLD0;;;CHEMBL3242793;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 503, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'RESPIRATORY SYSTEM', 'l2': 'Effects on Air Ways', 'l3': 'General Airway Models', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];BALB/c;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiallergic activity in house dust mite-induced allergic airway disease BALB/c mouse model assessed as reduction in airway inflammation at 1 mg/kg, ip qd after 17 days;CHEMBL3232705;Non-molecular target assigned;N;627199;1;CHEMBL375;;
CLD0;;;CHEMBL3241423;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Displacement of TAMRA-labeled dexamethasone from glucocorticoid receptor (unknown origin) by fluorescence polarization assay;CHEMBL3232739;Direct protein target assigned;D;662800;1;CHEMBL2034;;
CLD0;;;CHEMBL3241424;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Displacement of TAMRA-labeled mifepristone from progesterone receptor (unknown origin) by fluorescence polarization assay;CHEMBL3232739;Direct protein target assigned;D;662801;1;CHEMBL208;;
CLD0;;;CHEMBL3241425;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Displacement of TAMRA-labeled dexamethasone from mineralocorticoid receptor (unknown origin) by fluorescence polarization assay;CHEMBL3232739;Direct protein target assigned;D;662804;1;CHEMBL1994;;
CLD0;;;CHEMBL3241426;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Agonist activity at glucocorticoid receptor in human foreskin fibroblasts assessed as inhibition of IL-1-induced IL-6 production by trans-repression assay;CHEMBL3232739;Direct protein target assigned;D;662805;1;CHEMBL2034;;
CLD0;;HeLa;CHEMBL3241430;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308376;Direct single protein target assigned;9;Transactivation of glucocorticoid receptor in human HeLa cells harboring MMTV promoter by luciferase reporter gene assay;CHEMBL3232739;Direct protein target assigned;D;662837;1;CHEMBL2034;;
CLD0;;;CHEMBL3282503;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Rattus norvegicus;[];;;10116.0;;Ear;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in immature rat assessed as inhibition of cantharidin-induced inflammation at 5 ug administered topically to outer surface of ear after 72 hrs relative to control;CHEMBL3272292;Non-molecular target assigned;N;675032;1;CHEMBL376;CHEMBL3987716;
CLD0;;;CHEMBL3282753;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Rattus norvegicus;[];;;10116.0;;Ear;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in immature rat assessed as inhibition of cantharidin-induced inflammation at 10 ug administered topically to outer surface of ear after 72 hrs relative to control;CHEMBL3272292;Non-molecular target assigned;N;675033;1;CHEMBL376;CHEMBL3987716;
CLD0;;;CHEMBL3282754;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Rattus norvegicus;[];;;10116.0;;Ear;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in immature rat assessed as inhibition of cantharidin-induced inflammation at 20 ug administered topically to outer surface of ear after 72 hrs relative to control;CHEMBL3272292;Non-molecular target assigned;N;675034;1;CHEMBL376;CHEMBL3987716;
CLD0;;;CHEMBL3282755;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Rattus norvegicus;[];;;10116.0;;Ear;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in immature rat assessed as inhibition of cantharidin-induced inflammation at 40 ug administered topically to outer surface of ear after 72 hrs relative to control;CHEMBL3272292;Non-molecular target assigned;N;675035;1;CHEMBL376;CHEMBL3987716;
CLD0;;;CHEMBL3282756;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Rattus norvegicus;[];;;10116.0;;Ear;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in immature rat assessed as inhibition of cantharidin-induced inflammation at 80 ug administered topically to outer surface of ear after 72 hrs relative to control;CHEMBL3272292;Non-molecular target assigned;N;675036;1;CHEMBL376;CHEMBL3987716;
CLD0;;;CHEMBL3282759;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in rat assessed as reduction in dry ganuloma tissue surrounding implanted cotton pellet at 10 ug per pellet after 72 hrs relative to control;CHEMBL3272292;Non-molecular target assigned;N;675039;1;CHEMBL376;;
CLD0;;;CHEMBL3282760;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in rat assessed as reduction in dry ganuloma tissue surrounding implanted cotton pellet at 20 ug per pellet after 72 hrs relative to control;CHEMBL3272292;Non-molecular target assigned;N;675040;1;CHEMBL376;;
CLD0;;;CHEMBL3282761;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in rat assessed as reduction in dry ganuloma tissue surrounding implanted cotton pellet at 40 ug per pellet after 72 hrs relative to control;CHEMBL3272292;Non-molecular target assigned;N;675041;1;CHEMBL376;;
CLD0;;;CHEMBL3282762;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in rat assessed as reduction in dry ganuloma tissue surrounding implanted cotton pellet at 80 ug per pellet after 72 hrs relative to control;CHEMBL3272292;Non-molecular target assigned;N;675042;1;CHEMBL376;;
CLD0;;Thymocyte;CHEMBL3292951;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308026;Default value - Target unknown or has yet to be assigned;0;Induction of apoptosis in mouse thymocytes assessed as internucleosomal DNA fragmentation at 1 uM after 24 hrs by agarose gel electrophoresis;CHEMBL3286163;Default value - Target has yet to be curated;U;688539;1;CHEMBL612545;;
CLD0;;B16-F10;CHEMBL3299613;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307762;Target assigned is non-molecular;1;Anticancer against mouse B16F10 cells after 72 hrs by MTT assay;CHEMBL3297734;Non-molecular target assigned;N;690688;1;CHEMBL3879801;;
CLD0;;MCF7;CHEMBL3299614;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Anticancer against human MCF7 cells after 72 hrs by MTT assay;CHEMBL3297734;Non-molecular target assigned;N;690690;1;CHEMBL387;;
CLD0;;A549;CHEMBL3299615;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Anticancer against human A549 cells after 72 hrs by MTT assay;CHEMBL3297734;Non-molecular target assigned;N;690691;1;CHEMBL392;;
CLD0;;CHO;CHEMBL3299616;[];Cricetulus griseus;[];;;10029.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308072;Target assigned is non-molecular;1;Cytotoxicity against CHO cells after 72 hrs by MTT assay;CHEMBL3297734;Non-molecular target assigned;N;690696;1;CHEMBL613853;;
CLD0;;HEK-293T;CHEMBL3299617;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3706569;Target assigned is non-molecular;1;Cytotoxicity against HEK293T cells after 72 hrs by MTT assay;CHEMBL3297734;Non-molecular target assigned;N;690698;1;CHEMBL3706568;;
CLD0;;Fibroblast;CHEMBL3299618;[];Mus musculus;[];;;10090.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308065;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against mouse fibroblasts after 72 hrs by MTT assay;CHEMBL3297734;Default value - Target has yet to be curated;U;690700;1;CHEMBL612558;;
CLD0;;B16-F10;CHEMBL3299619;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307762;Target assigned is non-molecular;1;Induction of apoptosis in mouse B16F10 cells assessed as necrotic cells at 10 uM after 48 hrs using FITC-annexin V-FITC/propidium iodide by flow cytometry (Rvb = 1.7%);CHEMBL3297734;Non-molecular target assigned;N;690736;1;CHEMBL612656;;
CLD0;;B16-F10;CHEMBL3299620;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307762;Target assigned is non-molecular;1;Induction of apoptosis in mouse B16F10 cells assessed as late apoptotic cells at 10 uM after 48 hrs using FITC-annexin V-FITC/propidium iodide by flow cytometry (Rvb = 2.5%);CHEMBL3297734;Non-molecular target assigned;N;690737;1;CHEMBL612656;;
CLD0;;B16-F10;CHEMBL3299777;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307762;Target assigned is non-molecular;1;Induction of apoptosis in mouse B16F10 cells assessed as early apoptotic cells at 10 uM after 48 hrs using FITC-annexin V-FITC/propidium iodide by flow cytometry (Rvb = 0.7%);CHEMBL3297734;Non-molecular target assigned;N;690738;1;CHEMBL612656;;
CLD0;;B16-F10;CHEMBL3299778;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307762;Target assigned is non-molecular;1;Induction of apoptosis in mouse B16F10 cells assessed as viable cells at 10 uM after 48 hrs using FITC-annexin V-FITC/propidium iodide by flow cytometry (Rvb = 95.1%);CHEMBL3297734;Non-molecular target assigned;N;690739;1;CHEMBL612656;;
CLD0;;MCF7;CHEMBL3299779;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Induction of apoptosis in human MCF7 cells assessed as necrotic cells at 10 uM after 48 hrs using FITC-annexin V-FITC/propidium iodide by flow cytometry (Rvb = 7.1%);CHEMBL3297734;Non-molecular target assigned;N;690745;1;CHEMBL387;;
CLD0;;MCF7;CHEMBL3299780;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Induction of apoptosis in human MCF7 cells assessed as late apoptotic cells at 10 uM after 48 hrs using FITC-annexin V-FITC/propidium iodide by flow cytometry (Rvb = 3.5%);CHEMBL3297734;Non-molecular target assigned;N;690747;1;CHEMBL387;;
CLD0;;MCF7;CHEMBL3299781;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Induction of apoptosis in human MCF7 cells assessed as early apoptotic cells at 10 uM after 48 hrs using FITC-annexin V-FITC/propidium iodide by flow cytometry (Rvb = 3%);CHEMBL3297734;Non-molecular target assigned;N;690749;1;CHEMBL387;;
CLD0;;MCF7;CHEMBL3299782;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Induction of apoptosis in human MCF7 cells assessed as viable cells at 10 uM after 48 hrs using FITC-annexin V-FITC/propidium iodide by flow cytometry (Rvb = 86.4%);CHEMBL3297734;Non-molecular target assigned;N;690750;1;CHEMBL387;;
CLD0;;CHO;CHEMBL3299783;[];Cricetulus griseus;[];;;10029.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308072;Target assigned is non-molecular;1;Induction of apoptosis in CHO cells assessed as necrotic cells at 10 uM after 48 hrs using FITC-annexin V-FITC/propidium iodide by flow cytometry (Rvb =6.6%);CHEMBL3297734;Non-molecular target assigned;N;690758;1;CHEMBL613853;;
CLD0;;CHO;CHEMBL3299784;[];Cricetulus griseus;[];;;10029.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308072;Target assigned is non-molecular;1;Induction of apoptosis in CHO cells assessed as late apoptotic cells at 10 uM after 48 hrs using FITC-annexin V-FITC/propidium iodide by flow cytometry (Rvb = 0%);CHEMBL3297734;Non-molecular target assigned;N;690760;1;CHEMBL613853;;
CLD0;;CHO;CHEMBL3300279;[];Cricetulus griseus;[];;;10029.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308072;Target assigned is non-molecular;1;Induction of apoptosis in CHO cells assessed as early apoptotic cells at 10 uM after 48 hrs using FITC-annexin V-FITC/propidium iodide by flow cytometry (Rvb = 0.1%);CHEMBL3297734;Non-molecular target assigned;N;690761;1;CHEMBL613853;;
CLD0;;CHO;CHEMBL3300280;[];Cricetulus griseus;[];;;10029.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308072;Target assigned is non-molecular;1;Induction of apoptosis in CHO cells assessed as viable cells at 10 uM after 48 hrs using FITC-annexin V-FITC/propidium iodide by flow cytometry (Rvb = 93.3%);CHEMBL3297734;Non-molecular target assigned;N;690763;1;CHEMBL613853;;
CLD0;;HEK-293T;CHEMBL3300281;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3706569;Target assigned is non-molecular;1;Induction of apoptosis in HEK293T cells assessed as necrotic cells at 10 uM after 48 hrs using FITC-annexin V-FITC/propidium iodide by flow cytometry (Rvb = 0.7%);CHEMBL3297734;Non-molecular target assigned;N;690767;1;CHEMBL3706568;;
CLD0;;HEK-293T;CHEMBL3300282;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3706569;Target assigned is non-molecular;1;Induction of apoptosis in HEK293T cells assessed as late apoptotic cells at 10 uM after 48 hrs using FITC-annexin V-FITC/propidium iodide by flow cytometry (Rvb = 0.4%);CHEMBL3297734;Non-molecular target assigned;N;690768;1;CHEMBL3706568;;
CLD0;;HEK-293T;CHEMBL3300283;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3706569;Target assigned is non-molecular;1;Induction of apoptosis in HEK293T cells assessed as early apoptotic cells at 10 uM after 48 hrs using FITC-annexin V-FITC/propidium iodide by flow cytometry (Rvb = 0.3%);CHEMBL3297734;Non-molecular target assigned;N;690770;1;CHEMBL3706568;;
CLD0;;HEK-293T;CHEMBL3300284;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3706569;Target assigned is non-molecular;1;Induction of apoptosis in HEK293T cells assessed as viable cells at 10 uM after 48 hrs using FITC-annexin V-FITC/propidium iodide by flow cytometry (Rvb = 98.6%);CHEMBL3297734;Non-molecular target assigned;N;690771;1;CHEMBL3706568;;
CLD0;;B16-F10;CHEMBL3300288;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '20.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '20.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307762;Target assigned is non-molecular;1;Antitumor activity against mouse B16F10 cells xenografted in C57BL/6 mouse assessed as inhibition tumor growth at 20 mg/kg, ip measured after 24 days of tumor inoculation;CHEMBL3297734;Non-molecular target assigned;N;690863;1;CHEMBL3879801;;
CLD0;;B16-F10;CHEMBL3300289;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '20.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '20.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307762;Target assigned is non-molecular;1;Antitumor activity against mouse B16F10 cells xenografted in C57BL/6 mouse assessed as apoptotic regions at 20 mg/kg, ip measured after 24 days of tumor inoculation by TUNEL assay;CHEMBL3297734;Non-molecular target assigned;N;690864;1;CHEMBL3879801;;
CLD0;;B16-F10;CHEMBL3300290;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '20.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '20.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307762;Target assigned is non-molecular;1;Antitumor activity against mouse B16F10 cells xenografted in C57BL/6 mouse assessed as apoptotic regions at 20 mg/kg, ip measured after 24 days of tumor inoculation by VE-cadherin;CHEMBL3297734;Non-molecular target assigned;N;690865;1;CHEMBL3879801;;
CLD0;;B16-F10;CHEMBL3300294;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307762;Target assigned is non-molecular;1;Induction of apoptosis in mouse B16F10 cells assessed as increase in ratio of BAX/Bcl2 expression at 10 uM after 48 hrs by Western blot analysis relative to untreated control;CHEMBL3297734;Non-molecular target assigned;N;691000;1;CHEMBL612656;;
CLD0;;;CHEMBL3301363;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;ASTRAZENECA: Octan-1-ol/water (pH7.4) distribution coefficent measured  by a shake flask method described in J. Biomol. Screen. 2011, 16, 348-355. Experimental range -1.5 to 4.5;CHEMBL3301361;Default value - Target has yet to be curated;U;2;27;CHEMBL2362975;;
CLD0;;;CHEMBL3301364;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;ASTRAZENECA: Solubility in pH7.4 buffer using solid starting material using the method described in J. Assoc. Lab. Autom. 2011, 16, 276-284. Experimental range 0.10 to 1500 uM;CHEMBL3301361;Default value - Target has yet to be curated;U;3;27;CHEMBL2362975;;
CLD0;;;CHEMBL3301365;[];Homo sapiens;[];;;9606.0;In vitro;Plasma;A;ADME;BAO_0000366;cell-free format;;Default value - Target unknown or has yet to be assigned;0;ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.;CHEMBL3301361;Default value - Target has yet to be curated;U;4;27;CHEMBL612558;CHEMBL3559721;
CLD0;;;CHEMBL3301366;[];Rattus norvegicus;[];SD, HW or BN;;10116.0;In vitro;Plasma;A;ADME;BAO_0000366;cell-free format;;Default value - Target unknown or has yet to be assigned;0;ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole rat plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.;CHEMBL3301361;Default value - Target has yet to be curated;U;5;27;CHEMBL612558;CHEMBL3559721;
CLD0;;Hepatocyte;CHEMBL3301371;[];Rattus norvegicus;[];CD1, BC, CD1, NMRI, SCID, or Nd;;10116.0;In vitro;Liver;A;ADME;BAO_0000219;cell-based format;CHEMBL3308022;Default value - Target unknown or has yet to be assigned;0;ASTRAZENECA: Intrinsic clearance measured in rat hepatocytes following incubation at 37C. Experimental range <3 to >150 microL/min/1E6 cells. Rapid Commun. Mass Spectrom. 2010, 24, 1730-1736;CHEMBL3301361;Default value - Target has yet to be curated;U;10;27;CHEMBL612558;CHEMBL3559723;
CLD0;;;CHEMBL3389360;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 301, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Paw Edema Test', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];Swiss Webster;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in Swiss Webster mouse assessed as reduction in paw edema at 2 mg/kg, ip dosed 40 mins before CFA injection and measured 2 to 6 hrs post CFA stimulus;CHEMBL3351240;Non-molecular target assigned;N;717006;1;CHEMBL375;;
CLD0;;;CHEMBL3389361;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 308, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'NERVOUS SYSTEM', 'l2': 'Analgesic Activity', 'l3': 'General Analgesic Nociceptic and Allodynic Activity', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];Swiss Webster;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in Swiss Webster mouse assessed as reduction in hyperalgesia at 2 mg/kg, ip dosed 40 mins before CFA injection and measured 2 to 6 hrs post CFA stimulus;CHEMBL3351240;Non-molecular target assigned;N;717007;1;CHEMBL375;;
CLD0;;;CHEMBL3389364;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];Swiss Webster;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Reduction in TNFalpha level in Swiss Webster mouse 2 mg/kg, ip dosed 40 mins before CFA injection and measured 3 hrs post CFA stimulus by ELISA method;CHEMBL3351240;Non-molecular target assigned;N;717010;1;CHEMBL375;;
CLD0;;;CHEMBL3389365;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];Swiss Webster;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Reduction in IL1-beta level in Swiss Webster mouse 2 mg/kg, ip dosed 40 mins before CFA injection and measured 3 hrs post CFA stimulus by ELISA method;CHEMBL3351240;Non-molecular target assigned;N;717011;1;CHEMBL375;;
CLD0;;HEK293;CHEMBL3385878;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307715;Direct single protein target assigned;9;Agonist activity at human GCR expressed in HEK293 cells by luciferase reporter gene assay;CHEMBL3352412;Direct protein target assigned;D;710133;1;CHEMBL2034;;
CLD0;;PBMC;CHEMBL3381134;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Antiinflammatory activity in human PBMC assessed as inhibition of LPS-induced IL-1beta expression pretreated 1 hr before LPS challenge followed by incubated for 16 hrs by flow cytometry;CHEMBL3351835;Non-molecular target assigned;N;716054;1;CHEMBL613107;;
CLD0;;PBMC;CHEMBL3381690;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Antiinflammatory activity in human PBMC assessed as inhibition of LPS-induced IL-8 expression pretreated 1 hr before LPS challenge followed by incubated for 16 hrs by flow cytometry;CHEMBL3351835;Non-molecular target assigned;N;716055;1;CHEMBL613107;;
CLD0;;PBMC;CHEMBL3381691;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Antiinflammatory activity in human PBMC assessed as inhibition of LPS-induced TNFalpha expression pretreated 1 hr before LPS challenge followed by incubated for 16 hrs by flow cytometry;CHEMBL3351835;Non-molecular target assigned;N;716056;1;CHEMBL613107;;
CLD0;;RAW264.7;CHEMBL3378989;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Inhibition of LPS-induced nitric oxide production in mouse RAW264.7 cells after 24 hrs by Griess assay relative to vehicle-treated control;CHEMBL3352470;Non-molecular target assigned;N;721178;1;CHEMBL612557;;
CLD0;;;CHEMBL3380187;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Inhibition of LPS-induced TNFalpha production in mouse inflammatory model at 1 mg/kg;CHEMBL3351266;Non-molecular target assigned;N;723236;1;CHEMBL375;;
CLD0;;;CHEMBL3380191;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Inhibition of LPS-induced IL6 production in mouse inflammatory model at 1 mg/kg;CHEMBL3351266;Non-molecular target assigned;N;723240;1;CHEMBL375;;
CLD0;;HFF;CHEMBL3374293;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307525;Direct single protein target assigned;9;Agonist activity at GR in HFF cells assessed as suppression of IL-1-induced IL-6 production;CHEMBL3352560;Direct protein target assigned;D;718875;1;CHEMBL2034;;
CLD0;;CUTLL1;CHEMBL3372621;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4651374;Default value - Target unknown or has yet to be assigned;0;Induction of PARP1 cleavage in human CUTLL1 cells at 1 uM after 24 hrs by western blotting method;CHEMBL3351896;Default value - Target has yet to be curated;U;699059;1;CHEMBL612545;;
CLD0;;CUTLL1;CHEMBL3372635;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4651374;Target assigned is non-molecular;1;Growth inhibition of human CUTLL1 cells with high GR expression levels after 48 hrs by alamar blue assay;CHEMBL3351896;Non-molecular target assigned;N;699073;1;CHEMBL3879801;;
CLD0;;CUTLL1;CHEMBL3372637;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4651374;Target assigned is non-molecular;1;Growth inhibition of human CUTLL1 cells with low GR expression levels after 48 hrs by alamar blue assay;CHEMBL3351896;Non-molecular target assigned;N;699075;1;CHEMBL3879801;;
CLD0;;;CHEMBL3362196;[];Cavia porcellus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '10.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '10.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];Hartley;;10141.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiasthmatic activity in ovalbumin-induced asthma model in Hartley guinea pig assessed as suppression of immediate asthmatic response at 10 mg/kg, po administered 16 hr before and 2 hrs after ovalbumin challenge;CHEMBL3352050;Non-molecular target assigned;N;702744;1;CHEMBL369;;
CLD0;;;CHEMBL3362199;[];Cavia porcellus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '10.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '10.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];Hartley;;10141.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiasthmatic activity in ovalbumin-induced asthma model in Hartley guinea pig assessed as suppression of late asthmatic response at 10 mg/kg, po administered 16 hr before and 2 hrs after ovalbumin challenge;CHEMBL3352050;Non-molecular target assigned;N;702748;1;CHEMBL369;;
CLD0;;;CHEMBL3362202;[{'assay_class_id': 503, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'RESPIRATORY SYSTEM', 'l2': 'Effects on Air Ways', 'l3': 'General Airway Models', 'source': 'phenotype'}];Cavia porcellus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '10.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '10.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];Hartley;;10141.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiasthmatic activity in ovalbumin-induced asthma model in Hartley guinea pig assessed as airway hyperactivity measured as provocative concentration of acetylcholine aerosols causing a 100% increase in the baseline airway resistance at 10 mg/kg, po administered 16 hr before and 2 hrs after ovalbumin challenge;CHEMBL3352050;Non-molecular target assigned;N;702751;1;CHEMBL369;;
CLD0;;;CHEMBL3370269;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of sPLA2-V (unknown origin) using substrate 1,2-bis(heptanoylthio)-glycerophosphocholine by Ellman's method based photometric assay;CHEMBL3352402;Default value - Target has yet to be curated;U;694983;1;CHEMBL612545;;
CLD0;;;CHEMBL3367194;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000019;assay format;;Homologous single protein target assigned;8;Inhibition of AP-1-mediated transcriptional activation in lipopolysaccharide-stimulated mouse RAW 264.7 cells assessed ratio of luciferase activity normalized to Renilla luciferase activity by luciferase reporter gene assay;CHEMBL3352097;Homologous protein target assigned;H;726826;1;CHEMBL5369;;
CLD0;;RAW264.7;CHEMBL3367634;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNF-alpha production at 20 ug/ml incubated for 1 hr prior to LPS challenge measured after 6 hrs by sandwich ELISA relative to control;CHEMBL3352443;Non-molecular target assigned;N;695644;1;CHEMBL612557;;
CLD0;;J774.A1;CHEMBL3367635;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307516;Target assigned is non-molecular;1;Antiinflammatory activity in mouse J774A1 cells assessed as inhibition of LPS-induced TNF-alpha production at 20 ug/ml incubated for 1 hr prior to LPS challenge measured after 6 hrs by sandwich ELISA relative to control;CHEMBL3352443;Non-molecular target assigned;N;695645;1;CHEMBL3879801;;
CLD0;;RAW264.7;CHEMBL3367636;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced IL-1beta production at 20 ug/ml incubated for 1 hr prior to LPS challenge measured after 12 hrs by sandwich ELISA relative to control;CHEMBL3352443;Non-molecular target assigned;N;695646;1;CHEMBL612557;;
CLD0;;J774.A1;CHEMBL3367637;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307516;Target assigned is non-molecular;1;Antiinflammatory activity in mouse J774A1 cells assessed as inhibition of LPS-induced IL-1beta production at 20 ug/ml incubated for 1 hr prior to LPS challenge measured after 12 hrs by sandwich ELISA relative to control;CHEMBL3352443;Non-molecular target assigned;N;695647;1;CHEMBL3879801;;
CLD0;;;CHEMBL3370677;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Binding affinity to glucocorticoid receptor (unknown origin) by fluorescence polarization assay;CHEMBL3351663;Direct protein target assigned;D;696367;1;CHEMBL2034;;
CLD0;;;CHEMBL3370894;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Binding affinity to progesterone receptor (unknown origin) by fluorescence polarization assay;CHEMBL3351663;Direct protein target assigned;D;696368;1;CHEMBL208;;
CLD0;;A549;CHEMBL3370895;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307651;Direct single protein target assigned;9;Agonist activity at glucocorticoid receptor in human A549 cells assessed as AP-1 transrepression by luciferase reporter gene assay;CHEMBL3351663;Direct protein target assigned;D;696369;1;CHEMBL2034;;
CLD0;;A549;CHEMBL3370897;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307651;Direct single protein target assigned;9;Agonist activity at glucocorticoid receptor in human A549 cells assessed as E-selectin transrepression by luciferase reporter gene assay;CHEMBL3351663;Direct protein target assigned;D;696372;1;CHEMBL2034;;
CLD0;;HeLa;CHEMBL3370899;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308376;Direct single protein target assigned;9;Agonist activity at glucocorticoid receptor in human HeLa cells assessed as NP-1 transactivation by luciferase reporter gene assay;CHEMBL3351663;Direct protein target assigned;D;696420;1;CHEMBL2034;;
CLD0;;;CHEMBL3370901;[];Homo sapiens;[];;;9606.0;;Blood;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Agonist activity at glucocorticoid receptor in human whole blood assessed as inhibition of LPS-induced TNF production incubated for 20 hrs prior to LPS challenge measured after 5 hrs by ELISA;CHEMBL3351663;Direct protein target assigned;D;696422;1;CHEMBL2034;CHEMBL3638178;
CLD0;;RAW264.7;CHEMBL3370458;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Inhibition of LPS-induced TNF-alpha release in mouse RAW264.7 cells compound preincubated for 1 hr before LPS treatment measured after 6 to 12 hrs by sandwich immunoassay;CHEMBL3352652;Non-molecular target assigned;N;701839;1;CHEMBL612557;;
CLD0;;J774.A1;CHEMBL3370459;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307516;Target assigned is non-molecular;1;Inhibition of LPS-induced TNF-alpha release in mouse J774A1 cells compound preincubated for 1 hr before LPS treatment measured after 6 to 12 hrs by sandwich immunoassay;CHEMBL3352652;Non-molecular target assigned;N;701840;1;CHEMBL614040;;
CLD0;;RAW264.7;CHEMBL3370460;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Inhibition of LPS-induced IL1-beta release in mouse RAW264.7 cells compound preincubated for 1 hr before LPS treatment measured after 6 to 12 hrs by sandwich immunoassay;CHEMBL3352652;Non-molecular target assigned;N;701841;1;CHEMBL612557;;
CLD0;;J774.A1;CHEMBL3370461;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307516;Target assigned is non-molecular;1;Inhibition of LPS-induced IL1-beta release in mouse J774A1 cells compound preincubated for 1 hr before LPS treatment measured after 6 to 12 hrs by sandwich immunoassay;CHEMBL3352652;Non-molecular target assigned;N;701842;1;CHEMBL614040;;
CLD0;;;CHEMBL3405069;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 503, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'RESPIRATORY SYSTEM', 'l2': 'Effects on Air Ways', 'l3': 'General Airway Models', 'source': 'phenotype'}];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Oral', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Oral', 'type': 'ROUTE', 'units': None, 'value': None}];brown Norway;;10116.0;;Lung;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity against ovalbumin-induced model of allergic inflammation in brown Norway rat assessed as inhibition of eosinophil infiltration in bronchoalveolar lavage fluid at 1 mg/kg, po bid 1 hr before and 6.5 hrs post ovalbumin challenge measured 24 hrs post challenge relative to vehicle-treated control;CHEMBL3399948;Non-molecular target assigned;N;729480;1;CHEMBL376;CHEMBL3638235;
CLD0;;RAW264.7;CHEMBL3405102;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Inhibition of TNFalpha production in mouse RAW264.7 cells incubated for 6 hrs by sandwich immunoassay;CHEMBL3400020;Non-molecular target assigned;N;731146;1;CHEMBL612557;;
CLD0;;J774.A1;CHEMBL3405104;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307516;Target assigned is non-molecular;1;Inhibition of TNFalpha production in mouse J774A.1 cells incubated for 6 hrs by sandwich immunoassay;CHEMBL3400020;Non-molecular target assigned;N;731148;1;CHEMBL614040;;
CLD0;;RAW264.7;CHEMBL3405106;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Inhibition of IL-1beta production in mouse RAW264.7 cells incubated for 12 hrs by sandwich immunoassay;CHEMBL3400020;Non-molecular target assigned;N;731150;1;CHEMBL612557;;
CLD0;;J774.A1;CHEMBL3405108;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307516;Target assigned is non-molecular;1;Inhibition of IL-1beta production in mouse J774A.1 cells incubated for 12 hrs by sandwich immunoassay;CHEMBL3400020;Non-molecular target assigned;N;731152;1;CHEMBL614040;;
CLD0;;;CHEMBL3405250;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in Sprague-Dawley rat assessed as inhibition of LPS-induced IL-1beta production at 150 umol/kg, po pre-administered at interval of 12 hrs followed by LPS-stimulation 6 hrs after final dose and measured 2 hrs post LPS challenge by ELISA method;CHEMBL3400020;Non-molecular target assigned;N;731156;1;CHEMBL376;;
CLD0;;;CHEMBL3405251;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in Sprague-Dawley rat assessed as inhibition of LPS-induced TNFalpha production at 150 umol/kg, po pre-administered at interval of 12 hrs followed by LPS-stimulation 2 hrs after final dose and measured 2 hrs post LPS challenge by ELISA method;CHEMBL3400020;Non-molecular target assigned;N;731155;1;CHEMBL376;;
CLD0;;;CHEMBL3419394;[{'assay_class_id': 518, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS', 'l2': 'Adrenal Steroid Hormones', 'l3': 'Breaking Strength of Bones Effects by Corticosteroids', 'source': 'Vogel_2008'}];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intramuscular', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intramuscular', 'type': 'ROUTE', 'units': None, 'value': None}];Wistar;;10116.0;;Blood;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in glucocorticoid-induced Wistar rat osteoporosis model assessed as white blood cells at 2.5 mg/kg/day, im administered twice each week for 8 weeks (Rvb = 6.28 +/- 2.78 x 10'9/L);CHEMBL3414511;Non-molecular target assigned;N;738419;1;CHEMBL376;CHEMBL3638178;
CLD0;;;CHEMBL3419399;[{'assay_class_id': 518, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS', 'l2': 'Adrenal Steroid Hormones', 'l3': 'Breaking Strength of Bones Effects by Corticosteroids', 'source': 'Vogel_2008'}];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intramuscular', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intramuscular', 'type': 'ROUTE', 'units': None, 'value': None}];Wistar;;10116.0;;Lymph;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in glucocorticoid-induced Wistar rat osteoporosis model assessed as lymph level at 2.5 mg/kg/day, im administered twice each week for 8 weeks (Rvb = 50.35 +/- 12.96%);CHEMBL3414511;Non-molecular target assigned;N;738424;1;CHEMBL376;CHEMBL3987826;
CLD0;;;CHEMBL3419402;[{'assay_class_id': 518, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS', 'l2': 'Adrenal Steroid Hormones', 'l3': 'Breaking Strength of Bones Effects by Corticosteroids', 'source': 'Vogel_2008'}];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intramuscular', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intramuscular', 'type': 'ROUTE', 'units': None, 'value': None}];Wistar;;10116.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in glucocorticoid-induced Wistar rat osteoporosis model assessed as neutrophilic granulocytes level at 2.5 mg/kg/day, im administered twice each week for 8 weeks (Rvb = 31.95 +/- 8.33%);CHEMBL3414511;Non-molecular target assigned;N;738430;1;CHEMBL376;;
CLD0;;;CHEMBL3419413;[{'assay_class_id': 518, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS', 'l2': 'Adrenal Steroid Hormones', 'l3': 'Breaking Strength of Bones Effects by Corticosteroids', 'source': 'Vogel_2008'}];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intramuscular', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intramuscular', 'type': 'ROUTE', 'units': None, 'value': None}];Wistar;;10116.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in glucocorticoid-induced Wistar rat osteoporosis model assessed as aspartate transaminase level at 2.5 mg/kg/day, im administered twice each week for 8 weeks (Rvb = 177.55 +/- 116.98 U/L);CHEMBL3414511;Non-molecular target assigned;N;738453;1;CHEMBL376;;
CLD0;;;CHEMBL3419583;[{'assay_class_id': 518, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS', 'l2': 'Adrenal Steroid Hormones', 'l3': 'Breaking Strength of Bones Effects by Corticosteroids', 'source': 'Vogel_2008'}];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intramuscular', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intramuscular', 'type': 'ROUTE', 'units': None, 'value': None}];Wistar;;10116.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in glucocorticoid-induced Wistar rat osteoporosis model assessed as alanine transaminase level at 2.5 mg/kg/day, im administered twice each week for 8 weeks (Rvb = 43.73 +/- 36.21 U/L);CHEMBL3414511;Non-molecular target assigned;N;738458;1;CHEMBL376;;
CLD0;;;CHEMBL3419588;[{'assay_class_id': 518, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS', 'l2': 'Adrenal Steroid Hormones', 'l3': 'Breaking Strength of Bones Effects by Corticosteroids', 'source': 'Vogel_2008'}];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intramuscular', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intramuscular', 'type': 'ROUTE', 'units': None, 'value': None}];Wistar;;10116.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in glucocorticoid-induced Wistar rat osteoporosis model assessed as triglycerides level at 2.5 mg/kg/day, im administered twice each week for 8 weeks (Rvb = 1.13 +/- 0.69 mmol/L);CHEMBL3414511;Non-molecular target assigned;N;738464;1;CHEMBL376;;
CLD0;;;CHEMBL3419692;[{'assay_class_id': 518, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS', 'l2': 'Adrenal Steroid Hormones', 'l3': 'Breaking Strength of Bones Effects by Corticosteroids', 'source': 'Vogel_2008'}];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intramuscular', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intramuscular', 'type': 'ROUTE', 'units': None, 'value': None}];Wistar;;10116.0;;Trabecula;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiosteoporotic activity in glucocorticoid-induced Wistar rat osteoporosis model assessed as appearance of turbulent and sparse rarefection of trabecula at 2.5 mg/kg/day, im administered twice each week for 8 weeks by toluidine blue staining-based light microscopic analysis;CHEMBL3414511;Non-molecular target assigned;N;738378;1;CHEMBL376;CHEMBL3988012;
CLD0;;;CHEMBL3419699;[{'assay_class_id': 518, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS', 'l2': 'Adrenal Steroid Hormones', 'l3': 'Breaking Strength of Bones Effects by Corticosteroids', 'source': 'Vogel_2008'}];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intramuscular', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intramuscular', 'type': 'ROUTE', 'units': None, 'value': None}];Wistar;;10116.0;;Trabecula;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiosteoporotic activity in glucocorticoid-induced Wistar rat osteoporosis model assessed as trabecular bone volume at 2.5 mg/kg/day, im administered twice each week for 8 weeks by fluorescence assay (Rvb = 33.09 +/- 5.15%);CHEMBL3414511;Non-molecular target assigned;N;738387;1;CHEMBL376;CHEMBL3988012;
CLD0;;;CHEMBL3419703;[{'assay_class_id': 518, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS', 'l2': 'Adrenal Steroid Hormones', 'l3': 'Breaking Strength of Bones Effects by Corticosteroids', 'source': 'Vogel_2008'}];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intramuscular', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intramuscular', 'type': 'ROUTE', 'units': None, 'value': None}];Wistar;;10116.0;;Trabecula;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiosteoporotic activity in glucocorticoid-induced Wistar rat osteoporosis model assessed as trabecula formation surface at 2.5 mg/kg/day, im administered twice each week for 8 weeks by fluorescence assay (Rvb = 7.82 +/- 2.46%);CHEMBL3414511;Non-molecular target assigned;N;738394;1;CHEMBL376;CHEMBL3988012;
CLD0;;;CHEMBL3419707;[{'assay_class_id': 518, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS', 'l2': 'Adrenal Steroid Hormones', 'l3': 'Breaking Strength of Bones Effects by Corticosteroids', 'source': 'Vogel_2008'}];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intramuscular', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intramuscular', 'type': 'ROUTE', 'units': None, 'value': None}];Wistar;;10116.0;;Trabecula;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiosteoporotic activity in glucocorticoid-induced Wistar rat osteoporosis model assessed as trabecula resorption surface at 2.5 mg/kg/day, im administered twice each week for 8 weeks by fluorescence assay (Rvb = 7.22 +/- 2.04%);CHEMBL3414511;Non-molecular target assigned;N;738401;1;CHEMBL376;CHEMBL3988012;
CLD0;;;CHEMBL3419711;[{'assay_class_id': 518, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS', 'l2': 'Adrenal Steroid Hormones', 'l3': 'Breaking Strength of Bones Effects by Corticosteroids', 'source': 'Vogel_2008'}];Rattus norvegicus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intramuscular', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intramuscular', 'type': 'ROUTE', 'units': None, 'value': None}];Wistar;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiosteoporotic activity in glucocorticoid-induced Wistar rat osteoporosis model assessed as mineral apposition rate at 2.5 mg/kg/day, im administered twice each week for 8 weeks by fluorescence assay (Rvb = 1.06 +/- 0.27 micrometer/day);CHEMBL3414511;Non-molecular target assigned;N;738405;1;CHEMBL376;;
CLD0;;;CHEMBL3424571;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Binding affinity to human GR;CHEMBL3421549;Direct protein target assigned;D;741757;1;CHEMBL2034;;
CLD0;;SW1353;CHEMBL3424572;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307462;Direct single protein target assigned;9;Transrepression activity at glucocorticoid receptor in human SW1353 cells assessed as repression of IL-1-induced MMP-13 production after 24 hrs by ELISA;CHEMBL3421549;Direct protein target assigned;D;741758;1;CHEMBL2034;;
CLD0;;;CHEMBL3424578;[];Homo sapiens;[];;;9606.0;;Blood;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Transrepression activity at glucocorticoid receptor in human whole blood assessed as repression of IL-1-induced TNF-alpha production after 4 hrs by ELISA;CHEMBL3421549;Direct protein target assigned;D;742095;1;CHEMBL2034;CHEMBL3638178;
CLD0;;RAW264.7;CHEMBL3428148;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity against mouse RAW264.7 cells assessed as reduction of LPS-induced TNF mRNA expression cells at 1 mM treated 30 mins before LPS challenge measured after 3 hrs by qRT-PCR analysis;CHEMBL3425463;Non-molecular target assigned;N;742419;1;CHEMBL612557;;
CLD0;;RAW264.7;CHEMBL3428151;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Inhibition of luminescence emission in mouse RAW264.7 cells transfected with luciferase plasmid containing universal promoter PKG at 1 mM after 6 hrs by luciferase reporter gene assay;CHEMBL3425463;Non-molecular target assigned;N;742422;1;CHEMBL612557;;
CLD0;;Sf21;CHEMBL3540573;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000249;cell membrane format;CHEMBL4106362;Direct single protein target assigned;9;Inhibition of human BSEP expressed in plasma membrane vesicles of Sf21 cells assessed as inhibition of ATP-dependent [3H]taurocholate uptake;CHEMBL3526080;Direct protein target assigned;D;644498;1;CHEMBL6020;;
CLD0;;Sf21;CHEMBL3540574;[];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;;B;Binding;BAO_0000249;cell membrane format;CHEMBL4106362;Direct single protein target assigned;9;Inhibition of Sprague-Dawley rat Bsep expressed in plasma membrane vesicles of Sf21 cells assessed as inhibition of ATP-dependent [3H]taurocholate uptake;CHEMBL3526080;Direct protein target assigned;D;644499;1;CHEMBL2073674;;
CLD0;;;CHEMBL3540575;[];Homo sapiens;[];;;9606.0;;Plasma;A;ADME;BAO_0000366;cell-free format;;Target assigned is non-molecular;1;Unbound Cmax in human plasma;CHEMBL3526080;Non-molecular target assigned;N;644500;1;CHEMBL613424;CHEMBL3559721;
CLD0;;;CHEMBL3541093;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human recombinant CYP2J2 assessed as reduction in astemizole O-demethylation by LC-MS/MS method;CHEMBL3526101;Direct protein target assigned;D;644080;1;CHEMBL3491;;
CLD0;;Hepatocyte;CHEMBL3537619;[];Rattus norvegicus;[];;;10116.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308022;Direct single protein target assigned;9;Activation of PXR in rat hepatocytes assessed as increase in CYP3A-mediated testosterone 6beta-hydroxylation at 10 uM after 24 hrs by HPLC analysis relative to control;CHEMBL3526076;Direct protein target assigned;D;644969;1;CHEMBL2146315;;
CLD0;;HepG2;CHEMBL3531874;[];Rattus norvegicus;[];;;10116.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307718;Direct single protein target assigned;9;Activation of rat PXR expressed in human HepG2 cells after 24 hrs by luciferase reporter gene based luminescent analysis;CHEMBL3525965;Direct protein target assigned;D;650817;1;CHEMBL2146315;;
CLD0;;Hepatocyte;CHEMBL3532305;[];Rattus norvegicus;[];;;10116.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308022;Direct single protein target assigned;9;Activation of PXR in rat hepatocytes assessed as upregulation of CYP3A23 mRNA expression at 10 uM after 24 hrs by RT-PCR analysis relative to control;CHEMBL3526076;Direct protein target assigned;D;644966;1;CHEMBL2146315;;
CLD0;;;CHEMBL3533246;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;1-Octanol-water distribution coefficient, log D of the compound at pH 7.4;CHEMBL3526071;Default value - Target has yet to be curated;U;645112;1;CHEMBL2362975;;
CLD0;;Caco-2;CHEMBL3533248;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Apparent permeability across human differentiated Caco2 cells;CHEMBL3526071;Default value - Target has yet to be curated;U;645114;1;CHEMBL612558;;
CLD0;confirmatory;;CHEMBL3561973;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 1 ratio channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117303;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562085;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, ratio channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117318;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562088;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, green channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117315;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562112;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, blue channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117311;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562133;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen1 green channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117302;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562135;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 1 blue channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117301;7;CHEMBL612545;;
CLD0;;CHO-K1;CHEMBL3583483;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307512;Direct single protein target assigned;9;Agonist activity at human glucocorticoid receptor transfected in CHOK1 cells assessed as induction of transcriptional activity at 10 nM after 6 hrs by luciferase reporter gene assay relative to control;CHEMBL3580565;Direct protein target assigned;D;748118;1;CHEMBL2034;;
CLD0;;;CHEMBL3588663;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];BALB/c;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in CIA-MAB-50-induced BALB/c mouse arthritis model assessed as decrease in LPS-induced paw size at 2 mg/kg, po qd administered on day 3 to 10 post LPS challenge measured on day 10 relative to vehicle-treated control;CHEMBL3585289;Non-molecular target assigned;N;752423;1;CHEMBL375;;
CLD0;;;CHEMBL3588677;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in C57BL/6 mouse assessed as suppression of LPS-induced IL-6 expression in lung at 10 mg/kg/day pretreated for 48 hrs followed by LPS challenge measured after 5 hrs by immunohistochemical analysis;CHEMBL3585308;Non-molecular target assigned;N;750877;1;CHEMBL375;;
CLD0;;;CHEMBL3587001;[];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vivo activation of Nrf2 in LPS-stimulated C57BL/6 mouse lung at 10 mg/kg/day pretreated for 48 hrs followed by LPS challenge measured after 5 hrs by DAPI staining-based laser scanning confocal microscopic analysis;CHEMBL3585308;Non-molecular target assigned;N;750882;1;CHEMBL375;;
CLD0;;;CHEMBL3587261;[];Mus musculus;[];C57BL/6;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in C57BL/6 mouse assessed as effect on body weight at 10 mg/kg/day measured after 3 days;CHEMBL3585308;Non-molecular target assigned;N;750856;1;CHEMBL375;;
CLD0;;;CHEMBL3587267;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in C57BL/6 mouse assessed as reduction of LPS-induced TNF-alpha level in serum at 10 mg/kg/day pretreated for 48 hrs followed by LPS challenge measured after 5 hrs by ELISA;CHEMBL3585308;Non-molecular target assigned;N;750866;1;CHEMBL375;;
CLD0;;;CHEMBL3587268;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in C57BL/6 mouse assessed as reduction of LPS-induced IFN-gamma level in serum at 10 mg/kg/day pretreated for 48 hrs followed by LPS challenge measured after 5 hrs by ELISA;CHEMBL3585308;Non-molecular target assigned;N;750867;1;CHEMBL375;;
CLD0;;;CHEMBL3587269;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in C57BL/6 mouse assessed as reduction of LPS-induced IL-6 level in serum at 10 mg/kg/day pretreated for 48 hrs followed by LPS challenge measured after 5 hrs by ELISA;CHEMBL3585308;Non-molecular target assigned;N;750868;1;CHEMBL375;;
CLD0;;;CHEMBL3587270;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in C57BL/6 mouse assessed as reduction of LPS-induced IL-12 level in serum at 10 mg/kg/day pretreated for 48 hrs followed by LPS challenge measured after 5 hrs by ELISA;CHEMBL3585308;Non-molecular target assigned;N;750869;1;CHEMBL375;;
CLD0;;;CHEMBL3587271;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in C57BL/6 mouse assessed as reduction of LPS-induced IL-17 level in serum at 10 mg/kg/day pretreated for 48 hrs followed by LPS challenge measured after 5 hrs by ELISA;CHEMBL3585308;Non-molecular target assigned;N;750870;1;CHEMBL375;;
CLD0;;;CHEMBL3587273;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in C57BL/6 mouse assessed as prevention of LPS-induced morphological changes in lung at 10 mg/kg/day pretreated for 48 hrs followed by LPS challenge measured after 5 hrs;CHEMBL3585308;Non-molecular target assigned;N;750872;1;CHEMBL375;;
CLD0;;RAW264.7;CHEMBL3594602;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs by Griess assay;CHEMBL3593223;Non-molecular target assigned;N;757620;1;CHEMBL612557;;
CLD0;;RAW264.7;CHEMBL3594603;[];Mus musculus;[];;;10090.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Cytotoxicity against mouse RAW264.7 cells assessed as survival rate at 200 uM after 48 hrs by MTT assay in absence of LPS relative to control;CHEMBL3593223;Non-molecular target assigned;N;757621;1;CHEMBL612557;;
CLD0;;RAW264.7;CHEMBL3594604;[];Mus musculus;[];;;10090.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Cytotoxicity against mouse RAW264.7 cells assessed as survival rate at 200 uM after 48 hrs by MTT assay in presence of LPS relative to control;CHEMBL3593223;Non-molecular target assigned;N;757622;1;CHEMBL612557;;
CLD0;;BV-2;CHEMBL3595635;[];Mus musculus;[];C57BL6/J;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307704;Target assigned is non-molecular;1;Antiinflammatory activity in C57BL6/J mouse BV2 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs by Griess assay;CHEMBL3593156;Non-molecular target assigned;N;757628;1;CHEMBL3879801;;
CLD0;;;CHEMBL3595637;[{'assay_class_id': 295, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Croton Oil Ear Edema', 'source': 'Vogel_2008'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];ICR;;10090.0;;Ear;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in ICR mouse assessed as inhibition of croton oil-induced ear edema at 1 mg/ml administered 1 hr prior to croton oil challenge measured after 4 hrs relative to control;CHEMBL3593156;Non-molecular target assigned;N;757630;1;CHEMBL375;CHEMBL3987716;
CLD0;;;CHEMBL3599479;[{'assay_class_id': 96, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Adjuvant Arthritis in Rats', 'source': 'Hock_2016'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 301, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Paw Edema Test', 'source': 'Hock_2016'}];Rattus norvegicus;[];Wistar;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Anti-inflammatory activity in Wistar rat model complete Freund's adjuvant-induced arthritis assessed as reduction in paw edema at 5 umol/kg, ip dosed from day 14 to day 21 after immunization and measured on day 16;CHEMBL3596111;Non-molecular target assigned;N;757879;1;CHEMBL376;;
CLD0;;;CHEMBL3603219;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Anti-inflammatory in LPS-challenged C57BL/6 mouse model of acute inflammation assessed as reduction in TNFalpha level at 10 mg/kg, ip for 3 days pre-treated for 3 days followed by LPS challenge 24 hrs after last dose and measured 5 hrs post LPS challenge by ELISA method;CHEMBL3600323;Non-molecular target assigned;N;761097;1;CHEMBL375;;
CLD0;;;CHEMBL3603220;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Anti-inflammatory in LPS-challenged C57BL/6 mouse model of acute inflammation assessed as reduction in IFNgamma level at 10 mg/kg, ip for 3 days pre-treated for 3 days followed by LPS challenge 24 hrs after last dose and measured 5 hrs post LPS challenge by ELISA method;CHEMBL3600323;Non-molecular target assigned;N;761098;1;CHEMBL375;;
CLD0;;;CHEMBL3603221;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Anti-inflammatory in LPS-challenged C57BL/6 mouse model of acute inflammation assessed as reduction in IL6 level at 10 mg/kg, ip for 3 days pre-treated for 3 days followed by LPS challenge 24 hrs after last dose and measured 5 hrs post LPS challenge by ELISA method;CHEMBL3600323;Non-molecular target assigned;N;761099;1;CHEMBL375;;
CLD0;;;CHEMBL3603222;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Anti-inflammatory in LPS-challenged C57BL/6 mouse model of acute inflammation assessed as reduction in IL12 level at 10 mg/kg, ip for 3 days pre-treated for 3 days followed by LPS challenge 24 hrs after last dose and measured 5 hrs post LPS challenge by ELISA method;CHEMBL3600323;Non-molecular target assigned;N;761100;1;CHEMBL375;;
CLD0;;;CHEMBL3603223;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Anti-inflammatory in LPS-challenged C57BL/6 mouse model of acute inflammation assessed as reduction in IL17 level at 10 mg/kg, ip for 3 days pre-treated for 3 days followed by LPS challenge 24 hrs after last dose and measured 5 hrs post LPS challenge by ELISA method;CHEMBL3600323;Non-molecular target assigned;N;761101;1;CHEMBL375;;
CLD0;;RAW264.7;CHEMBL3611158;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Inhibition of LPS-induced nitric oxide production in mouse RAW264.7 cells after 24 hrs by Griess assay;CHEMBL3608307;Non-molecular target assigned;N;764396;1;CHEMBL612557;;
CLD0;;;CHEMBL3742765;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];ICR;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in ICR mouse assessed as inhibition of xylene-induced edema at 25.5 umol/kg, po administered for 30 mins prior to xylene challenge measured after 2 hrs;CHEMBL3739418;Non-molecular target assigned;N;788258;1;CHEMBL375;;
CLD0;;;CHEMBL3742767;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];ICR;;10090.0;;Plasma;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in xylene-induced ICR mouse edema model assessed as decrease in plasma TNFalpha level at 25.5 umol/kg, po after 60 mins by microplate reader analysis;CHEMBL3739418;Non-molecular target assigned;N;788260;1;CHEMBL375;CHEMBL3559721;
CLD0;;;CHEMBL3742768;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];ICR;;10090.0;;Plasma;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in xylene-induced ICR mouse edema model assessed as decrease in plasma IL8 level at 25.5 umol/kg, po after 60 mins by microplate reader analysis;CHEMBL3739418;Non-molecular target assigned;N;788261;1;CHEMBL375;CHEMBL3559721;
CLD0;;A549;CHEMBL3742769;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Downregulation of DNA replication in human A549 cells at 1 uM after 48 hrs by UV-visible spectrophotometric analysis;CHEMBL3739418;Non-molecular target assigned;N;788262;1;CHEMBL392;;
CLD0;;;CHEMBL3742770;[];Mus musculus;[];BALB/C;;10090.0;;Femur;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in BALB/C mouse assessed as femur loss at 1.43 umol/kg/day, po administered for 15 days by pQCT analysis;CHEMBL3739418;Non-molecular target assigned;N;788265;1;CHEMBL375;CHEMBL3638194;
CLD0;;;CHEMBL3742772;[];Mus musculus;[];BALB/C;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in BALB/C mouse assessed as total volumetric bone mineral density at 1.43 umol/kg/day, po administered for 15 days (Rvb = 554.3 +/- 17.2 mg/cm3);CHEMBL3739418;Non-molecular target assigned;N;788266;1;CHEMBL375;;
CLD0;;;CHEMBL3742773;[];Mus musculus;[];BALB/C;;10090.0;;Femur;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in BALB/C mouse assessed as decrease in dry femur weight at 1.43 umol/kg/day, po administered for 15 days;CHEMBL3739418;Non-molecular target assigned;N;788267;1;CHEMBL375;CHEMBL3638194;
CLD0;;;CHEMBL3742774;[];Mus musculus;[];BALB/C;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in BALB/C mouse assessed as decrease in ash weight at 1.43 umol/kg/day, po administered for 15 days;CHEMBL3739418;Non-molecular target assigned;N;788269;1;CHEMBL375;;
CLD0;;;CHEMBL3742775;[];Mus musculus;[];BALB/C;;10090.0;;Femur;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in BALB/C mouse assessed as decrease in femur calcium level at 1.43 umol/kg/day, po administered for 15 days by o-methylphenolphthalein complexing ketone-based assay;CHEMBL3739418;Non-molecular target assigned;N;788270;1;CHEMBL375;CHEMBL3638194;
CLD0;;;CHEMBL3742776;[];Mus musculus;[];BALB/C;;10090.0;;Femur;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in BALB/C mouse assessed as decrease in femur phosphor level at 1.43 umol/kg/day, po administered for 15 days by molybdenum blue-based assay;CHEMBL3739418;Non-molecular target assigned;N;788271;1;CHEMBL375;CHEMBL3638194;
CLD0;;IM-9;CHEMBL3776014;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307412;Direct single protein target assigned;9;Displacement of [3H]dexamethasone from glucocorticoid receptor in human IM9 cells;CHEMBL3774372;Direct protein target assigned;D;811638;1;CHEMBL2034;;
CLD0;;J774;CHEMBL3801510;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307540;Target assigned is non-molecular;1;Antiinflammatory activity against mouse J774 cells assessed as inhibition of LPS-induced nitric oxide production at 10 uM by Griess assay;CHEMBL3797069;Non-molecular target assigned;N;828712;1;CHEMBL614123;;
CLD0;;J774;CHEMBL3801511;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307540;Target assigned is non-molecular;1;Antiinflammatory activity against mouse J774 cells assessed as inhibition of LPS-induced iNOS expression at 10 uM after 24 hrs by Western blot analysis;CHEMBL3797069;Non-molecular target assigned;N;828713;1;CHEMBL614123;;
CLD0;;J774;CHEMBL3801512;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307540;Target assigned is non-molecular;1;Antiinflammatory activity against mouse J774 cells assessed as inhibition of LPS-induced COX-2 expression at 10 uM after 24 hrs by Western blot analysis;CHEMBL3797069;Non-molecular target assigned;N;828714;1;CHEMBL614123;;
CLD0;;J774;CHEMBL3801513;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307540;Target assigned is non-molecular;1;Antiinflammatory activity against mouse J774 cells assessed as inhibition of LPS-induced IL-6 production at 10 uM after 24 hrs by ELISA;CHEMBL3797069;Non-molecular target assigned;N;828715;1;CHEMBL614123;;
CLD0;;J774;CHEMBL3801514;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307540;Target assigned is non-molecular;1;Antiinflammatory activity against mouse J774 cells assessed as inhibition of LPS-induced MCP-1 production at 10 uM after 24 hrs by ELISA;CHEMBL3797069;Non-molecular target assigned;N;828716;1;CHEMBL614123;;
CLD0;;RAW264.7;CHEMBL3810847;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in mouse RAW264.7 cells assessed as reduction in LPS-induced iNOS protein levels at 10 uM preincubated for 10 mins followed by LPS challenge for 16 hrs by Western blot analysis;CHEMBL3808310;Non-molecular target assigned;N;832826;1;CHEMBL612557;;
CLD0;;RAW264.7;CHEMBL3810848;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in mouse RAW264.7 cells assessed as reduction in LPS-induced COX-2 protein levels at 10 uM preincubated for 10 mins followed by LPS challenge for 16 hrs by Western blot analysis;CHEMBL3808310;Non-molecular target assigned;N;832831;1;CHEMBL612557;;
CLD0;;;CHEMBL3831116;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 503, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'RESPIRATORY SYSTEM', 'l2': 'Effects on Air Ways', 'l3': 'General Airway Models', 'source': 'phenotype'}];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-induced C57BL/6 mouse model of lung inflammation assessed as decrease in neutrophil infiltration in bronchoalveolar lavage fluid at 10 mg/kg, ip administered 1 hr prior to LPS-challenge measured after 3 hrs by Diff-Quik staining-based coulter particle counter method;CHEMBL3826917;Non-molecular target assigned;N;843959;1;CHEMBL375;;
CLD0;;;CHEMBL3828912;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];C57BL/6;;10090.0;;Liver;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in LPS-induced C57BL/6 mouse model of lung inflammation assessed as change in liver weight at 10 mg/kg, ip administered 1 hr prior to LPS-challenge measured after 3 hrs relative to control;CHEMBL3826917;Non-molecular target assigned;N;843960;1;CHEMBL375;CHEMBL3559723;
CLD0;;;CHEMBL3828913;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];C57BL/6;;10090.0;;Spleen;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in LPS-induced C57BL/6 mouse model of lung inflammation assessed as change in spleen weight at 10 mg/kg, ip administered 1 hr prior to LPS-challenge measured after 3 hrs relative to control;CHEMBL3826917;Non-molecular target assigned;N;843961;1;CHEMBL375;CHEMBL3559722;
CLD0;;;CHEMBL3828914;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 503, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'RESPIRATORY SYSTEM', 'l2': 'Effects on Air Ways', 'l3': 'General Airway Models', 'source': 'phenotype'}];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-induced C57BL/6 mouse model of lung inflammation assessed as reduction in TNF-alpha release in bronchoalveolar lavage fluid at 10 mg/kg, ip administered 1 hr prior to LPS-challenge measured after 3 hrs by ELISA;CHEMBL3826917;Non-molecular target assigned;N;843962;1;CHEMBL375;;
CLD0;;;CHEMBL3828915;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 503, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'RESPIRATORY SYSTEM', 'l2': 'Effects on Air Ways', 'l3': 'General Airway Models', 'source': 'phenotype'}];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-induced C57BL/6 mouse model of lung inflammation assessed as reduction in keratinocyte-derived chemokine release in bronchoalveolar lavage fluid at 10 mg/kg, ip administered 1 hr prior to LPS-challenge measured after 3 hrs by ELISA;CHEMBL3826917;Non-molecular target assigned;N;843963;1;CHEMBL375;;
860972;;;CHEMBL3854484;[];Mus musculus;[];C57BL/6;;10090.0;;Knee joint;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in C57BL/6 mouse assessed as inhibition of zymosan-induced knee joint edema formation at 10 mg/kg, ip administered 1 hr prior to zymosan challenge measured at 6 hrs relative to control;CHEMBL3853307;Non-molecular target assigned;N;;1;CHEMBL3879801;CHEMBL3987791;
860973;;;CHEMBL3854485;[];Mus musculus;[];C57BL/6;;10090.0;;Knee joint;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in C57BL/6 mouse assessed as inhibition of zymosan-induced knee joint edema formation at 10 mg/kg, ip administered 1 hr prior to zymosan challenge measured at 24 hrs relative to control;CHEMBL3853307;Non-molecular target assigned;N;;1;CHEMBL3879801;CHEMBL3987791;
861019;;;CHEMBL3854491;[];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in C57BL/6 mouse assessed as inhibition of zymosan-induced total leukocyte accumulation in articular cavity at 10 mg/kg, ip administered 1 hr prior to zymosan challenge measured at 6 to 24 hrs;CHEMBL3853307;Non-molecular target assigned;N;;1;CHEMBL3879801;;
861020;;;CHEMBL3854492;[];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in C57BL/6 mouse assessed as inhibition of zymosan-induced neutrophil migration in articular cavity at 10 mg/kg, ip administered 1 hr prior to zymosan challenge measured at 6 to 24 hrs;CHEMBL3853307;Non-molecular target assigned;N;;1;CHEMBL3879801;;
861021;;;CHEMBL3854493;[];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in C57BL/6 mouse assessed as inhibition of zymosan-induced mononuclear cells migration in articular cavity at 10 mg/kg, ip administered 1 hr prior to zymosan challenge measured at 6 to 24 hrs;CHEMBL3853307;Non-molecular target assigned;N;;1;CHEMBL3879801;;
861028;;;CHEMBL3854498;[];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in C57BL/6 mouse assessed as inhibition of zymosan-induced synovial hyperplasia at 10 mg/kg, ip administered 1 hr prior to zymosan challenge measured at 6 to 24 hrs by hematoxylin and eosin staining-based optical microscopy;CHEMBL3853307;Non-molecular target assigned;N;;1;CHEMBL3879801;;
861029;;;CHEMBL3854499;[];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in C57BL/6 mouse assessed as inhibition of zymosan-induced infiltration of inflammatory cells into synovial tissue at 10 mg/kg, ip administered 1 hr prior to zymosan challenge measured at 6 to 24 hrs by hematoxylin and eosin staining-based optical microscopy;CHEMBL3853307;Non-molecular target assigned;N;;1;CHEMBL3879801;;
861030;;;CHEMBL3854500;[];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in C57BL/6 mouse assessed as inhibition of zymosan-induced bleeding in synovial tissue at 10 mg/kg, ip administered 1 hr prior to zymosan challenge measured at 6 to 24 hrs by hematoxylin and eosin staining-based optical microscopy;CHEMBL3853307;Non-molecular target assigned;N;;1;CHEMBL3879801;;
861031;;;CHEMBL3854501;[];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in C57BL/6 mouse assessed as inhibition of zymosan-induced arthritis score at 10 mg/kg, ip administered 1 hr prior to zymosan challenge measured at 6 to 24 hrs by hematoxylin and eosin staining-based optical microscopy;CHEMBL3853307;Non-molecular target assigned;N;;1;CHEMBL3879801;;
861038;;;CHEMBL3854508;[];Mus musculus;[];C57BL/6;;10090.0;;Knee joint;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in C57BL/6 mouse assessed as inhibition of zymosan-induced IL6 production in cell-free supernatant of knee joint synovial washes at 10 mg/kg, ip administered 1 hr prior to zymosan challenge measured at 6 to 24 hrs by sandwich ELISA method;CHEMBL3853307;Non-molecular target assigned;N;;1;CHEMBL3879801;CHEMBL3987791;
861039;;;CHEMBL3854509;[];Mus musculus;[];C57BL/6;;10090.0;;Knee joint;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in C57BL/6 mouse assessed as inhibition of zymosan-induced TNFalpha production in cell-free supernatant of knee joint synovial washes at 10 mg/kg, ip administered 1 hr prior to zymosan challenge measured at 6 to 24 hrs by sandwich ELISA method;CHEMBL3853307;Non-molecular target assigned;N;;1;CHEMBL3879801;CHEMBL3987791;
861040;;;CHEMBL3854510;[];Mus musculus;[];C57BL/6;;10090.0;;Knee joint;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in C57BL/6 mouse assessed as inhibition of zymosan-induced IL-1beta production in cell-free supernatant of knee joint synovial washes at 10 mg/kg, ip administered 1 hr prior to zymosan challenge measured at 6 to 24 hrs by sandwich ELISA method;CHEMBL3853307;Non-molecular target assigned;N;;1;CHEMBL3879801;CHEMBL3987791;
861041;;;CHEMBL3854511;[];Mus musculus;[];C57BL/6;;10090.0;;Knee joint;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in C57BL/6 mouse assessed as inhibition of zymosan-induced CXCL1/KC production in cell-free supernatant of knee joint synovial washes at 10 mg/kg, ip administered 1 hr prior to zymosan challenge measured at 6 to 24 hrs by sandwich ELISA method;CHEMBL3853307;Non-molecular target assigned;N;;1;CHEMBL3879801;CHEMBL3987791;
861042;;;CHEMBL3854512;[];Mus musculus;[];C57BL/6;;10090.0;;Knee joint;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in C57BL/6 mouse assessed as inhibition of zymosan-induced PGE2 production in cell-free supernatant of knee joint synovial washes at 10 mg/kg, ip administered 1 hr prior to zymosan challenge measured at 6 to 24 hrs by immunosorbent assay;CHEMBL3853307;Non-molecular target assigned;N;;1;CHEMBL3879801;CHEMBL3987791;
861043;;;CHEMBL3854513;[];Mus musculus;[];C57BL/6;;10090.0;;Knee joint;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in C57BL/6 mouse assessed as inhibition of zymosan-induced LTB4 production in cell-free supernatant of knee joint synovial washes at 10 mg/kg, ip administered 1 hr prior to zymosan challenge measured at 6 to 24 hrs by immunosorbent assay;CHEMBL3853307;Non-molecular target assigned;N;;1;CHEMBL3879801;CHEMBL3987791;
861050;;Neutrophil;CHEMBL3854516;[];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308052;Target assigned is non-molecular;1;Antiinflammatory activity in C57BL/6 mouse neutrophils assessed as inhibition of CXCL1/KC-induced neutrophil chemotaxis at 50 nM preincubated for 1 hr followed by CXCL1/KC-induction measured after 1 hr by Wright-Giemsa staining-based light microscopic method;CHEMBL3853307;Non-molecular target assigned;N;;1;CHEMBL3879801;;
861057;;J774.A1;CHEMBL3854520;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307516;Target assigned is non-molecular;1;Antiinflammatory activity in mouse J774A.1 cells assessed as inhibition of zymosan and IFNgamma-induced IL6 production in cell-free supernatant at 1 uM preincubated for 1 hr followed by zymosan and IFNgamma addition measured after 24 hrs by sandwich ELISA;CHEMBL3853307;Non-molecular target assigned;N;;1;CHEMBL3879801;;
861944;;J774.A1;CHEMBL3854523;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307516;Target assigned is non-molecular;1;Antiinflammatory activity in mouse J774A.1 cells assessed as inhibition of zymosan and IFNgamma-induced COX2 expression at 1 uM preincubated for 1 hr followed by zymosan and IFNgamma addition measured after 24 hrs by Western blot analysis;CHEMBL3853307;Non-molecular target assigned;N;;1;CHEMBL3879801;;
861947;;J774.A1;CHEMBL3854526;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307516;Target assigned is non-molecular;1;Antiinflammatory activity in mouse J774A.1 cells assessed as inhibition of zymosan and IFNgamma-induced nitric oxide production at 1 uM preincubated for 1 hr followed by zymosan and IFNgamma addition measured after 24 hrs by colorimetric Griess test;CHEMBL3853307;Non-molecular target assigned;N;;1;CHEMBL3879801;;
861948;;J774.A1;CHEMBL3854527;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307516;Target assigned is non-molecular;1;Antiinflammatory activity in mouse J774A.1 cells assessed as inhibition of zymosan and IFNgamma-induced iNOS expression at 1 uM preincubated for 1 hr followed by zymosan and IFNgamma addition measured after 24 hrs by Western blot analysis;CHEMBL3853307;Non-molecular target assigned;N;;1;CHEMBL3879801;;
864296;;;CHEMBL3859190;[];Mus musculus;[];DBA;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiarthritic activity in DBA mouse assessed as decrease in collagen/CFA-induced arthritic score at 0.3 mg/kg, po qd administered on day 21 to 34 post collagen/CFA challenge measured on day 35;CHEMBL3856256;Non-molecular target assigned;N;;1;CHEMBL3879801;;
873026;;;CHEMBL3868160;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Binding affinity to GR (unknown origin) by FP assay;CHEMBL3867467;Direct protein target assigned;D;;1;CHEMBL2034;;
873027;;;CHEMBL3868169;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Binding affinity to PR (unknown origin) by FP assay;CHEMBL3867467;Direct protein target assigned;D;;1;CHEMBL208;;
873028;;;CHEMBL3868170;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Binding affinity to AR (unknown origin) by FP assay;CHEMBL3867467;Direct protein target assigned;D;;1;CHEMBL1871;;
873029;;;CHEMBL3868171;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Displacement of 3H-aldosterone from MR (unknown origin) ligand binding domain by SPA assay;CHEMBL3867467;Direct protein target assigned;D;;1;CHEMBL1994;;
873030;;;CHEMBL3868172;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Binding affinity to ERalpha (unknown origin) by FP assay;CHEMBL3867467;Direct protein target assigned;D;;1;CHEMBL206;;
873031;;;CHEMBL3868173;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Binding affinity to ERbeta (unknown origin) by FP assay;CHEMBL3867467;Direct protein target assigned;D;;1;CHEMBL242;;
875362;;RAW264.7;CHEMBL3869505;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs in presence of LPS by Griess assay;CHEMBL3868605;Non-molecular target assigned;N;;1;CHEMBL3879801;;
875363;;RAW264.7;CHEMBL3869506;[];Mus musculus;[];;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;CHEMBL3307977;Target assigned is non-molecular;1;Cytotoxicity against mouse RAW264.7 cells assessed as cell survival rate at 200 uM after 24 hrs in absence of LPS by MTT assay;CHEMBL3868605;Non-molecular target assigned;N;;1;CHEMBL375;;
875364;;RAW264.7;CHEMBL3869507;[];Mus musculus;[];;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;CHEMBL3307977;Target assigned is non-molecular;1;Cytotoxicity against mouse RAW264.7 cells assessed as cell survival rate at 200 uM after 24 hrs in presence of LPS by MTT assay;CHEMBL3868605;Non-molecular target assigned;N;;1;CHEMBL375;;
879283;;;CHEMBL3872104;[];Mus musculus;[];;;10090.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Agonist activity at GR in mouse C2C12 myotubes assessed as induction of Fkbp5 mRNA levels after 24 hrs by qPCR analysis relative to vehicle control;CHEMBL3871302;Direct protein target assigned;D;;1;CHEMBL3144;;
881764;;IM-9;CHEMBL3876400;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307412;Direct single protein target assigned;9;Displacement of [3H]dexamethasone from GR receptor in human IM9 cells;CHEMBL3875185;Direct protein target assigned;D;;1;CHEMBL2034;;
887211;;PBMC;CHEMBL3879488;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Inhibition of LPS-stimulated TNF-alpha release in human PBMC at 600 ng/ml after 20 hrs by ELISPOT test;CHEMBL3877318;Non-molecular target assigned;N;;1;CHEMBL613107;;
881561;;U2OS;CHEMBL3881163;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307757;Direct single protein target assigned;9;Activation of glulcocorticoid receptor (unknown origin) expressed in human U2OS cells at 0.1 uM incubated for 24 hrs by luciferase reporter gene assay;CHEMBL3880423;Direct protein target assigned;D;;38;CHEMBL2034;;
2;;;CHEMBL3885863;[];Schistosoma mansoni;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'AGE', 'standard_type_fixed': 0, 'standard_units': 'weeks', 'standard_value': '6.0', 'text_value': None, 'type': 'AGE', 'units': 'weeks', 'value': '6.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Male', 'standard_type': 'GENDER', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Male', 'type': 'GENDER', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Single', 'standard_type': 'REGIMEN', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Single', 'type': 'REGIMEN', 'units': None, 'value': None}];Puerto Rican;;6183.0;In vivo;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vitro activity on S. mansoni schistosomula at 10 uM;CHEMBL3885861;Non-molecular target assigned;N;;11;CHEMBL612893;;
1;;;CHEMBL3885882;[];Schistosoma mansoni;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '6-8', 'standard_type': 'AGE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '6-8', 'type': 'AGE', 'units': 'weeks', 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Male', 'standard_type': 'GENDER', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Male', 'type': 'GENDER', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Daily Repeat', 'standard_type': 'REGIMEN', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Daily Repeat', 'type': 'REGIMEN', 'units': None, 'value': None}];Puerto Rican;;6183.0;In vivo;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vitro activity on S. mansoni schistosomula at 50 uM;CHEMBL3885881;Non-molecular target assigned;N;;15;CHEMBL612893;;
900974;;;CHEMBL3995152;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of TNFalpha (unknown origin) at 1 uM relative to control;CHEMBL3994585;Direct protein target assigned;D;;1;CHEMBL1825;;
895281;;RAW264.7;CHEMBL4002854;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced IL-6 production at 50 uM pretreated for 1 hr followed by LPS stimulation measured after 24 hrs by ELISA relative to control;CHEMBL4002555;Non-molecular target assigned;N;;1;CHEMBL612557;;
895282;;RAW264.7;CHEMBL4002855;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced IL-6 production at 10 uM pretreated for 1 hr followed by LPS stimulation measured after 24 hrs by ELISA relative to control;CHEMBL4002555;Non-molecular target assigned;N;;1;CHEMBL612557;;
895283;;RAW264.7;CHEMBL4002856;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced IL-6 production at 2 uM pretreated for 1 hr followed by LPS stimulation measured after 24 hrs by ELISA relative to control;CHEMBL4002555;Non-molecular target assigned;N;;1;CHEMBL612557;;
895284;;RAW264.7;CHEMBL4002857;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced IL-6 production at 0.4 uM pretreated for 1 hr followed by LPS stimulation measured after 24 hrs by ELISA relative to control;CHEMBL4002555;Non-molecular target assigned;N;;1;CHEMBL612557;;
895286;;RAW264.7;CHEMBL4002858;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNF-alpha production at 50 uM pretreated for 1 hr followed by LPS stimulation measured after 24 hrs by ELISA relative to control;CHEMBL4002555;Non-molecular target assigned;N;;1;CHEMBL612557;;
895287;;RAW264.7;CHEMBL4002859;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNF-alpha production at 10 uM pretreated for 1 hr followed by LPS stimulation measured after 24 hrs by ELISA relative to control;CHEMBL4002555;Non-molecular target assigned;N;;1;CHEMBL612557;;
895288;;RAW264.7;CHEMBL4002860;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNF-alpha production at 2 uM pretreated for 1 hr followed by LPS stimulation measured after 24 hrs by ELISA relative to control;CHEMBL4002555;Non-molecular target assigned;N;;1;CHEMBL612557;;
895289;;RAW264.7;CHEMBL4002861;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNF-alpha production at 0.4 uM pretreated for 1 hr followed by LPS stimulation measured after 24 hrs by ELISA relative to control;CHEMBL4002555;Non-molecular target assigned;N;;1;CHEMBL612557;;
906714;;;CHEMBL4008503;[{'assay_class_id': 44, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ALIMENTARY TRACT AND METABOLISM', 'l2': 'Intestinal Function', 'l3': 'Experimental Colitis Inflammatory Gut Disease', 'source': 'Vogel_2008'}];Mus musculus;[];BALB/c;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vivo inhibition of NAMPT in DNBS-induced BALB/c mouse colitis model assessed as reduction in loss of body weight at 20 mg/kg, ip bid administered for 3 days post DNBS challenge;CHEMBL4007408;Non-molecular target assigned;N;;1;CHEMBL375;;
906715;;;CHEMBL4008504;[{'assay_class_id': 44, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ALIMENTARY TRACT AND METABOLISM', 'l2': 'Intestinal Function', 'l3': 'Experimental Colitis Inflammatory Gut Disease', 'source': 'Vogel_2008'}];Mus musculus;[];BALB/c;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vivo inhibition of NAMPT in DNBS-induced BALB/c mouse colitis model assessed as reduction in mucosal congestion at 20 mg/kg, ip bid administered for 3 days post DNBS challenge;CHEMBL4007408;Non-molecular target assigned;N;;1;CHEMBL375;;
906716;;;CHEMBL4008505;[{'assay_class_id': 44, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ALIMENTARY TRACT AND METABOLISM', 'l2': 'Intestinal Function', 'l3': 'Experimental Colitis Inflammatory Gut Disease', 'source': 'Vogel_2008'}];Mus musculus;[];BALB/c;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vivo inhibition of NAMPT in DNBS-induced BALB/c mouse colitis model assessed as reduction in erosion at 20 mg/kg, ip bid administered for 3 days post DNBS challenge;CHEMBL4007408;Non-molecular target assigned;N;;1;CHEMBL375;;
906717;;;CHEMBL4008506;[{'assay_class_id': 24, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ALIMENTARY TRACT AND METABOLISM', 'l2': 'Gastric Function', 'l3': 'General Models of Anti-Ulcer Activity', 'source': 'phenotype'}, {'assay_class_id': 44, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ALIMENTARY TRACT AND METABOLISM', 'l2': 'Intestinal Function', 'l3': 'Experimental Colitis Inflammatory Gut Disease', 'source': 'Vogel_2008'}];Mus musculus;[];BALB/c;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vivo inhibition of NAMPT in DNBS-induced BALB/c mouse colitis model assessed as reduction in hemorrhagic ulcerations at 20 mg/kg, ip bid administered for 3 days post DNBS challenge;CHEMBL4007408;Non-molecular target assigned;N;;1;CHEMBL375;;
906725;;;CHEMBL4008508;[{'assay_class_id': 44, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ALIMENTARY TRACT AND METABOLISM', 'l2': 'Intestinal Function', 'l3': 'Experimental Colitis Inflammatory Gut Disease', 'source': 'Vogel_2008'}];Mus musculus;[];BALB/c;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vivo inhibition of NAMPT in DNBS-induced BALB/c mouse colitis model assessed as reduction in neutrophil infiltration by measuring myeloperoxidase levels at 20 mg/kg, ip bid administered for 3 days post DNBS challenge by ELISA;CHEMBL4007408;Non-molecular target assigned;N;;1;CHEMBL375;;
906938;;;CHEMBL4011663;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Direct single protein target assigned;9;Inhibition of human BSEP expressed in fall armyworm sf9 cell plasma membrane vesicles assessed as reduction in vesicle-associated [3H]-taurocholate transport preincubated for 10 mins prior to ATP addition measured after 15 mins in presence of [3H]-taurocholate by topcount based membrane vesicle transport assay;CHEMBL4011581;Direct protein target assigned;D;;1;CHEMBL6020;;
914239;;;CHEMBL4015441;[];Mus musculus;[];C57BL/6;;10090.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of NLRP3 inflammasome in LPS-primed C57BL/6 mouse bone marrow derived macrophages assessed as reduction in ATP-induced pyroptosis at 100 to 250 nM preincubated for 1 hr followed by stimulation with ATP measured after 30 mins by LDH release assay;CHEMBL4014309;Direct protein target assigned;D;;1;CHEMBL3779755;;
914240;;;CHEMBL4015442;[];Mus musculus;[];C57BL/6;;10090.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of NLRP3 inflammasome in LPS-primed C57BL/6 mouse bone marrow derived macrophages assessed as reduction in nigericin-induced pyroptosis at 100 to 250 nM preincubated for 1 hr followed by stimulation with ATP measured after 30 mins by LDH release assay;CHEMBL4014309;Direct protein target assigned;D;;1;CHEMBL3779755;;
914241;;;CHEMBL4015443;[];Mus musculus;[];C57BL/6;;10090.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of NLRP3 inflammasome in LPS-primed C57BL/6 mouse bone marrow derived macrophages assessed as reduction in ATP-induced IL-1beta production at 10 to 250 nM preincubated for 1 hr followed by stimulation with ATP measured after 30 mins by ELISA;CHEMBL4014309;Direct protein target assigned;D;;1;CHEMBL3779755;;
914242;;;CHEMBL4015444;[];Mus musculus;[];C57BL/6;;10090.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of NLRP3 inflammasome in LPS-primed C57BL/6 mouse bone marrow derived macrophages assessed as reduction in nigericin-induced IL-1beta production at 10 to 250 nM preincubated for 1 hr followed by stimulation with nigericin measured after 30 mins by ELISA;CHEMBL4014309;Direct protein target assigned;D;;1;CHEMBL3779755;;
914263;;;CHEMBL4015461;[{'assay_class_id': 44, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ALIMENTARY TRACT AND METABOLISM', 'l2': 'Intestinal Function', 'l3': 'Experimental Colitis Inflammatory Gut Disease', 'source': 'Vogel_2008'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in DNBS-induced Sprague-Dawley rat colitis model assessed as body weight recovery at 1 mg/kg/day, ig administered as methylcellulose suspension for 6 days simulatneously with 6 days of DNBS-challenge measured daily during compound dosing;CHEMBL4014309;Non-molecular target assigned;N;;1;CHEMBL376;;
914267;;;CHEMBL4015465;[{'assay_class_id': 44, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ALIMENTARY TRACT AND METABOLISM', 'l2': 'Intestinal Function', 'l3': 'Experimental Colitis Inflammatory Gut Disease', 'source': 'Vogel_2008'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in DNBS-induced Sprague-Dawley rat colitis model assessed as reduction in DNBS-induced spleen weight increase by measuring increase in spleen weight at 1 mg/kg/day, ig administered as methylcellulose suspension for 6 days simulatneously with 6 days of DNBS-challenge measured daily during compound dosing (Rvb = 39.3%);CHEMBL4014309;Non-molecular target assigned;N;;1;CHEMBL376;;
914275;;;CHEMBL4015473;[{'assay_class_id': 44, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ALIMENTARY TRACT AND METABOLISM', 'l2': 'Intestinal Function', 'l3': 'Experimental Colitis Inflammatory Gut Disease', 'source': 'Vogel_2008'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in DNBS-induced Sprague-Dawley rat colitis model assessed as DNBS-induced macroscopic damage score at 1 mg/kg/day, ig for 6 days simulatneously with 6 days of DNBS-challenge (Rvb = 8.6 +/- 0.6 No_unit);CHEMBL4014309;Non-molecular target assigned;N;;1;CHEMBL376;;
914277;;;CHEMBL4015475;[{'assay_class_id': 44, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ALIMENTARY TRACT AND METABOLISM', 'l2': 'Intestinal Function', 'l3': 'Experimental Colitis Inflammatory Gut Disease', 'source': 'Vogel_2008'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Anti-inflammatory activity in DNBS-induced Sprague-Dawley rat colitis model assessed as reduction in DNBS-induced increase in MPO levels in colon at 1 mg/kg/day, ig for 6 days simulatneously with 6 days of DNBS-challenge by ELISA;CHEMBL4014309;Non-molecular target assigned;N;;1;CHEMBL376;;
914282;;;CHEMBL4015480;[{'assay_class_id': 44, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ALIMENTARY TRACT AND METABOLISM', 'l2': 'Intestinal Function', 'l3': 'Experimental Colitis Inflammatory Gut Disease', 'source': 'Vogel_2008'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Anti-inflammatory activity in DNBS-induced Sprague-Dawley rat colitis model assessed as DNBS-induced IL-1beta levels in colon at 1 mg/kg/day, ig for 6 days simulatneously with 6 days of DNBS-challenge by ELISA (Rvb = 22.3 +/- 2.9 ng/mg);CHEMBL4014309;Non-molecular target assigned;N;;1;CHEMBL376;;
914286;;;CHEMBL4015484;[{'assay_class_id': 44, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ALIMENTARY TRACT AND METABOLISM', 'l2': 'Intestinal Function', 'l3': 'Experimental Colitis Inflammatory Gut Disease', 'source': 'Vogel_2008'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Anti-inflammatory activity in DNBS-induced Sprague-Dawley rat colitis model assessed as DNBS-induced TNFalpha levels in colon at 1 mg/kg/day, ig for 6 days simulatneously with 6 days of DNBS-challenge by ELISA (Rvb = 5.9 +/- 0.6 pg/mg);CHEMBL4014309;Non-molecular target assigned;N;;1;CHEMBL376;;
914881;;;CHEMBL4015495;[];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in Sprague-Dawley rat assessed as body weight loss at 1 mg/kg/day, ig;CHEMBL4014309;Non-molecular target assigned;N;;1;CHEMBL376;;
906990;;;CHEMBL4017550;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Direct single protein target assigned;9;Inhibition of human BSEP expressed in baculovirus transfected fall armyworm Sf21 cell membranes vesicles assessed as reduction in ATP-dependent [3H]-taurocholate transport into vesicles incubated for 5 mins by Topcount based rapid filtration method;CHEMBL4017441;Direct protein target assigned;D;;1;CHEMBL6020;;
927522;;Mesenchymal stem cell;CHEMBL4018956;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Induction of adipogenesis in human bone marrow-derived mesenchymal stem cells assessed as adiponectin level at 20 uM measured on day 7 after 48 hrs by ELISA;CHEMBL4017496;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
927523;;Mesenchymal stem cell;CHEMBL4018957;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Induction of adipogenesis in human bone marrow-derived mesenchymal stem cells assessed as adiponectin level at 4 uM measured on day 7 after 48 hrs by ELISA;CHEMBL4017496;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
926011;;;CHEMBL4019482;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Inhibition of sEH in human HepG2 cells assessed as NF-kappaB mRNA expression at 1 uM after 8 to 16 hrs by SYBR green based qRT-PCR analysis relative to DMSO control;CHEMBL4017509;Direct protein target assigned;D;;1;CHEMBL2409;;
937293;;RAW264.7;CHEMBL4022133;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in mouse RAW264.7 cells assessed as reduction in LPS-induced NO production pretreated for 30 mins followed by LPS stimulation for 24 hrs by Griess assay;CHEMBL4020772;Non-molecular target assigned;N;;1;CHEMBL612557;;
937805;;;CHEMBL4022145;[];Rattus norvegicus;[];Lewis;;10116.0;;Plasma;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Terminal plasma concentration in Lewis rat at 3 mg/kg, po administered once daily;CHEMBL4020773;Non-molecular target assigned;N;;1;CHEMBL376;CHEMBL3559721;
941520;;;CHEMBL4022150;[];Rattus norvegicus;[];Lewis;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Invivo inhibition of IRAK4 in Lewis rat assessed as reduction in R848-stimulated serum IL-6 secretion at 3 mg/kg, po administered once daily pretreated for 1 hr followed by R848 challenge measured after 1.5 hrs relative to control;CHEMBL4020773;Non-molecular target assigned;N;;1;CHEMBL376;;
906943;;;CHEMBL4028921;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Inhibition of human BSEP overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-taurocholate in presence of ATP measured after 15 to 20 mins by membrane vesicle transport assay;CHEMBL4028801;Direct protein target assigned;D;;1;CHEMBL6020;;
906944;;;CHEMBL4028922;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Inhibition of human MRP2 overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 20 mins by membrane vesicle transport assay;CHEMBL4028801;Direct protein target assigned;D;;1;CHEMBL5748;;
906945;;;CHEMBL4028923;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Inhibition of human MRP3 overexpressed in Sf9 insect cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 10 mins by membrane vesicle transport assay;CHEMBL4028801;Direct protein target assigned;D;;1;CHEMBL5918;;
906946;;;CHEMBL4028924;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Inhibition of human MRP4 overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 20 mins by membrane vesicle transport assay;CHEMBL4028801;Direct protein target assigned;D;;1;CHEMBL1743128;;
911630;;;CHEMBL4029349;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Target assigned is non-molecular;1;Liver toxicity in human assessed as induction of drug-induced liver injury by measuring severity class index;CHEMBL4028802;Non-molecular target assigned;N;;1;CHEMBL372;;
911633;;;CHEMBL4029350;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Target assigned is non-molecular;1;Liver toxicity in human assessed as induction of drug-induced liver injury by measuring verified drug-induced liver injury concern status;CHEMBL4028802;Non-molecular target assigned;N;;1;CHEMBL372;;
920049;;;CHEMBL4030504;[{'assay_class_id': 105, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'General Rheumatoid Arthritis Models', 'source': 'phenotype'}];Rattus norvegicus;[];Lewis;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiarthritic activity in Lewis rat assessed as collagen oligomeric matrix protein level in serum at 1 mg/kg, po qd administered for 10 days (Rbv = 0.17 +/- 0.02 U/l);CHEMBL4028848;Non-molecular target assigned;N;;1;CHEMBL376;;
925445;;Mino;CHEMBL4031049;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Antiproliferative activity against human Mino cells at 100 uM preincubated for 48 hrs followed by thymidine addition measure after 16 hrs by Thymidine incorporation assay;CHEMBL4028857;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
944413;;;CHEMBL4036729;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Rattus norvegicus;[];Lewis;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in Lewis rat CIA model assessed as reduction in ankle thickness at 0.05 mg/kg measured between day 10 and day 17;CHEMBL4033752;Non-molecular target assigned;N;;1;CHEMBL376;;
890741;;HeLa;CHEMBL4042886;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308376;Direct single protein target assigned;9;Transrepression activity at glucocorticoid receptorin human HeLa cells assessed as inhibition of TPA-induced collagenase promoter activity by luciferase reporter gene assay;CHEMBL4041544;Direct protein target assigned;D;;1;CHEMBL2034;;
890743;;HeLa;CHEMBL4042888;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308376;Direct single protein target assigned;9;Transactivation activity at glucocorticoid receptor in human HeLa cells assessed as induction of MMTV promoter activity by luciferase reporter gene assay;CHEMBL4041544;Direct protein target assigned;D;;1;CHEMBL2034;;
890745;;;CHEMBL4042890;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Transrepression activity at glucocorticoid receptor in human THP1 cells assessed as receptor-mediated anti-inflammatory activity by measuring inhibition of LPS-induced IL-8 production;CHEMBL4041544;Direct protein target assigned;D;;1;CHEMBL2034;;
890747;;;CHEMBL4042892;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Binding affinity to recombinant human glucocorticoid receptor expressed in baculovirus infected sf9 cells;CHEMBL4041544;Direct protein target assigned;D;;1;CHEMBL2034;;
890748;;;CHEMBL4042893;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Binding affinity to recombinant human progesterone receptor expressed in baculovirus infected sf9 cells;CHEMBL4041544;Direct protein target assigned;D;;1;CHEMBL208;;
890749;;;CHEMBL4042894;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Binding affinity to recombinant human mineralocorticoid receptor expressed in baculovirus infected sf9 cells;CHEMBL4041544;Direct protein target assigned;D;;1;CHEMBL1994;;
890750;;;CHEMBL4042895;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Binding affinity to recombinant human androgen receptor expressed in baculovirus infected sf9 cells;CHEMBL4041544;Direct protein target assigned;D;;1;CHEMBL1871;;
890751;;;CHEMBL4042896;[];Homo sapiens;[];; microsome;9606.0;;Liver;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;Stability in human liver microsomes assessed as drug recovery after 30 mins;CHEMBL4041544;Non-molecular target assigned;N;;1;CHEMBL613419;CHEMBL3559723;
953783;;;CHEMBL4044439;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Rattus norvegicus;[];Lewis;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Anti-inflammatory activity in Lewis rat mBSA-induced arthritis model assessed as inhibition of mBSA-induced knee swelling at 0.3 mg/kg, po, administered daily via gavage measured after 7 days post last dose relative to control;CHEMBL4043105;Non-molecular target assigned;N;;1;CHEMBL376;;
958803;;;CHEMBL4044452;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Rattus norvegicus;[];Lewis;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Anti-inflammatory activity in Lewis rat antigen-induced arthritis model assessed as inhibition of joint damage or erosion at 0.3 mg/kg, po bid administered via gavage measured after 7 days;CHEMBL4043105;Non-molecular target assigned;N;;1;CHEMBL376;;
982379;;HEK293;CHEMBL4119299;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Activation of PGC1alpha transcriptional activity (unknown origin) expressed in HEK293 cells at 100 nM after overnight incubation by luciferase reporter gene assay relative to control;CHEMBL4118042;Direct protein target assigned;D;;1;CHEMBL6116;;
982388;;HEK293;CHEMBL4119301;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Activation of PGC1alpha transcriptional activity (unknown origin) expressed in HEK293 cells at 100 nM after 24 hrs by luciferase reporter gene assay relative to control;CHEMBL4118042;Direct protein target assigned;D;;1;CHEMBL6116;;
982777;;A549;CHEMBL4119355;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Modulation of glucocorticoid receptor in human A549 cells harboring NFkB-Luc assessed as reduction in TNFalpha-induced NFkB activity by measuring NFkB activity at 30 uM preincubated for 1 hr followed by TNFalpha stimulation measured after 5 hrs by luciferase reporter gene assay (Rvb = 100%);CHEMBL4118052;Direct protein target assigned;D;;1;CHEMBL2034;;
982778;;A549;CHEMBL4119356;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Modulation of glucocorticoid receptor in human A549 cells harboring NFkB-Luc assessed as reduction in TNFalpha-induced NFkB activity by measuring NFkB activity at 1 uM preincubated for 1 hr followed by TNFalpha stimulation measured after 5 hrs by luciferase reporter gene assay (Rvb = 100%);CHEMBL4118052;Direct protein target assigned;D;;1;CHEMBL2034;;
982780;;A549;CHEMBL4119358;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Modulation of glucocorticoid receptor in human A549 cells harboring AP-1-Luc assessed as reduction in PMA-induced AP-1 activity by measuring AP-1 activity at 30 uM preincubated for 1 hr followed by PMA stimulation measured after 5 hrs by luciferase reporter gene assay (Rvb = 100%);CHEMBL4118052;Direct protein target assigned;D;;1;CHEMBL2034;;
982795;;A549;CHEMBL4119371;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Inhibition of TNFalpha-induced NFkB activity in GR knockout human A549 cells harboring NFkB-Luc assessed as NFkB activity at 1 uM preincubated for 1 hr followed by TNFalpha stimulation measured after 5 hrs by luciferase reporter gene assay (Rvb = 100%);CHEMBL4118052;Non-molecular target assigned;N;;1;CHEMBL392;;
982801;;A549;CHEMBL4119377;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Modulation of glucocorticoid receptor in human A549 cells assessed as TNFalpha-induced CCL2 production at 1 uM preincubated for 1 hr followed by TNFalpha stimulation measured after 5 hrs by ELISA (Rvb = 100%);CHEMBL4118052;Direct protein target assigned;D;;1;CHEMBL2034;;
996618;;RAW264.7;CHEMBL4136750;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production by griess assay;CHEMBL4130603;Non-molecular target assigned;N;;1;CHEMBL612557;;
996624;;RAW264.7;CHEMBL4136751;[];Mus musculus;[];;;10090.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Cytotoxicity against mouse RAW264.7 cells assessed as survival rate at 200 uM measured in absence of LPS by MTT assay relative to control;CHEMBL4130603;Non-molecular target assigned;N;;1;CHEMBL612557;;
996625;;RAW264.7;CHEMBL4136752;[];Mus musculus;[];;;10090.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Cytotoxicity against mouse RAW264.7 cells assessed as survival rate at 200 uM measured in presence of LPS by MTT assay relative to control;CHEMBL4130603;Non-molecular target assigned;N;;1;CHEMBL612557;;
1002069;;Multiple myeloma cancer stem cell;CHEMBL4138368;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295508;Target assigned is non-molecular;1;Antiproliferative activity against human multiple myeloma cancer stem cells after 72 hrs by MTT assay;CHEMBL4138044;Non-molecular target assigned;N;;1;CHEMBL4296513;;
1002072;;;CHEMBL4138369;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Antiproliferative activity against human RPMI18226 cells after 72 hrs by XTT assay;CHEMBL4138044;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1002808;;RAW264.7;CHEMBL4144554;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-stimulated nitric oxide production at 20 uM after 48 hrs by Griess assay relative to control;CHEMBL4138274;Non-molecular target assigned;N;;1;CHEMBL612557;;
1002826;;RBL-2H3;CHEMBL4144595;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307666;Target assigned is non-molecular;1;Antiallergic activity in rat RBL2H3 cells assessed as inhibition of A23187-induced beta hexosaminidase release at 10 nM pretreated for 20 hrs followed by A23187 addition measured after 1 hr by p-NAG substrate based assay relative to control;CHEMBL4138279;Non-molecular target assigned;N;;1;CHEMBL614632;;
1002827;;RBL-2H3;CHEMBL4144596;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307666;Target assigned is non-molecular;1;Antiallergic activity in anti-DNP IgE-sensitized rat RBL2H3 cells assessed as inhibition of DNP-BSA-induced beta hexosaminidase release at 10 nM pretreated for 20 hrs followed by anti-DNP IgE-sensitization for 2 hrs and subsequent DNP-BSA addition measured after 1 hr by p-NAG substrate based assay relative to control;CHEMBL4138279;Non-molecular target assigned;N;;1;CHEMBL614632;;
1002347;;RAW264.7;CHEMBL4144631;[];Mus musculus;[];;;10090.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at PPARgamma in LPS-stimulated mouse RAW264.7 cells assessed as inhibition of NF-kappaB p65 phosphorylation at 10 uM pretreated with compound for 1 hr followed by LPS stimulation for 30 mins by Western blot assay relative to control;CHEMBL4138282;Direct protein target assigned;D;;1;CHEMBL2459;;
1002372;;RAW264.7;CHEMBL4144645;[];Mus musculus;[];;;10090.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at PPARgamma in LPS-stimulated mouse RAW264.7 cells assessed as inhibition of NF-kappaB signaling by measuring reduction in iNOS protein level at 10 uM pretreated with compound for 1 hr followed by LPS stimulation measured after 24 hrs by Western blot analysis;CHEMBL4138282;Direct protein target assigned;D;;1;CHEMBL2459;;
1002385;;RAW264.7;CHEMBL4144650;[];Mus musculus;[];;;10090.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at PPARgamma in LPS-stimulated mouse RAW264.7 cells assessed as inhibition of NF-kappaB signaling by measuring reduction in NO production at 10 uM pretreated with compound for 1 hr followed by LPS stimulation measured after 24 hrs by Griess assay;CHEMBL4138282;Direct protein target assigned;D;;1;CHEMBL2459;;
1002387;;RAW264.7;CHEMBL4144651;[];Mus musculus;[];;;10090.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at PPARgamma in LPS-stimulated mouse RAW264.7 cells assessed as inhibition of NF-kappaB signaling by measuring reduction in IL-1beta production at 10 uM pretreated with compound for 1 hr followed by LPS stimulation measured after 24 hrs by ELISA;CHEMBL4138282;Direct protein target assigned;D;;1;CHEMBL2459;;
1002388;;RAW264.7;CHEMBL4144652;[];Mus musculus;[];;;10090.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at PPARgamma in LPS-stimulated mouse RAW264.7 cells assessed as inhibition of NF-kappaB signaling by measuring reduction in IL-6 production at 10 uM pretreated with compound for 1 hr followed by LPS stimulation measured after 24 hrs by ELISA;CHEMBL4138282;Direct protein target assigned;D;;1;CHEMBL2459;;
1002389;;RAW264.7;CHEMBL4144653;[];Mus musculus;[];;;10090.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at PPARgamma in LPS-stimulated mouse RAW264.7 cells assessed as inhibition of NF-kappaB signaling by measuring reduction in TNFalpha production at 10 uM pretreated with compound for 1 hr followed by LPS stimulation measured after 3 hrs by ELISA;CHEMBL4138282;Direct protein target assigned;D;;1;CHEMBL2459;;
1002393;;RAW264.7;CHEMBL4144654;[];Mus musculus;[];;;10090.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at PPARgamma in LPS-stimulated mouse RAW264.7 cells assessed as inhibition of NF-kappaB signaling by measuring reduction in iNOS mRNA level at 10 uM pretreated with compound for 1 hr followed by LPS stimulation for 6 hrs by RT-PCR analysis;CHEMBL4138282;Direct protein target assigned;D;;1;CHEMBL2459;;
1002394;;RAW264.7;CHEMBL4144655;[];Mus musculus;[];;;10090.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at PPARgamma in LPS-stimulated mouse RAW264.7 cells assessed as inhibition of NF-kappaB signaling by measuring reduction in COX2 mRNA level at 10 uM pretreated with compound for 1 hr followed by LPS stimulation for 6 hrs by RT-PCR analysis;CHEMBL4138282;Direct protein target assigned;D;;1;CHEMBL2459;;
1002395;;RAW264.7;CHEMBL4144656;[];Mus musculus;[];;;10090.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at PPARgamma in LPS-stimulated mouse RAW264.7 cells assessed as inhibition of NF-kappaB signaling by measuring reduction in TNFalpha mRNA level at 10 uM pretreated with compound for 1 hr followed by LPS stimulation for 6 hrs by RT-PCR analysis;CHEMBL4138282;Direct protein target assigned;D;;1;CHEMBL2459;;
1002396;;RAW264.7;CHEMBL4144657;[];Mus musculus;[];;;10090.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at PPARgamma in LPS-stimulated mouse RAW264.7 cells assessed as inhibition of NF-kappaB signaling by measuring reduction in IL-1beta mRNA level at 10 uM pretreated with compound for 1 hr followed by LPS stimulation for 6 hrs by RT-PCR analysis;CHEMBL4138282;Direct protein target assigned;D;;1;CHEMBL2459;;
1002397;;RAW264.7;CHEMBL4144658;[];Mus musculus;[];;;10090.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at PPARgamma in LPS-stimulated mouse RAW264.7 cells assessed as inhibition of NF-kappaB signaling by measuring reduction in IL-6 mRNA level at 10 uM pretreated with compound for 1 hr followed by LPS stimulation for 6 hrs by RT-PCR analysis;CHEMBL4138282;Direct protein target assigned;D;;1;CHEMBL2459;;
1010692;;;CHEMBL4149445;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 301, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Paw Edema Test', 'source': 'Hock_2016'}];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in carrageenan induced C57BL/6 mouse model of inflammation assessed as reduction in paw edema at 2 mg/kg, ip pretreated for 1 to 2 hrs followed by carrageenan challenge measured after 3 to 6 hrs by plethysmometer;CHEMBL4145567;Non-molecular target assigned;N;;1;CHEMBL375;;
1010701;;;CHEMBL4149450;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in carrageenan induced C57BL/6 mouse model of inflammation assessed as reduction in IL6 expression in hind paw at 2 mg/kg, ip pretreated for 1 to 2 hrs followed by carrageenan challenge measured after 6 hrs by ELISA;CHEMBL4145567;Non-molecular target assigned;N;;1;CHEMBL375;;
1010702;;;CHEMBL4149451;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in carrageenan induced C57BL/6 mouse model of inflammation assessed as reduction in MCP1 expression in hind paw at 2 mg/kg, ip pretreated for 1 to 2 hrs followed by carrageenan challenge measured after 6 hrs by ELISA;CHEMBL4145567;Non-molecular target assigned;N;;1;CHEMBL375;;
1012460;;RAW264.7;CHEMBL4149465;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production;CHEMBL4145570;Non-molecular target assigned;N;;1;CHEMBL612557;;
1015049;;;CHEMBL4152019;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];Balb/c;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Anti-inflammatory activity in Balb/c mouse model of hypereosinophilia assessed as inhibition of eosinophil infiltration at 2.5 umol/kg, ip dosed 2 hrs before allergen challenge;CHEMBL4145692;Non-molecular target assigned;N;;1;CHEMBL375;;
1015053;;;CHEMBL4152022;[];Mus musculus;[];Balb/c;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in Balb/c mouse model of hypereosinophilia assessed as reduction in body weight at 2.5 umol/kg, ip dosed daily 2 hrs before allergen challenge for 3 days and measured 24 hrs after last dose;CHEMBL4145692;Non-molecular target assigned;N;;1;CHEMBL375;;
1015054;;;CHEMBL4152023;[];Mus musculus;[];Balb/c;;10090.0;;Spleen;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in Balb/c mouse model of hypereosinophilia assessed as reduction in spleen weight at 2.5 umol/kg, ip dosed daily 2 hrs before allergen challenge for 3 days and measured 24 hrs after last dose;CHEMBL4145692;Non-molecular target assigned;N;;1;CHEMBL375;CHEMBL3559722;
1033001;;;CHEMBL4157883;[{'assay_class_id': 295, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Croton Oil Ear Edema', 'source': 'Vogel_2008'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];Balb/c;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in Balb/c mouse ear edema model assessed as inhibition of croton oil-induced ear edema at 0.1 mg/ear administered topically immediately post croton oil treatment and measured after 4 hrs relative to control;CHEMBL4152358;Non-molecular target assigned;N;;1;CHEMBL375;;
1033022;;;CHEMBL4157884;[{'assay_class_id': 295, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Croton Oil Ear Edema', 'source': 'Vogel_2008'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];Balb/c;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in croton oil-induced Balb/c mouse ear edema model assessed as inhibition of leucocyte infiltration at 0.1 mg/ear administered topically immediately post croton oil treatment and measured after 4 hrs by hematoxylin and eosin staining based light microscopic method;CHEMBL4152358;Non-molecular target assigned;N;;1;CHEMBL375;;
969014;;;CHEMBL4188026;[];Danio rerio;[];;;7955.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Anti-inflammatory activity in EGFP transgenic Zebrafish model of neutrophil inflammation assessed as reduction in number of neutrophil migration at 30 ug/ml incubated for 3 hrs by stereofluorescence microscopy;CHEMBL4184239;Non-molecular target assigned;N;;1;CHEMBL613963;;
969020;;;CHEMBL4188029;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 301, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Paw Edema Test', 'source': 'Hock_2016'}];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Anti-inflammatory activity in Sprague-Dawley rat model of carrageenan-induced paw edema assessed as reduction in hind paw volume at 5 mg/kg, po dosed for 2 times at 2 hrs after carrageenan injection measured after 6 to 10 hrs;CHEMBL4184239;Non-molecular target assigned;N;;1;CHEMBL376;;
969029;;;CHEMBL4188034;[{'assay_class_id': 96, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Adjuvant Arthritis in Rats', 'source': 'Hock_2016'}, {'assay_class_id': 105, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'General Rheumatoid Arthritis Models', 'source': 'phenotype'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Rattus norvegicus;[];Wistar;;10116.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in Wistar rat model of Freund's complete adjuvant-induced rheumatoid arthritis model assessed as increase in body weight at 1 mg/kg, po dosed every day from day 16 after initial inflammation (Rvb = 84.6 g);CHEMBL4184239;Non-molecular target assigned;N;;1;CHEMBL376;;
972158;;BV-2;CHEMBL4189049;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307704;Target assigned is non-molecular;1;Antiinflammatory activity in mouse BV2 cells assessed as inhibition of LPS-induced nitric oxide production;CHEMBL4184303;Non-molecular target assigned;N;;1;CHEMBL614781;;
985601;;;CHEMBL4191482;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 301, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Paw Edema Test', 'source': 'Hock_2016'}];Mus musculus;[];Swiss;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in Swiss mouse assessed as inhibition of carrageenan-induced paw edema 30 ng/paw administered as intraplantar injection pretreated for 1 hr followed by carrageenan challenge measured after 1 to 4 hrs;CHEMBL4190213;Non-molecular target assigned;N;;1;CHEMBL375;;
984801;;RAW264.7;CHEMBL4191504;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Inhibition of LPS-induced NO production in mouse RAW264.7 cells after 24 hrs by Griess assay;CHEMBL4190215;Non-molecular target assigned;N;;1;CHEMBL612557;;
1018597;;;CHEMBL4199447;[];;[];;;;;;A;ADME;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Effective permeability of the compound at pH 7.4 by PAMPA-BBB assay;CHEMBL4196107;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
1021864;;RAW264.7;CHEMBL4201877;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced nitrite production at 20 uM pretreated for 6 hrs followed by LPS stimulation measured after 24 hrs by ELISA;CHEMBL4196211;Non-molecular target assigned;N;;1;CHEMBL612557;;
1021865;;RAW264.7;CHEMBL4201878;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced TNFalpha production at 20 uM pretreated for 6 hrs followed by LPS stimulation measured after 24 hrs by ELISA;CHEMBL4196211;Non-molecular target assigned;N;;1;CHEMBL612557;;
1021866;;RAW264.7;CHEMBL4201879;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced IL-6 production at 20 uM pretreated for 6 hrs followed by LPS stimulation measured after 24 hrs by ELISA;CHEMBL4196211;Non-molecular target assigned;N;;1;CHEMBL612557;;
1021867;;RAW264.7;CHEMBL4201880;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced IL-1beta production at 20 uM pretreated for 6 hrs followed by LPS stimulation measured after 24 hrs by ELISA;CHEMBL4196211;Non-molecular target assigned;N;;1;CHEMBL612557;;
975877;;J774;CHEMBL4221993;[];Mus musculus;[];BALB/c;;10090.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307540;Target assigned is non-molecular;1;Cytotoxicity against BALB/c mouse J774 cells assessed as reduction in cell viability after 72 hrs by alamarBlue assay;CHEMBL4219127;Non-molecular target assigned;N;;1;CHEMBL614123;;
975879;;J774;CHEMBL4221994;[];Mus musculus;[];BALB/c;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307540;Target assigned is non-molecular;1;Antiinflammatory activity in BALB/c mouse J774 cells assessed as inhibition of LPS/IFNgamma-induced nitric oxide production at 20 uM after 24 hrs by Griess method relative to control;CHEMBL4219127;Non-molecular target assigned;N;;1;CHEMBL614123;;
975888;;Splenocyte;CHEMBL4221995;[];Mus musculus;[];BALB/c;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307957;Target assigned is non-molecular;1;Immunomodulatory activity in BALB/c mouse splenocytes assessed as inhibition of concanavalin A-induced lymphocyte proliferation by measuring [3H]-thymidine uptake after 48 to 72 hrs by scintillation counting analysis;CHEMBL4219127;Non-molecular target assigned;N;;1;CHEMBL612422;;
975933;;Splenocyte;CHEMBL4222008;[];Mus musculus;[];BALB/c;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307957;Target assigned is non-molecular;1;Antiinflammatory activity in BALB/c mouse splenocytes assessed as inhibition of concanavalin A-induced IL-2 level at 1 uM after 48 hrs by ELISA;CHEMBL4219127;Non-molecular target assigned;N;;1;CHEMBL612422;;
975934;;Splenocyte;CHEMBL4222009;[];Mus musculus;[];BALB/c;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307957;Target assigned is non-molecular;1;Antiinflammatory activity in BALB/c mouse splenocytes assessed as inhibition of concanavalin A-induced IL-4 level at 10 uM after 48 hrs by ELISA;CHEMBL4219127;Non-molecular target assigned;N;;1;CHEMBL612422;;
975935;;Splenocyte;CHEMBL4222010;[];Mus musculus;[];BALB/c;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307957;Target assigned is non-molecular;1;Antiinflammatory activity in BALB/c mouse splenocytes assessed as inhibition of concanavalin A-induced IL-10 level at 10 uM after 48 hrs by ELISA;CHEMBL4219127;Non-molecular target assigned;N;;1;CHEMBL612422;;
975936;;Splenocyte;CHEMBL4222011;[];Mus musculus;[];BALB/c;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307957;Target assigned is non-molecular;1;Antiinflammatory activity in BALB/c mouse splenocytes assessed as inhibition of concanavalin A-induced IL-17A level at 10 uM after 48 hrs by ELISA;CHEMBL4219127;Non-molecular target assigned;N;;1;CHEMBL612422;;
975937;;Splenocyte;CHEMBL4222012;[];Mus musculus;[];BALB/c;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307957;Target assigned is non-molecular;1;Antiinflammatory activity in BALB/c mouse splenocytes assessed as inhibition of concanavalin A-induced IFN-gamma level at 10 uM after 48 hrs by ELISA;CHEMBL4219127;Non-molecular target assigned;N;;1;CHEMBL612422;;
1025524;;J774.2;CHEMBL4232689;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307942;Target assigned is non-molecular;1;Antiinflammatory activity against mouse J774.2 cells assessed as inhibition of LPS-induced TNFalpha release at 1 mM after 24 hrs by ELISA relative to control;CHEMBL4229405;Non-molecular target assigned;N;;1;CHEMBL614484;;
1025531;;J774.2;CHEMBL4232692;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307942;Target assigned is non-molecular;1;Antiinflammatory activity against mouse J774.2 cells assessed as inhibition of LPS-induced IL-6 release at 0.5 mM after 24 hrs by ELISA relative to control;CHEMBL4229405;Non-molecular target assigned;N;;1;CHEMBL614484;;
1008860;;RAW264.7;CHEMBL4255561;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Inhibition of LPS-induced nitric oxide production in mouse RAW264.7 cells after 24 hrs by Griess assay;CHEMBL4251682;Non-molecular target assigned;N;;1;CHEMBL612557;;
1008332;;THP-1;CHEMBL4256050;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Antiinflammatory activity in PMA-differentiated human THP1 cells assessed as inhibition of LPS-induced TNF-alpha production at 1 uM after 24 hrs by ELISA relative to control;CHEMBL4251708;Non-molecular target assigned;N;;1;CHEMBL614245;;
1008338;;THP-1;CHEMBL4256052;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Antiinflammatory activity in PMA-differentiated human THP1 cells assessed as inhibition of LPS-induced IL-6 production at 1 uM after 24 hrs by ELISA relative to control;CHEMBL4251708;Non-molecular target assigned;N;;1;CHEMBL614245;;
1008340;;THP-1;CHEMBL4256054;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Cytotoxicity against PMA-differentiated human THP1 cells assessed as reduction in cell viability at 1 uM after 4.5 hrs by MTS assay relative to control;CHEMBL4251708;Non-molecular target assigned;N;;1;CHEMBL614245;;
1009511;;HeLa;CHEMBL4256410;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Transrepression of GCR in human HeLa cells assessed as suppression of DEX-induced GILZ mRNA expression at 0.4 uM after 24 hrs by Taqman-based real-time PCR analysis;CHEMBL4251737;Direct protein target assigned;D;;1;CHEMBL2034;;
1054761;;RAW264.7;CHEMBL4258187;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-induced mouse RAW264.7 cells assessed as TNFalpha levels at 1.25 uM pretreated for 2 hrs followed by LPS stimulation and measured after 12 hrs by ELISA (Rvb = 5313.7 +/- 420.9 pg/ml);CHEMBL4257465;Non-molecular target assigned;N;;1;CHEMBL612557;;
1054760;;RAW264.7;CHEMBL4258188;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-induced mouse RAW264.7 cells assessed as TNFalpha levels at 2.5 uM pretreated for 2 hrs followed by LPS stimulation and measured after 12 hrs by ELISA (Rvb = 5313.7 +/- 420.9 pg/ml);CHEMBL4257465;Non-molecular target assigned;N;;1;CHEMBL612557;;
1054759;;RAW264.7;CHEMBL4258189;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-induced mouse RAW264.7 cells assessed as TNFalpha levels at 5 uM pretreated for 2 hrs followed by LPS stimulation and measured after 12 hrs by ELISA (Rvb = 5313.7 +/- 420.9 pg/ml);CHEMBL4257465;Non-molecular target assigned;N;;1;CHEMBL612557;;
1054757;;RAW264.7;CHEMBL4258190;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-induced mouse RAW264.7 cells assessed as TNFalpha levels at 1.25 uM pretreated for 2 hrs followed by LPS stimulation and measured after 6 hrs by ELISA (Rvb = 4377.1 +/- 318.6 pg/ml);CHEMBL4257465;Non-molecular target assigned;N;;1;CHEMBL612557;;
1054756;;RAW264.7;CHEMBL4258191;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-induced mouse RAW264.7 cells assessed as TNFalpha levels at 2.5 uM pretreated for 2 hrs followed by LPS stimulation and measured after 6 hrs by ELISA (Rvb = 4377.1 +/- 318.6 pg/ml);CHEMBL4257465;Non-molecular target assigned;N;;1;CHEMBL612557;;
1054755;;RAW264.7;CHEMBL4258192;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-induced mouse RAW264.7 cells assessed as TNFalpha levels at 5 uM pretreated for 2 hrs followed by LPS stimulation and measured after 6 hrs by ELISA (Rvb = 4377.1 +/- 318.6 pg/ml);CHEMBL4257465;Non-molecular target assigned;N;;1;CHEMBL612557;;
1054754;;RAW264.7;CHEMBL4258193;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-induced mouse RAW264.7 cells assessed as TNFalpha levels at 10 uM pretreated for 2 hrs followed by LPS stimulation and measured after 6 hrs by ELISA (Rvb = 4377.1 +/- 318.6 pg/ml);CHEMBL4257465;Non-molecular target assigned;N;;1;CHEMBL612557;;
1054758;;RAW264.7;CHEMBL4258195;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-induced mouse RAW264.7 cells assessed as TNFalpha levels at 10 uM pretreated for 2 hrs followed by LPS stimulation and measured after 12 hrs by ELISA (Rvb = 5313.7 +/- 420.9 pg/ml);CHEMBL4257465;Non-molecular target assigned;N;;1;CHEMBL612557;;
1054751;;RAW264.7;CHEMBL4258197;[];Mus musculus;[];;;10090.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Cytotoxicity against mouse RAW264.7 cells assessed as cell viability at 10 uM after 48 hrs by MTT assay (Rvb = 100%);CHEMBL4257465;Non-molecular target assigned;N;;1;CHEMBL612557;;
1054750;;RAW264.7;CHEMBL4258198;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production pretreated for 2 hrs followed by LPS stimulation measured after 24 hrs by Griess assay;CHEMBL4257465;Non-molecular target assigned;N;;1;CHEMBL612557;;
1054762;;RAW264.7;CHEMBL4258199;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-induced mouse RAW264.7 cells assessed as TNFalpha levels at 10 uM pretreated for 2 hrs followed by LPS stimulation and measured after 24 hrs by ELISA (Rvb = 9653.7 +/- 377.3 pg/ml);CHEMBL4257465;Non-molecular target assigned;N;;1;CHEMBL612557;;
1054763;;RAW264.7;CHEMBL4258200;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-induced mouse RAW264.7 cells assessed as TNFalpha levels at 5 uM pretreated for 2 hrs followed by LPS stimulation and measured after 24 hrs by ELISA (Rvb = 9653.7 +/- 377.3 pg/ml);CHEMBL4257465;Non-molecular target assigned;N;;1;CHEMBL612557;;
1054764;;RAW264.7;CHEMBL4258201;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-induced mouse RAW264.7 cells assessed as TNFalpha levels at 2.5 uM pretreated for 2 hrs followed by LPS stimulation and measured after 24 hrs by ELISA (Rvb = 9653.7 +/- 377.3 pg/ml);CHEMBL4257465;Non-molecular target assigned;N;;1;CHEMBL612557;;
1054765;;RAW264.7;CHEMBL4258202;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-induced mouse RAW264.7 cells assessed as TNFalpha levels at 1.25 uM pretreated for 2 hrs followed by LPS stimulation and measured after 24 hrs by ELISA (Rvb = 9653.7 +/- 377.3 pg/ml);CHEMBL4257465;Non-molecular target assigned;N;;1;CHEMBL612557;;
1058219;;RAW264.7;CHEMBL4258209;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-induced mouse RAW264.7 cells assessed as IL-6 levels at 10 uM pretreated for 2 hrs followed by LPS stimulation and measured after 12 hrs by ELISA (Rvb = 1394 +/- 62.6 pg/ml);CHEMBL4257465;Non-molecular target assigned;N;;1;CHEMBL612557;;
1058218;;RAW264.7;CHEMBL4258210;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-induced mouse RAW264.7 cells assessed as IL-6 levels at 1.25 uM pretreated for 2 hrs followed by LPS stimulation and measured after 6 hrs by ELISA (Rvb = 472.3 +/- 25.8 pg/ml);CHEMBL4257465;Non-molecular target assigned;N;;1;CHEMBL612557;;
1058217;;RAW264.7;CHEMBL4258211;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-induced mouse RAW264.7 cells assessed as IL-6 levels at 2.5 uM pretreated for 2 hrs followed by LPS stimulation and measured after 6 hrs by ELISA (Rvb = 472.3 +/- 25.8 pg/ml);CHEMBL4257465;Non-molecular target assigned;N;;1;CHEMBL612557;;
1058216;;RAW264.7;CHEMBL4258212;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-induced mouse RAW264.7 cells assessed as IL-6 levels at 5 uM pretreated for 2 hrs followed by LPS stimulation and measured after 6 hrs by ELISA (Rvb = 472.3 +/- 25.8 pg/ml);CHEMBL4257465;Non-molecular target assigned;N;;1;CHEMBL612557;;
1058215;;RAW264.7;CHEMBL4258213;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-induced mouse RAW264.7 cells assessed as IL-6 levels at 10 uM pretreated for 2 hrs followed by LPS stimulation and measured after 6 hrs by ELISA (Rvb = 472.3 +/- 25.8 pg/ml);CHEMBL4257465;Non-molecular target assigned;N;;1;CHEMBL612557;;
1058220;;RAW264.7;CHEMBL4258214;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-induced mouse RAW264.7 cells assessed as IL-6 levels at 5 uM pretreated for 2 hrs followed by LPS stimulation and measured after 12 hrs by ELISA (Rvb = 1394 +/- 62.6 pg/ml);CHEMBL4257465;Non-molecular target assigned;N;;1;CHEMBL612557;;
1058221;;RAW264.7;CHEMBL4258215;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-induced mouse RAW264.7 cells assessed as IL-6 levels at 2.5 uM pretreated for 2 hrs followed by LPS stimulation and measured after 12 hrs by ELISA (Rvb = 1394 +/- 62.6 pg/ml);CHEMBL4257465;Non-molecular target assigned;N;;1;CHEMBL612557;;
1058222;;RAW264.7;CHEMBL4258216;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-induced mouse RAW264.7 cells assessed as IL-6 levels at 1.25 uM pretreated for 2 hrs followed by LPS stimulation and measured after 12 hrs by ELISA (Rvb = 1394 +/- 62.6 pg/ml);CHEMBL4257465;Non-molecular target assigned;N;;1;CHEMBL612557;;
1058223;;RAW264.7;CHEMBL4258217;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-induced mouse RAW264.7 cells assessed as IL-6 levels at 10 uM pretreated for 2 hrs followed by LPS stimulation and measured after 24 hrs by ELISA (Rvb = 1966.6 +/- 102.3 pg/ml);CHEMBL4257465;Non-molecular target assigned;N;;1;CHEMBL612557;;
1058224;;RAW264.7;CHEMBL4258218;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-induced mouse RAW264.7 cells assessed as IL-6 levels at 5 uM pretreated for 2 hrs followed by LPS stimulation and measured after 24 hrs by ELISA (Rvb = 1966.6 +/- 102.3 pg/ml);CHEMBL4257465;Non-molecular target assigned;N;;1;CHEMBL612557;;
1058225;;RAW264.7;CHEMBL4258219;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-induced mouse RAW264.7 cells assessed as IL-6 levels at 2.5 uM pretreated for 2 hrs followed by LPS stimulation and measured after 24 hrs by ELISA (Rvb = 1966.6 +/- 102.3 pg/ml);CHEMBL4257465;Non-molecular target assigned;N;;1;CHEMBL612557;;
1058226;;RAW264.7;CHEMBL4258220;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-induced mouse RAW264.7 cells assessed as IL-6 levels at 1.25 uM pretreated for 2 hrs followed by LPS stimulation and measured after 24 hrs by ELISA (Rvb = 1966.6 +/- 102.3 pg/ml);CHEMBL4257465;Non-molecular target assigned;N;;1;CHEMBL612557;;
1051103;;;CHEMBL4263479;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at GAL4 DNA-binding domain fused GR (unknown origin) ligand binding domain expressed in UAS-bla HEK 293T cells assessed as beta-lactamase transcriptional activation by FRET-based GeneBLAzer assay;CHEMBL4261581;Direct protein target assigned;D;;1;CHEMBL2034;;
1045990;;;CHEMBL4267987;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Anti-asthmatic activity in mouse model of ovalbumin-induced asthma assessed as decrease in methacholine-induced lung resistance at 10 mg/kg aerosolized daily by plethysmographic method;CHEMBL4265934;Non-molecular target assigned;N;;1;CHEMBL375;;
1046003;;;CHEMBL4267991;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Anti-inflammatory activity in mouse model of ovalbumin-induced asthma assessed as decrease in total leukocytic infilterate in BAL at 10 mg/kg aerosolized daily;CHEMBL4265934;Non-molecular target assigned;N;;1;CHEMBL375;;
1041557;;;CHEMBL4274933;[];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Inhibition of LPS-induced TNFalpha level in Sprague-Dawley rat serum at 25 mg/kg, po pretreated for 1 hr followed by LPS treatment measured after 90 mins by ELISA relative to control;CHEMBL4270610;Non-molecular target assigned;N;;1;CHEMBL376;;
1043414;;Splenocyte;CHEMBL4276127;[];Mus musculus;[];BALB/c;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307957;Target assigned is non-molecular;1;Immunomodulatory activity in BALB/c mouse splenocytes assessed as inhibition of concanavalin A-induced lymphocyte proliferation by measuring [methyl-3H]-thymidine uptake at 50 uM after 48 hrs;CHEMBL4270658;Non-molecular target assigned;N;;1;CHEMBL612422;;
GP_020;;;CHEMBL4296184;[];Staphylococcus aureus subsp. aureus;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Bacterial Growth', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Bacterial Growth', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Absorption (OD600)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Absorption (OD600)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'CAMHB', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'CAMHB', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; NBS; CORNING #3640 ', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; NBS; CORNING #3640 ', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC 43300;;46170.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antibacterial activity against Staphylococcus aureus MRSA ATCC 43300 (CO-ADD:GP_020); MIC in CAMBH media, using NBS plates, by OD(600)";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL2366800;;
GN_001;;;CHEMBL4296185;[];Escherichia coli;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Bacterial Growth', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Bacterial Growth', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Absorption (OD600)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Absorption (OD600)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'CAMHB', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'CAMHB', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; NBS; CORNING #3640 ', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; NBS; CORNING #3640 ', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC 25922;;562.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antibacterial activity against Escherichia coli ATCC 25922 (CO-ADD:GN_001); MIC in CAMBH media using NBS plates, by OD(600)";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL354;;
GN_003;;;CHEMBL4296186;[];Klebsiella pneumoniae;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Bacterial Growth', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Bacterial Growth', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Absorption (OD600)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Absorption (OD600)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'CAMHB', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'CAMHB', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; NBS; CORNING #3640 ', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; NBS; CORNING #3640 ', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC 700603;;573.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antibacterial activity against Klebsiella pneumoniae MDR ATCC 70063 (CO-ADD:GN_003); MIC in CAMBH media using NBS plates, by OD(600)";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL350;;
GN_042;;;CHEMBL4296187;[];Pseudomonas aeruginosa;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Bacterial Growth', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Bacterial Growth', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Absorption (OD600)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Absorption (OD600)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'CAMHB', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'CAMHB', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; NBS; CORNING #3640 ', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; NBS; CORNING #3640 ', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC 27853;;287.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 (CO-ADD:GN_042); MIC in CAMBH media using NBS plates, by OD(600)";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL348;;
GN_034;;;CHEMBL4296188;[];Acinetobacter baumannii;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Bacterial Growth', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Bacterial Growth', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Absorption (OD600)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Absorption (OD600)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'CAMHB', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'CAMHB', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; NBS; CORNING #3640 ', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; NBS; CORNING #3640 ', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC 19606;;470.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antibacterial activity against Acinetobacter baumannii ATCC 19606 (CO-ADD:GN_034); MIC in CAMBH media using NBS plates, by OD600";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL614425;;
FG_001;;;CHEMBL4296189;[];Candida albicans;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Fungal Growth', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Fungal Growth', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Absorption (OD530)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Absorption (OD530)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'CAMHB', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'CAMHB', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; NBS; CORNING #3640 ', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; NBS; CORNING #3640 ', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC 90028;;5476.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antifungal activity against Candida albicans ATCC 90028 (CO-ADD:FG_001); MIC in YNB media using NBS plates, by OD630";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL366;;
FG_002R;;;CHEMBL4296190;[];Cryptococcus neoformans;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Fungal Growth', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Fungal Growth', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Resazurin; Absorption (OD600-OD570)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Resazurin; Absorption (OD600-OD570)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'CAMHB', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'CAMHB', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; NBS; CORNING #3640 ', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; NBS; CORNING #3640 ', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC 208821;;5207.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antifungal activity against Cryptococcus neoformans H99 ATCC 208821 (CO-ADD:FG_002); MIC in YNB media using NBS plates, by Resazurin OD(600-570)";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL365;;
1068094;;RAW264.7;CHEMBL4311821;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Anti-inflammatory activity in mouse RAW264.7 cells assessed as reduction in LPS-induced TNF-alpha production after 48 hrs by ELISA;CHEMBL4308916;Non-molecular target assigned;N;;1;CHEMBL612557;;
1068095;;RAW264.7;CHEMBL4311822;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Anti-inflammatory activity in mouse RAW264.7 cells assessed as reduction in LPS-induced IL-6 production after 48 hrs by ELISA;CHEMBL4308916;Non-molecular target assigned;N;;1;CHEMBL612557;;
1093524;;RAW264.7;CHEMBL4321488;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production preincubated for 30 mins followed by LPS-stimulation and measured after 24 hrs by Griess assay;CHEMBL4316631;Non-molecular target assigned;N;;1;CHEMBL612557;;
1179287;;;CHEMBL4322137;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of glucocorticoid receptor (unknown origin);CHEMBL4321790;Direct protein target assigned;D;;1;CHEMBL2034;;
1059118;;;CHEMBL4327030;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at recombinant human glucocorticoid receptor expressed in African green monkey CV1 cells by MMTV luciferase reporter gene assay;CHEMBL4325858;Direct protein target assigned;D;;1;CHEMBL2034;;
1146008;;;CHEMBL4335795;[{'assay_class_id': 96, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Adjuvant Arthritis in Rats', 'source': 'Hock_2016'}, {'assay_class_id': 301, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Paw Edema Test', 'source': 'Hock_2016'}];Mus musculus;[];DBA/1;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiarthritic activity in complete freund's adjuvant-induced DBA/1 mouse arthritis model assessed as reduction in paw volume at 0.2 mg/kg, po qd administered starting from 29 day post-CFA challenge and measured on day 29, 33, 36, 40 and 43 by caliper method;CHEMBL4334447;Non-molecular target assigned;N;;1;CHEMBL375;;
1146010;;;CHEMBL4335797;[];Mus musculus;[];DBA/1;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Toxicity in complete freund's adjuvant-induced DBA/1 mouse arthritis model assessed as effect on appetite at 0.2 mg/kg, po qd administered starting from 29 day post-CFA challenge and measured on day 29, 33, 36, 40 and 43;CHEMBL4334447;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
1169327;;RAW264.7;CHEMBL4337905;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-stimulated NO production at 15 uM preincubated with LPS and measured after 20 hrs by Griess reagent-based assay relative to control;CHEMBL4334500;Non-molecular target assigned;N;;1;CHEMBL612557;;
1172275;;THP-1;CHEMBL4338633;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Antiinflammatory activity against human THP1 cells assessed as inhibition of LPS-induced TNFalpha production at 200 uM preincubated for 4 hrs followed by LPS challenge and measured after 24 hrs incubation by ELISA;CHEMBL4334531;Non-molecular target assigned;N;;1;CHEMBL614245;;
1094843;;RAW264.7;CHEMBL4340269;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production preincubated for 12 hrs followed by LPS-stimulation and measured after 24 hrs by Griess assay;CHEMBL4339236;Non-molecular target assigned;N;;1;CHEMBL612557;;
1099502;;;CHEMBL4340882;[{'assay_class_id': 295, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Croton Oil Ear Edema', 'source': 'Vogel_2008'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];CD1;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity against TPA-induced ear edema in CD1 mouse assessed as reduction in weight of ear punches at 225 ug/ear, each surface administered topically for 15 mins prior to TPA challenge and measured after 6 hrs;CHEMBL4340511;Non-molecular target assigned;N;;1;CHEMBL375;;
1099504;;;CHEMBL4340884;[{'assay_class_id': 295, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Croton Oil Ear Edema', 'source': 'Vogel_2008'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];CD1;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity against TPA-induced ear edema in CD1 mouse assessed as reduction in ear edema at 225 ug/ear, each surface administered topically for 15 mins prior to TPA challenge and measured after 6 hrs;CHEMBL4340511;Non-molecular target assigned;N;;1;CHEMBL375;;
1099511;;;CHEMBL4340886;[{'assay_class_id': 295, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Croton Oil Ear Edema', 'source': 'Vogel_2008'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];CD1;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in CD1 mouse model of TPA-induced ear edema assessed as decrease in COX-2 expression at 250 ug/ear, each surface administered topically for 15 mins prior to TPA challenge and measured after 6 hrs by qRT-PCR analysis;CHEMBL4340511;Non-molecular target assigned;N;;1;CHEMBL375;;
1099515;;;CHEMBL4340888;[{'assay_class_id': 295, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Croton Oil Ear Edema', 'source': 'Vogel_2008'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];CD1;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in CD1 mouse model of TPA-induced ear edema assessed as decrease in TNFalpha expression at 250 ug/ear, each surface administered topically for 15 mins prior to TPA challenge and measured after 6 hrs by qRT-PCR analysis;CHEMBL4340511;Non-molecular target assigned;N;;1;CHEMBL375;;
1099520;;;CHEMBL4340890;[{'assay_class_id': 295, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Croton Oil Ear Edema', 'source': 'Vogel_2008'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];CD1;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in CD1 mouse model of TPA-induced ear edema assessed as decrease in IL-6 expression at 250 ug/ear, each surface administered topically for 15 mins prior to TPA challenge and measured after 6 hrs by qRT-PCR analysis;CHEMBL4340511;Non-molecular target assigned;N;;1;CHEMBL375;;
1099522;;;CHEMBL4340892;[{'assay_class_id': 295, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Croton Oil Ear Edema', 'source': 'Vogel_2008'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];CD1;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in CD1 mouse model of TPA-induced ear edema assessed as decrease in MIF expression at 250 ug/ear, each surface administered topically for 15 mins prior to TPA challenge and measured after 6 hrs by qRT-PCR analysis;CHEMBL4340511;Non-molecular target assigned;N;;1;CHEMBL375;;
1099571;;;CHEMBL4340894;[{'assay_class_id': 295, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Croton Oil Ear Edema', 'source': 'Vogel_2008'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];CD1;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in CD1 mouse model of TPA-induced ear edema assessed as decrease in IFNgamma expression at 250 ug/ear, each surface administered topically for 15 mins prior to TPA challenge and measured after 6 hrs by qRT-PCR analysis;CHEMBL4340511;Non-molecular target assigned;N;;1;CHEMBL375;;
1099576;;;CHEMBL4340896;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];CD1;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in CD1 mouse assessed as reduction in TPA-induced ear flushing at 250 ug/ear, each surface administered topically for 15 mins prior to TPA challenge and measured after 6 hrs;CHEMBL4340511;Non-molecular target assigned;N;;1;CHEMBL375;;
1101184;;;CHEMBL4341379;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Binding affinity to GR (unknown origin);CHEMBL4340528;Direct protein target assigned;D;;1;CHEMBL2034;;
1101245;;Sf9;CHEMBL4341396;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308860;Direct single protein target assigned;9;Displacement of [3H] dexamethasone from human recombinant GR expressed in Sf9 insect cells at 10 uM incubated for 4 hrs by scintillation counting method;CHEMBL4340528;Direct protein target assigned;D;;1;CHEMBL2034;;
1101266;;SH-SY5Y;CHEMBL4341404;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307740;Target assigned is non-molecular;1;Induction of neurite outgrowth in human SH-SY5Y cells assessed as increase in neurite length of more than 50 micrometer by measuring cell differentiation at 1 uM incubated for 6 days by Giemsa staining based phase contrast microscopic analysis relative to control;CHEMBL4340528;Non-molecular target assigned;N;;1;CHEMBL614910;;
1197390;;RAW264.7;CHEMBL4344052;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of lipopolysaccharide-induced nitric oxide production;CHEMBL4342446;Non-molecular target assigned;N;;1;CHEMBL612557;;
1112504;;;CHEMBL4349994;[];Mus musculus;[];Balb/c;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Inhibition of anti-CD3-induced IL-17A level in Balb/c mouse plasma at 5 mg/kg, po treated prior to stimulation with anti-CD3 for 3 hrs relative to control;CHEMBL4346735;Non-molecular target assigned;N;;1;CHEMBL375;;
1116117;;Peritoneal macrophage;CHEMBL4350316;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295503;Target assigned is non-molecular;1;Anti-inflammatory activity in mouse peritoneal macrophages assessed as inhibition of LPS-induced NO production incubated for 22 hrs by Griess reagent based colorimetric assay;CHEMBL4346753;Non-molecular target assigned;N;;1;CHEMBL613703;;
1125292;;RAW264.7;CHEMBL4354282;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity against LPS-induced mouse RAW264.7 cells assessed as inhibition of NO overproduction preincubated for 1 hr prior to Escherichia coli LPS stimulation followed by further incubation for 24 hrs by Griess reagent based spectrophotometry;CHEMBL4351012;Non-molecular target assigned;N;;1;CHEMBL612557;;
1125293;;RAW264.7;CHEMBL4354283;[];Mus musculus;[];;;10090.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Cytotoxicity against mouse RAW264.7 cells assessed as inhibition of cell viability preincubated for 1 hr followed by LPS stimulation measured after 24 hrs by WST-1 assay;CHEMBL4351012;Non-molecular target assigned;N;;1;CHEMBL612557;;
1125364;;RAW264.7;CHEMBL4354284;[];Mus musculus;[];;;10090.0;;;U;Unassigned;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Selectivity index, ratio of IC50 for cytotoxicity against mouse RAW264.7 cells to IC50 for antiinflammatory activity in LPS-induced mouse RAW264.7 cells assessed as inhibition of NO release;CHEMBL4351012;Non-molecular target assigned;N;;1;CHEMBL612557;;
1139100;;;CHEMBL4367853;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];ICR;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in DNFB-induced ICR mouse model of auricle edema assessed as inhibition of ear swelling at 0.5 mg/kg, ig administered once daily for 6 days followed by 1% DNFB solution applied on right ear measured after 24 hrs relative to untreated control;CHEMBL4364303;Non-molecular target assigned;N;;1;CHEMBL375;;
1071030;;RAW264.7;CHEMBL4372745;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNFalpha production pretreated for 30 mins followed by LPS stimulation for 24 hrs by ELISA;CHEMBL4371055;Non-molecular target assigned;N;;1;CHEMBL612557;;
1071031;;RAW264.7;CHEMBL4372746;[];Mus musculus;[];;;10090.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Cytotoxicity against mouse RAW264.7 cells assessed as reduction in cell viability after 24 hrs by CCK8 assay;CHEMBL4371055;Non-molecular target assigned;N;;1;CHEMBL612557;;
1071032;;RAW264.7;CHEMBL4372747;[];Mus musculus;[];;;10090.0;;;T;Toxicity;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Selectivity index, ratio of CC50 for mouse RAW264.7 cells to IC50 for inhibition of LPS-induced TNFalpha production in mouse RAW264.7 cells;CHEMBL4371055;Non-molecular target assigned;N;;1;CHEMBL612557;;
1164190;;;CHEMBL4374575;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 301, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Paw Edema Test', 'source': 'Hock_2016'}];Mus musculus;[];Swiss;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in Swiss mouse assessed as inhibition of bradykinin-induced paw edema at 0.5 mg/kg, po treated 1 hr prior to bradykinin challenge measured after 15 to 90 mins by plethysmometer analysis;CHEMBL4373671;Non-molecular target assigned;N;;1;CHEMBL375;;
1062775;;;CHEMBL4383673;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at ALX/FPR2 in human THP1 cells harboring NF-kB-Luc assessed as inhibition of LPS-induced NFkB signalling activation by measuring NF-kB activation level at 10'-6 M pretreated for 30 mins followed by LPS stimulation for 24 hrs by luciferase reporter gene assay (Rvb = 100%);CHEMBL4382216;Direct protein target assigned;D;;1;CHEMBL4227;;
1062782;;;CHEMBL4383680;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Activation of Luc-fused NFkB (unknown origin) expressed in non-stimulated human THP1 cells assessed as relative luminescence unit at 10'-6 M after 24 hrs by luciferase reporter gene assay (Rvb = 100%);CHEMBL4382216;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1062787;;;CHEMBL4383685;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at ALX/FPR2 in human THP1 cells harboring NF-kB-Luc assessed as inhibition of LPS-induced NFkB signalling activation by measuring IL-1beta secretion at 10'-6 M pretreated for 30 mins followed by LPS stimulation for 24 hrs by electrochemiluminescence assay (Rvb = 100%);CHEMBL4382216;Direct protein target assigned;D;;1;CHEMBL4227;;
1062792;;;CHEMBL4383690;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at ALX/FPR2 in human THP1 cells harboring NF-kB-Luc assessed as inhibition of LPS-induced NFkB signalling activation by measuring IL-6 secretion at 10'-6 M pretreated for 30 mins followed by LPS stimulation for 24 hrs by electrochemiluminescence assay (Rvb = 100%);CHEMBL4382216;Direct protein target assigned;D;;1;CHEMBL4227;;
1062797;;;CHEMBL4383695;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at ALX/FPR2 in human THP1 cells harboring NF-kB-Luc assessed as inhibition of LPS-induced NFkB signalling activation by measuring IL-12p70 secretion at 10'-6 M pretreated for 30 mins followed by LPS stimulation for 24 hrs by electrochemiluminescence assay (Rvb = 100%);CHEMBL4382216;Direct protein target assigned;D;;1;CHEMBL4227;;
1062802;;;CHEMBL4383700;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at ALX/FPR2 in human THP1 cells harboring NF-kB-Luc assessed as inhibition of LPS-induced NFkB signalling activation by measuring IFNgamma secretion at 10'-6 M pretreated for 30 mins followed by LPS stimulation for 24 hrs by electrochemiluminescence assay (Rvb = 100%);CHEMBL4382216;Direct protein target assigned;D;;1;CHEMBL4227;;
1062807;;;CHEMBL4383705;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at ALX/FPR2 in human THP1 cells harboring NF-kB-Luc assessed as inhibition of LPS-induced NFkB signalling activation by measuring TNFalpha secretion at 10'-6 M pretreated for 30 mins followed by LPS stimulation for 24 hrs by electrochemiluminescence assay (Rvb = 100%);CHEMBL4382216;Direct protein target assigned;D;;1;CHEMBL4227;;
1062824;;THP-1;CHEMBL4383721;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Cytotoxicity against human THP1 cells harboring NFkB-Luc assessed as LDH release at 10'6 M after 24 hrs by spectrophotometric method relative to control;CHEMBL4382216;Non-molecular target assigned;N;;1;CHEMBL614245;;
1062839;;;CHEMBL4383735;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];C57BL/6J;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Anti-inflammatory activity in zymosan-induced C57BL/6J mouse peritonitis model assessed as total cell count in peritoneal cavity at 25 ug, ip pretreated for 1 hr followed by zymosan treatment and redosing of test compound at 1 hr post zymosan addition and measured 4 hrs post zymosan addition by flow cytometry (Rvb = 100%);CHEMBL4382216;Non-molecular target assigned;N;;1;CHEMBL375;;
1062842;;;CHEMBL4383738;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];C57BL/6J;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Anti-inflammatory activity in zymosan-induced C57BL/6J mouse peritonitis model assessed as PMN leukocytes level in peritoneal cavity at 25 ug, ip pretreated for 1 hr followed by zymosan treatment and redosing of test compound at 1 hr post zymosan addition and measured 4 hrs post zymosan addition by flow cytometry (Rvb = 100%);CHEMBL4382216;Non-molecular target assigned;N;;1;CHEMBL375;;
1108498;;RAW264.7;CHEMBL4390549;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitirc oxide production preincubated for 1 hr followed by LPS-stimulation and measured after 18 hrs by Griess assay;CHEMBL4387783;Non-molecular target assigned;N;;1;CHEMBL612557;;
1127719;;Macrophage;CHEMBL4400274;[];Not specified;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307986;Default value - Target unknown or has yet to be assigned;0;Inhibition of TNFalpha expression in LPS-induced macrophages (unknown origin) at 10 uM incubated for 24 hrs by ELISA relative to control;CHEMBL4396958;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1127720;;Macrophage;CHEMBL4400275;[];Not specified;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307986;Default value - Target unknown or has yet to be assigned;0;Inhibition of TNFalpha expression in LPS-induced macrophages (unknown origin) incubated for 24 hrs by ELISA;CHEMBL4396958;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1087932;;RAW264.7;CHEMBL4402048;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production preincubated for 1 hr followed by LPS-stimulation and measured after 18 hrs by Griess reagent-based assay;CHEMBL4400561;Non-molecular target assigned;N;;1;CHEMBL612557;;
1087933;;RAW264.7;CHEMBL4402049;[];Mus musculus;[];;;10090.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Cytotoxicity against mouse RAW264.7 cells at anti-inflammatory IC50 after 19 hrs by MTT assay;CHEMBL4400561;Non-molecular target assigned;N;;1;CHEMBL612557;;
1142572;;RAW264.7;CHEMBL4407509;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity against mouse RAW264.7 cells assessed as downregulation of LPS-stimulated iNOS protein expression at 10 uM pretreated for 1 hrs followed by LPS addition and measured after 24 hrs by Western blot analysis;CHEMBL4406809;Non-molecular target assigned;N;;1;CHEMBL612557;;
1142573;;RAW264.7;CHEMBL4407510;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity against mouse RAW264.7 cells assessed as downregulation of LPS-stimulated COX2 protein expression at 10 uM pretreated for 1 hrs followed by LPS addition and measured after 24 hrs by Western blot analysis;CHEMBL4406809;Non-molecular target assigned;N;;1;CHEMBL612557;;
1147029;;;CHEMBL4408880;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000019;assay format;;Direct single protein target assigned;9;Agonist activity at FXR in guggulsterone-treated human LO2 cells assessed as increase in BSEP mRNA expression at 0.25 uM treated with FXR antagonist, guggulsterone for 24 hrs followed by incubation with compound for 24 hrs by RT-qPCR analysis;CHEMBL4406841;Direct protein target assigned;D;;1;CHEMBL2047;;
1147030;;;CHEMBL4408881;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000019;assay format;;Direct single protein target assigned;9;Agonist activity at FXR in guggulsterone-treated human LO2 cells assessed as increase in UGT2A4 mRNA expression at 0.25 uM treated with FXR antagonist, guggulsterone for 24 hrs followed by incubation with compound for 24 hrs by RT-qPCR analysis;CHEMBL4406841;Direct protein target assigned;D;;1;CHEMBL2047;;
1151906;;;CHEMBL4408905;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at FXR in human LO2 cells assessed as UGT2A4 mRNA expression at 0.25 uM after 24 hrs by RT-qPCR analysis;CHEMBL4406841;Direct protein target assigned;D;;1;CHEMBL2047;;
1151905;;;CHEMBL4408906;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at FXR in human LO2 cells assessed as BSEP mRNA expression at 0.25 uM after 24 hrs by RT-qPCR analysis;CHEMBL4406841;Direct protein target assigned;D;;1;CHEMBL2047;;
1151904;;;CHEMBL4408907;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at FXR in human LO2 cells assessed as SHP1 mRNA expression at 0.25 uM after 24 hrs by RT-qPCR analysis;CHEMBL4406841;Direct protein target assigned;D;;1;CHEMBL2047;;
1151903;;L02;CHEMBL4408908;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295475;Target assigned is non-molecular;1;Effect on FXR mRNA expression in human LO2 cells at 0.25 uM after 24 hrs by RT-qPCR analysis;CHEMBL4406841;Non-molecular target assigned;N;;1;CHEMBL4296457;;
1151810;;L02;CHEMBL4408921;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295475;Target assigned is non-molecular;1;Upregulation of FXR protein expression in human LO2 cells at 0.25 uM after 24 hrs by Western blot analysis;CHEMBL4406841;Non-molecular target assigned;N;;1;CHEMBL4296457;;
1151811;;;CHEMBL4408922;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at FXR in human LO2 cells assessed as increase in SHP1 protein expression at 0.25 uM after 24 hrs by Western blot analysis;CHEMBL4406841;Direct protein target assigned;D;;1;CHEMBL2047;;
1151812;;;CHEMBL4408923;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at FXR in human LO2 cells assessed as increase in BSEP protein expression at 0.25 uM after 24 hrs by Western blot analysis;CHEMBL4406841;Direct protein target assigned;D;;1;CHEMBL2047;;
1151813;;;CHEMBL4408924;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at FXR in human LO2 cells assessed as increase in MRP2 protein expression at 0.25 uM after 24 hrs by Western blot analysis;CHEMBL4406841;Direct protein target assigned;D;;1;CHEMBL2047;;
1151814;;;CHEMBL4408925;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at FXR in human LO2 cells assessed as increase in SULT2A protein expression at 0.25 uM after 24 hrs by Western blot analysis;CHEMBL4406841;Direct protein target assigned;D;;1;CHEMBL2047;;
1151815;;;CHEMBL4408926;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at FXR in human LO2 cells assessed as decrease in CYP7A1 protein expression at 0.25 uM after 24 hrs by Western blot analysis;CHEMBL4406841;Direct protein target assigned;D;;1;CHEMBL2047;;
1151816;;;CHEMBL4408927;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at FXR in human LO2 cells assessed as decrease in CYP8B1 protein expression at 0.25 uM after 24 hrs by Western blot analysis;CHEMBL4406841;Direct protein target assigned;D;;1;CHEMBL2047;;
1151817;;;CHEMBL4408928;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at FXR in human LO2 cells assessed as decrease in NTCP protein expression at 0.25 uM after 24 hrs by Western blot analysis;CHEMBL4406841;Direct protein target assigned;D;;1;CHEMBL2047;;
1175085;;RAW264.7;CHEMBL4415304;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition LPS-induced NO production at 254.8 uM measured after 24 hrs by griess reagent based assay;CHEMBL4414566;Non-molecular target assigned;N;;1;CHEMBL612557;;
1173447;;RAW264.7;CHEMBL4416267;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production incubated for 24 hrs by Griess reagent-based assay;CHEMBL4414604;Non-molecular target assigned;N;;1;CHEMBL612557;;
1173448;;RAW264.7;CHEMBL4416268;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced IL-6 secretion after 24 hrs by ELISA;CHEMBL4414604;Non-molecular target assigned;N;;1;CHEMBL612557;;
1173449;;RAW264.7;CHEMBL4416269;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced TNF-alpha secretion after 24 hrs by ELISA;CHEMBL4414604;Non-molecular target assigned;N;;1;CHEMBL612557;;
1127652;;;CHEMBL4476956;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Reduction in in LPS-induced acute lung injury in mouse assessed as reduction in number of cells in BALF at 5 mg/kg dosed 2 hrs post LPS challenge;CHEMBL4476870;Non-molecular target assigned;N;;38;CHEMBL375;;
1127655;;;CHEMBL4476959;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Reduction in in LPS-induced acute lung injury in mouse assessed as reduction in protein concentration at 5 mg/kg dosed 2 hrs post LPS challenge;CHEMBL4476870;Non-molecular target assigned;N;;38;CHEMBL375;;
1085253;;RAW264.7;CHEMBL4481795;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production preincubated for 3 hrs followed by LPS-stimulation and measured after 24 hrs by Griess assay;CHEMBL4480428;Non-molecular target assigned;N;;1;CHEMBL612557;;
1201908;;T-cell;CHEMBL4604478;[];Mus musculus;[];BALB/C;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307588;Target assigned is non-molecular;1;Immunosuppressive activity against BALB/C mouse T lymphocytes assessed as reduction in concanavalin A-induced cell proliferation by measuring [3H]-thymidine uptake incubated for 8 hrs by Beta scintillation counting method;CHEMBL4602661;Non-molecular target assigned;N;;1;CHEMBL614309;;
1201910;;B-cell;CHEMBL4604479;[];Mus musculus;[];BALB/C;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307687;Target assigned is non-molecular;1;Immunosuppressive activity against BALB/C mouse B lymphocytes assessed as reduction in LPS-induced cell proliferation by measuring [3H]-thymidine uptake incubated for 8 hrs by Beta scintillation counting method;CHEMBL4602661;Non-molecular target assigned;N;;1;CHEMBL614724;;
1209949;;;CHEMBL4617826;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 301, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Paw Edema Test', 'source': 'Hock_2016'}];Mus musculus;[];Swiss;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Inhibition of carrageenan-induced paw edema in Swiss mouse at 0.5 mg/kg, sc pretreated for 1 hr followed by carrageenan-stimulation and measured after 6 hrs relative to control;CHEMBL4616633;Non-molecular target assigned;N;;1;CHEMBL375;;
1209985;;;CHEMBL4617830;[{'assay_class_id': 308, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'NERVOUS SYSTEM', 'l2': 'Analgesic Activity', 'l3': 'General Analgesic Nociceptic and Allodynic Activity', 'source': 'phenotype'}];Mus musculus;[];Swiss;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Inhibition of carrageenan-induced thermal allodynia in Swiss mouse at 0.5 mg/kg, sc pretreated for 1 hr followed by carrageenan-stimulation and measured after 6 hrs relative to control;CHEMBL4616633;Non-molecular target assigned;N;;1;CHEMBL375;;
1209995;;;CHEMBL4617835;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 301, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Paw Edema Test', 'source': 'Hock_2016'}];Mus musculus;[];Swiss;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Inhibition of zymosan-induced TLR2/Dectin-1 Signaling Pathway assessed as reduction in paw edema in Swiss mouse at 0.5 mg/kg, sc pretreated for 1 hr followed by LPS-stimulation and measured after 48 hrs relative to control;CHEMBL4616633;Non-molecular target assigned;N;;1;CHEMBL375;;
1209682;;;CHEMBL4617949;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in C57BL/6 mouse model of CS-induced pulmonary injury assessed as reduction in thickening of the alveolar septa in lungs at 1 mg/kg, ip for 5 days by hematoxylin and eosin staining based fluorescence microscopic analysis;CHEMBL4616634;Non-molecular target assigned;N;;1;CHEMBL375;;
1209688;;;CHEMBL4617952;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in C57BL/6 mouse model of CS-induced pulmonary injury assessed as reduction in hyperplasia of pneumo-cytes in lungs at 1 mg/kg, ip for 1 days by hematoxylin and eosin staining based fluorescence microscopic analysis;CHEMBL4616634;Non-molecular target assigned;N;;1;CHEMBL375;;
1209692;;;CHEMBL4617955;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in C57BL/6 mouse model of CS-induced pulmonary injury assessed as reduction in distinct infiltration of leukocytes in lungs at 1 mg/kg, ip for 5 days by hematoxylin and eosin staining based fluorescence microscopic analysis;CHEMBL4616634;Non-molecular target assigned;N;;1;CHEMBL375;;
1209695;;;CHEMBL4617958;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in C57BL/6 mouse model of CS-induced pulmonary injury assessed as reduction in goblet cell hyperplasia in peribronchial in lungs at 1 mg/kg, ip for 5 days by hematoxylin and eosin staining based fluorescence microscopic analysis;CHEMBL4616634;Non-molecular target assigned;N;;1;CHEMBL375;;
1209698;;;CHEMBL4617961;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in C57BL/6 mouse model of CS-induced pulmonary injury assessed as reduction in goblet cell hyperplasia in perivascular areas in lungs at 1 mg/kg, ip for 5 days by hematoxylin and eosin staining based fluorescence microscopic analysis;CHEMBL4616634;Non-molecular target assigned;N;;1;CHEMBL375;;
1209721;;;CHEMBL4617968;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in C57BL/6 mouse model of CS-induced pulmonary injury assessed as reduction in 8-oxo-dG in lungs at 1 mg/kg, ip for 5 days by ELISA;CHEMBL4616634;Non-molecular target assigned;N;;1;CHEMBL375;;
1217513;;Hepatocyte;CHEMBL4620754;[];Rattus norvegicus;[];;;10116.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308027;Target assigned is non-molecular;1;Induction of CYP3A23 mRNA expression in rat hepatocytes at 10 uM;CHEMBL4619752;Non-molecular target assigned;N;;1;CHEMBL613362;;
1222762;;RAW264.7;CHEMBL4624693;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity against mouse RAW264.7 cells assessed as reduction in IL6 level;CHEMBL4622912;Non-molecular target assigned;N;;1;CHEMBL612557;;
1222763;;RAW264.7;CHEMBL4624694;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity against mouse RAW264.7 cells assessed as reduction in TNFalpha level;CHEMBL4622912;Non-molecular target assigned;N;;1;CHEMBL612557;;
1223688;;;CHEMBL4624975;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Partition coefficient, logP of compound by RP-HPLC analysis;CHEMBL4622926;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
1221717;;HeLa;CHEMBL4625187;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308376;Default value - Target unknown or has yet to be assigned;0;Inhibition of collagenase (unknown origin) transfected in human HeLa cells by luciferase reporter gene assay;CHEMBL4622936;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1221719;;HeLa;CHEMBL4625188;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308376;Default value - Target unknown or has yet to be assigned;0;Inhibition of collagenase (unknown origin) transfected in human HeLa cells by luciferase reporter gene assay relative to control;CHEMBL4622936;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1221729;;THP-1;CHEMBL4625189;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Immunomodulatory activity in human THP1 cells assessed as reduction in LPS-induced IL-8 production;CHEMBL4622936;Non-molecular target assigned;N;;1;CHEMBL614245;;
1221730;;THP-1;CHEMBL4625190;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Immunomodulatory activity in human THP1 cells assessed as reduction in LPS-induced IL-8 production relative to control;CHEMBL4622936;Non-molecular target assigned;N;;1;CHEMBL614245;;
1221733;;PBMC;CHEMBL4625192;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Inhibition of LPS-induced TNFalpha release in human PBMC cells;CHEMBL4622936;Non-molecular target assigned;N;;1;CHEMBL613107;;
1221734;;PBMC;CHEMBL4625193;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Inhibition of LPS-induced TNFalpha release in human PBMC cells relative to control;CHEMBL4622936;Non-molecular target assigned;N;;1;CHEMBL613107;;
1221735;;PBMC;CHEMBL4625194;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Inhibition of LPS-induced IL12p40 release in human PBMC cells;CHEMBL4622936;Non-molecular target assigned;N;;1;CHEMBL613107;;
1221736;;PBMC;CHEMBL4625195;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Inhibition of LPS-induced IL12p40 release in human PBMC cells relative to control;CHEMBL4622936;Non-molecular target assigned;N;;1;CHEMBL613107;;
1221737;;PBMC;CHEMBL4625196;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Inhibition of PHA-induced IL2 release in human PBMC cells;CHEMBL4622936;Non-molecular target assigned;N;;1;CHEMBL613107;;
1221738;;PBMC;CHEMBL4625197;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Inhibition of PHA-induced IL2 release in human PBMC cells relative to control;CHEMBL4622936;Non-molecular target assigned;N;;1;CHEMBL613107;;
1221739;;PBMC;CHEMBL4625198;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Inhibition of PHA-induced IFNgamma release in human PBMC cells;CHEMBL4622936;Non-molecular target assigned;N;;1;CHEMBL613107;;
1221740;;PBMC;CHEMBL4625199;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Inhibition of PHA-induced IFNgamma release in human PBMC cells relative to control;CHEMBL4622936;Non-molecular target assigned;N;;1;CHEMBL613107;;
1221741;;PBMC;CHEMBL4625200;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Inhibition of PHA-induced IL4 release in human PBMC cells;CHEMBL4622936;Non-molecular target assigned;N;;1;CHEMBL613107;;
1221742;;PBMC;CHEMBL4625201;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Target assigned is non-molecular;1;Inhibition of PHA-induced IL4 release in human PBMC cells relative to control;CHEMBL4622936;Non-molecular target assigned;N;;1;CHEMBL613107;;
1221803;;;CHEMBL4625677;[];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Protection against imiquimod-induced psoriasis in C57BL/6 mouse assessed as inhibition of skin scaling at 3 mg/kg, po dosed via gavage once daily and measured on day 6 relative to control;CHEMBL4622963;Non-molecular target assigned;N;;1;CHEMBL375;;
1221808;;;CHEMBL4625681;[];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Protection against imiquimod-induced psoriasis in C57BL/6 mouse assessed as inhibition of skin erythema level at 3 mg/kg, po dosed via gavage once daily and measured on day 6 relative to control;CHEMBL4622963;Non-molecular target assigned;N;;1;CHEMBL375;;
1215586;;RAW264.7;CHEMBL4628191;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production preincubated for 1 hr followed by LPS stimulation and measured after 24 hrs by Griess reagent based assay;CHEMBL4627292;Non-molecular target assigned;N;;1;CHEMBL612557;;
1215688;;J774;CHEMBL4629697;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307540;Target assigned is non-molecular;1;Antiinflammatory activity in mouse J774 cells assessed as inhibition of LPS/IFNgamma-induced NO production incubated for 24 hrs by Griess method;CHEMBL4627391;Non-molecular target assigned;N;;1;CHEMBL614123;;
1215694;;J774;CHEMBL4629703;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307540;Target assigned is non-molecular;1;Antiinflammatory activity in mouse J774 cells assessed as inhibition of LPS/IFNgamma-induced IL-1beta level at 10 uM incubated for 24 hrs by ELISA relative to control;CHEMBL4627391;Non-molecular target assigned;N;;1;CHEMBL614123;;
CARE_1_ELL;;Vero C1008;CHEMBL4651403;[];Chlorocebus sabaeus;[];;;60711.0;In vitro;;F;Functional;BAO_0000218;organism-based format;CHEMBL4295411;Target assigned is non-molecular;1;Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging;CHEMBL4651402;Non-molecular target assigned;N;;57;CHEMBL4303835;;
1237189;;;CHEMBL4666828;[{'assay_class_id': 96, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Adjuvant Arthritis in Rats', 'source': 'Hock_2016'}, {'assay_class_id': 105, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'General Rheumatoid Arthritis Models', 'source': 'phenotype'}];Mus musculus;[];DBA/1;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiarthritic activity in collagen/complete freund's adjuvant-induced arthritis DBA/1 mouse model assessed as paw thickness at 1 mg/kg, po administered via gavage starting from day 21 to day 41 post collagen/CFA challenge and measured on day 21 by caliper analysis (Rvb = 2.48 millimeter);CHEMBL4665641;Non-molecular target assigned;N;;1;CHEMBL375;;
1237163;;;CHEMBL4666832;[];Mus musculus;[];DBA/1;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Toxicity in collagen/CFA induced arthritis DBA/1 mouse model assessed as body weight loss at 1 mg/kg, po administered via gavage starting from day 21 to day 41 post collagen/CFA challenge and measured on day 0, 18, 21 followed by three times weekly up to 42 days;CHEMBL4665641;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
1237168;;;CHEMBL4666837;[{'assay_class_id': 96, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Adjuvant Arthritis in Rats', 'source': 'Hock_2016'}, {'assay_class_id': 105, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'General Rheumatoid Arthritis Models', 'source': 'phenotype'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];DBA/1;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in collagen/complete freund's adjuvant-induced arthritis DBA/1 mouse model assessed as IL-1 beta level in rear right paw at 1 mg/kg, po administered via gavage starting from day 21 to day 41 post collagen/CFA challenge and measured on day 42 measured per mg protein (Rvb = 3.15 pg);CHEMBL4665641;Non-molecular target assigned;N;;1;CHEMBL375;;
1237169;;;CHEMBL4666838;[{'assay_class_id': 96, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Adjuvant Arthritis in Rats', 'source': 'Hock_2016'}, {'assay_class_id': 105, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'General Rheumatoid Arthritis Models', 'source': 'phenotype'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];DBA/1;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in collagen/complete freund's adjuvant-induced arthritis DBA/1 mouse model assessed as IL-2 level in rear right paw at 1 mg/kg, po administered via gavage starting from day 21 to day 41 post collagen/CFA challenge and measured on day 42 measured per mg protein (Rvb = 0.2 pg);CHEMBL4665641;Non-molecular target assigned;N;;1;CHEMBL375;;
1237170;;;CHEMBL4666839;[{'assay_class_id': 96, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Adjuvant Arthritis in Rats', 'source': 'Hock_2016'}, {'assay_class_id': 105, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'General Rheumatoid Arthritis Models', 'source': 'phenotype'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];DBA/1;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in collagen/complete freund's adjuvant-induced arthritis DBA/1 mouse model assessed as IL-6 level in rear right paw at 1 mg/kg, po administered via gavage starting from day 21 to day 41 post collagen/CFA challenge and measured on day 42 measured per mg protein (Rvb = 180.7 pg);CHEMBL4665641;Non-molecular target assigned;N;;1;CHEMBL375;;
1237171;;;CHEMBL4666840;[{'assay_class_id': 96, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Adjuvant Arthritis in Rats', 'source': 'Hock_2016'}, {'assay_class_id': 105, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'General Rheumatoid Arthritis Models', 'source': 'phenotype'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];DBA/1;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in collagen/complete freund's adjuvant-induced arthritis DBA/1 mouse model assessed as IP-10 level in rear right paw at 1 mg/kg, po administered via gavage starting from day 21 to day 41 post collagen/CFA challenge and measured on day 42 measured per mg protein (Rvb = 6.23 pg);CHEMBL4665641;Non-molecular target assigned;N;;1;CHEMBL375;;
1237172;;;CHEMBL4666841;[{'assay_class_id': 96, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Adjuvant Arthritis in Rats', 'source': 'Hock_2016'}, {'assay_class_id': 105, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'General Rheumatoid Arthritis Models', 'source': 'phenotype'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];DBA/1;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in collagen/complete freund's adjuvant-induced arthritis DBA/1 mouse model assessed as MCP-1 level in rear right paw at 1 mg/kg, po administered via gavage starting from day 21 to day 41 post collagen/CFA challenge and measured on day 42 measured per mg protein (Rvb = 126.24 pg);CHEMBL4665641;Non-molecular target assigned;N;;1;CHEMBL375;;
1237173;;;CHEMBL4666842;[{'assay_class_id': 96, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Adjuvant Arthritis in Rats', 'source': 'Hock_2016'}, {'assay_class_id': 105, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'General Rheumatoid Arthritis Models', 'source': 'phenotype'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];DBA/1;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in collagen/complete freund's adjuvant-induced arthritis DBA/1 mouse model assessed as TNF-alpha level in rear right paw at 1 mg/kg, po administered via gavage starting from day 21 to day 41 post collagen/CFA challenge and measured on day 42 measured per mg protein (Rvb = 0.88 pg);CHEMBL4665641;Non-molecular target assigned;N;;1;CHEMBL375;;
1237174;;;CHEMBL4666843;[{'assay_class_id': 96, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Adjuvant Arthritis in Rats', 'source': 'Hock_2016'}, {'assay_class_id': 105, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'General Rheumatoid Arthritis Models', 'source': 'phenotype'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];DBA/1;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in collagen/complete freund's adjuvant-induced arthritis DBA/1 mouse model assessed as IFN-gamma level in rear right paw at 1 mg/kg, po administered via gavage starting from day 21 to day 41 post collagen/CFA challenge and measured on day 42 measured per mg protein (Rvb = 0.78 pg);CHEMBL4665641;Non-molecular target assigned;N;;1;CHEMBL375;;
1237175;;;CHEMBL4666844;[{'assay_class_id': 96, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Adjuvant Arthritis in Rats', 'source': 'Hock_2016'}, {'assay_class_id': 105, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'General Rheumatoid Arthritis Models', 'source': 'phenotype'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];DBA/1;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in collagen/complete freund's adjuvant-induced arthritis DBA/1 mouse model assessed as M-CSF level in rear right paw at 1 mg/kg, po administered via gavage starting from day 21 to day 41 post collagen/CFA challenge and measured on day 42 measured per mg protein (Rvb = 3.49 pg);CHEMBL4665641;Non-molecular target assigned;N;;1;CHEMBL375;;
1237176;;;CHEMBL4666845;[{'assay_class_id': 96, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Adjuvant Arthritis in Rats', 'source': 'Hock_2016'}, {'assay_class_id': 105, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'General Rheumatoid Arthritis Models', 'source': 'phenotype'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];DBA/1;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in collagen/complete freund's adjuvant-induced arthritis DBA/1 mouse model assessed as VEGF level in rear right paw at 1 mg/kg, po administered via gavage starting from day 21 to day 41 post collagen/CFA challenge and measured on day 42 measured per mg protein (Rvb = 0.98 pg);CHEMBL4665641;Non-molecular target assigned;N;;1;CHEMBL375;;
1237190;;;CHEMBL4666858;[];Mus musculus;[];DBA/1;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Toxicity in collagen/CFA induced arthritis DBA/1 mouse model assessed as body weight at 1 mg/kg, po administered via gavage starting from day 21 to day 41 post collagen/CFA challenge and measured on day 21 relative to initial weight (Rvb = 94.96%);CHEMBL4665641;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
1231553;;RAW264.7;CHEMBL4669414;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-stimulated NO production;CHEMBL4665728;Non-molecular target assigned;N;;1;CHEMBL612557;;
1231552;;RAW264.7;CHEMBL4669415;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of TNFalpha-stimulated NF-kappaB activation by luciferase assay;CHEMBL4665728;Non-molecular target assigned;N;;1;CHEMBL612557;;
1237353;;RAW264.7;CHEMBL4670975;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production preincubated for 2 hrs followed by LPS addition and measured after 18 hrs by Griess reagent-based assay;CHEMBL4665814;Non-molecular target assigned;N;;1;CHEMBL612557;;
1248779;;Splenocyte;CHEMBL4678436;[];Rattus norvegicus;[];Wistar;;10116.0;;;A;ADME;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against Wistar rat splenocytes assessed as reduction in cell viability at 100 uM after 48 hrs by MTT assay relative to control;CHEMBL4673339;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1273080;;HEK293T;CHEMBL4680589;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Induction of translocation of human glucocorticoid receptor expressed in HEK293T cells transduced with lentiviral vector expressing H2B-mCherry and GFP-GR assessed as effective dissociation constant measured every 130 sec for 22 mins by fluorescence imaging analysis;CHEMBL4680066;Direct protein target assigned;D;;1;CHEMBL2034;;
1273084;;REH;CHEMBL4680590;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308823;Target assigned is non-molecular;1;Cytotoxicity against human REH cells overexpressing GR assessed as reduction in cell viability measured after 3 days by resazurin based assay;CHEMBL4680066;Non-molecular target assigned;N;;1;CHEMBL2366320;;
1273278;;HEK293T;CHEMBL4680591;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Induction of translocation of human glucocorticoid receptor expressed in HEK293T cells transduced with lentiviral vector expressing H2B-mCherry and GFP-GR assessed as the time at which half of the GFP-GR is translocated to the nucleus measured every 7 to 8 sec for 10 mins by fluorescence imaging analysis;CHEMBL4680066;Direct protein target assigned;D;;1;CHEMBL2034;;
1273279;;HEK293T;CHEMBL4680592;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Induction of translocation of human glucocorticoid receptor expressed in HEK293T cells transduced with lentiviral vector expressing H2B-mCherry and GFP-GR assessed as the time at which half of the GFP-GR is translocated to the nucleus measured every 130 sec for 22 mins by fluorescence imaging analysis;CHEMBL4680066;Direct protein target assigned;D;;1;CHEMBL2034;;
1269654;;;CHEMBL4681191;[{'assay_class_id': 96, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Adjuvant Arthritis in Rats', 'source': 'Hock_2016'}];Rattus norvegicus;[];Lewis;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiarthritic activity in Lewis rat model of Complete Freund's adjuvant-induced arthritis assessed as reduction in paw swelling at 0.1 mg/kg, po qd administered for 21 days after CFA injection and measured weekly three times upto day 21 by water displacement plethysmometry;CHEMBL4680083;Non-molecular target assigned;N;;1;CHEMBL376;;
1288486;;;CHEMBL4707876;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];BALB/c;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity against imiquimod-induced psoriasis BALB/c mouse model assessed as reduction in ear thickness at 5 mg/kg, ip administered once daily for 12 days by hematoxylin and eosin staining based analysis;CHEMBL4706491;Non-molecular target assigned;N;;1;CHEMBL375;;
1288491;;;CHEMBL4707881;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];BALB/c;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity against imiquimod-induced psoriasis BALB/c mouse model assessed as body weight loss at 5 mg/kg, ip administered once daily for 12 days (Rvb = 19.86 +/- 1.3 g);CHEMBL4706491;Non-molecular target assigned;N;;1;CHEMBL375;;
1288494;;;CHEMBL4707884;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];BALB/c;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity against imiquimod-induced psoriasis BALB/c mouse model assessed as inhibition of back skin erythema at 5 mg/kg, ip administered once daily for 12 days;CHEMBL4706491;Non-molecular target assigned;N;;1;CHEMBL375;;
1288495;;;CHEMBL4707885;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];BALB/c;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity against imiquimod-induced psoriasis BALB/c mouse model assessed as inhibition of back skin scaling at 5 mg/kg, ip administered once daily for 12 days;CHEMBL4706491;Non-molecular target assigned;N;;1;CHEMBL375;;
1287460;;;CHEMBL4709608;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-induced C57BL/6 mouse model assessed as reduction in IFNgamma production at 10 mg/kg, ip treated for 3 days measured 24 hrs post last dose by ELISA;CHEMBL4706544;Non-molecular target assigned;N;;1;CHEMBL375;;
1287461;;;CHEMBL4709609;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-induced C57BL/6 mouse model assessed as reduction in IL1beta production at 10 mg/kg, ip treated for 3 days measured 24 hrs post last dose by ELISA;CHEMBL4706544;Non-molecular target assigned;N;;1;CHEMBL375;;
1287462;;;CHEMBL4709610;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-induced C57BL/6 mouse model assessed as reduction in IL6 production at 10 mg/kg, ip treated for 3 days measured 24 hrs post last dose by ELISA;CHEMBL4706544;Non-molecular target assigned;N;;1;CHEMBL375;;
1287463;;;CHEMBL4709611;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-induced C57BL/6 mouse model assessed as reduction in TNFalpha production at 10 mg/kg, ip treated for 3 days measured 24 hrs post last dose by ELISA;CHEMBL4706544;Non-molecular target assigned;N;;1;CHEMBL375;;
1259646;;;CHEMBL4719244;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Rattus norvegicus;[];Wistar;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in Wistar rat model of LPS-induced uveitis assessed as reduction in infiltrating cells in aqueous humor at 10 ug/10ul/eye administered 24 hrs after LPS stimulation and measured after 1 hr by hemocytometry relative to control;CHEMBL4715779;Non-molecular target assigned;N;;1;CHEMBL376;;
1264837;;;CHEMBL4775447;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];ICR;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in ICR mouse assessed as reduction in LPS-induced neutrophil level in BALF at 0.5 mg/kg, INH administered 18 hrs before LPS-stimulation and measured after 24 hrs by FACS analysis relative to control;CHEMBL4765476;Non-molecular target assigned;N;;1;CHEMBL375;;
1264838;;;CHEMBL4775448;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];ICR;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in ICR mouse assessed as reduction in LPS-induced macrophage level in BALF at 0.5 mg/kg, INH administered 18 hrs before LPS-stimulation and measured after 24 hrs by FACS analysis relative to control;CHEMBL4765476;Non-molecular target assigned;N;;1;CHEMBL375;;
1264839;;;CHEMBL4775449;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];ICR;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in ICR mouse assessed as reduction in LPS-induced lymphocyte level in BALF at 0.5 mg/kg, INH administered 18 hrs before LPS-stimulation and measured after 24 hrs by FACS analysis relative to control;CHEMBL4765476;Non-molecular target assigned;N;;1;CHEMBL375;;
1264849;;;CHEMBL4775456;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];ICR;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in ICR mouse assessed as reduction in LPS-induced neutrophil level in BALF at 0.5 mg/kg, ip administered 18 hrs before LPS-stimulation and measured after 24 hrs by FACS analysis relative to control;CHEMBL4765476;Non-molecular target assigned;N;;1;CHEMBL375;;
1264850;;;CHEMBL4775457;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];ICR;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in ICR mouse assessed as reduction in LPS-induced macrophage level in BALF at 0.5 mg/kg, ip administered 18 hrs before LPS-stimulation and measured after 24 hrs by FACS analysis relative to control;CHEMBL4765476;Non-molecular target assigned;N;;1;CHEMBL375;;
1264851;;;CHEMBL4775458;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];ICR;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in ICR mouse assessed as reduction in LPS-induced lymphocyte level in BALF at 0.5 mg/kg, ip administered 18 hrs before LPS-stimulation and measured after 24 hrs by FACS analysis relative to control;CHEMBL4765476;Non-molecular target assigned;N;;1;CHEMBL375;;
1264858;;;CHEMBL4775461;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];ICR;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in ICR mouse assessed as reduction in LPS-induced neutrophil infiltration in lungs at 0.5 mg/kg, INH administered 18 hrs before LPS-stimulation and measured after 24 hrs by H and E staining based imaging analysis relative to control;CHEMBL4765476;Non-molecular target assigned;N;;1;CHEMBL375;;
1264862;;;CHEMBL4775464;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];ICR;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in ICR mouse assessed as reduction in LPS-induced neutrophil infiltration in lungs at 0.5 mg/kg, ip administered 18 hrs before LPS-stimulation and measured after 24 hrs by H and E staining based imaging analysis relative to control;CHEMBL4765476;Non-molecular target assigned;N;;1;CHEMBL375;;
1264870;;;CHEMBL4775470;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];ICR;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in ICR mouse assessed as reduction in LPS-induced IL-1beta mRNA expression in lungs at 0.5 mg/kg, INH administered 18 hrs before LPS-stimulation and measured after 24 hrs by qRT-PCR analysis;CHEMBL4765476;Non-molecular target assigned;N;;1;CHEMBL375;;
1264871;;;CHEMBL4775471;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];ICR;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in ICR mouse assessed as reduction in LPS-induced IL-8 mRNA expression in lungs at 0.5 mg/kg, INH administered 18 hrs before LPS-stimulation and measured after 24 hrs by qRT-PCR analysis;CHEMBL4765476;Non-molecular target assigned;N;;1;CHEMBL375;;
1264872;;;CHEMBL4775472;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];ICR;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in ICR mouse assessed as reduction in LPS-induced TGF-beta1 mRNA expression in lungs at 0.5 mg/kg, INH administered 18 hrs before LPS-stimulation and measured after 24 hrs by qRT-PCR analysis;CHEMBL4765476;Non-molecular target assigned;N;;1;CHEMBL375;;
1264873;;;CHEMBL4775473;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];ICR;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in ICR mouse assessed as reduction in LPS-induced MMP-9 mRNA expression in lungs at 0.5 mg/kg, INH administered 18 hrs before LPS-stimulation and measured after 24 hrs by qRT-PCR analysis;CHEMBL4765476;Non-molecular target assigned;N;;1;CHEMBL375;;
1264880;;;CHEMBL4775478;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];ICR;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in ICR mouse assessed as reduction in LPS-induced IL-1beta mRNA expression in lungs at 0.5 mg/kg, ip administered 18 hrs before LPS-stimulation and measured after 24 hrs by qRT-PCR analysis;CHEMBL4765476;Non-molecular target assigned;N;;1;CHEMBL375;;
1264881;;;CHEMBL4775479;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];ICR;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in ICR mouse assessed as reduction in LPS-induced IL-8 mRNA expression in lungs at 0.5 mg/kg, ip administered 18 hrs before LPS-stimulation and measured after 24 hrs by qRT-PCR analysis;CHEMBL4765476;Non-molecular target assigned;N;;1;CHEMBL375;;
1264882;;;CHEMBL4775480;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];ICR;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in ICR mouse assessed as reduction in LPS-induced TGF-beta1 mRNA expression in lungs at 0.5 mg/kg, ip administered 18 hrs before LPS-stimulation and measured after 24 hrs by qRT-PCR analysis;CHEMBL4765476;Non-molecular target assigned;N;;1;CHEMBL375;;
1264883;;;CHEMBL4775481;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];ICR;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in ICR mouse assessed as reduction in LPS-induced MMP-9 mRNA expression in lungs at 0.5 mg/kg, ip administered 18 hrs before LPS-stimulation and measured after 24 hrs by qRT-PCR analysis;CHEMBL4765476;Non-molecular target assigned;N;;1;CHEMBL375;;
1264888;;;CHEMBL4775484;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];ICR;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in ICR mouse assessed as reduction in LPS-induced IL-1beta expression in lungs at 0.5 mg/kg, INH administered 18 hrs before LPS-stimulation and measured after 24 hrs by Western blot analysis;CHEMBL4765476;Non-molecular target assigned;N;;1;CHEMBL375;;
1264889;;;CHEMBL4775485;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];ICR;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in ICR mouse assessed as reduction in LPS-induced caspase-1 expression in lungs at 0.5 mg/kg, INH administered 18 hrs before LPS-stimulation and measured after 24 hrs by Western blot analysis;CHEMBL4765476;Non-molecular target assigned;N;;1;CHEMBL375;;
1264892;;;CHEMBL4775488;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];ICR;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in ICR mouse assessed as reduction in LPS-induced IL-1beta expression in lungs at 0.5 mg/kg, ip administered 18 hrs before LPS-stimulation and measured after 24 hrs by Western blot analysis;CHEMBL4765476;Non-molecular target assigned;N;;1;CHEMBL375;;
1264893;;;CHEMBL4775489;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];ICR;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in ICR mouse assessed as reduction in LPS-induced caspase-1 expression in lungs at 0.5 mg/kg, ip administered 18 hrs before LPS-stimulation and measured after 24 hrs by Western blot analysis;CHEMBL4765476;Non-molecular target assigned;N;;1;CHEMBL375;;
1264896;;;CHEMBL4775492;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];ICR;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in ICR mouse assessed as reduction in LPS-induced IL-1beta expression in serum at 0.5 mg/kg, INH administered 18 hrs before LPS-stimulation and measured after 24 hrs by ELISA;CHEMBL4765476;Non-molecular target assigned;N;;1;CHEMBL375;;
1264897;;;CHEMBL4775493;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];ICR;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in ICR mouse assessed as reduction in LPS-induced IL-18 expression in serum at 0.5 mg/kg, INH administered 18 hrs before LPS-stimulation and measured after 24 hrs by ELISA;CHEMBL4765476;Non-molecular target assigned;N;;1;CHEMBL375;;
1264900;;;CHEMBL4775496;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];ICR;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in ICR mouse assessed as reduction in LPS-induced IL-1beta expression in serum at 0.5 mg/kg, ip administered 18 hrs before LPS-stimulation and measured after 24 hrs by ELISA;CHEMBL4765476;Non-molecular target assigned;N;;1;CHEMBL375;;
1264901;;;CHEMBL4775497;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];ICR;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in ICR mouse assessed as reduction in LPS-induced IL-18 expression in serum at 0.5 mg/kg, ip administered 18 hrs before LPS-stimulation and measured after 24 hrs by ELISA;CHEMBL4765476;Non-molecular target assigned;N;;1;CHEMBL375;;
1308236;;RAW264.7;CHEMBL4815169;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production at 10 uM preincubated for 1 hrs followed by LPS stimulation and measured after 24 hrs by Griess assay relative to control;CHEMBL4813945;Non-molecular target assigned;N;;1;CHEMBL612557;;
1308237;;L02;CHEMBL4815170;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295475;Target assigned is non-molecular;1;Antiinflammatory activity against human L02 assessed as inhibition of LPS-induced NO production preincubated for 1 hrs followed by LPS stimulation and measured after 24 hrs by Griess assay relative to control;CHEMBL4813945;Non-molecular target assigned;N;;1;CHEMBL4296457;;
1308238;;RAW264.7;CHEMBL4815171;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Inhibition of LPS-induced NO release in mouse RAW264.7 cells preincubated for 1 hrs followed by LPS stimulation and measured after 24 hrs by Griess reagent based assay;CHEMBL4813945;Non-molecular target assigned;N;;1;CHEMBL612557;;
1308239;;RAW264.7;CHEMBL4815172;[];Mus musculus;[];;;10090.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Inhibition of LPS induced NO-dependent iNOS activity in mouse RAW 264.7 cells preincubated for 1 hrs followed by LPS stimulation and measured after 24 hrs by Griess reagent based assay;CHEMBL4813945;Direct protein target assigned;D;;1;CHEMBL3464;;
1308240;;RAW264.7;CHEMBL4815173;[];Mus musculus;[];;;10090.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Cytotoxicity against LPS-induced mouse RAW 264.7 cells assessed as cell viability measured by MTT assay;CHEMBL4813945;Non-molecular target assigned;N;;1;CHEMBL612557;;
1308241;;RAW264.7;CHEMBL4815174;[];Mus musculus;[];;;10090.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Cytotoxicity against mouse RAW 264.7 cells assessed as cell viability by MTT assay;CHEMBL4813945;Non-molecular target assigned;N;;1;CHEMBL612557;;
1308242;;L02;CHEMBL4815175;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL4295475;Target assigned is non-molecular;1;Cytotoxicity against human L02 cells cells assessed as cell viability by MTT assay;CHEMBL4813945;Non-molecular target assigned;N;;1;CHEMBL4296457;;
1306502;;RAW264.7;CHEMBL4817126;[];Mus musculus;[];;;10090.0;;;B;Binding;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of NFkappaB transcriptional activity in LPS-stimulated mouse RAW264.7 cells;CHEMBL4813996;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1311694;;SIM-A9;CHEMBL4820241;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4879541;Default value - Target unknown or has yet to be assigned;0;Anti-inflammatory activity in mouse SIM-A9 cells assessed as decrease in LPS-induced IL-6 production at 1 ug/ml preincubated for 1 hr followed by stimulation with LPS and measured after 23 hrs by ELISA assay;CHEMBL4819016;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1311698;;SIM-A9;CHEMBL4820245;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4879541;Default value - Target unknown or has yet to be assigned;0;Anti-inflammatory activity in mouse SIM-A9 cells assessed as decrease in LPS-induced TNF-alpha production at 1 ug/ml preincubated for 1 hr followed by stimulation with LPS and measured after 23 hrs by ELISA assay;CHEMBL4819016;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1326452;;;CHEMBL4823487;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;Substrate activity at P-gp (unknown origin) assessed as net efflux ratio;CHEMBL4823245;Direct protein target assigned;D;;1;CHEMBL4302;;
1326515;;;CHEMBL4823488;[];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;Plasma;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Unbound plasma concentration in P-gp knock out Sprague-Dawley rat at 5 mg/ml/kg, po measured upto 4 hrs by LC-MS analysis;CHEMBL4823245;Default value - Target has yet to be curated;U;;1;CHEMBL612558;CHEMBL3559721;
1326516;;;CHEMBL4823489;[];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;Brain;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Unbound brain concentration in P-gp knock out Sprague-Dawley rat at 5 mg/ml/kg, po measured upto 4 hrs by LC-MS analysis;CHEMBL4823245;Default value - Target has yet to be curated;U;;1;CHEMBL612558;CHEMBL3638188;
1326517;;;CHEMBL4823490;[];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;Brain/Plasma;A;ADME;BAO_0000366;cell-free format;;Default value - Target unknown or has yet to be assigned;0;Ratio of drug concentration in brain to plasma of P-gp knock out Sprague-Dawley rat;CHEMBL4823245;Default value - Target has yet to be curated;U;;1;CHEMBL612558;CHEMBL3833101;
1326518;;;CHEMBL4823491;[];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;Brain/Plasma;A;ADME;BAO_0000366;cell-free format;;Default value - Target unknown or has yet to be assigned;0;Unbound brain-to-plasma concentration ratio in P-gp knock out Sprague-Dawley rat;CHEMBL4823245;Default value - Target has yet to be curated;U;;1;CHEMBL612558;CHEMBL3833101;
1330454;;RAW264.7;CHEMBL4826328;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production incubated for 24 hrs in presence of LPS by Griess reagent-based assay;CHEMBL4825675;Non-molecular target assigned;N;;1;CHEMBL612557;;
1331348;;;CHEMBL4827877;[];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of activation of T cell in C57BL/6 mouse Staphylococcal enterotoxin B (SEB)-mediated acute T cell activation model assessed as inhibition of IL-2 release in plasma at 10 mg/kg, po measured after 2.5 hrs of SEB challenge;CHEMBL4825732;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1331349;;;CHEMBL4827878;[];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of activation of T cell in C57BL/6 mouse Staphylococcal enterotoxin B (SEB)-mediated acute T cell activation model assessed as inhibition of IL-2 release in spleen at 10 mg/kg, po measured after 2.5 hrs of SEB challenge;CHEMBL4825732;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1340395;;Peritoneal macrophage;CHEMBL4830700;[];Mus musculus;[];C57BL/6J;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295503;Target assigned is non-molecular;1;Inhibition of LPS-induced NO production in C57BL/6J mouse peritoneal macrophages at 1 uM measured after 24 hrs in presence of LPS by Griess reagent based assay relative to control;CHEMBL4828748;Non-molecular target assigned;N;;1;CHEMBL613703;;
1340396;;Peritoneal macrophage;CHEMBL4830701;[];Mus musculus;[];C57BL/6J;;10090.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL4295503;Target assigned is non-molecular;1;Cytotoxicity against C57BL/6J mouse peritoneal macrophages assessed as reduction of cell viability at 1 uM incubated for 24 hrs in presence of LPS by MTT assay;CHEMBL4828748;Non-molecular target assigned;N;;1;CHEMBL613703;;
1341757;;RAW264.7;CHEMBL4832603;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production preincubated for 3 hrs followed by LPS-stimulation and measured after 24 hrs by Griess reagent based assay;CHEMBL4831508;Non-molecular target assigned;N;;1;CHEMBL612557;;
1341758;;RAW264.7;CHEMBL4832604;[];Mus musculus;[];;;10090.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Cytotoxicity against mouse RAW264.7 cells assessed as cell viability measured after 24 hrs by CCK8 assay;CHEMBL4831508;Non-molecular target assigned;N;;1;CHEMBL612557;;
1332706;;RAW264.7;CHEMBL4837660;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production after 24 hrs by Griess reagent-based assay;CHEMBL4837186;Non-molecular target assigned;N;;1;CHEMBL612557;;
1333810;;INS-1 832/13;CHEMBL4840200;[];Rattus norvegicus;[];;;10116.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at glucocorticoid receptor in rat INS-1 832/13 cells transfected with CCL2-promoter luciferase plasmid construct assessed as reduction in IL-1 beta induced inflammation by luciferase reporter gene assay;CHEMBL4837265;Direct protein target assigned;D;;1;CHEMBL3368;;
1333812;;INS-1 832/13;CHEMBL4840201;[];Rattus norvegicus;[];;;10116.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at glucocorticoid receptor in rat INS-1 832/13 cells transfected with CCL2-promoter luciferase plasmid construct assessed as maximum efficacy by luciferase reporter gene assay;CHEMBL4837265;Direct protein target assigned;D;;1;CHEMBL3368;;
1333815;;INS-1 832/13;CHEMBL4840203;[];Rattus norvegicus;[];;;10116.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at glucocorticoid receptor in rat INS-1 832/13 cells transfected with CCL2-promoter luciferase plasmid construct assessed as reduction in IL-1 beta induced inflammation by luciferase reporter gene assay relative to hydrocortisone;CHEMBL4837265;Direct protein target assigned;D;;1;CHEMBL3368;;
1333816;;INS-1 832/13;CHEMBL4840204;[];Rattus norvegicus;[];;;10116.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at glucocorticoid receptor in rat INS-1 832/13 cells transfected with 3XGRE-promoter luciferase plasmid construct assessed as induction of receptor transactivation by luciferase reporter gene assay;CHEMBL4837265;Direct protein target assigned;D;;1;CHEMBL3368;;
1333819;;INS-1 832/13;CHEMBL4840205;[];Rattus norvegicus;[];;;10116.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at glucocorticoid receptor in rat INS-1 832/13 cells transfected with 3XGRE-promoter luciferase plasmid construct assessed as maximum efficacy by luciferase reporter gene assay;CHEMBL4837265;Direct protein target assigned;D;;1;CHEMBL3368;;
1333822;;INS-1 832/13;CHEMBL4840207;[];Rattus norvegicus;[];;;10116.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at glucocorticoid receptor in rat INS-1 832/13 cells transfected with 3XGRE-promoter luciferase plasmid construct assessed as induction of receptor transactivation by luciferase reporter gene assay relative to hydrocortisone;CHEMBL4837265;Direct protein target assigned;D;;1;CHEMBL3368;;
1343958;;;CHEMBL4840752;[];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Effect on C57BL/6 mouse model of LPS induced sepsis assessed as survival rate in 24 hrs at 5 mg/kg, ip (Rvb = 71.4%);CHEMBL4840312;Non-molecular target assigned;N;;1;CHEMBL375;;
1343961;;;CHEMBL4840755;[];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Effect on C57BL/6 mouse model of LPS induced sepsis assessed as survival rate in 72 hrs at 5 mg/kg, ip (Rvb = 28.6%);CHEMBL4840312;Non-molecular target assigned;N;;1;CHEMBL375;;
1345031;;;CHEMBL4840846;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];CD-1;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in zymosan-induced CD-1 mouse peritonitis model assessed as reduction in zymosan-induced IL-6 level in peritoneal exudate at 3 mg/kg, ip treated with compound for 30 mins after 4 to 24 hrs zymosan stimulation by ELISA;CHEMBL4840316;Non-molecular target assigned;N;;1;CHEMBL375;;
1345019;;;CHEMBL4840858;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];CD-1;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in zymosan-induced CD-1 mouse peritonitis model assessed as reduction in zymosan-induced neutrophil recruitment at 10 mg/kg, ip treated with compound for 30 mins after 4 hrs zymosan stimulation by ELISA;CHEMBL4840316;Non-molecular target assigned;N;;1;CHEMBL375;;
1345021;;;CHEMBL4840860;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];CD-1;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in zymosan-induced CD-1 mouse peritonitis model assessed as reduction in zymosan-induced neutrophil recruitment at 10 mg/kg, ip treated with compound for 30 mins after 24 hrs zymosan stimulation by ELISA;CHEMBL4840316;Non-molecular target assigned;N;;1;CHEMBL375;;
1345029;;;CHEMBL4840865;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];CD-1;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in zymosan-induced CD-1 mouse peritonitis model assessed as reduction in zymosan-induced IL-1beta level in peritoneal exudate at 3 mg/kg, ip treated with compound for 30 mins after 4 to 24 hrs zymosan stimulation by ELISA;CHEMBL4840316;Non-molecular target assigned;N;;1;CHEMBL375;;
1345030;;;CHEMBL4840866;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];CD-1;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in zymosan-induced CD-1 mouse peritonitis model assessed as reduction in zymosan-induced TNF-alpha level in peritoneal exudate at 3 mg/kg, ip treated with compound for 30 mins after 4 to 24 hrs zymosan stimulation by ELISA;CHEMBL4840316;Non-molecular target assigned;N;;1;CHEMBL375;;
1335420;;RAW264.7;CHEMBL4842526;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production measured after 24 hrs by Griess assay;CHEMBL4842317;Non-molecular target assigned;N;;1;CHEMBL612557;;
1335102;;RAW264.7;CHEMBL4842528;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production at 20 uM after 24 hrs by Griess assay;CHEMBL4842317;Non-molecular target assigned;N;;1;CHEMBL612557;;
1335110;;RAW264.7;CHEMBL4842536;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity against mouse RAW264.7 cells assessed as decrease in LPS-induced TNF-alpha mRNA expression at 20 uM in presence of LPS by qRT-PCR analysis;CHEMBL4842317;Non-molecular target assigned;N;;1;CHEMBL612557;;
1335445;;;CHEMBL4842556;[{'assay_class_id': 44, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ALIMENTARY TRACT AND METABOLISM', 'l2': 'Intestinal Function', 'l3': 'Experimental Colitis Inflammatory Gut Disease', 'source': 'Vogel_2008'}, {'assay_class_id': 124, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'BLOOD AND BLOOD FORMING ORGANS', 'l2': 'Hemostasis Bleeding Models', 'l3': 'General Bleeding Models', 'source': 'phenotype'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity against DSS-induced colitis C57BL/6 mouse model assessed as reduction in scores of stool consistency and bleeding at 20 mg/kg, ip administered for 7 days by immunohistochemistry analysis;CHEMBL4842317;Non-molecular target assigned;N;;1;CHEMBL375;;
1335448;;;CHEMBL4842558;[{'assay_class_id': 44, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ALIMENTARY TRACT AND METABOLISM', 'l2': 'Intestinal Function', 'l3': 'Experimental Colitis Inflammatory Gut Disease', 'source': 'Vogel_2008'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];C57BL/6;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity against DSS-induced colitis C57BL/6 mouse model assessed as dispersed CD86-positive cells in colon at 20 mg/kg, ip administered for 7 days by hematoxylin and eosin staining based microscopic analysis;CHEMBL4842317;Non-molecular target assigned;N;;1;CHEMBL375;;
1359338;;THP-1;CHEMBL5040065;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Anti-inflammatory activity against human THP-1 monocytes assessed as reduction in LPS-induced IL-6 release at 1 uM pretreated for 30 mins followed LPS stimulation and measured after 24 hrs by multiplex chemiluminescence detection method;CHEMBL5038597;Non-molecular target assigned;N;;1;CHEMBL614245;;
1359343;;THP-1;CHEMBL5040069;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Anti-inflammatory activity against human THP-1 monocytes assessed as reduction in LPS-induced IL-1beta release at 1 uM pretreated for 30 mins followed LPS stimulation and measured after 24 hrs by multiplex chemiluminescence detection method;CHEMBL5038597;Non-molecular target assigned;N;;1;CHEMBL614245;;
1359348;;THP-1;CHEMBL5040073;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Anti-inflammatory activity against human THP-1 monocytes assessed as reduction in LPS-induced IFNgamma release at 1 uM pretreated for 30 mins followed LPS stimulation and measured after 24 hrs by multiplex chemiluminescence detection method;CHEMBL5038597;Non-molecular target assigned;N;;1;CHEMBL614245;;
1359351;;THP-1;CHEMBL5040076;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Anti-inflammatory activity against human THP-1 monocytes assessed as fold increase in LPS-induced IL-8 release at 1 uM pretreated for 30 mins followed LPS stimulation and measured after 24 hrs by multiplex chemiluminescence detection method;CHEMBL5038597;Non-molecular target assigned;N;;1;CHEMBL614245;;
1359371;;THP-1;CHEMBL5040078;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Cytotoxicity against human THP-1 monocytes assessed as LDH release at 1 uM incubated for 24 hrs in absence of LPS by LDH assay;CHEMBL5038597;Non-molecular target assigned;N;;1;CHEMBL614245;;
1359376;;THP-1;CHEMBL5040082;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Cytoprotection against LPS-stimulated human THP-1 monocytes toxicity assessed as reduction LDH release at 1 uM incubated for 24 hrs by LDH assay;CHEMBL5038597;Non-molecular target assigned;N;;1;CHEMBL614245;;
1359419;;Neutrophil;CHEMBL5040090;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];C57BL/6J;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308052;Target assigned is non-molecular;1;Anti-inflammatory activity in zymosan-induced C57BL/6J mouse model of peritonitis assessed as reduced neutrophil influx at 11 mg/kg, ip treated 1 hr prior to zymosan administration (Rvb = 100 %);CHEMBL5038597;Non-molecular target assigned;N;;1;CHEMBL375;;
1359427;;;CHEMBL5040092;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];C57BL/6J;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Anti-inflammatory activity in zymosan-induced C57BL/6J mouse model of peritonitis assessed as change in polymorphonuclear cell count;CHEMBL5038597;Non-molecular target assigned;N;;1;CHEMBL375;;
1359429;;Monocyte;CHEMBL5040093;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];C57BL/6J;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308025;Target assigned is non-molecular;1;Anti-inflammatory activity in zymosan-induced C57BL/6J mouse model of peritonitis assessed as change in monocyte cell count;CHEMBL5038597;Non-molecular target assigned;N;;1;CHEMBL375;;
1359430;;;CHEMBL5040094;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];C57BL/6J;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Anti-inflammatory activity in zymosan-induced C57BL/6J mouse model of peritonitis assessed as change in macrophage cell count;CHEMBL5038597;Non-molecular target assigned;N;;1;CHEMBL375;;
1359436;;;CHEMBL5040096;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];C57BL/6J;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Anti-inflammatory activity in zymosan-induced C57BL/6J mouse model of peritonitis assessed as total number of polymorphonuclear cells at 1 mg/kg, ip treated 30 mins prior to zymosan administration and once again 1 hr after zymosan administration and measured 24 hrs post zymosan injection by flow cytometry analysis (Rvb = 4.7 +/- 0.5 x10^6 /ml);CHEMBL5038597;Non-molecular target assigned;N;;1;CHEMBL375;;
1359439;;;CHEMBL5040099;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];C57BL/6J;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Anti-inflammatory activity in zymosan-induced C57BL/6J mouse model of peritonitis assessed as maximal response at 1 mg/kg, ip treated 30 mins prior to zymosan administration and once again 1 hr after zymosan administration and measured 24 hrs post zymosan injection by flow cytometry analysis (Rvb = 100 %);CHEMBL5038597;Non-molecular target assigned;N;;1;CHEMBL375;;
1373922;;RAW264.7;CHEMBL5048029;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in mouse RAW 264.7 cells assessed as inhibition of LPS-induced nitric oxide production measured after 24 hrs by Griess reagent assay;CHEMBL5046258;Non-molecular target assigned;N;;1;CHEMBL612557;;
1366750;;;CHEMBL5052986;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in mouse model of LPS-induced acute lung injury assessed as reduction in total cell count in BALF at 5 mg/kg, ip administered immediately or 6 hrs after LPS stimulation;CHEMBL5052829;Non-molecular target assigned;N;;38;CHEMBL375;;
1366755;;;CHEMBL5052991;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in mouse model of LPS-induced acute lung injury assessed as reduction in BALF protein at 5 mg/kg, ip administered immediately or 6 hrs after LPS stimulation;CHEMBL5052829;Non-molecular target assigned;N;;38;CHEMBL375;;
1347097;;;CHEMBL5056273;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}, {'assay_class_id': 301, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'Paw Edema Test', 'source': 'Hock_2016'}];Mus musculus;[];Swiss Webster;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in Swiss Webster mouse model of complete freund's adjuvant-induced paw edema assessed as reduction in paw edema at 2 mg/kg, ip administered 40 mins before CFA injection by plethysmometer analysis;CHEMBL5055632;Non-molecular target assigned;N;;1;CHEMBL375;;
INCU_cv013_HEK293T;;HEK-293T;CHEMBL5058565;[];Homo sapiens;[];;;9606.0;In vitro;;T;Toxicity;BAO_0000219;cell-based format;CHEMBL3706569;Target assigned is non-molecular;1;Incucyte cell viability with HEK293T;CHEMBL5058564;Non-molecular target assigned;N;;55;CHEMBL3706568;;
INCU_cv014_U2OS;;U2OS;CHEMBL5058566;[];Homo sapiens;[];;;9606.0;In vitro;;T;Toxicity;BAO_0000219;cell-based format;CHEMBL3307757;Target assigned is non-molecular;1;Incucyte cell viability with U2OS;CHEMBL5058564;Non-molecular target assigned;N;;55;CHEMBL615023;;
INCU_cv015_human fibroblast;;Fibroblast;CHEMBL5058567;[];Homo sapiens;[];;;9606.0;In vitro;;T;Toxicity;BAO_0000219;cell-based format;CHEMBL4295351;Target assigned is non-molecular;1;Incucyte cell viability with human fibroblast;CHEMBL5058564;Non-molecular target assigned;N;;55;CHEMBL613838;;
INCU_cv016_HEK293T;;HEK-293T;CHEMBL5058568;[];Homo sapiens;[];;;9606.0;In vitro;;T;Toxicity;BAO_0000219;cell-based format;CHEMBL3706569;Target assigned is non-molecular;1;Incucyte cell viability with HEK293T;CHEMBL5058564;Non-molecular target assigned;N;;55;CHEMBL3706568;;
INCU_cv017_U2OS;;U2OS;CHEMBL5058569;[];Homo sapiens;[];;;9606.0;In vitro;;T;Toxicity;BAO_0000219;cell-based format;CHEMBL3307757;Target assigned is non-molecular;1;Incucyte cell viability with U2OS;CHEMBL5058564;Non-molecular target assigned;N;;55;CHEMBL615023;;
INCU_cv018_human fibroblast;;Fibroblast;CHEMBL5058570;[];Homo sapiens;[];;;9606.0;In vitro;;T;Toxicity;BAO_0000219;cell-based format;CHEMBL4295351;Target assigned is non-molecular;1;Incucyte cell viability with human fibroblast;CHEMBL5058564;Non-molecular target assigned;N;;55;CHEMBL613838;;
MULTI_CQ1-ctf022_HEK293T;;HEK-293T;CHEMBL5058578;[];Homo sapiens;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Number of replicates', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '1.0', 'text_value': None, 'type': 'Number of replicates', 'units': None, 'value': '1.0'}];;;9606.0;In vitro;;T;Toxicity;BAO_0000219;cell-based format;CHEMBL3706569;Target assigned is non-molecular;1;Multiplex assay against HEK293T;CHEMBL5058577;Non-molecular target assigned;N;;55;CHEMBL3706568;;
MULTI_CQ1-ctf023_U2OS;;U2OS;CHEMBL5058579;[];Homo sapiens;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Number of replicates', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '1.0', 'text_value': None, 'type': 'Number of replicates', 'units': None, 'value': '1.0'}];;;9606.0;In vitro;;T;Toxicity;BAO_0000219;cell-based format;CHEMBL3307757;Target assigned is non-molecular;1;Multiplex assay against U2OS;CHEMBL5058577;Non-molecular target assigned;N;;55;CHEMBL615023;;
MULTI_CQ1-ctf024_human fibroblast;;Fibroblast;CHEMBL5058580;[];Homo sapiens;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Number of replicates', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '1.0', 'text_value': None, 'type': 'Number of replicates', 'units': None, 'value': '1.0'}];;;9606.0;In vitro;;T;Toxicity;BAO_0000219;cell-based format;CHEMBL4295351;Target assigned is non-molecular;1;Multiplex assay against human fibroblast;CHEMBL5058577;Non-molecular target assigned;N;;55;CHEMBL613838;;
MULTI_CQ1-ctf025_HEK293T;;HEK-293T;CHEMBL5058581;[];Homo sapiens;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Number of replicates', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2.0', 'text_value': None, 'type': 'Number of replicates', 'units': None, 'value': '2.0'}];;;9606.0;In vitro;;T;Toxicity;BAO_0000219;cell-based format;CHEMBL3706569;Target assigned is non-molecular;1;Multiplex assay against HEK293T;CHEMBL5058577;Non-molecular target assigned;N;;55;CHEMBL3706568;;
MULTI_CQ1-ctf026_U2OS;;U2OS;CHEMBL5058582;[];Homo sapiens;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Number of replicates', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2.0', 'text_value': None, 'type': 'Number of replicates', 'units': None, 'value': '2.0'}];;;9606.0;In vitro;;T;Toxicity;BAO_0000219;cell-based format;CHEMBL3307757;Target assigned is non-molecular;1;Multiplex assay against U2OS;CHEMBL5058577;Non-molecular target assigned;N;;55;CHEMBL615023;;
MULTI_CQ1-ctf027_human fibroblast;;Fibroblast;CHEMBL5058583;[];Homo sapiens;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Number of replicates', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2.0', 'text_value': None, 'type': 'Number of replicates', 'units': None, 'value': '2.0'}];;;9606.0;In vitro;;T;Toxicity;BAO_0000219;cell-based format;CHEMBL4295351;Target assigned is non-molecular;1;Multiplex assay against human fibroblast;CHEMBL5058577;Non-molecular target assigned;N;;55;CHEMBL613838;;
TSA_ABL1A-pf002_127862;;;CHEMBL5060641;[];;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'MHHHHHHSSGVDLGTENLYFQSMSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGK', 'standard_type': 'Protein Sequences', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'MHHHHHHSSGVDLGTENLYFQSMSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGK', 'type': 'Protein Sequences', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'S229-K512', 'standard_type': 'Refseq Start/Stop', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'S229-K512', 'type': 'Refseq Start/Stop', 'units': None, 'value': None}];;;;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Thermal Shift Assay. Domain: start/stop: S229-K512;CHEMBL5060014;Homologous protein target assigned;H;;55;CHEMBL1862;;
TSA_BRD4A-pf005_128602;;;CHEMBL5061570;[];;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'MHHHHHHSSGVDLGTENLYFQSMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE', 'standard_type': 'Protein Sequences', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'MHHHHHHSSGVDLGTENLYFQSMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE', 'type': 'Protein Sequences', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'N44-E168', 'standard_type': 'Refseq Start/Stop', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'N44-E168', 'type': 'Refseq Start/Stop', 'units': None, 'value': None}];;;;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Thermal Shift Assay. Domain: start/stop: N44-E168;CHEMBL5060014;Homologous protein target assigned;H;;55;CHEMBL1163125;;
TSA_BRPF1B-pf001_128972;;;CHEMBL5062499;[];;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'MHHHHHHSSGVDLGTENLYFQSMEMQLTPFLILLRKTLEQLQEKDTGNIFSEPVPLSEVPDYLDHIKKPMDFFTMKQNLEAYRYLNFDDFEEDFNLIVSNCLKYNAKDTIFYRAAVRLREQGGAVLRQARRQAEKMG', 'standard_type': 'Protein Sequences', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'MHHHHHHSSGVDLGTENLYFQSMEMQLTPFLILLRKTLEQLQEKDTGNIFSEPVPLSEVPDYLDHIKKPMDFFTMKQNLEAYRYLNFDDFEEDFNLIVSNCLKYNAKDTIFYRAAVRLREQGGAVLRQARRQAEKMG', 'type': 'Protein Sequences', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'M626-G740', 'standard_type': 'Refseq Start/Stop', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'M626-G740', 'type': 'Refseq Start/Stop', 'units': None, 'value': None}];;;;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Thermal Shift Assay. Domain: start/stop: M626-G740;CHEMBL5060014;Homologous protein target assigned;H;;55;CHEMBL3132741;;
TSA_CDK2A-pf001_129342;;;CHEMBL5063428;[];;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'MHHHHHHSSGVDLGTENLYFQSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL', 'standard_type': 'Protein Sequences', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'MHHHHHHSSGVDLGTENLYFQSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL', 'type': 'Protein Sequences', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'M1-L298', 'standard_type': 'Refseq Start/Stop', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'M1-L298', 'type': 'Refseq Start/Stop', 'units': None, 'value': None}];;;;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Thermal Shift Assay. Domain: start/stop: M1-L298;CHEMBL5060014;Homologous protein target assigned;H;;55;CHEMBL301;;
TSA_CSNK1DA-pf001_129712;;;CHEMBL5064357;[];;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'MHHHHHHSSGVDLGTENLYFQSMMELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK', 'standard_type': 'Protein Sequences', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'MHHHHHHSSGVDLGTENLYFQSMMELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK', 'type': 'Protein Sequences', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'M1-K294', 'standard_type': 'Refseq Start/Stop', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'M1-K294', 'type': 'Refseq Start/Stop', 'units': None, 'value': None}];;;;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Thermal Shift Assay. Domain: start/stop: M1-K294;CHEMBL5060014;Homologous protein target assigned;H;;55;CHEMBL2828;;
TSA_FGFR3A-pf002_130082;;;CHEMBL5065286;[];;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'MHHHHHHSSGVDLGTENLYFQSMPTLANVSELELPADPKWELSRARLTLGKPLGEGCFGQVVMAEAIGIDKDRAAKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQGGPLYVLVEYAAKGNLREFLRARRPPGLDYSFDTSKPPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNLDYYKETTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHDLYMIMREXWHAAPSQRPTFKQLVEDLDRVLTVTSTDE', 'standard_type': 'Protein Sequences', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'MHHHHHHSSGVDLGTENLYFQSMPTLANVSELELPADPKWELSRARLTLGKPLGEGCFGQVVMAEAIGIDKDRAAKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQGGPLYVLVEYAAKGNLREFLRARRPPGLDYSFDTSKPPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNLDYYKETTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHDLYMIMREXWHAAPSQRPTFKQLVEDLDRVLTVTSTDE', 'type': 'Protein Sequences', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'P449-E759', 'standard_type': 'Refseq Start/Stop', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'P449-E759', 'type': 'Refseq Start/Stop', 'units': None, 'value': None}];;;;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Thermal Shift Assay. Domain: start/stop: P449-E759;CHEMBL5060014;Homologous protein target assigned;H;;55;CHEMBL2742;;
TSA_GSK3BB-pf002_130452;;;CHEMBL5066215;[];;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'MKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARAHHHHHH', 'standard_type': 'Protein Sequences', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'MKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARAHHHHHH', 'type': 'Protein Sequences', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'M26-R383', 'standard_type': 'Refseq Start/Stop', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'M26-R383', 'type': 'Refseq Start/Stop', 'units': None, 'value': None}];;;;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Thermal Shift Assay. Domain: start/stop: M26-R383;CHEMBL5060014;Homologous protein target assigned;H;;55;CHEMBL262;;
TSA_MAPK1A-pf002_130822;;;CHEMBL5067144;[];;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'MHHHHHHSSGVDLGTENLYFQSMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS', 'standard_type': 'Protein Sequences', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'MHHHHHHSSGVDLGTENLYFQSMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS', 'type': 'Protein Sequences', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'M1-S360', 'standard_type': 'Refseq Start/Stop', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'M1-S360', 'type': 'Refseq Start/Stop', 'units': None, 'value': None}];;;;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Thermal Shift Assay. Domain: start/stop: M1-S360;CHEMBL5060014;Homologous protein target assigned;H;;55;CHEMBL4040;;
TSA_STK6A-pf004_128232;;;CHEMBL5068073;[];;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'MKHHHHHHPMSDYDIPTTENLYFQGAMESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS', 'standard_type': 'Protein Sequences', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'MKHHHHHHPMSDYDIPTTENLYFQGAMESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS', 'type': 'Protein Sequences', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'E122-S403', 'standard_type': 'Refseq Start/Stop', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'E122-S403', 'type': 'Refseq Start/Stop', 'units': None, 'value': None}];;;;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Thermal Shift Assay. Domain: start/stop: E122-S403;CHEMBL5060014;Homologous protein target assigned;H;;55;CHEMBL4722;;
TSA_TIF1A-pf001_131192;;;CHEMBL5069002;[];;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'MHHHHHHHHHHSSGVDLGTENLYFQSMGLVKLTPIDKRKCERLLLFLYCHEMSLAFQDPVPLTVPDYYKIIKNPMDLSTIKKRLQEDYSMYSKPEDFVADFRLIFQNCAEFNEPDSEVANAGIKLENYFEELLKNLYPEKRFPKPE', 'standard_type': 'Protein Sequences', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'MHHHHHHHHHHSSGVDLGTENLYFQSMGLVKLTPIDKRKCERLLLFLYCHEMSLAFQDPVPLTVPDYYKIIKNPMDLSTIKKRLQEDYSMYSKPEDFVADFRLIFQNCAEFNEPDSEVANAGIKLENYFEELLKNLYPEKRFPKPE', 'type': 'Protein Sequences', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'G861-E979', 'standard_type': 'Refseq Start/Stop', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'G861-E979', 'type': 'Refseq Start/Stop', 'units': None, 'value': None}];;;;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Thermal Shift Assay. Domain: start/stop: G861-E979;CHEMBL5060014;Homologous protein target assigned;H;;55;CHEMBL3108638;;
1440504;;;CHEMBL5097192;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}, {'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in LPS induced mouse model assessed as reduction in tumor necrosis factor alpha level in plasma at 1 mg/kg, po preincubated for 1 hr followed by LPS stimulation and measured after 2 hrs by ELISA method relative to control;CHEMBL5096164;Non-molecular target assigned;N;;1;CHEMBL375;;
1440505;;;CHEMBL5097193;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in LPS induced mouse model assessed as reduction in IL-6 level in plasma at 1 mg/kg, po preincubated for 1 hr followed by LPS stimulation and measured after 2 hrs by ELISA method relative to control;CHEMBL5096164;Non-molecular target assigned;N;;1;CHEMBL375;;
1442836;;;CHEMBL5098459;[];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Toxicity in Sprague-Dawley rat assessed as body weight loss at 125 ug, IA measured upto 16 days;CHEMBL5096198;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
1442855;;;CHEMBL5098462;[];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiarthritic activity against MIA-induced Sprague-Dawley rat OA model assessed as reduction in articular cartilage damage at 125, IA measured for 16 days;CHEMBL5096198;Non-molecular target assigned;N;;1;CHEMBL376;;
1442856;;;CHEMBL5098463;[];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiarthritic activity against MIA-induced Sprague-Dawley rat OA model assessed as restoration of chondrocytes and proteoglycan in the cartilage at 125, IA measured for 16 days;CHEMBL5096198;Non-molecular target assigned;N;;1;CHEMBL376;;
1442863;;Osteoclast;CHEMBL5098466;[];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307971;Target assigned is non-molecular;1;Antiarthritic activity against MIA-induced Sprague-Dawley rat OA model assessed as reduction in formation of TRAP positive osteoclast at 125, IA measured for 16 days;CHEMBL5096198;Non-molecular target assigned;N;;1;CHEMBL376;;
1435372;;RAW264.7;CHEMBL5109052;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Inhibition of NO release in mouse RAW264.7 incubated for 15 mins by fluoroscence-luminescence reader infinite M200 Pro analysis;CHEMBL5107966;Non-molecular target assigned;N;;1;CHEMBL612557;;
1435375;;RAW264.7;CHEMBL5109053;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Cytotoxicity against mouse RAW264.7 by WST-1 vital dye reagent method;CHEMBL5107966;Non-molecular target assigned;N;;1;CHEMBL612557;;
1432196;;PBMC;CHEMBL5109350;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308021;Default value - Target unknown or has yet to be assigned;0;Inhibition of TNF-alpha production in LPS-stimulated human PBMC measured after 24 hrs by ELISA;CHEMBL5107987;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1436145;;;CHEMBL5110872;[];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Protection against cecal ligation-induced Sprague-Dawley rat sepsis associated acute lung injury model assessed as reduction in lung injury at 50 mg/kg, ip and measured after 24 hrs by H and E staining based analysis;CHEMBL5108033;Non-molecular target assigned;N;;1;CHEMBL376;;
1436147;;;CHEMBL5110873;[];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Protection against cecal ligation-induced Sprague-Dawley rat sepsis associated acute lung injury model assessed as reduction in serum IL-1beta at 50 mg/kg, ip and measured after 24 hrs by ELISA;CHEMBL5108033;Non-molecular target assigned;N;;1;CHEMBL376;;
1436148;;;CHEMBL5110874;[];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Protection against cecal ligation-induced Sprague-Dawley rat sepsis associated acute lung injury model assessed as reduction in serum TNF-alpha at 50 mg/kg, ip and measured after 24 hrs by ELISA;CHEMBL5108033;Non-molecular target assigned;N;;1;CHEMBL376;;
1436149;;;CHEMBL5110875;[];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Protection against cecal ligation-induced Sprague-Dawley rat sepsis associated acute lung injury model assessed as reduction in serum IL-6 at 50 mg/kg, ip and measured after 24 hrs by ELISA;CHEMBL5108033;Non-molecular target assigned;N;;1;CHEMBL376;;
1436151;;;CHEMBL5110876;[];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Protection against cecal ligation-induced Sprague-Dawley rat sepsis associated acute lung injury model assessed as reduction in total cell number in BALF at 50 mg/kg, ip and measured after 24 hrs by cell counter analysis;CHEMBL5108033;Non-molecular target assigned;N;;1;CHEMBL376;;
1436152;;Neutrophil;CHEMBL5110877;[];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308052;Target assigned is non-molecular;1;Protection against cecal ligation-induced Sprague-Dawley rat sepsis associated acute lung injury model assessed as reduction in neutrophil number in BALF at 50 mg/kg, ip and measured after 24 hrs by cell counter analysis;CHEMBL5108033;Non-molecular target assigned;N;;1;CHEMBL376;;
1436153;;Neutrophil;CHEMBL5110878;[];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308052;Target assigned is non-molecular;1;Protection against cecal ligation-induced Sprague-Dawley rat sepsis associated acute lung injury model assessed as reduction in neutrophil elastase activity in BALF at 50 mg/kg, ip and measured after 24 hrs by Elastase assay;CHEMBL5108033;Non-molecular target assigned;N;;1;CHEMBL376;;
1436154;;;CHEMBL5110879;[];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Protection against cecal ligation-induced Sprague-Dawley rat sepsis associated acute lung injury model assessed as reduction in lung wet weight to dry weight ratio at 50 mg/kg, ip and measured after 24 hrs;CHEMBL5108033;Non-molecular target assigned;N;;1;CHEMBL376;;
1436156;;;CHEMBL5110880;[];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Protection against cecal ligation-induced Sprague-Dawley rat sepsis associated acute lung injury model assessed as reduction in lung water content at 50 mg/kg, ip and measured after 24 hrs;CHEMBL5108033;Non-molecular target assigned;N;;1;CHEMBL376;;
1436157;;;CHEMBL5110881;[];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Protection against cecal ligation-induced Sprague-Dawley rat sepsis associated acute lung injury model assessed as reduction in albumin content in alveolar lavage fluid supernatant at 50 mg/kg, ip and measured after 24 hrs;CHEMBL5108033;Non-molecular target assigned;N;;1;CHEMBL376;;
1436163;;;CHEMBL5110882;[];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Protection against cecal ligation-induced Sprague-Dawley rat sepsis associated acute lung injury model assessed as upregulation of cecal ligation inhibited PPP1R15A at 50 mg/kg, ip and measured after 24 hrs;CHEMBL5108033;Non-molecular target assigned;N;;1;CHEMBL376;;
1436165;;;CHEMBL5110883;[];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Protection against cecal ligation-induced Sprague-Dawley rat sepsis associated acute lung injury model assessed as downregulation of cecal ligation induced phosphorylated eIF-2alpha level at 50 mg/kg, ip and measured after 24 hrs;CHEMBL5108033;Non-molecular target assigned;N;;1;CHEMBL376;;
1436169;;;CHEMBL5110884;[];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Protection against cecal ligation-induced Sprague-Dawley rat sepsis associated acute lung injury model assessed as downregulation of cecal ligation induced GRP78 level at 50 mg/kg, ip and measured after 24 hrs;CHEMBL5108033;Non-molecular target assigned;N;;1;CHEMBL376;;
1436170;;;CHEMBL5110885;[];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Protection against cecal ligation-induced Sprague-Dawley rat sepsis associated acute lung injury model assessed as downregulation of cecal ligation induced ATF4 level at 50 mg/kg, ip and measured after 24 hrs;CHEMBL5108033;Non-molecular target assigned;N;;1;CHEMBL376;;
1436171;;;CHEMBL5110886;[];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Protection against cecal ligation-induced Sprague-Dawley rat sepsis associated acute lung injury model assessed as downregulation of cecal ligation induced CHOP level at 50 mg/kg, ip and measured after 24 hrs;CHEMBL5108033;Non-molecular target assigned;N;;1;CHEMBL376;;
1409300;;RAW264.7;CHEMBL5123331;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Anti-inflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production at 25 uM incubated for 16 hrs by Greiss reagent assay;CHEMBL5120844;Non-molecular target assigned;N;;1;CHEMBL612557;;
1409437;;A549;CHEMBL5123337;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Induction of glucocorticoid receptor nuclear translocation in human A549 cells incubated for 2 hrs by confocal microscopic analysis;CHEMBL5120844;Direct protein target assigned;D;;1;CHEMBL2034;;
1409467;;A549;CHEMBL5123338;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Anti-inflammatory activity against human A549 cells assessed as reduction in TNFalpha induced IL-1beta mRNA expression level by qRT-PCR analysis;CHEMBL5120844;Non-molecular target assigned;N;;1;CHEMBL392;;
1409485;;PC-3;CHEMBL5123340;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at progesterone receptor (unknown origin) expressed in PC3 cells co-transfected with ARR3tk-luciferase/Renilla at 10 to 25 uM incubated for 16 hrs by luciferase reporter gene assay;CHEMBL5120844;Direct protein target assigned;D;;1;CHEMBL208;;
1409491;;HEK293T;CHEMBL5123341;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at mineralocorticoid receptor (unknown origin) expressed in HEK293T cells co-transfected with pGL4.36[luc2P MMTV Hygro]/Renilla at 10 to 25 uM incubated for 16 hrs by luciferase reporter gene assay;CHEMBL5120844;Direct protein target assigned;D;;1;CHEMBL1994;;
1409537;;MG-63;CHEMBL5123342;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308498;Default value - Target unknown or has yet to be assigned;0;Induction of osteoporosis in human MG-63 cells assessed as decrease in OPG mRNA expression level at 10 uM by qRT-PCR analysis;CHEMBL5120844;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1409538;;MG-63;CHEMBL5123343;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308498;Default value - Target unknown or has yet to be assigned;0;Induction of osteoporosis in human MG-63 cells assessed as decrease in RANKL mRNA expression level at 10 uM by qRT-PCR analysis;CHEMBL5120844;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1409546;;RAW264.7;CHEMBL5123346;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Anti-inflammatory activity against mouse RAW264.7 cells assessed as reduction in LPS-induced IL-1beta mRNA expression level preincubated for 1 hr followed by LPS addition and measured after 16 hrs by qRT-PCR analysis;CHEMBL5120844;Non-molecular target assigned;N;;1;CHEMBL612557;;
1409549;;RAW264.7;CHEMBL5123349;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Anti-inflammatory activity against mouse RAW264.7 cells assessed as reduction in LPS-induced GLIZ mRNA expression level preincubated for 1 hr followed by LPS addition and measured after 16 hrs by qRT-PCR analysis;CHEMBL5120844;Non-molecular target assigned;N;;1;CHEMBL612557;;
1404060;;;CHEMBL5124338;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];ICR;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-induced ICR sepsis mouse model assessed as attenuation of LPS-induced inflammatory cell infiltration at 5 mg/kg, ip pretreated with compound for 5 days followed by LPS stimulation and measured 2 hrs post last dose by hematoxylin and eosin staining based microscopic analysis;CHEMBL5120875;Non-molecular target assigned;N;;1;CHEMBL375;;
1404061;;;CHEMBL5124339;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];ICR;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in LPS-induced ICR sepsis mouse model assessed as attenuation of LPS-induced lung damage at 5 mg/kg, ip pretreated with compound for 5 days followed by LPS stimulation and measured 2 hrs post last dose by hematoxylin and eosin staining based microscopic analysis;CHEMBL5120875;Non-molecular target assigned;N;;1;CHEMBL375;;
1405002;;RAW264.7;CHEMBL5124785;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Anti-inflammartory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production at 50 uM pretreated with compound for 1 hr followed by incubation with LPS for 12 hrs by Griess reagent based analysis;CHEMBL5120901;Non-molecular target assigned;N;;1;CHEMBL612557;;
1405003;;RAW264.7;CHEMBL5124786;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Anti-inflammartory activity against LPS-activated mouse RAW264.7 cells assessed as reduction in TNF-alpha levels at 50 uM pretreated with compound for 1 hr followed by incubation with LPS for 12 hrs by ELISA;CHEMBL5120901;Non-molecular target assigned;N;;1;CHEMBL612557;;
1405004;;RAW264.7;CHEMBL5124787;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Anti-inflammartory activity against LPS-activated mouse RAW264.7 cells assessed as reduction in IL-6 levels at 50 uM pretreated with compound for 1 hr followed by incubation with LPS for 12 hrs by ELISA;CHEMBL5120901;Non-molecular target assigned;N;;1;CHEMBL612557;;
1404552;;INS-1 832/13;CHEMBL5126488;[];Rattus norvegicus;[];;;10116.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at glucocorticoid receptor in rat INS-1 832/13 cells transfected with CCL2-promoter luciferase plasmid construct assessed as reduction in IL-1 beta induced inflammation by luciferase reporter gene assay;CHEMBL5120980;Direct protein target assigned;D;;1;CHEMBL3368;;
1404554;;INS-1 832/13;CHEMBL5126489;[];Rattus norvegicus;[];;;10116.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at glucocorticoid receptor in rat INS-1 832/13 cells transfected with CCL2-promoter luciferase plasmid construct assessed as maximum efficacy by luciferase reporter gene assay;CHEMBL5120980;Direct protein target assigned;D;;1;CHEMBL3368;;
1404556;;INS-1 832/13;CHEMBL5126491;[];Rattus norvegicus;[];;;10116.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at glucocorticoid receptor in rat INS-1 832/13 cells transfected with CCL2-promoter luciferase plasmid construct assessed as reduction in IL-1 beta induced inflammation by luciferase reporter gene assay relative to hydrocortisone;CHEMBL5120980;Direct protein target assigned;D;;1;CHEMBL3368;;
1404557;;INS-1 832/13;CHEMBL5126492;[];Rattus norvegicus;[];;;10116.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at glucocorticoid receptor in rat INS-1 832/13 cells transfected with 3XGRE-promoter luciferase plasmid construct assessed as induction of receptor transactivation by luciferase reporter gene assay;CHEMBL5120980;Direct protein target assigned;D;;1;CHEMBL3368;;
1404558;;INS-1 832/13;CHEMBL5126493;[];Rattus norvegicus;[];;;10116.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at glucocorticoid receptor in rat INS-1 832/13 cells transfected with 3XGRE-promoter luciferase plasmid construct assessed as maximum efficacy by luciferase reporter gene assay;CHEMBL5120980;Direct protein target assigned;D;;1;CHEMBL3368;;
1404560;;INS-1 832/13;CHEMBL5126495;[];Rattus norvegicus;[];;;10116.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at glucocorticoid receptor in rat INS-1 832/13 cells transfected with 3XGRE-promoter luciferase plasmid construct assessed as induction of receptor transactivation by luciferase reporter gene assay relative to hydrocortisone;CHEMBL5120980;Direct protein target assigned;D;;1;CHEMBL3368;;
1419730;;RAW264.7;CHEMBL5130483;[];Mus musculus;[];;;10090.0;;;T;Toxicity;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Cytotoxicity in LPS-stimulated mouse RAW264.7 cells assessed as reduction in cell viability incubated for 72 hrs by alamar blue dye based colorimetric assay;CHEMBL5126624;Non-molecular target assigned;N;;1;CHEMBL612557;;
1419732;;RAW264.7;CHEMBL5130484;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in mouse RAW264.7 cells assessed as decrease in IFN-gamma and LPS-induced nitric oxide production after 24 hrs by ELISA;CHEMBL5126624;Non-molecular target assigned;N;;1;CHEMBL612557;;
1419754;;RAW264.7;CHEMBL5130489;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity in mouse RAW264.7 cells assessed as decrease in IFN-gamma and LPS-induced IL-1beta production by measuring IL-1beta level at 10 uM after 24 hrs by ELISA (Rvb = 73.3 +/- 1.8 pg/mg);CHEMBL5126624;Non-molecular target assigned;N;;1;CHEMBL612557;;
1399588;;CHO-K1;CHEMBL5149355;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Agonist activity at human GR expressed in CHO-K1 cells by PathHunter assay;CHEMBL5143733;Direct protein target assigned;D;;1;CHEMBL2034;;
1447966;;;CHEMBL5153179;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];ICR;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in ICR mouse model of LPS-induced acute peritonitis assessed as reduction in IL-6 level in peritoneal fluid at 5 mg/kg, ip pretreated for 1 hr followed by LPS stimulation and measured after 6 hrs by qRT-PCR analysis;CHEMBL5150046;Non-molecular target assigned;N;;1;CHEMBL375;;
1447967;;;CHEMBL5153180;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];ICR;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in ICR mouse model of LPS-induced acute peritonitis assessed as reduction in IL-1beta level in peritoneal fluid at 5 mg/kg, ip pretreated for 1 hr followed by LPS stimulation and measured after 6 hrs by qRT-PCR analysis;CHEMBL5150046;Non-molecular target assigned;N;;1;CHEMBL375;;
1447968;;;CHEMBL5153181;[{'assay_class_id': 296, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'MUSCULO-SKELETAL SYSTEM', 'l2': 'Anti-Inflammatory Activity', 'l3': 'General Anti-Inflammatory Models', 'source': 'phenotype'}];Mus musculus;[];ICR;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiinflammatory activity in ICR mouse model of LPS-induced acute peritonitis assessed as reduction in TNF-alpha level in peritoneal fluid at 5 mg/kg, ip pretreated for 1 hr followed by LPS stimulation and measured after 6 hrs by qRT-PCR analysis;CHEMBL5150046;Non-molecular target assigned;N;;1;CHEMBL375;;
1390076;;RAW264.7;CHEMBL5157857;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307977;Target assigned is non-molecular;1;Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production preincubated for 3 hrs followed by LPS stimulation and measured after 24 hrs by Griess reagent based assay;CHEMBL5154706;Non-molecular target assigned;N;;1;CHEMBL612557;;
GPCR_ADGRF1_1;;;CHEMBL5209802;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;GPCR beta-arrestin recruitment assay with target: ADGRF1 Assay Type: PRESTO-Tango Concentration: 0.00001;CHEMBL5209801;Direct protein target assigned;D;;55;CHEMBL4523872;;
GPCR_ADGRF1_2;;;CHEMBL5209803;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;GPCR beta-arrestin recruitment assay with target: ADGRF1 Assay Type: PRESTO-Tango Concentration: 0.000002;CHEMBL5209801;Direct protein target assigned;D;;55;CHEMBL4523872;;
GPCR_ADGRF1_4;;;CHEMBL5209804;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;GPCR beta-arrestin recruitment assay with target: ADGRF1 Assay Type: PRESTO-Tango Concentration: 0.0000004;CHEMBL5209801;Direct protein target assigned;D;;55;CHEMBL4523872;;
GPCR_ADRA2A_1;;;CHEMBL5209805;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;GPCR beta-arrestin recruitment assay with target: ADRA2A Assay Type: PRESTO-Tango Concentration: 0.00001;CHEMBL5209801;Direct protein target assigned;D;;55;CHEMBL1867;;
GPCR_ADRA2A_2;;;CHEMBL5209806;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;GPCR beta-arrestin recruitment assay with target: ADRA2A Assay Type: PRESTO-Tango Concentration: 0.000002;CHEMBL5209801;Direct protein target assigned;D;;55;CHEMBL1867;;
GPCR_ADRA2A_4;;;CHEMBL5209807;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;GPCR beta-arrestin recruitment assay with target: ADRA2A Assay Type: PRESTO-Tango Concentration: 0.0000004;CHEMBL5209801;Direct protein target assigned;D;;55;CHEMBL1867;;
GPCR_ADRB2_1;;;CHEMBL5209808;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;GPCR beta-arrestin recruitment assay with target: ADRB2 Assay Type: PRESTO-Tango Concentration: 0.00001;CHEMBL5209801;Direct protein target assigned;D;;55;CHEMBL210;;
GPCR_ADRB2_2;;;CHEMBL5209809;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;GPCR beta-arrestin recruitment assay with target: ADRB2 Assay Type: PRESTO-Tango Concentration: 0.000002;CHEMBL5209801;Direct protein target assigned;D;;55;CHEMBL210;;
GPCR_ADRB2_4;;;CHEMBL5209810;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;GPCR beta-arrestin recruitment assay with target: ADRB2 Assay Type: PRESTO-Tango Concentration: 0.0000004;CHEMBL5209801;Direct protein target assigned;D;;55;CHEMBL210;;
GPCR_AGTR1_1;;;CHEMBL5209811;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;GPCR beta-arrestin recruitment assay with target: AGTR1 Assay Type: PRESTO-Tango Concentration: 0.00001;CHEMBL5209801;Direct protein target assigned;D;;55;CHEMBL227;;
GPCR_AGTR1_2;;;CHEMBL5209812;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;GPCR beta-arrestin recruitment assay with target: AGTR1 Assay Type: PRESTO-Tango Concentration: 0.000002;CHEMBL5209801;Direct protein target assigned;D;;55;CHEMBL227;;
GPCR_AGTR1_4;;;CHEMBL5209813;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;GPCR beta-arrestin recruitment assay with target: AGTR1 Assay Type: PRESTO-Tango Concentration: 0.0000004;CHEMBL5209801;Direct protein target assigned;D;;55;CHEMBL227;;
GPCR_APLNR_1;;;CHEMBL5209814;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;GPCR beta-arrestin recruitment assay with target: APLNR Assay Type: PRESTO-Tango Concentration: 0.00001;CHEMBL5209801;Direct protein target assigned;D;;55;CHEMBL1628481;;
GPCR_APLNR_2;;;CHEMBL5209815;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;GPCR beta-arrestin recruitment assay with target: APLNR Assay Type: PRESTO-Tango Concentration: 0.000002;CHEMBL5209801;Direct protein target assigned;D;;55;CHEMBL1628481;;
GPCR_APLNR_4;;;CHEMBL5209816;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;GPCR beta-arrestin recruitment assay with target: APLNR Assay Type: PRESTO-Tango Concentration: 0.0000004;CHEMBL5209801;Direct protein target assigned;D;;55;CHEMBL1628481;;
GPCR_C5AR1_1;;;CHEMBL5209817;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;GPCR beta-arrestin recruitment assay with target: C5AR1 Assay Type: PRESTO-Tango Concentration: 0.00001;CHEMBL5209801;Direct protein target assigned;D;;55;CHEMBL2373;;
GPCR_C5AR1_2;;;CHEMBL5209818;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;GPCR beta-arrestin recruitment assay with target: C5AR1 Assay Type: PRESTO-Tango Concentration: 0.000002;CHEMBL5209801;Direct protein target assigned;D;;55;CHEMBL2373;;
GPCR_C5AR1_4;;;CHEMBL5209819;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;GPCR beta-arrestin recruitment assay with target: C5AR1 Assay Type: PRESTO-Tango Concentration: 0.0000004;CHEMBL5209801;Direct protein target assigned;D;;55;CHEMBL2373;;
GPCR_CX3CR1_1;;;CHEMBL5209820;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;GPCR beta-arrestin recruitment assay with target: CX3CR1 Assay Type: PRESTO-Tango Concentration: 0.00001;CHEMBL5209801;Direct protein target assigned;D;;55;CHEMBL4843;;
GPCR_CX3CR1_2;;;CHEMBL5209821;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;GPCR beta-arrestin recruitment assay with target: CX3CR1 Assay Type: PRESTO-Tango Concentration: 0.000002;CHEMBL5209801;Direct protein target assigned;D;;55;CHEMBL4843;;
GPCR_CX3CR1_4;;;CHEMBL5209822;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;GPCR beta-arrestin recruitment assay with target: CX3CR1 Assay Type: PRESTO-Tango Concentration: 0.0000004;CHEMBL5209801;Direct protein target assigned;D;;55;CHEMBL4843;;
GPCR_FFAR4_1;;;CHEMBL5209823;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;GPCR beta-arrestin recruitment assay with target: FFAR4 Assay Type: PRESTO-Tango Concentration: 0.00001;CHEMBL5209801;Direct protein target assigned;D;;55;CHEMBL5339;;
GPCR_FFAR4_2;;;CHEMBL5209824;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;GPCR beta-arrestin recruitment assay with target: FFAR4 Assay Type: PRESTO-Tango Concentration: 0.000002;CHEMBL5209801;Direct protein target assigned;D;;55;CHEMBL5339;;
GPCR_FFAR4_4;;;CHEMBL5209825;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;GPCR beta-arrestin recruitment assay with target: FFAR4 Assay Type: PRESTO-Tango Concentration: 0.0000004;CHEMBL5209801;Direct protein target assigned;D;;55;CHEMBL5339;;
GPCR_FPR2_1;;;CHEMBL5209826;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;GPCR beta-arrestin recruitment assay with target: FPR2 Assay Type: PRESTO-Tango Concentration: 0.00001;CHEMBL5209801;Direct protein target assigned;D;;55;CHEMBL4227;;
GPCR_FPR2_2;;;CHEMBL5209827;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;GPCR beta-arrestin recruitment assay with target: FPR2 Assay Type: PRESTO-Tango Concentration: 0.000002;CHEMBL5209801;Direct protein target assigned;D;;55;CHEMBL4227;;
GPCR_FPR2_4;;;CHEMBL5209828;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;GPCR beta-arrestin recruitment assay with target: FPR2 Assay Type: PRESTO-Tango Concentration: 0.0000004;CHEMBL5209801;Direct protein target assigned;D;;55;CHEMBL4227;;
GPCR_GLP1R_1;;;CHEMBL5209829;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;GPCR beta-arrestin recruitment assay with target: GLP1R Assay Type: PRESTO-Tango Concentration: 0.00001;CHEMBL5209801;Direct protein target assigned;D;;55;CHEMBL1784;;
GPCR_GLP1R_2;;;CHEMBL5209830;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;GPCR beta-arrestin recruitment assay with target: GLP1R Assay Type: PRESTO-Tango Concentration: 0.000002;CHEMBL5209801;Direct protein target assigned;D;;55;CHEMBL1784;;
GPCR_GLP1R_4;;;CHEMBL5209831;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;GPCR beta-arrestin recruitment assay with target: GLP1R Assay Type: PRESTO-Tango Concentration: 0.0000004;CHEMBL5209801;Direct protein target assigned;D;;55;CHEMBL1784;;
GPCR_GPR119_1;;;CHEMBL5209832;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;GPCR beta-arrestin recruitment assay with target: GPR119 Assay Type: PRESTO-Tango Concentration: 0.00001;CHEMBL5209801;Direct protein target assigned;D;;55;CHEMBL5652;;
GPCR_GPR119_2;;;CHEMBL5209833;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;GPCR beta-arrestin recruitment assay with target: GPR119 Assay Type: PRESTO-Tango Concentration: 0.000002;CHEMBL5209801;Direct protein target assigned;D;;55;CHEMBL5652;;
GPCR_GPR119_4;;;CHEMBL5209834;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;GPCR beta-arrestin recruitment assay with target: GPR119 Assay Type: PRESTO-Tango Concentration: 0.0000004;CHEMBL5209801;Direct protein target assigned;D;;55;CHEMBL5652;;
GPCR_GPR35_1;;;CHEMBL5209835;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;GPCR beta-arrestin recruitment assay with target: GPR35 Assay Type: PRESTO-Tango Concentration: 0.00001;CHEMBL5209801;Direct protein target assigned;D;;55;CHEMBL1293267;;
GPCR_S1PR1_1;;;CHEMBL5209836;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;GPCR beta-arrestin recruitment assay with target: S1PR1 Assay Type: PRESTO-Tango Concentration: 0.00001;CHEMBL5209801;Direct protein target assigned;D;;55;CHEMBL4333;;
GPCR_S1PR1_2;;;CHEMBL5209837;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;GPCR beta-arrestin recruitment assay with target: S1PR1 Assay Type: PRESTO-Tango Concentration: 0.000002;CHEMBL5209801;Direct protein target assigned;D;;55;CHEMBL4333;;
GPCR_S1PR1_4;;;CHEMBL5209838;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;GPCR beta-arrestin recruitment assay with target: S1PR1 Assay Type: PRESTO-Tango Concentration: 0.0000004;CHEMBL5209801;Direct protein target assigned;D;;55;CHEMBL4333;;
